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Abstract
The focus of this thesis is to develop new methods towards the synthesis of nitrogen-
containing heterocycles. Chapter one contains a brief introduction into previous work by 
the Dobbs group, involving the optimisation of the silyl-Prins reaction and aza-silyl-Prins 
reaction, which afford substituted dihydropyrans and tetrahydropyridines respectively.
Chapter two initially provides a literature overview towards the synthesis of piperidines 
using  this  methodology.  Following  this,  our  results  demonstrate  that  using  different 
substitution  patterns  in  the  homoallylic  amine  precursors  has  quite  a  significant 
regiochemical effect on the reaction. These effects include the formation of pyrrolidine 
structures, which can be isolated and characterised. 
Chapter three presents the utilization of the previously optimised silyl-Prins and aza-silyl-
Prins  reaction  to  obtain  oxa-  and  aza-cycles containing  a  trifluoromethyl group,  a 
functionality known to have significant effects on the lipophilicity of drug molecules. 
Next in chapter four, again the advantages of using the aza-silyl-Prins reaction to obtain 
high functionality in a  simple coupling reaction are presented, with the formation of 
pipecolate and pipecolic acid analogues. Chapter five includes attempts to use the aza-
silyl-Prins to form tetrasubstituted tetrahydropyridines using precedent from studies in the 
silyl-Prins reaction.  However,  although  the  similarities  between  these  two  coupling 
reactions are obvious, the differences in heteroatom in the substrates and products have a 
significant effect. Following previous attempts in the group to form nitrogen heterocycles 
in high enantiopurity with little success, chapter six discusses the optimisation of a new 
Lewis  acid  mediated  imine-vinylsilane  cyclisation  reaction.  The  formation  of  2-
substituted free amine tetrahydropyridines was successful for racemic examples, but the 
studies into utilising this methodology towards an asymmetric synthesis are yet to be 
finalised. Finally, chapter seven investigates the use of the aza-silyl-Prins reaction into 
forming more complex natural products such as cannabisativine.
Part of this work has been published in: 
1) A.P.Dobbs, R.J.Parker, J.Skidmore, Tetrahedron Letters, 2008, 49, 827-831. 
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Introduction
Research into novel  routes  for the synthesis  of  nitrogen-containing heterocycles is  a 
common interest  amongst  organic  chemists,  mostly  due  to  their  presence in  natural 
products such as piperidine alkaloids. Much success has been founded in producing the 
related oxygen-containing tetrahydropyrans via a Prins type cyclisation. It has long been 
an objective of synthetic  chemists  to  develop a  nitrogen or aza version of the Prins 
reaction. Work within our group has successfully investigated the silyl-Prins and the aza-
silyl-Prins reactions, to  afford dihydropyrans and tetrahydropyridines respectively,  by 
coupling of silylated homo-allylic compounds and aldehydes in the presence of a Lewis 
acid catalyst (Scheme 1).
XH
R1
XR1 R2
R2CHO, Lewis acid
X = O, silyl-Prins reaction; 
X = NR, aza-silyl-Prins reaction
TMS
Scheme 1. General scheme of silyl-Prins methodology.
The terminal vinylsilane is vital not only for forming the olefin function but also for 
stabilisation of a cationic intermediate, therefore raising doubt when considering whether 
an aza-Prins reaction could be successful without the silicon function. It has been found 
that  the  vinylsilane  is  not  essential  in  the  oxygen  series,  for  example,  affording 
tetrahydropyrans  via a  Prins type cyclisation,  which couples homoallylic  alcohols  to 
aldehydes using Lewis acids. Although mechanistically the Prins and aza-Prins reactions 
are potentially  analogous, the difference in heteroatoms could alter the reaction rates 
significantly. 
Piperidine synthesis has already been achieved within our group, using the aza-silyl-Prins 
reaction towards the total synthesis of (-)-solenopsin A (Scheme 2). 
N
H 10
(±)-solenopsin A
N
Bn 10TMS
N
H
Ph
a b
Scheme  2.  Reagents  and  conditions:  (a)  C11H23CHO,  InCl3,  CH3CN,  reflux,  14h,  69%; (b)  H2, 
Pd(OH)2/C, EtOH, rt, 4 h, quant.
Use  of  the  aza-silyl-Prins  reaction  afforded  exclusively  the  trans-2,6-disubstituted 
tetrahydropyridine and subsequent hydrogenation of the olefin function with simultaneous 
removal of the protecting group gave the racemic piperidine alkaloid. 
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Studies  on  the  formation  of  heterocycles  in  the  group  began  by  synthesizing 
dihydropyrans, using (Z)-trimethylsilyl homoallylic alcohols and commercially available 
aldehydes as precursors, via the silyl-Prins reaction. In order to avoid complex mixtures 
of products using Brønsted acids as promoters, Lewis acids were proposed and screened. 
Indium trichloride with DCM as solvent at room temperature was found to be optimal, 
initially giving simple 2-substituted tetrahydropyrans in high yields. This particular Lewis 
acid has benefits in that it is crystalline, easy to handle and reasonably moisture tolerant. 
Studies progressed to produce 2,6-disubstituted dihydropyrans also in high yields with 
exclusive cis stereochemistry observed across the oxygen (Figure 3). Similar precursors 
and  conditions  became  transferable to  the  analogous  nitrogen  based  aza-silyl-Prins 
reaction. This  reaction progresses  via a  vinylsilane-iminium ion cyclisation using  N-
alkylated  (Z)-silylated  homoallylic  amines.  Again  monosubstituted  and  disubstituted 
heterocycles were formed in high yields, with only a change in solvent to acetonitrile and 
a need for reflux conditions. Interesting however in this case, was the exclusive formation 
of trans disubstituted heterocycles (Figure 1).
O N
R
R1 R2 R1 R2
cis trans
Figure 1. Relative stereochemistry in heterocycles synthesised from silyl-Prins methodology.
The proposed aza-Prins reaction would presumably be identical in mechanism to the aza-
silyl-Prins minus the stabilising effect and eventual elimination of the silane. The trapping 
of  a  cyclic  carbocation  by  available  nucleophiles  in  this  case  would  terminate the 
reaction. The similarities between the two nitrogen-containing cyclisation reactions will 
be investigated fully in this report as well as comparisons to the oxygen associated Prins 
and silyl-Prins reactions. Also reported upon will be associated reactions which progress 
via other allylic-iminium ion intermediates.
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Chapter One
Piperidine cores are  widespread in  nature;  the  synthesis  usually  involves  multi-step 
processes. Initially  our  group has  focussed on  the  formation of  dihydropyrans  and 
tetrahydropyridines via the silyl-Prins and aza-silyl-Prins reactions respectively. Although 
both types of heterocycle are not as abundant as their saturated counterparts, they do serve 
as a useful handle towards analogues of piperidine alkaloids. In this chapter, both silylated 
reactions will be reviewed which will be beneficial when considering a non-silylated aza-
Prins reaction.
. IThe Silyl-Prins Reaction
This  area  of  study seemed attractive  when considering that  basic  Prins  cyclisations 
involving Brønsted acids as catalysts, afforded a complex mixture of products. Studies by 
Li and co-workers suggested a Lewis acid mediated approach; however the use of tin and 
also two equivalents of aldehyde only afforded symmetrical dihydropyran substituents. 
Methods  for  the  total  synthesis  of  dihydropyrans  included  intramolecular  Sakarai 
reactions,  ring  closing  metathesis,  or  a  hetero  Diels-Alder  approach  but  all  have 
drawbacks. 
Within the Dobbs group, the desired substrate for initial study was (Z)-4-trimethylsilyl-3-
buten-1-ol 1. When screened against simple aldehydes and a variety of Lewis acids, this 
homoallylic alcohol gave 2-substituted dihydropyrans 2 with a maximum yield of 90%. 
The reagents used in this instance were boron trifluoride etherate and phenylacetaldehyde 
in DCM at -78 ºC. However comparable yields were obtained with indium trichloride at 
room temperature and  so  this  Lewis  acid  was  chosen  for  further  study  since  it  is 
crystalline,  does  not  require strict  anhydrous  conditions,  and  can  be  used  at  room 
temperature as opposed to -78 ºC (Table 1).
Table 1. The silyl-Prins reaction between a homoallylic alcohol and aldehydes.
OH
TMS O R
1 eq.InCl3O
R DCM, rt
+
1 2
Entry R % Yield
1 PhCH2 88
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2 n-C5H11 65
3 c-Hex 72
4 Ph2CH 85
5 Ph 39
6 p-NO2-Ph 86
7 p-CF3-Ph 54
Indium trichloride gave high yields of products for a variety of aldehydes, with only 
benzaldehyde giving less than 50% yield (Table 1, entry 5). This observation does follow 
the pattern for aromatic aldehydes as previously reported, but yields were improved with 
p-NO2 and p-CF3 substituents, presumably due to electronic effects (Table 1, entries 6-7). 
It is interesting to observe that when sub-stoichiometric amounts of indium trichloride 
were used, the yield slightly declined, proving some catalytic activity, albeit presumably 
with  low catalyst  turnovers. Progression of  this  work continued with  use  of  the C1 
methylated alcohol substrate 3 with a range of aldehydes to provide 2,6-disubstituted-3,4-
dihydropyrans  4 in good yields with exclusive  cis  stereochemistry as proven by nOe 
studies (Table 2). 
Table 2. The silyl-Prins reaction between a methyl substituted homoallylic alcohol and aldehydes.
OH
TMS O R
1
1 eq.InCl3O
R1 DCM, rt
+
3 4
Entry R1 %Yield
1 PhCH2 50
2 n-C5H11 65
3 c-Hex 69
4 Ph2CH 78
5 p-NO2-Ph 60
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The mechanism is assumed to progress via nucleophilic attack on the Lewis acid activated 
aldehyde  5,  followed  by  cationic  cyclisation  to  give  a  six-membered  secondary 
carbocation 6 stabilised by the β–effect from the silicon. Subsequent elimination of the 
silane moiety to form the olefin function gives the dihydropyrans. The stereochemistry is 
assumed to result from the favoured equatorial positions adopted in a chair-like transition 
state (Scheme 3). In comparison to an approach by Li, epoxides were used in place of the 
aldehyde and again dihydropyrans were afforded in good yields.
O
TMS
R R1
TMS
OH
O
R1
R LA
+ O
TMS
R R1 OR R1
5 6
Scheme 3. The cis geometry across the heteroatom keeps the ring substituents equitorial.
. IIThe Aza-Silyl-Prins Reaction
The idea for a nitrogen version of the silyl-Prins cyclisation stemmed from the success 
found  in  producing  dihydropyrans. The  comparable tetrahydropyridines  are  not  so 
widespread in nature but their related piperidine alkaloids are found in a variety of natural 
products,  e.g,  (-)-solenopsin A. Examples of methods for piperidine synthesis include 
Ireland  Claisen  rearrangements,  aza  Diels  Alder  reactions  and  also  aza[2,3]-Wittig 
reactions. Work  carried out  by  Overman on  acid  catalysed  vinylsilane-iminium  ion 
cyclisations encouraged this field of study. Within the Dobbs group, the main precursors 
for initial study were  N-substituted-N-(Z)-(4-trimethylsilylbut-3-enyl) amines 7, formed 
from the amination of the associated tosylated alcohol by a series of primary amines. 
When initially screened with indium trichloride and hexanal or benzaldehyde in DCM at 
room temperature (as  with the  silyl-Prins reaction), only  starting  material remained. 
Raising the temperature only gave trace amounts of monosubstituted tetrahydropyridines 
8 at reflux temperature. However when using the higher boiling solvent acetonitrile at 
reflux temperature, good yields were obtained for a variety of N-protected amines such as 
alkyl (e.g,  n-Pr), aryl (e.g, Ph), and benzyl,  as well as a number of Lewis acids and 
aldehydes. The maximum yield obtained using the preferred indium trichloride was 95% 
with the Bn protected amine, and either phenylacetaldehyde or hexanal (Table 3).
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Table 3. The aza-silyl-Prins reaction between homoallylic amines and aldehydes.
NHR1
TMS
+
O
R2 N
R1
R2
1 eq.InCl3
CH3CN reflux
7 8
Entry R1 R2 Time(h) %Yield 
1
2
Ph n-Pn 3 95
Bn 3 85
3
4
n-Pr Ph 24 22
Bn 24 55
5
6
7
8
Bn n-Pr 12 63
n-Pn 12 62
Ph 24 64
Bn 12 95
Aromatic aldehydes were again less successful as with the silyl-Prins reaction. Studies 
using the C2 methylated amines found that  these afforded exclusively the  trans-2,6-
disubstituted  tetrahydropyridines,  shown by  X-ray  crystallography.  This  was  further 
supported by nOe studies; a 2.2% enhancement of the C6 methyl group and a lack of 
enhancement of the C6 proton was observed on irradiation of the proton at C2 (Figure 2).
N Ph
Ph
H
2.2%
Figure 2.  Exclusive stereochemistry proven by nOe studies.
The maximum yield for trans-2,6-disubstituted tetrahydropyridines 10 obtained from the 
C2 methylated precursors 9 was 85% with indium trichloride, the n-Pr substituted amine 
and phenylacetaldehyde (Table 4, entry 3).
Table 4. The aza-silyl-Prins reaction between substituted homoallylic amines and aldehydes.
NHR1
TMS
+
O
R2 N
R1
R2
1 eq.InCl3
CH3CN, reflux
9 10
Entry R1 R2 Time (h) %Yield 
1 Ph n-Pn 36 23
2
3
4
n-Pr n-Pn 24 73
Bn 24 85
Ph 24 40
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5
6
7
8
9
10
11
12
Bn n-Pr 14 56
n-Pn 14 70
-(CH2)10-CH3 24 70
Bn 24 60
Ph 12 69
p-Me-Ph 24 55
p-Br-Ph 16 65
p-NO2-Ph 14 70
The proposed mechanism is comparable to the silyl-Prins reaction except for the presence 
of an iminium ion intermediate 12 instead of an oxonium ion. Initially, formation of the 
iminium  ion  with  an  indium  hydroxide  counter-ion  is  achieved  via condensation 
involving a Lewis acid activated aldehyde 11 or activated amine pathway (Scheme 4). On 
investigation, the activated aldehyde pathway which involves addition of the aldehyde 
before the amine substrate produced enhanced rates and yields. Also, introduction of the 
aldehyde before the amine was observed to aid the dissolution of the Lewis acid.
TMS
NR1
R2 O
InCl3
TMS
NR1
R2 O
InCl3
H
TMS
NHR1
O
R2
InCl3
O
R2
TMS
NR1
R2 O
InCl3
H
TMS
NHR1
InCl3
H
11
12
Scheme 4. Proposed mechanism for condenstion of precursors in aza-silyl-Prins reaction.
The reaction proceeds via the cyclisation of the vinylsilane onto the iminium ion followed 
by elimination of the silane on to the formed cyclic carbocation 14. It is proposed that the 
indium hydroxide species attacks the  silane  to  give  TMSOH and also  to  regenerate 
indium trichloride (Scheme 5). However catalytic turnovers have been found to be low 
suggesting this mechanistic rationale is not entirely accurate. Alternatively the iminium 
ionic pair 13 participates in a [3,3]-sigmatropic aza-Cope rearrangement to give the more 
reactive allyl silane 15, which can cyclise to give the same silicon stabilised carbenium 14 
(Scheme 5).
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NR1
R2
TMS
NR1
R2TMS
NR1
R2
TMS
NR1
R2
InCl3HOInCl3
HOInCl3
HOInCl3
TMSOH
+
[3,3] +
13
14
15
Scheme 5. Proposed mechanism for cyclisation of intermediates in aza-silyl-Prins reaction.
The vinylsilane moiety is  key  to  a  successful  reaction:  the  silicon induced β-effect 
(overlap of the vacant p-orbital on the β-carbon and the polarised σ-orbital between the 
silicon and the α carbon) offers stabilisation of the carbocation intermediate (Figure 3).
Si
+
Overlap
Figure 3. Orbitals involved in the β-effect of silicon.
The  by-products  from  this  procedure  are  minimal  but  may  become  important  in 
monitoring the development of the aza-Prins cyclisation. One is the hydrolysed aza-Cope 
rearrangement adduct 17. Also formed is the (E)-isomer of the silyated allylic amine 16 
formed  via the  aza-Cope rearrangement,  followed by  the  reversible reactions  in  the 
condensation pathway (Scheme 6). The latter is capable of cyclisation as reported by 
Overman.
R N
H
PhN
Ph
R N
Ph
R
O+InCl3HOInCl3
+ +HOInCl3
TMS
[3,3] TMS
TMS
N
H
Ph
TMS
16
17
Scheme 6. Side-products from aza-silyl-Prins reaction.
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The stereochemical outcome of trans substituents across the ring nitrogen is presumably 
due to a minimisation of a phenomenon called A1,3 strain, which is based upon the steric 
interactions between the C-2, C-6 and N-substituents (Figure 4).
N
H
R2
H
N
R2
H
H
trans cis
Figure 4. Minimisation of A1,3 strain leads to exclusive trans product. 
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CHAPTER TWO: The Aza-Prins Reaction
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. ILiterature Review of Prins Methodology.
Previous studies by our group in forming substituted heterocycles, via the silyl-Prins and 
aza-silyl-Prins have been reviewed. The intention now is to introduce the Prins reaction, 
which will prove that the vinylsilane moiety is not essential for success in the oxygen 
series. The success found in forming tetrahydropyrans using this methodology encourages 
studies into forming piperidines  via an aza-Prins reaction. However, the progression of 
the silyl-Prins reaction to the aza-silyl-Prins reaction showed that the latter requires more 
harsh conditions to  achieve success. Therefore, it  is  likely  that there will  be similar 
contrasts between the Prins reaction and the aza-Prins reaction. 
Reported in  1899,  the  condensation of  olefins  with  aldehydes under strongly  acidic 
conditions is called the Prins reaction (Scheme 7). 
O
HH
R+
R
OH
OH
R OH O O
R
+ +
H
H2O
18 19 20
Scheme 7. The initial components involved in the Prins reaction.
The  initial  mixture  of  products  consisted  of  1,3-dioxanes  20,  1,3-glycols  18 and 
unsaturated alcohols 19 but later the reaction was developed in the late 1960s by Stapp to 
form tetrahydropyran  derivatives.  This  reaction proceeded in  anhydrous  media  and 
involved the condensation of 1-olefins 21 with paraformaldehyde and hydrogen halides to 
give 3-alkyl-4-halotetrahydropyrans 22 (Scheme 8).
O
HH
+
HX
R
O
X
R H2O+
21 22
Scheme 8. The evolution of the Prins reaction to form tetrahydropyrans.
Recently  Li  has  reported the  indium  trichloride-mediated cross-cyclization  between 
epoxides  or  aldehydes  and  homoallylic  alcohols.  These  condensation-cyclisation 
reactions, often mediated by Lewis acids, are the most modern evolution of the Prins 
reaction (Scheme 9).
. 1The  Prins 
Reaction
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R
O R'
OH
InCl3 R O
Cl
R'O
R
or
Scheme 9. Modern Prins reaction by Li utilised to form tetrahydropyrans.
Their primary reaction involved the use of styrene epoxide and the homoallylic alcohol, 
3-buten-1-ol. These were treated with indium trichloride in DCM at room temperature for 
5 hours to yield 2-benzyl-4-chlorotetrahydropyran in 94% yield with a 3:1  cis to  trans 
stereochemistry. 
Cyclisations have also been performed with aldehydes (yields not published) in place of 
epoxides, also in high yields. Li has suggested a mechanism for the use of an epoxide, 
which should be highly similar to an aldehyde activated pathway.  Firstly the epoxide 23 
is activated by indium trichloride to afford a chloride anion. Then the migration of the R 
group 24 forms the carbenium ion  25 adjacent to the indium-oxy-anion leaving group. 
This  allows  substitution  using  the  homoallylic  alcohol,  with  the  terminal olefin  26 
cyclising onto the carbenium ion. This yields a six membered carbocation  27  (with no 
obvious aided stabilisation),  which is  trapped by  the  chloride anion,  assumed to  be 
produced from the Lewis acid (Scheme 10).
O
R R
O
InCl2
O
InCl2
R
OH
O
R
O
R
Cl
O
Cl
R
InCl2
Cl
23 24
25
2627
Scheme 10. Li’s proposed mechanism of Prins reaction.
Li has  also described the synthesis  of polysubsituted tetrahydropyrans via an indium 
trichloride mediated Prins cyclisation. This  introduces some intriguing regiochemical 
issues surrounding the Prins reaction. They demonstrate that variations in the geometry of 
the double bond of the homoallylic alcohol precursor can affect the diastereoselectivity of 
six-membered heterocyclic products. Assuming success can be found in optimising an 
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intermolecular aza-Prins reaction, then it  is envisaged that similar stereochemical and 
regiochemical effects might be observed. Most of the homoallyl alcohols used in the 
cyclisations  are  commercially  available.  The  treatment  of  trans-3-hexen-1-ol  with 
benzaldehyde  in  the  presence  of  indium  trichloride  afforded  exclusively  2,3,4-
trisubstituted tetrahydropyrans 28 with an up-down-up diastereoselectivity. Extending the 
chain  length  beyond  the  internal  olefin  as  in  trans-3-nonen-1-ol did  not  affect  the 
stereoselectivity but the yield was decreased. This was assumed to be due to the increased 
steric  hindrance in  the  transition  state  for  the  ring-closing  step.  A similar effect  of 
decreasing yields was found when aliphatic aldehydes were used in comparison with the 
aromatic aldehydes (Table 5, entry 6 and 8). 
Table 5. Homoallylic alcohols coupled to aromatic aldehydes in the Prins reaction.
OH
R
CHO
R1
R2CHO
O
R
R1 O R2
R
+ or
or
InCl3, DCM
rt
Cl Cl
28
Entry R R1 R2 %Yield 
1 Et H - 85
2 Et F - 90
3 Et Cl - 86
4 Et Br - 88
5 n-Pn H - 80
6 Et - Me 71
7 Et - n-Pn 81
8 Et - (CH2)8(CH)CH2 46
Next, changing the geometry of the double bond was investigated, with highly intriguing 
results.  When the condensation of  cis-3-hexen-1-ol  to benzaldehyde was attempted, a 
mixture of (up,up,up)-2,3,4-trisubstituted tetrahydropyran  29 as the major product and 
cis-2,3-disubstituted tetrahydrofuran 30 as the minor product, was afforded. When the 
starting material was altered to  cis-3-nonen-1-ol the ratio of 6-membered species to 5-
membered increased to 1:1 (Table 6, entry 5). 
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Table 6. Regiochemical effects in Prins reaction. 
OH
CHO
R1 O
R
R1+ or
InCl3, DCM
rt
R
O
RCl
R1
Cl
29 30
Entry R R1 %Yield of 29 %Yield of 30
1 Et H 54 13
2 Et F 65 Trace
3 Et Cl 50 9
4 Et Br 69 9
5 n-Pn H 23 28
A possible explanation behind the formation of  the  tetrahydrofuran product  involves 
firstly envisaging the chair intermediate 31. In the case of the trans homoallyl alcohol, all 
the  substituents are  equatorial  whereas  in  the  case of  the  cis homoallyl  alcohol the 
disfavoured pseudo 1,3-diaxial interactions lead to a mixture of carbocations 32 and 33. 
From here, subsequent nucleophilic attack from the chloride ion will either give the more 
stable tetrahydropyran or the tetrahydrofuran (Scheme 11). 
O Ph
H
O Ph
O Ph
+
O Ph
O Ph
Cl
+
disfavoured pseudo 
1,3-diaxial interaction
Cl
31
32
33
Scheme 11. Possible explanation for the formation of tetrahydrofuran.
Thus, examples exist of Prins and related cyclisations, which occur, unlike the silyl-Prins 
reaction, without stabilisation of the intermediate carbocation. Therefore if amines are 
considered as nitrogen-analogues of alcohols (albeit less-reactive), an aza-Prins reaction 
may be possible.
A variety of methods for the synthesis of piperidines involve olefin cyclisations onto 
iminium ion intermediates, often lacking any stabilisation adjacent to the olefin function. 
These could offer a direct comparison to the proposed aza-Prins reaction. Even more 
. 2Iminium  Ion-Olefin  Cyclisation 
Reactions 
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promising is that Lewis acids have been employed in a few of these examples to activate 
the starting materials. These examples will be discussed briefly.
The potent NK1 antagonist CGP 49823, contains a 2-benzyl-4-aminopiperidine moiety 
and  has  been prepared by  Veenstra.  The synthesis  included production  of  a  benzyl 
carbamate protected allylic amine  35,  derived from the associated carboxylic acid  34 
using Hofmann conditions. This was readily alkylated with a chloromethyl ethyl ether to 
afford an acyl iminium ion  36 capable of undergoing cyclisation with the unactivated 
olefin in acetonitrile and in the presence of two equivalents of chlorosulfonic acid. The 
cyclic carbenium ion  37 provided was trapped by  the solvent acetonitrile, which on 
aqueous work-up  produced the  trans-2-benzyl-4-acetamidopiperidine  38 in  adequate 
yield of 73% (Scheme 12). 
O
N
N
H N
 CGP 49823
NH
O OH
O
BnO N
O
BnO
OEt
N
O
BnON
O
BnO
N
O
BnO
NHAc
a, b, c d
e
34 35
36
37
38
Scheme 12.  Reagents and conditions: (a) i) SOCl2; ii) aq. NH3; (b) Br2,  NaOH; (c) ClCO2Bn, aq. 
NaHCO3, 68% for 3 steps; (d) ClCH2OEt, 50% aq. NaOH, DCM, benzyltributylammonium chloride, 
5-10 °C, 80%; (e) ClSO3H, CH3CN, -20 °C, 30 min, 73%.
It  was  assumed that  the  trans diastereoselectivity  dominated because  N-acylated 2-
alkylpiperidines have strong preference for axial conformations; therefore it is sterically 
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favourable for acetonitrile to attack from the opposite side of the ring. Debate on whether 
acetonitrile would be favoured for carbocation trapping in the presence of a Lewis acid 
was  answered in  the  SAR studies  of  the  substituent  on  C2.  Introduction  of  varied 
substituents into this position was achieved either via the allylic carboxylic acid or via a 
novel one-pot synthesis to a CBz-protected homoallylic amine 39. This involved the use 
of equimolar amounts of aldehyde or acetal, benzylcarbamate, allyltrimethylsilane, and 
boron trifluoride diethyletherate. The  trans-2-substituted–acetamidopiperidine  41  could 
also be synthesised using the unsubstituted CBz-protected allylic amine 40 via a one-pot 
aza-Prins cyclisation reaction. This  was  limited  to  aromatic aldehydes however and 
required the  presence of  acetic  anhydride.  Reagents  for  this  step  also  included  tin 
tetrachloride in acetonitrile  at  -20 °C. Interestingly only acetonitrile trapped products 
were obtained unlike examples of other Prins methodology where the anions of Lewis 
acid salts quench the cation (Scheme 13).
R
NH
O
BnOO
R H
OMe
R OMe
R
N
O
BnO
NHAc
NH
O
BnO
or
a
b,c
d
39
40 41
Scheme 13. Reagents and conditions: (a) BnOCONH2, allyltrimethylsilane, BF3.OEt2, CH3CN, 0-25 °C; 
(b) ClCH2OEt, 50% aq. NaOH, DCM, benzyltributylammonium chloride; (c) CF3SO3H, CH3CN, -20 
°C, 30 min; (d) PhCHO, SnCl4, Ac2O, CH3CN, -20 °C.
Iminium ion-olefin  cyclisations  have  been  utilised  by  Aubé  in  studies  towards  the 
tricyclic core of a group of bradykinin antagonists called Martinellines. These possess a 
pyrroloquinoline ring system. This system was targetted using an unusual imine-olefin 
cyclization  via an acyl iminium ion intermediate  43.  This intermediate is formed  via 
intramolecular attack from the imine 42 on to a Lewis acid activated t-butyl carbamate 
function. This publication then suggests that a concerted process occurs involving the 
chloride attacking the olefin, which in turn cyclises onto the iminium ion (Scheme 14).
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Scheme 14. Proposed mechanism for iminium ion-olefin cyclisation.
Reactions involving imines 44 without the N-protected aniline function and with a variety 
of groups of differing electronic effects on the aryl system only gave moderate yields of 
2-substituted-4-chloropiperidines 45 and these could not be isolated cleanly (Table 7).
Table 7. Imine-olefin  cyclisation reaction mediated by titanium(IV) chloride.
R3
R1
N
R2
R3
R1
N
H
Cl
R2
TiCl4, DCM,
reflux, 72 h44 45
Entry R1 R2 R3 %Yield 
1 H H H 25
2 H OMe H 18
3 H NO2 H 31
4 H CO2Me H 52
5 NO2 H Cl 21
In conclusion, in the imines containing the o-NHBoc aromatic substituent, the yields were 
consistently higher and with cleaner products.
Hanessian has employed an iminium ion-olefin cyclisation with carbocation trapping in 
the total synthesis of Oscillarin, a member of the aeruginosin family. These secondary 
metabolites are produced by blue-algal species of prokaryotic aquatic microorganisms and 
are linear peptides that possess serine protease inhibitory properties. This family shares a 
common 1-aza[4.3.0]-bicyclic core, which in the case of oscillarin is more specifically a 
(2S,3aS,6R-hydroxy,7aS) octahydroindole 2-carboxylic acid core (L-Choi). To access the 
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bicyclic core, an approach involving an N-acyloxyiminium ion 46 aza-Prins cyclization to 
form 6-halo-octahydroindole 2-carboxylates 47 was chosen (Scheme 15).
NHO
O
HN O
HO
O
NH
N NH2
NH
H
H NBoc
CO2Me
H
H
Br
N
Boc
CO2Me
H
Br
L-Choi 46
47
Scheme 15. Summary of intramolecular cyclisation to form L-Choi.
The intramolecular cyclizations  take place  between a  hemiaminal acetate  48 and an 
olefinic tether by treatment with tin tetrabromide in DCM, at -78 °C for approximately 5 
minutes to form product 49 in 78% yield (Scheme 16). 
N
Boc
CO2MeAcO
N
Boc
CO2Me
H
Br NBoc
CO2Me
H
H
Br
a
48 49
Scheme 16. Reagents and conditions: (a) SnBr4, DCM, -78 °C, 78%.
The stereochemistry at  C6 was confirmed by  X-ray crystallography of  an  advanced 
intermediate.  The  authors  go  on  to  classify  intramolecular  aza-Prins  cyclizations 
involving N-acyliminium ions. It is reported that there are many examples of nucleophilic 
attack of the N-olefinic tether on to an endocyclic iminium cation. These endo aza-Prins 
cyclizations, which lead to the nitrogen atom at the junction of the bicyclic unit such as 
with pyrrolizidinones or indolizidinones, are said to be Type I. There are however fewer 
examples of intramolecular cyclizations in which the olefinic tether is attatched to a distal 
carbon and cyclises onto an incipient endocyclic N-acyliminium ion (Type II) (Scheme 
17). 
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Scheme 17. Types of aza-Prins reaction.
The use of Prins methodology to perform iminium ion-olefin cyclisations and so form 
nitrogen-containing heterocycles has been reviewed. In the proposal for the aza-Prins 
reaction, the aim was to form specifically 4-halopiperidines, as it  was felt that these 
would have significant value in pharmaceuticals or become useful intermediates in total 
synthesis  of  natural  products.  The  literature  precedent  for  the  formation  of  these 
heterocycles by a variety of different routes will now be reviewed.
Liotta has reported the synthesis of 4-halopiperidines from the [3+3] annelation between 
α,α’-dimethoxylated  amides  53 and  allyltrimethylsilane.  The  α,α’-dimethoxylated 
amides  were  prepared  by  one  of  two  routes,  route  A,  involving  the  anodic  α-
monomethoxylation of  N-monoalkylamides  50 followed by  methoxyalkylation of  the 
product 51. The second route, route B, involves the anodic α,α’-dimethoxylation of N,N-
dialkylamides 52. The typical procedure for the synthesis of the 4-chloropiperidines 54 
involves the treatment of  α,α’-dimethoxylated amides 53 and allyltrimethylsilane with 
titanium(IV) chloride in moderate to excellent yields (Table 8). 
. 3 Synthesis  of  4-
Halopiperidines.
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Table 8. Formation of 4-chloropiperidines via [3+3]-type annelation.
Y NH
R1
O
Y NH
R1
O
OMe
Y N
R1
O
OMe
OMe
R2
R2
OMe
Cl
Y N
R1
O R2
TMS
N
Cl
OY
R2R1
MeOH
NaH
MeOH
TiCl4, rt
route A
route B
50 51
52 53 54
-2e
-4e
Entry α,α’–Dimethoxylated 
amide
4-Chloropiperidine %Yield 
1
MeO N
O
OMe
OMe MeO N
O
Cl 75
2
N
O
OMe
OMe N
O
Cl 83
3
N
O
OMe
OMe N
O
Cl 50
4
N
O
OMe
OMe N
O
Cl 62
5
N
O
OMe
OMeO N
O
Cl
O
77
6
N
O
MeO
MeO
OMe
N
Cl
O
MeO
85
This methodology has been applied to the synthesis of (±)-δ-coniceine 59, which is a 
bicyclic nitrogen heterocycle. The synthesis began with a lactam 55, which after using 
route  A,  furnished the  desired [3+3]-type  annelation  precursor  56.  Treatment under 
standard conditions afforded the  indolizidine  57,  which was then hydrogenated over 
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Raney Nickel to give  58 followed by hydride reduction to give the desired bicycle  59 
(Scheme 18).
N
H
O N
H
O OMe NO OMe
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Cl
NON
a b
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de
55 56
575859
Scheme  18.  Synthesis  of  (±)-δ-coniceine. Reagents  and  conditions:  (a)  MeOH,  -2e-,  67%;  (b) 
ClCH2OMe, NaH, 71%; (c) TiCl4, rt, 77%; (d) H2, Raney Ni, KOH, 85%; (e) NaBH4, AcOH, 34%.
Speckamp  and  Hiemstra  describe  the  Lewis  acid  mediated  transformation  of  N-
(chloromethyl)alk-3-enylcarbamates into 4-chloropiperidines via a cationic ring-closure. 
These conditions were then compared to a radical transfer process which involved a 
comparable alkenylcarbamate  precursor treated with  tributyltin  hydride to  afford the 
corresponding  pyrrolidine.  The  initial  conditions  that  were  screened  involved  the 
treatment of  a  N-(chloromethyl-carboxylate)alk-3-enylcarbamate  60a with  a  copper(I) 
chloride/2,2’-bipyridine complex, secondly treatment of the  N-(thiophenyl-carboxylate) 
derivative  60b with tributyltin hydride and thirdly the treatment of the  N-(acetyloxy-
carboxylate) derivative 60c with tin tetrachloride. The copper complex mediated reaction 
led to formation of the 2-carboxylate-3-(1-chloropropyl)pyrrolidine  61 (5-exo product) 
exclusively (Table 9, entry 1) and the tributyltin hydride treated reaction led to the un-
chlorinated proline derivative  63 (Table 9, entry 2). However, the tin tetrachloride and 
also the un-catalysed control reaction only led to 4-chloropiperidine 62 (6-endo product), 
although the Lewis acid mediated reaction produced much higher yields (Table 9, entries 
3 and 4).
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Table 9. Piperidine and pyrrolidine formation via radical or cationic processes.
  
N
CO2Me
X
CO2Me N
Cl
CO2Me
CO2Me
N CO2Me
CO2Me
N CO2Me
CO2Me
or or
Cl
60a-c 61 62 63
Entry X Promoter %Yield
of 61
%Yield
of 62
%Yield
of 63
1 Cl (60a) Cu(bpy)Cl 78 
(20:80;cis:trans)
2 0
2 SPh (60b) Bu3SnH 0 0 93 
(35:65;cis:trans)
3 OAc (60c) SnCl4 0 80 0
4 Cl (60a) Blank 0 33 0
Interestingly, when the alkenylcarbamate precursor was altered for carbamates that did 
not possess the methylcarboxylate function 64a-c, the outcome was quite different. For 
the copper complex, tin tetrachloride and blank control, the 4-chloropiperidine 66 was the 
sole product with excellent yields in all cases, albeit slightly lower in the un-catalysed 
control  (Table 10,  entries 1,3 and 4).  The diastereoselectivity  of  all  three cases was 
different, in the control the cis diastereomer was favoured, whilst in the tin tetrachloride 
mediated reaction the  trans diastereomer was almost exclusively favoured. However in 
the copper complex mediated reaction, a 1:1 mixture of diastereomers was observed. 
When the carbamate precursor was treated with tributyltin hydride, the un-chlorinated 
pyrrolidine 67 was the only product to be observed, albeit in low yields (Table 10, entry 
2).
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 Table 10. Piperidine and pyrrolidine formation minus carboxylate stabilisation of substrate.
. 
N
CO2Me
X
N
Cl
CO2Me
N
CO2Me
N
CO2Me
or or
Cl
64a-c 65 66 67  
Entry X Promoter %Yield
of 65
%Yield
of 66
%Yield
of 67
1 Cl (64a) Cu(bpy)Cl 0 82 
(46:54;cis:trans)
0
2 SPh (64b) Bu3SnH 0 0 30
3 OMe (64c) SnCl4 0 95 (5:95;cis:trans) 0
4 Cl (64a) blank 0 66 (87:13;cis:trans) 0
These results may be explained by the Lewis acid-mediated reaction proceeding via an 
iminium ion-olefin cyclisation which is  terminated  via the nucleophilic trapping with 
chloride ions, while the tributyltin hydride reaction involves a radical-olefin cyclisation. 
On  use  of  the  N-(thiophenyl-carboxylate)alk-3-enylcarbamate  precursor  64b,  the 
intermediate radical formed is  stabilised by the adjacent ester function. The so-called 
captodative radical stabilisation is absent in the second precursor and thus detrimental to 
the yields of the pyrrolidine product (Scheme 19). 
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Scheme 19. Iminium ion and radical pathways.
To  test  the  Lewis  acid  strength  of  the  copper  complex,  a  carbamate  68 with  a 
cyclopentenyl function and an alkyl chloride was introduced to the conditions containing 
tin tetrachloride, the blank control and also the copper complex. When the carbamate was 
introduced to the copper complex, a mixture of a bridged bicyclic system  69 (6-endo 
product) and a bicyclic pyrrolidine 70 (5-exo product) was formed with equal quantities 
of each. A similar ratio of products was formed on use of tin tetrachloride, whereas in the 
un-promoted reaction, no cyclisation products were formed (Table 11). This suggests that 
since the regioselectivities of the copper promoted cyclisation and the tin tetrachloride 
mediated  cyclisation  are  essentially  the  same,  the  cuprous  chloride/2,2’-bipyridine 
complex functions as a Lewis acid promoter. Interestingly, the tin tetrachloride mediated 
conditions  in  the  first  two examples (Table  9,  entry 3  and Table  10,  entry 3)  only 
produced 6-membered  piperidine  whereas  in  the  last  example,  a  mixture  with  5-
membered pyrrolidine was obtained (Table 11, entry 2).
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Table 11. Formation of bicyclic systems on use of copper and tin promoters.
N
X
CO2Me
N
H
HCl
CO2Me NCl
CO2Me
or
68 69 70
Entry X Catalyst %Yield of 69 %Yield of 70
1 Cl Cu(bpy)Cl 30 32
2 Cl SnCl4 37 32
3 Cl blank 0 0
Yang  described  the  titanium(IV)  chloride-induced  iminium  ion  cyclisations  of  α-
cyanoamines. This report showed examples where iminium ion-olefin cyclisations lead to 
6  or  5-membered  heterocycles.  The  prerequisite  tertiary  cyanoamine  cyclisation 
precursors 71 were all prepared by the alkylation of primary amines with alkyl halides 
and 2-chloroacetonitrile in the presence of triethylamine. The cyclisations were induced 
by the treatment of the cyanoamines 71 with 3-4 equivalents of titanium(IV) chloride. 
Use of the but-3-enyl cyanoamine in the presence of 3 equivalents of Lewis acid at -78 °C 
to room temperature yielded a 4-chloropiperidine 72 as the single product (Table 12, entry 
1). The precursor was then altered to the 3-methylbut-3-enyl derivative and with the same 
conditions but with a constant temperature of 0 °C, a mixture of the 4-chloropiperidine 
product  72 and  a  tetrahydropyridine  73 was  afforded  (Table  12,  entry  2).  The 
tetrahydropyridine  product  is  most  likely  formed  by  the  E1  elimination  of  the  4-
chloropiperidine product via a stable intermediate tertiary carbocation. 
Table 12. Formation of azacycles on use of titanium(IV) chloride.
N
Ph
CN
R1
N
Ph
R1
N
Ph
R1
N
Ph
Cl R1
N
Ph
R1
endo
or
71 72 73
Entry R1 Temp. %Yield
of 72
%Yield
of 73
1 H -78 °C to rt 70 0
2 Me 0 °C 35 50
37
Chapter Two
When the  precursor was  altered to  the  4-methylpent-3-enyl  cyanoamine  74 and  the 
reaction  was  carried  out  at  room  temperature,  formation  of  a  mixture  of  3-(2-
chloropropan-2-yl)pyrrolidine  76 as  the  major product and  an  associated eliminated 
pyrrolidine 77 as the minor product was observed. It is most likely that the explanation 
for the formation of the 5-membered species over the 6-membered piperidine is that the 
latter was formed via a secondary carbocation, whereas the former via a tertiary one 75 
(Scheme 19). 
N
Ph
CN
N
Ph
N
Ph
N
Ph
Cl
N
Ph
or
exo a
50% 10%
74 75 76 77
Scheme 19. Reagents and conditions: (a) 3 equiv.TiCl4, rt.
Speckamp and Hiemstra used aza-Prins methodology in the formation of pipecolic acid 
analogues. The cyclisations  of  homoallyl  tertiary  amines are  again promoted by  tin 
tetrachloride with the regioselectivity and stereoselectivity of these reactions being highly 
variable. The precursors to these reactions are  N,O-acetals 78 that were prepared from 
homoallyl carbamates or 2-pyrrolidinones. 
The cyclisation of these precursors was effected by treatment with 2 equivalents of tin 
tetrachloride in DCM at –78 °C, followed by warming to room temperature. On use of the 
but-3-enyl carbamate, a (up-down)-2-carboxylate-4-chloropiperidine  79 was afforded in 
good yields (Table 13, entry 1). When the precursor was altered to the hex-(3E)-enyl 
derivative,  the  2,4-trans geometry  was  maintained  in  the  formed  (up-up-down)-2-
carboxylate-3-ethyl-4-chloropiperidine  product  (Table  13,  entry  2).  With  a  simple 
alteration in the olefin geometry to the hex-(3Z)-enyl carbamate, the ethyl substituent 
becomes axial in the (up-down-down)-2-carboxylate-3-ethyl-4-chloropiperidine product, 
but in much lower yield (Table 13, entry 3). An interesting result  occured when the 
precursor was changed to the 2-methylbut-3-enyl carbamate with firstly the formation of 
the  (up-down-up)-2-carboxylate-4-chloro-5-methylpiperidine  as  the  major  product. 
However, the 2-carboxylate-4-(1-chloroethyl)pyrrolidine 80 was also formed as a minor 
product (Table 13, entry 4,  side product yield in  brackets). It  was presumed that  an 
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intermediate rearrangement of a primary carbocation to a secondary carbocation was the 
reason behind the production of the 4-(1-chloroethyl) substituent. 
Table 13. Formation of piperidine in tin mediated aza-Prins type reactions.
N
CO2Me
R1
OAc
CO2Me
R4
R3
N
MeO2C
Cl
O
MeO
R4
R3
R1SnCl4, DCM
-78 °C to rt,
then aq.NaHCO3
78 79
Entry R1 R3 R4 %Yield 
of 79
1 H H H 77
2 H Et H 80
3 H H Et 33
4 Me H H 44
N
Cl
CO2Me
CO2Me
80
(12)
In all the examples involving homoallyl carbamates, a separate series of reactions was 
studied where the reaction  was quenched at  –78  °C with  aqueous sodium hydrogen 
carbonate (instead of warming to room temperature). In each case, a 2-carboxylate-4-
hydroxypiperidine was formed rather than the 4-chloropiperidine. The geometry of the 
other ring substituents was the same in both series. However, the hydroxy function was 
always found to be axial on comparison to the equatorial chlorine found in the earlier 
examples. The 4-hydroxypiperidines  82a-c  that were isolated from the reaction of tin 
tetrachloride with but-3-enyl  (81a),  hex-(3E)-enyl  (81b)  and hex-(3Z)-enyl carbamate 
(81c) precursors, were treated with hydrochloric acid at reflux. After isolation from an 
ion-exchange resin, the 4-hydroxy pipecolic acid analogues  83 were afforded (Scheme 
20).  Interestingly,  when the  same carbamate precursors  81a-c were  treated with  tin 
tetrachloride in acetonitrile at -20  °C, the 4-chloropiperidine species were not formed. 
Instead the solvent acetonitrile trapped the intermediate carbocation and after aqueous 
work-up, a trans-2-carboxylate-4-(acetylamino)piperidine 84 was formed which is highly 
comparable with the work by Veenstra (Scheme 20).
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N
CO2Me
OAc
CO2Me
R1
R2
N
MeO2C
N
H
O
MeO
R2 R
1
N
MeO2C
O
MeO
R2
R1
SnCl4, CH3CN
-20 °C
OH
H2N
O
O
R2
R1
OH
1) 2N HCl, reflux
2) ion exchange resin
R1=R2=H; 82a
R1=Et, R2=H; 82b
R1=H, R2=Et; 82c
O
Me
R1=R2=H; 81a
R1=Et, R2=H; 81b
R1=H, R2=Et; 81c
83
84
Scheme 20. Synthesis of pipecolic acid analogues and cyclisations in acetonitrile.
. IIResults and Discussion: Studies into the Aza-Prins Reaction
Having successfully achieved the synthesis of dihydropyrans and tetrahydropyridines in 
the group, it was proposed to afford the piperidine skeleton via an intermolecular aza-
Prins reaction (Scheme 21). This would involve the coupling of homoallylic N-substituted 
amines to aldehydes in the presence of a Lewis acid. By further substituting the amine 
starting material, it would be possible to afford multiply substituted piperidines, which 
would  further  our  study  on  the  diastereoselectivity  of  the  reaction.  The  successful 
conditions found from the aza-silyl-Prins reaction were used as a starting point.
NHR
R1
N
R
R1R2
R2CHO, 
Lewis acid
X
(X= Cl, Br, F, OTf)
Scheme 21. Proposed scheme for an intermolecular aza-Prins reaction 
By applying the same methodology used to investigate the aza-silyl-Prins reaction, the 
desired precursors were synthesised in order to afford both  N,2,4-substituted piperidine 
alkaloids and also N,2,4,6-substituted analogues. The N,2,4-substituted piperidines would 
. 4Preliminary  Studies:  The  Aza-Prins 
Reaction
. aPrecursor Synthesis for the Aza-Prins 
Reaction I 
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require the coupling of commercially available aldehydes, under Lewis acid mediated 
conditions with N-substituted-N-(3-butenyl) amines (Scheme 22). These were obtained in 
2 steps starting from the commercially available homoallylic alcohol, 3-buten-1-ol 85. In 
order to displace the hydroxyl function to yield the secondary amines, the alcohol was 
first converted to the corresponding tosylate to provide a better leaving group using a 
literature  method.  Thus,  p-toluenesulfonyl  chloride,  4-dimethylaminopyridine  and 
triethylamine in DCM were mixed at 0 °C to afford the tosyl-substituted alcohol  86 in 
78% yield. Simple amination of the tosyl-substituted alcohol 86 using primary amines in 
ethanol at reflux temperature gave the secondary amines in poor yields using a modified 
literature method. This included formation of the N-benzyl-N-(3-butenyl) amine 87 using 
benzyl amine, in a moderate 50% yield, and formation of a N-alkyl analogue 88 using n-
butylamine in a very poor 8% yield (Scheme 22). 
OH
O
NHR
R=Bn, 50%; 87
R=n-Bu, 8%; 88
a b
S
O
O85 86
Scheme 22.  Reagents and conditions: (a) TsCl, Et3N, 4-DMAP, DCM, 0 °C, 22 h, 78%; (b) EtOH, 
RNH2, 110 °C, R=Bn, benzylamine, 20 h, 50%, R=n-Bu, n-butylamine, 22 h, 8%.
In  order  to  obtain  the  N,2,4,6-substituted  piperidines  and  thus  investigate  the 
diastereoselectivity of the aza-Prins reaction, the synthesis of N-substituted-1-substituted 
but-3-enylamines was required. These were obtained  via an  iodine-catalysed one-pot 
multi-component  reaction,  described  in  the  literature.  Stoichiometric  quantities  of 
aldehyde, benzyl carbamate, and allyltrimethylsilane were combined with 10 mol% of 
iodine  in  acetonitrile  at  room  temperature  to  afford  CBz-protected-1-substituted 
homoallylic amines in moderate yields. The use of phenylacetaldehyde gave the protected 
secondary amine 89 in 45% yield, while use of octanal to give 90 gave a lower yield of 
34% (Scheme 23). 
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N
H
O
O
Ph
R
SiMe3
R=Bn, 45%; 89
R=C7H15, 34%; 90
a
Scheme 23. Reagents and conditions: (a) RCHO, CBzNH2, I2 (10 mol%), CH3CN, rt, R=CH2Ph, 20 h, 
45%, R=n-C7H15, 20 h, 34%.
A typical procedure for the aza-silyl-Prins reaction involved treatment of an N-protected 
silylated homoallylic amine and an aldehyde in the presence of a Lewis acid in a 1:1:1 
ratio in acetonitrile at reflux, with reaction times ranging from 3-36 hours. Previous work 
towards optimising the aza-silyl-Prins reaction showed that the use of phenylacetaldehyde 
or hexanal with benzyl N-protection of the homoallylic amine precursor gave good yields. 
Therefore our initial  screening for the aza-Prins  cyclisation towards the synthesis of 
N,2,4-substituted piperidine alkaloids  91 involved mostly these substrates. These were 
utilised in conjunction with a range of Lewis acids that had found success in promoting 
the aza-silyl-Prins reaction and also other Prins-type cyclisations in the literature. The 
solvent  of  choice  was  acetonitrile  as  this  gave  optimal  yields  in  the  aza-silyl-Prins 
reaction and it was assumed that the high boiling temperature would enhance the chances 
of success in the aza-Prins reaction. This solvent also allowed full  dissolution of the 
Lewis acids (Table 14).
. bInitial  Screening  for  Aza-
Prins Reaction
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Table 14. Initial screening towards the aza-Prins reaction; synthesis of N,2,4-substituted piperidines.
NHR
N
R
R1
R1CHO, CH3CN
Lewis acid
X
91
Entry Lewis 
Acid
R R1 X Temp. Time 
(h)
%Yield
of 91
1
2
3
InCl3 n-Bu CO2Et
Bn
Bn CO2Et
Cl
4
5
In(OTf)3 Bn
n-C5H11
OTf
6
7
AlCl3 Bn
n-C5H11
Cl
8
9
TiCl4 Bn
n-C5H11
Cl
reflux 48 0
48 0
48 0
72 0
72 0
24 0
24 0
24 0
24 0
10 TMSOTf Bn OTf
11 BF3.OEt2 n-C5H11 F
-30°C 
to rt
72 0
72 0
After workup, GCMS and 1H NMR analysis of the crude reaction material, in all cases 
showed mostly amine starting material, which was recovered in quantitative yields, also 
with small amounts of aldehyde (Table 14, entry 1-11). Most of the Lewis acids screened 
had found success in promoting the aza-silyl-Prins reaction (Table 14, entries 1-7 and 10-
11).  Also  screened was  titanium(IV) chloride,  which had  proven successful  for  the 
synthesis of piperidine alkaloids by Aubé by utilising imine-olefin cyclisations. Use of 
boron trifluoride etherate and trimethylsilyl triflate was only compatible at sub-zero to 
room temperatures. All other Lewis acids were screened at room temperature and when 
no  positive  progress was  observed, the  temperature was  raised  to  reflux.  In  some 
instances, use of the N-alkyl homoallylic amine substrate and also highly reactive ethyl 
glyoxylate also produced negative results (Table 14, entries 1-3). Although mostly starting 
material was recovered, an additional compound was also detected in trace quantities by 
GCMS and 1H NMR analysis in a few examples (Table 14, entries 4-5). This compound is 
the hydrolysis product of the aza-Cope rearrangement. This aza-Cope adduct 94 proves 
that iminium-ion 92 formation does occur from the condensation of aldehydes and the 
benzyl  protected  amine  and  that  it  subsequently  undergoes  a  [3,3]-  sigmatropic 
rearrangment to another iminium species 93 (Scheme 24).
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N
H
Ph N
H
PhN
Ph
N
Ph
N
Ph
N
Ph
RR
RR
R
InCl3,
RCHO
[3,3]
Cl
9492 93
Scheme 24. Aza-Cope rearrangement leading to hydrolysis product.
These initial results suggest that iminium ion formation does occur but that the cyclisation 
of the olefin onto the iminium ion is unfavourable, presumably due to the instability of 
the cyclic carbocation formed. This suggests that the extra stability provided by the  β-
effect from the silane function present in the aza-silyl-Prins reaction may be a necessity 
for these cyclisations to proceed.
The screening of  the  aza-Prins reaction  towards the  synthesis  of  N,2,4,6-substituted 
piperidines  95 was run in parallel to the first data set  (Table 14) and the results  are 
presented (Table 15). In this case, the amine precursor contains an N-carbamate function 
and this functionality found success in the aza-silyl-Prins reaction. It was expected that 
the N-carbamate function would reduce the nucleophilicity of the nitrogen lone pair by 
delocalisation. However this group would be expected to enhance the reactivity of the 
intermediate iminium ion and so promote the cyclisation step.
Table  15.  Further  screening  of  aza-Prins  reaction,  towards  the  synthesis  of  1,2,4,6-substituted 
piperidine alkaloids.
N R1
R1CHO, solvent
Lewis acid
X
N
H
O
O
Ph
R
OOPh
R
95
Entry Lewis Acid R R1 X Temp. Time 
(h)
Solvent %Yield
of 95
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1
2
3
InCl3 n-C7H15 n-C5H11
Bn Bn
Cl
4
5
In(OTf)3 n-C5H11
Bn
OTf
reflux 48
72
72
72
72
6
7
BF3.OEt2 n-C5H11
Bn
F
8
9
TMSOTf n-C5H11
Bn
OTf
-30°C to 
rt
72
72
72
72
CH3CN 0
0
0
0
0
0
0
0
0
10
11
SnBr4 n-C5H11
CO2Et
Br -78°C to 
reflux
48
48
DCM 0
0
Again after workup, GCMS and 1H NMR analysis of the crude reaction material in all 
instances  showed  mostly  amine  starting  material,  recovered  in  quantitative  yields. 
Acetonitrile  was preferred as  solvent  in  most cases due  to  past  success. Studies by 
Hanessian, which involved an intramolecular aza-Prins cyclisation of an olefin tethered 
onto an iminium ion, included the use of tin tetrabromide at  -78 °C in DCM. These 
conditions were applied to our studies and again no positive results were obtained (Table 
15,  entries  10-11).  Again  it  was  assumed  that  the  instability  of  the  intermediate 
carbocation contributes significantly to the failures observed.
Veenstra successfully accomplished piperidine synthesis via aza-Prins coupling of CBz-
protected homoallylic amines to aromatic aldehydes, but the formation required the use of 
acetic anhydride and tin tetrachloride. No yields were published and Veenstra suggests 
that the solvent acetonitrile traps the carbenium ion, as opposed to the leaving group from 
the Lewis acid. This procedure was attempted using equimolar amounts of reagents at -20 
°C. Two trials were attempted, one following the literature procedure precisely with 16 
hours at -20 °C, the other slowly warming from -20 °C to room temperature and then an 
additional 7 days at room temperature. The literature procedure yielded mostly starting 
material, but the longer run gave a complex mixture of unwanted products, which even 
after  chromatography,  were  impossible  to  characterise (Scheme 25).  Based  on  this 
literature precedent, all our previous studies on the aza-Prins cyclisation were reviewed to 
identify acetonitrile-trapped piperidines, but again no positive results were found.
. cSolvent Effects of 
Acetonitrile
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N
H
O
O
Ph
N
O OPh
Ph
HN
O
a
90
Scheme 25. Reagents and conditions: (a) SnCl4, Ac2O, PhCHO, CH3CN (i) -20 °C, 16 h, 0%; (ii) -20 °C, 
5 h, rt, 178 h, 0%.
Since the major difference between the aza-Prins and the cyclisations involving silylated 
precursors is the stabilisation of the intermediate carbocation, it was proposed to induce 
stabilisation by using 3-alkylated homoallylic amines, which have a  more substituted 
alkene function. The cyclisation should be more favourable due to the formation of a 
tertiary carbocation over a secondary one. To obtain the more substituted homoallylic 
amine,  procedures  as  previously  described  were  used,  starting  with  commercially 
available  3-methyl-3-buten-1-ol  96.  Again  the  action  of  p-toluenesulfonyl  chloride 
afforded the crude tosyl-protected alcohol 97 in 75% yield. Amination of the tosylate 97 
using benzylamine gave N-benzyl-3-methyl-3-butenamine 98 in 97% yield (Scheme 26). 
OH O S
O
O N
H
Pha b
96 97 98
Scheme 26.  Reagents and conditions: (a) TsCl, 4-DMAP, Et3N, DCM, 0 °C, 48 h, 75%; (b) BnNH2, 
EtOH, 110 °C, 18 h, 97%.
After coupling of this amine 98 with the highly reactive ethyl glyoxylate in the presence 
of indium trichloride after 3 days at reflux, TLC showed complete consumption of the 
amine substrate. After flash chromatography a product 99 obtained in trace quantities was 
positively identified as the acetonitrile trapped piperidine by GC-MS analysis, however 
1H NMR data were inconclusive due to the small quantities obtained (Scheme 27).
. dStabilisa
tion Effects 
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N
H
Ph
N
Ph
O
O
N
Ph
HN
O
O
O
via
a
98
99
Scheme 27. Reagents and conditions: (a) InCl3, (CO2Et)CHO, CH3CN, 75 °C, 72 h, trace.
The substituted homoallylic amine was also screened with cyclohexanecarbaldehyde and 
indium trichloride or trimethylsilyl triflate. After 20 hours at reflux both attempts showed 
complete consumption of starting material 98 but after analysis by 1H NMR, it seemed 
that no piperidine 100 was formed in either case. Instead it seemed that the allylic amine 
had isomerised to the more substituted amine 101 by double bond migration, proven by 
1H NMR analysis (Scheme 28). 
N
H
Ph
N
Ph
HN
O
0 %
N
H
Ph
major product
a
98
100 101
Scheme 28. Reagents and conditions: (a) InCl3 or TMSOTf, c-HexCHO, CH3CN, 75 °C, 20 h.
Based on these studies it would again seem that the enhanced stabilisation present in a 
tertiary carbocation does not promote the vital cyclisation step of the olefin function onto 
the intermediate iminium ion. On condensation of the highly reactive ethyl glyoxylate and 
the amine substrate, it seemed that perhaps piperidine 99 formation was present, albeit in 
trace quantities. Perhaps, this is a result of the enhanced reactivity of the intermediate 
iminium ion caused by the neighbouring carboxylate function. 
Concurrent with  our  studies,  Martin  and  Padron published details  of  a  study of  an 
intermolecular  aza-Prins  reaction  between  homoallyl  amines  and  aldehydes  in  the 
presence of  a  Lewis acid  promoter.  This  work was  a  direct  progression  from their 
previous work on the Prins cyclisation of homopropargylic alcohols and aldehydes to give 
. 5Iron(III)  Halide  Mediated  Aza-Prins 
Reaction
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halo-dihydropyrans in the presence of iron trihalides. Here, the use of iron trihalides to 
generate  γ,δ–unsaturated-iminium  ion  intermediates,  which  further  cyclise  to  six-
membered azacycles, was  explored.  They  were  able  to  form  trans-2-alkyl-4-halo-1-
tosylpiperidines  from  homoallyl  tosylamines  102 and  2-alkyl-4-halo-1-tosyl-1,2,5,6-
tetrahydropyridines  from homopropargyl tosylamines via the aza-Prins reaction. Both 
iron trichloride and tribromide-based Lewis acids produced good yields of trans-2-alkyl-
4-halo-N-tosylpiperidines 103, although iron tribromide enhanced the yield in most cases. 
The aza-Prins cyclisation worked well with both aliphatic and aromatic aldehydes, with 
the  trans-diastereomer  being  formed  as  the  exclusive  product,  although  the 
diastereoselectivity is reduced in aldehydes containing an aromatic substituent (Table 16, 
entries 4-5 and 10-11). 
Table 16. The aza-Prins reaction of N-tosyl homoallylamine and aldehydes by Martin and Padron.
NHTs
N
Ts
X
R N
Ts
X
R
+    RCHO +
FeX3, DCM
10 mins.
102 103 104
Entry R X Trans:cis Total %Yield of 
103 and 104
1 c-Hex Cl 98:2 68
2 i-Bu Cl 99:1 82
3 n-C7H15 Cl 97:3 88
4 Ph Cl 90:10 46
5 PhCH2 Cl 83:17 78
6 H Cl - 91
7 c-Hex Br 98:2 82
8 i-Bu Br 97:3 96
9 n-C7H15 Br 98:2 90
10 Ph Br 92:8 82
11 PhCH2 Br 86:14 94
12 H Br - 90
The stereochemical outcome of these reactions was studied by ab initio calculations of the 
trans-2-alkyl-4-halo-tosylpiperidine  products  and  their  N-sulfonyl  iminium  ion 
intermediates. The calculations showed that in the cases of aliphatic aldehydes, the (E)-
iminium ion 105, which leads to trans-piperidine 106, is more stable than the (Z)-iminium 
ions  107 that lead to  cis-isomers  108.  In one instance, with an aldehyde bearing an 
aromatic ring, the (Z)-iminium ion was more stable (Table 17). They suggest that this 
could  account  for  the  fact  that  in  cases  where  an  aryl  aldehyde  was  used,  the 
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diastereoselectivity of the aza-Prins reactions was less selective. It must be said at this 
point that the authors make no comment on the Curtin-Hammett principle which dictates 
that the product  ratio  depends only on the difference in the activation energy of the 
transition state  going to  each product  (and therefore, reaction rate),  and not  on  the 
equilibrium constant between the intermediates. Another interesting comment made by 
the authors was that in both cis- and trans-isomers, where aliphatic aldehydes were used, 
the most stable conformer has the N-tosyl group endo over the piperidine ring. However, 
in the case where the aldehyde bore an aromatic ring, then the N-tosyl group had an exo 
disposition and this was evident in the X-ray crystallographic structures. 
Table 17. Stability of (E)-iminium ions from ab intio calculations by Martin and Padron.
N
O2S
R
N
O2S
R
N
O2S
R X
N
O2S
X
R
X X
(Z)-iminium (E)-iminium 105
106
107
108
Entry R EE-iminium-EZ-
iminium (kcal/mol)
E106-E108 
(kcal/mol)
1 Me -0.78 -1.25
2 Et -1.77 -2.12
3 i-Pr -1.25 -0.41
4 s-Bu -1.56 -0.74
5 CH2Ph +0.37 -2.12
Next their work proceeded towards an alkyne aza-Prins reaction where homopropargylic 
amines were coupled to  a  range of  aldehydes  in  the  presence of  iron  trihalides  as 
promoters. The precursor N-(but-3-ynyl)-4-methylbenzenesulfonamide 109 gave 2-alkyl-
4-halo-1-tosyl-1,2,5,6-tetrahydropyridines  110 in  good  yields,  albeit  on  reaction with 
benzaldehyde. Again the Lewis acid of choice was iron tribromide as it gave higher yields 
in most cases (Table 18).
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Table 18. Alkyne aza-Prins reaction between homopropargylic amines and aldehydes.
NHTs
N
Ts
X
R
+    RCHO
FeX3, DCM
10 mins.
109 110
Entry R X %Yield of 
110
1 c-Hex Cl 74
2 i-Bu Cl 85
3 n-C7H15 Cl 91
4 Ph Cl 29
5 PhCH2 Cl 63
6 H Cl 83
7 c-Hex Br 84
8 i-Bu Br 85
9 n-C7H15 Br 90
10 Ph Br 38
11 PhCH2 Br 67
12 H Br 96
DCM or 1,2-dichloroethane as solvent gave the greatest yields. When iron tribromide was 
used as  a  promoter and DCM as  solvent,  a  mixture  of  chlorovinyl  and bromovinyl 
derivatives was isolated. This was assumed to be a result of halide exchange between the 
halogenated solvent and the Lewis acid metal, as well as capture of the solvent halogen 
by the vinyl cation intermediate. The advantage of using iron trihalides over other metal 
halides was proven when indium trihalides were screened in the alkyne aza-Prins reaction 
in the presence of  iso-butyraldehyde. Although both indium Lewis acids promoted this 
reaction, it was with detriment to both yields of product and time of reaction. The indium 
trichloride mediated reaction produced 2-alkyl-4-halo-1-tosyl-1,2,5,6-tetrahydropyridine 
product 110 in 32% yield after 96 hours at room temperature, c.f. iron trichloride (85% 
yield in 10 minutes). Indium tribromide mediated reaction produced the 2-alkyl-4-halo-1-
tosyl-1,2,5,6-tetrahydropyridine product 110 in an improved 42% yield and after 24 hours 
at room temperature, a contrast to the use of iron tribromide which gave the product in 
85% yield after only 10 minutes. 
It  is interesting to observe that success was found with high yields and in very short 
reaction times in  Martin and Padron’s  studies, begging the question of  why did our 
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cyclisations show so little success? The first difference between our screening and this 
study is that the homoallyl amine is N-tosyl protected as opposed to benzyl, butyl, or CBz 
in our examples. It is noted by Martin and Padron that the sulfonamide nitrogen is of 
similar chemical reactivity to an alcohol moiety, which have found success in the Prins 
reaction. More specifically, it was believed that the benefit of the  N-tosyl group is the 
enhancement of the electrophilicity of the iminium ion, which would aid the cyclisation 
step. The next difference between our research is the use of iron(III) halides over indium 
trichloride. In Martin and Padron’s studies on the alkyne aza-Prins and the oxa-Prins 
reactions they found that iron(III) halides promote these cyclisations in 10 minutes and in 
very good yields, whereas indium trichloride required much longer reaction times and 
produced low yields  of product  in  some examples. The final difference between the 
studies is  the use of DCM and at  room temperature, whereas our studies have used 
acetonitrile  at  harsher  reflux  temperatures.  Based  on  their  studies  of  alternating 
halogenated solvents and iron(III) halides in  the  alkyne aza-Prins and  the  oxa-Prins 
reactions, they found that the solvent could contribute to the trapping of the intermediate 
cyclic carbocation. A disadvantage of the use of acetonitrile is that it could compete as a 
Lewis base with the aldehyde for the Lewis acid catalyst. It was found that the advantages 
of using acetonitrile were the solubility of the Lewis acid in this solvent as well as its high 
boiling point. 
It  is  believed that  indium trichloride  can  still  have  success in  promoting  aza-Prins 
reactions based on our initial studies and the success found by Martin and Padron in the 
alkyne aza-Prins reaction. In their examples they required anhydrous iron(III) halides, 
which are moisture-sensitive crystalline solids. Success has been found with both silyl-
Prins and aza-silyl-Prins when using indium trichloride, which is a crystalline solid, is 
easily handled in air, and has even promoted these reactions in the presence of water. Next 
the Dobbs group’s success in adopting indium trichloride in the aza-Prins reaction will be 
reported.  Also  reported  will  be  the  effect  on  the  diastereoselectivity  and  the 
regioselectivity of the reaction when using substituted N-tosyl homoallyl amines (Scheme 
29).
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NHTs
N
Ts
R
+    RCHO
InCl3, DCM
Cl
R4
R1
R4
+   other products
R2
R3 R1
R2
R3
Scheme 29. Proposed scheme for indium trichloride-mediated aza-Prins reaction.
For  the  initial  investigations  it  was  decided  to  focus  on  synthesising  homoallyl 
tosylamines that contained an internal olefin function instead of a terminal alkene. It was 
postulated that this would allow us to form 2,3,4-trisubstituted piperidines. By varying the 
geometry of  the  double  bond,  perhaps  this  would  have a  controlling  effect  on  the 
diastereoselectivity  of  the  aza-Prins  reaction.  The  simple  N-(pent-3-enyl)-4-
methylbenzenesulfonamides were obtained in 3 steps from commercially available pent-
3-yn-1-ol 111(Scheme 30). 
OH OH
OH OTs
OTs
NHTsNHTs
or
or
a
b
c
d
111 112
113
114
115
116117
Scheme 30.  Reagents and conditions: (a) H2,  Lindlar’s catalyst, MeOH, rt,  17 h,  79%; (b)  LAH, 
triglyme, THF, 85 °C, 72 h, 65%; (c) TsCl, DMAP, Et3N, DCM, 0 °C, 17 h, (Z)=88% or (E)=57%; (d) 
NaI, p-TsNH2, KOH, DMSO, 50 °C, 20 h, (Z)=94% or (E)=97%. 
The (Z)-pent-3-en-1-ol 112 was obtained by a literature method, catalytic hydrogenation 
over Lindlar’s  catalyst  affording the homoallylic  alcohol as  a  10:1  (Z:E)  inseparable 
mixture of geometric isomers in 79% yield. This ratio of isomers was maintained at each 
step in the precursor synthesis, even after flash column chromatography. The (E)-alkene 
113 was  exclusively  formed  in  65% yield,  again  by  a  known procedure, by  LAH 
reduction in triglyme and THF at 85 °C. The alcohol was fully characterised as its tosylate 
because even after distillation it  remained a mixture with triglyme. Both homoallylic 
alcohols were then transformed to the tosylates, each under the same conditions by the 
. a Precursor Synthesis for the Aza-Prins 
Reaction II
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action  of  tosyl  chloride  to  afford  the  (Z)-alkenyl  tosylate  114 in  88%  yield,  but 
disappointingly  the  (E)-alkenyl  tosylate  115 in  54%  yield.  Lastly,  the  homoallyl 
tosylamines  were  generated  by  the  substitution  of  the  tosylates  with  4-
methylbenzenesulfonamide in the presence of catalytic quantities of sodium iodide, using 
a  modified  literature  procedure.  Action  of  potassium  hydroxide  deprotonates  the 
sulfonamide and the tosylate is transformed in situ to the iodide by sodium iodide. Overall 
the  substitution  reaction  gave (Z)-homoallyl tosylamine  116 in  94% yield  and  (E)-
homoallylamine 117 in an excellent 97% yield. The geometry of the double bond in both 
homoallyl  tosylamines was confirmed by NOESY experiments with enhancements of 
3.2% and 2.1% between alkenyl protons  in  the (Z)-homoallylamine  116 and smaller 
enhancements of 2.4% and 0.5% in the (E)-homoallylamine 117. The synthesis of the (Z)-
isomer 116 was completed in 65% overall yield and the (E)-isomer 117 completed in 36% 
overall yield, both over 3 steps. 
Here the success of using homoallyl tosylamines with internal olefin functions in indium 
trichloride mediated aza-Prins reactions is reported. Small-scale reactions were performed 
to test the batch of indium trichloride and  1H NMR and GCMS data showed positive 
results for piperidine formation. Another Lewis acid, scandium triflate, which has been 
shown to be recyclable from an aqueous work-up, was screened with the same substrates 
with less success. With the positive result for indium trichloride in hand, a collection of 
aldehydes  were  screened  with  N-(pent-(3Z)-enyl)-4-methylbenzenesulfonamide  116. 
Success was found by Martin and Padron when using a stoichiometry of 1:1.5:1.5 for 
amine: Lewis  acid:  aldehyde,  so  these  quantities  were followed.  The  (Z)-homoallyl 
tosylamine 116 was screened with aliphatic and aromatic aldehydes as well as the highly 
reactive ethyl glyoxylate on <0.7 mmol scale and all reactions went to completion (Table 
19). 
. bAza-Prins  Cyclisations:  Effects  of  (Z)-
Homoallyl Amine 
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Table 19. The aza-Prins reactions of (Z)-homoallyl tosylamine.
NHTs
N
Ts
R
+    RCHO
InCl3, DCM
rt NTs
R
Cl
+
H
Cl
116 118a-e 119a-e
Entry R Time (h) %Yield
of 118a-e 
%Yield 
of 119a-e
1 n-C7H15 17 35 (a) 35 (a)
2 Ph 144 15 (b) 0   (b)
3 Ph(CH2)2 17 40 (c) 36 (c)
4 c-Hex 144 26 (d) 50 (d)
5 CO2Et 1 20 (e) 0   (e)
Performing  these  reactions  with  the  (Z)-homoallyl  tosylamine  116 formed  the  4-
chloropiperidine products 118, but in some cases also produced unexpected side-products 
of 3-(1-chloroethyl)pyrrolidines  119.  It  is  important to mention that since the starting 
material contained a  10:1(Z:E)  mixture  of  geometric  isomers, the  product therefore 
contained trace quantities of other cyclised products, the stereochemistry of which proved 
impossible to determine. These trace quantities were identified as 4-chloropiperidines and 
were inseparable after chromatography from the major diastereomer. Low yields of 4-
chloropiperidine 118 were observed on use of benzaldehyde or ethyl glyoxylate (Table 19, 
entries 2 and 5) and perhaps this is why no pyrrolidine product 119 was isolated. It was 
expected that the yields for benzaldehyde would be low, in accordance with previous 
examples of the aza-silyl-Prins reaction and also the examples reported by Martin and 
Padron. As with previous studies, ethyl glyoxylate seems highly reactive based on the 
short reaction time. However the low yields suggest the products formed are unstable. 
The high overall yield for cyclised material formed on the use of the three aliphatic 
aldehydes (Table 19, entries 1,3 and 4) was expected based on previous studies. The 
reactivity  of  hydrocinnamaldehyde and octanal  (Table  19,  entries 1  and 3)  in  these 
reactions seems comparable based on the overall cyclised yields and reaction times. The 
reactivity of cyclohexanecarboxaldehyde (Table 19, entry 4) seems low based on reaction 
times,  although  the  yield  of  cyclised  material  is  high.  The  formation  of  3-(1-
chloroethyl)pyrrolidine 119 in these reactions can be explained based on previous oxa-
Prins cyclisations by Li.  When homoallylic alcohols with internal double bonds were 
cyclised under Lewis acid-catalysed Prins conditions, then a mixture of tetrahydropyran 
or tetrahydrofuran products was observed. Li only observed this when the internal olefin 
54
Chapter Two
had a cis geometry and not when trans double bonds were utilised. A possible explanation 
behind the formation of the tetrahydrofuran product is to first envisage the usual chair 
intermediate. In the case of the trans homoallyl alcohol, all the substituents are equatorial 
whereas in  the case of  the  cis homoallyl alcohol the disfavoured pseudo 1,3-diaxial 
interaction leads to a mixture of carbocations. From here, subsequent nucleophilic attack 
from the chloride ion will either give the tetrahydropyran or the tetrahydrofuran (Scheme 
31). 
O Ph
H
O Ph
O Ph
+
O Ph
O Ph
Cl
+
Cl
Scheme 31. Outcome of disfavoured pseudo 1,3-diaxial interaction. 
There are examples in the literature on the formation of pyrrolidines on the use of internal 
olefin functions in iminium-olefin cyclisation reactions. It was believed that the reason for 
the formation of pyrrolidines 119 in our examples is based upon the disfavoured pseudo 
1,3-diaxial interactions. The reactions involving octanal or hydrocinnamaldehyde (Table 
19, entry 1 and 3) produced a 1:1 mixture of 6-membered 118 and 5-membered species 
119. This is a significant increase in the amount of 5-membered species 119 compared to 
Li’s examples. In the case of cyclohexanecarboxaldehyde the ratio further increased to 1:2 
and it was believed that this is based on further steric interactions from the cyclohexane 
ring.  The  stereochemistry  observed  in  both  4-chloropiperidine  products  and  3-(1-
chloroethyl)pyrrolidine  could  be  explained  based  on  ab  initio calculations  that  the 
intermediate (E)-iminium ion is more stable than the (Z)-iminium ion. However, again it 
must be stated that according to the Curtin-Hammett principle, the ratio between different 
isomers of the products are reliant only on the free energy of the transition states and not 
on the equilibrium constant between the intermediates. The observation that the (E)-
iminium ion is more stable does however allow us to explain the stereochemistry of the 
aza-Prins reactions. 
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Scheme 32. Effect of (E)-iminium geometry on stereochemistry in 4-chloropiperidines.
In  the  case of  4-chloropiperidine  syntheses,  the  (E)-iminium ion  119 allows the  C2 
substituent of the forming piperidine to adopt a pseudo-axial conformation and so leads to 
an axial substituent in the product 118. The cis geometry of the internal olefin allows the 
C3 substituent to again adopt  a pseudo-axial conformation and overall a  down-up-up 
configuration. The intermediate secondary carbocation 120 is then trapped by a chloride 
anion from the least hindered opposite face to the C2 substituent (Scheme 32). 
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Scheme 33. Effect of (E)-iminium ion geometry on stereochemistry in 3-(1-chloroethyl)pyrrolidine.
In the case of forming a 3-(1-chloroethyl)pyrrolidine 119 the (E)-iminium ion 121 again 
forces an axial C2 substituent (Scheme 33). Based on the chair transition state, it is visible 
that the sp2 carbon of the alkene allows a pseudo-axial conformation of the C3 substituent. 
It is debatable how the configuration of the third stereocentre is controlled. If the chloride 
anion traps the trigonal planar carbocation 122, then this could occur equally from either 
face. Possibly, neighbouring groups could hinder the attack of the carbocation 122 by the 
chloride anion. Alternatively a transition state  123 can be invisaged where the chloride 
ion attacks the sp2 alkene carbon at the point of cyclisation and so the geometry of the 
olefin is important (Scheme 34). 
56
Chapter Two
N
Ts
R
N
R
Ts
N
Ts
R
Cl
R1
ClR1
H
Cl
R1
Cl
δ- δ
+ 
δ+ δ- δ- 
122119123
Scheme 34. Contrast of carbocation formation and its effect on stereochemistry.
Overall the stereochemistry of the 3-(1-chloroethyl)pyrrolidine 119 is  cis across the C2 
and  C3  substituents  which  is  the  opposite  of  the  trans geometry observed in  the 
tetrahydrofuran analogues in Li’s work. The difference observed is based on the pseudo-
axial conformation related to the (E)-iminium ion and the pseudo equatorial conformation 
of the oxonium ion. 
The stereochemistry and the configuration of both 6-membered and 5-membered species 
were supported by NOESY experiments and X-ray crystallography.  In the trisubstituted 
piperidine  118b derived  from  the  coupling  of  the  (Z)-homoallylamine  116 and 
benzaldehyde there is firstly a trans relationship between C2 and C3 substituents.  This is 
proven by  the  1.6% enhancement of  the  methyl  hydrogens  in  the  C3  position  on 
irradiation of the hydrogen in the C2 position. There is a cis relationship between C2 and 
C3 substituents proven by the 1.4 and 1.1% enhancement on irradiation of each hydrogen 
at those positions. Similar nOe effects are observed in all piperidines derived from the 
(Z)-homoallylamine 118a-e (Figure 5). 
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Figure 5. The nOe effects of 2,3,4-trisubstituted piperidines.
In the disubstituted pyrrolidine derived from the coupling of the (Z)-homoallylamine 116 
and hydrocinnamaldehyde 119c there is firstly a  trans relationship between C2 and C3 
substituents. This  is  proven by the small 0.5% enhancement of the C3 hydrogen on 
irradiation  of  the  C2  hydrogen.  This  is  further  supported  by  the  1.3  and  1.4% 
enhancements  between the  C2  hydrogen and  the  C1  hydrogen of  the  1-chloroethyl 
substituent. There is also a 1.1% enhancement of the C3 hydrogen on irradiation of the C1 
hydrogen in the 1-chloroethyl  substituent, although it  is  difficult  to use this value to 
accurately  determine  the  relative  stereochemistry  at  these  positions.  Again  all 
disubstituted pyrrolidines derived from the (Z)-homoallylamine 116 showed similar nOe 
effects (Figure 6).
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Figure 6. The nOe effects of 2,4-disubstituted pyrrolidines.
It was not possible to determine which substituents were orientated axially or equatorially 
in these compounds. Fortunately the X-ray structure for 3-(1-chloroethyl)-2-cyclohexyl-1-
tosylpyrrolidine 119d was obtained (Figure 7). However an X-ray structure could not be 
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obtained for the 4-chloro-2-substituted-3-methyl-1-tosylpiperidines  118a-e derived from 
the (Z)-homoallylamine 116, although it was possible for a highly comparable compound, 
which will be discussed later.
                                     119d
N
Ts
H
Cl
Figure 7. X-ray structure of 3-(1-chloroethyl)-2-cyclohexyl-1-tosylpyrrolidine.
This clearly supports the NOESY experiments previously described, and also confirms 
the relative configuration of the compound. Here it  can be seen that  the cyclohexyl 
substituent adopts an axial conformation and the 1-chloroethyl substituent also adopts an 
axial conformation on the opposite face. It is interesting to observe that the N-tosyl group 
is  endo over the  pyrrolidine  ring  like  a  “sunshade”,  comparable with the  piperidine 
examples shown by Martin and Padron.
Now described are the results of the aza-Prins cyclisation on coupling N-(pent-(3E)-enyl)-
4-methylbenzenesulfonamides  117 with different aldehydes. The same aldehydes were 
screened as previously,  albeit without an aromatic example and all  reactions went  to 
completion on <0.7 mmol scale (Table 20).
. cAza-Prins  Cyclisations:  Effects  of  (E)-
Homoallyl Amine
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Table 20. The aza-Prins reactions of (E)-homoallyl tosylamine.
NHTs
N
Ts
R
+    RCHO
InCl3, DCM
rt NTs
R
Cl
+
H
124a-d 125a-d117
Cl
Entry R Time (h) %Yield 
of 124a-d
%Yield 
of 125a-d
1 n-C7H15 17 66 (a) 0  (a)
2 (CH2)2Ph 17 64 (b) 0  (b)
3 c-Hex 240 0   (c) 70 (c)
4 CO2Et 1 21 (d) 0  (d)
Performing  these  reactions  with  the  (E)-homoallyl  tosylamine  117 formed  the  4-
chloropiperidine product 124, exclusively in all but one case. In this other example the 
side-product of 3-(1-chloroethyl)pyrrolidine 125 was formed exclusively. The use of ethyl 
glyoxylate (Table 20, entry 4) is comparable with the example involving the (Z)-amine 
precursor 116, since the reaction time was very short but the yield was disappointingly 
low. Again the aliphatic aldehydes produced good yields in reasonably short reaction 
times (Table  20,  entries 1-3) with  a  slight  depreciation against  the overall yields  of 
cyclised  product  for  the  (Z)-amine  precursor  116.  As  expected,  no  3-(1-
chloroethyl)pyrrolidine product  125 was seen in three of the four examples due to the 
absence of the disfavoured pseudo 1,3-diaxial interaction in the chair transition state. This 
is consistent with the absence of tetrahydrofuran product in Li’s examples when using 
(E)-homoallylic  alcohols.  However,  most  surprisingly  the  formation  of  only  3-(1-
chloroethyl)pyrrolidine  125c was  observed  in  good  yields  on  use  of 
cyclohexanecarboxaldehyde (Table 20, entry 3). Again the actual reaction times were very 
long for use of this aldehyde (Scheme 35).
N
H
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Ts Ts
N
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Scheme 35. Unexpected pyrrolidine formation on use of cyclohexanecarboxyaldehyde. 
Again  the  stereochemistry observed  in  both  4-chloropiperidine  products  and  3-(1-
chloroethyl)pyrrolidine  can  be  explained  based  on  ab  initio calculations  that  the 
intermediate  (E)-iminium  ion  is  more  stable  than  the  (Z)-iminium  ion.  The  axial 
conformation of  the  C2  substituent  in  both  products  is  based  on  the  pseudo-axial 
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conformation resulting from the more stable (E)-iminium. The only difference in the 4-
chloropiperidine products 124 is that the (E)-alkene allows the C3 methyl group to adopt 
a  pseudo-equatorial  conformation (Scheme  36).  The  only  difference  in  the  trans-
disubstituted  pyrrolidine  125 in  that  the  third  stereocentre is  inverted based on  the 
geometry of the double bond.
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Scheme 36. Iminium ion and olefin geometry effects in 4-chloropiperidine formation. 
The  stereochemistry was  confirmed  again  by  use  of  NOESY experiments and  also 
analysis of the X-ray crystallography data. The nOe effects show that in the 4-chloro-2-
substituted-3-methyl-1-tosylpiperidines 124a-d, the relationship between the C2 and C3 
substituents is  cis.  This  is  based on  the  4.1% enhancement of  the  C3 hydrogen on 
irradiation of the C2 hydrogen in the example 124b taken from hydrocinnamaldehyde. In 
the same example there were enhancements of 1.4 and 1.8% between the C3 methyl 
hydrogens and the C4 hydrogen. This proves that there is a trans relationship between C3 
and C4 substituents. Similar nOe effects were observed in other examples of 4-chloro-2-
substituted-3-methyl-1-tosylpiperidines  124a-d obtained from the (E)-homoallyl amine 
117 (Figure  8).  In  the  1H  NMR  spectra  of  the  single  example  of  3-(1-
chloroethyl)pyrrolidine  125c occurring from the (E)-amine precursor  117,  the signals 
were too close together and so NOESY experiments are essentially inaccurate.
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Figure 8. The nOe of 2,3,4-trisubstituted piperidines.
The  configuration of  4-chloro-2-phenethyl-3-methyl-1-tosylpiperidine  124b and  3-(1-
chloroethyl)-2-cyclohexyl-1-tosylpyrrolidine 125c were confirmed on analysis of the X-
ray data (Figure 9). 
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124b 125c               
Figure 9. X-ray structure of 4-chloro-2-phenethyl-3-methyl-1-tosylpiperidine and 3-(1-chloroethyl)-2-
cyclohexyl-1-tosylpyrrolidine.
Again, for both heterocycles, the axial conformation of the C2 substituent is shown, a 
result of the intermediate (E)-iminium ion. For the 4-chloropiperidine 124b derivative the 
C3 methyl group adopts an equatorial position, a result from the geometry of the double 
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bond of the (E)-amine precursor. The equatorial chlorine in the C4 position is a result of 
attack on the intermediate carbocation from the least hindered face. The only difference 
for the pyrrolidine product 125c is that the third stereocentre is the opposite configuration 
to that observed in examples taken from the (Z)-amine precursor 116. This could be a 
result of the geometry of the olefin in the starting material. Interestingly, it  was also 
observed in these X-ray structures that the  N-tosyl group is  endo over the ring in both 
cases, consistent with observations by Martin and Padron (Figure 9).
There are a few comparisons that can be drawn when comparing the aza-Prins reaction 
mediated by  indium trichloride  or  iron(III) halides.  Firstly,  it  would  appear that  the 
iron(III) halides are better promoters of these cyclisations,  with regards to  the much 
shorter reaction times and the greater yields of product. This however must be taken into 
context as different amine precursors were used. Conversely, perhaps the use of indium 
trichloride has allowed us to witness the formation of the 5-membered pyrrolidines. 
Here,  an  attempt  will  be  made  to  support  the  observation  that  the  formation  of 
pyrrolidines  from the  indium  trichloride-mediated aza-Prins  reaction  was  reliant  on 
disfavoured pseudo 1,3-diaxial interactions in the chair transition state. It was planned to 
achieve this by increasing the chain length of the external (Z)-olefin associated group 
from  methyl  to  ethyl,  so  (Z)-N-(hex-3-enyl)-4-methylbenzenesulfonamide  128 was 
prepared in two steps from commercially available (Z)-hex-3-en-1-ol 126 (Scheme 37). 
OH OTs NHTs
a b
126 127 128
Scheme 37. Reagents and conditions: (a) TsCl, DMAP, Et3N, DCM, 0 °C, 20 h, 84%; (d) NaI, p-TsNH2, 
KOH, DMSO, 50 °C, 17 h, 62%. 
(Z)-Hex-3-en-1-ol 126  was treated with tosyl chloride to give the tosylate  127 in 84% 
yield  using previous  methods.  The sodium iodide-catalysed amination  procedure was 
used to generate the (Z)-homoallylic tosylamine 128 in 62% yield on treatment of the 
tosylate  127 with 4-methylbenzenesulfonamide. The yield of this substitution reaction 
was disappointing in comparison to the previous examples although it was performed on a 
26 mmol scale instead of 4 mmol. To confirm that the geometry of the double bond was 
. 6Studies into the Regiochemistry of  the Aza-Prins 
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retained from the commercially available starting material, NOESY experiments were 
completed on the (Z)-homoallylic tosylamine 128. A 1.4 and 2.7% enhancements between 
the two olefinic hydrogens on irradiation of each, confirmed the cis geometry. 
With the (Z)-homoallylic tosylamine in hand, the indium trichloride-mediated aza-Prins 
reaction was performed with the three aliphatic aldehydes that gave a mixture of six and 
five-membered  products  on  reaction  with  (Z)-4-methyl-N-(pent-3-
enyl)benzenesulfonamide 116 (Table 21). 
Table 21. Further aza-Prins reactions of (Z)-homoallyl tosylamines.
NHTs
N
Ts
R
+ RCHO
InCl3, DCM
rt N
Ts
R
Cl
+
N
Ts
R
+
Cl
H
128 129a-c 130a-c 131a-c
Entry R Time(h) %Yield
of 
129a-c
%Yield
of 130a-
c
%Yield
of 
131a-c
Ratio 
6:5*
Ratio 6:5#
1 n-C7H15 17 34 (a) 43 (a) 7  (a) 17:25 1:1
2 (CH2)2 Ph 17 31 (b) 49 (b) 10 (b) 31:59 10:9
3 c-Hex 72 14 (c) 62 (c) 10 (c) 7:36 13:25
*= ratio of 6-membered product to 5 membered product, includes 5 membered eliminated product.
# = previous example using (Z)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 116.
Each  aliphatic  aldehyde  gave  a  mixture  of  4-chloropiperidine  129,  3-(1-
chloropropyl)pyrrolidine 130 and a previously not observed, eliminated pyrrolidine 131. 
The total yield for cyclised material in each case increased on comparison to the reactions 
performed  with  (Z)-4-methyl-N-(pent-3-enyl)benzenesulfonamide  116.  Again  the 
reactions performed with octanal or hydrocinnamaldehyde (Table 21, entries 1-2) led to 
the amine subsrate being consumed within a day. Also as before, longer reaction times 
were observed on use of cyclohexanecarboxaldehyde (Table 21, entry 3). However the 
reaction of this tosylamine substrate with the cyclic aliphatic aldehyde was completed in a 
significantly  shorter  time  compared  to  the  use  of  (Z)-4-methyl-N-(pent-3-
enyl)benzenesulfonamide  116.  The  first  major  difference  to  be  observed  in  these 
examples was the formation of an unsaturated pyrrolidine 131, which was assumed to be 
a reaction by-product of the 3-(1-chloropropyl)pyrrolidine 130. It was assumed that the 3-
. b Aza-Prins  Cyclisations:  Effects  of  (Z)-
Homoallyl Amine II.
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(1-chloropropyl)pyrrolidine  130  underwent  an E1 elimination, based on the fact there 
was an absence of a strong base as found in E2 eliminations (Scheme 38). 
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Scheme 38. E1 elimination of 3-(1-chloropropyl)pyrrolidine.
In each case the eliminated species 131 was a minor reaction product and was inseparable 
from  the  4-chloropiperidine  129 by  chromatography.  Only  in  the  example  using 
cyclohexanecarboxaldehyde (Table 21, entry 3) was this species accurately characterised 
by  1H NMR. It is clear from this study that the quantity of 5-membered product was 
enhanced compared to the six membered product, a result of the chain elongation. It was 
assumed that the disfavoured pseudo 1,3-diaxial interactions in the chair intermediate 132 
were more prominent with the ethyl group and so the increased yield of 5-membered 
product  was  observed  (Scheme  39).  The  reactions  performed  with  octanal  or 
hydrocinnamaldehyde with the methyl substituent (Table 21, entries 1-2) produced a ratio 
of 1:1 for six membered to five membered products. However using the ethyl substituent 
improves the ratio to approximately 3:5 for octanal and 1:2 for hydrocinnamaldehyde. 
The  biggest  enhancement  in  pyrrolidine  production  was  on  use  of 
cyclohexanecarboxaldehyde where the ratio improves from approximately 1:2 to 1:6. 
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Scheme 39. Enhancement of disfavoured pseudo 1,3-diaxial interactions by chain elongation.
The  relative  stereochemistry  of  the  4-chloropiperidine  129 and  the  3-(1-
chloropropyl)pyrrolidine  products  130 was  confirmed by  NOESY experiments. This 
relative stereochemistry was the same as observed on use of the (Z)-4-methyl-N-(pent-3-
enyl)benzenesulfonamide  precursor  116.  In  the  4-chloro-2-substituted-3-ethyl-1-
tosylpiperidine 129b derived from the use of hydrocinnamaldehyde (Table 21, entry 2), 
the relationship between the substituents at C2 and C3 is trans. This was supported by the 
1.7% enhancement of the C3 methylene hydrogens on irradiation of the C2 hydrogen. The 
relationship between the C3 and C4 substituents in the same piperidine was cis, proven by 
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the 3.8% enhancement of the C3 hydrogen on irradiation of the C4 hydrogen. Similar nOe 
effects were observed for the other 4-chloropiperidines 129a-c (Figure 10).
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Figure 10. The nOe of 2,3,4-trisubstituted piperidines.
In the 3-(1-chloropropyl)pyrrolidine 130a, derived from octanal, the relationship between 
C2 and C3 substituents was trans in keeping with previous examples. This relationship 
was proven by the small 0.5% enhancement of the C3 hydrogen on irradiation of the C2 
hydrogen. This was further supported by the 1.0 and 1.4% enhancements between the C2 
hydrogen and the hydrogen on the third stereocentre, on irradiation of each (Figure 11). It 
is difficult to comment on the configuration of the third stereocentre based on nOe effects.
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Figure 11. The nOe of 2,4-disubstituted pyrrolidines.
It is believed that since the stereochemistry of the 4-chloropiperidine is exclusive and no 
trace  of  other  stereoisomers  was  found,  little  or  no  aza-Cope  [3,3]  sigmatropic 
rearrangement occurs in these aza-Prins reactions. This is in contrast to the aza-silyl-Prins 
reaction  where  evidence  of  this  rearrangement  was  found  when  a  silylated  (E)-
homoallylic  amine  16 was  isolated  from the  (Z)-starting  material. Initially  in  these 
reactions, a  silylated (Z)-homoallylic  amine was  coupled to  a  Lewis  acid  activated 
aldehyde to form an iminium-vinylsilane intermediate. This intermediate can undergo a 
[3,3] sigmatropic rearrangement and so the geometry of the vinylsilane is lost. When the 
retro-[3,3] sigmatropic rearrangement occurs, the more stable (E)-vinylsilane is likely to 
be formed, and the subsequent  reverse reactions lead to the silylated (E)-homoallylic 
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amine. If this explanation is applied to this example of the aza-Prins reaction, then the (Z) 
geometry of the iminium ion-olefin intermediate 133 could be altered to the (E) form 134 
via the  rearrangement.  If  this  were  the  case,  it  would  be  expected  to  observe  a 
stereochemistry in the piperidine product 135 comparable with the examples involving an 
(E)-homoallylic tosylamine 117 (Scheme 40). 
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Scheme 40. The aza-Cope rearrangement in the aza-Prins reaction, not observed.
Previously it has been observed that aza-Cope rearrangement does occur in the aza-Prins 
reaction based on the recovery of an aza-Cope hydrolysis product 94 (Table 14, entry 4-
5). It is assumed that in the examples involving homoallyl tosylamines, the cyclisation 
occurs rapidly and so little or no aza-Cope rearrangement can occur.
 The configuration  of  4-chloro-3-ethyl-2-phenethyl-1-tosylpiperidine  129b and  its  5-
membered  counterpart,  3-(1-chloropropyl)-2-phenethyl-1-tosylpyrrolidine  130b were 
proven on analysis of the X-ray crystallographic data (Figure 12). 
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Figure 12. X-ray structure of 4-chloro-3-ethyl-2-phenethyl-1-tosylpiperidine and 3-(1-chloropropyl)-
2-phenethyl-1-tosylpyrrolidine.
The configuration of products derived from the reaction with cyclohexanecarboxaldehyde 
(Table 21, entry 3) is also obtained from the X-ray data. These are the structures of the 5-
membered  3-(1-chloropropyl)-2-cyclohexyl-1-tosylpyrrolidine  130c and  also  the 
eliminated by-product, 2-cyclohexyl-3-(prop-1-enyl)-1-tosylpyrrolidine 131c (Figure 13). 
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Figure 13. X-ray structure of 3-(1-chloropropyl)-2-cyclohexyl-1-tosylpyrrolidine and 2-cyclohexyl-3-
(prop-1-enyl)-1-tosylpyrrolidine.
Once again, the C2 substituents adopt an axial conformation, a result of the intermediate 
(E)-iminium ion.  In  the 4-chloro-3-ethyl-2-phenethyl-1-tosylpiperidine structure  129b, 
the axial conformation of the C3 ethyl group and also the trans relationship between itself 
and the C2 substituent can be seen. This is in contrast  to the  cis geometry witnessed 
between C2 and C3 in the same product 124b derived from the (E)-homoallyl tosylamine 
117, highlighting the effect of the geometry of the double bond in the starting material. 
This  X-ray analysis  supports  the  stereochemical assignments  previously  made from 
NOESY experiments. The 4-chloro group adopts an equatorial conformation, a result of 
trapping the intermediate carbocation from the least hindered face. The most surprising 
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observation from this X-ray crystal structure is that the N-tosyl group does not adopt an 
endo conformation over the piperidine ring as in other examples (Figure 12).
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Scheme 41.  Steric effects between N-tosyl and C3 substituent. 
It is assumed that this is due to the steric hindrance caused by the axial C3 ethyl group, 
which means that the  N-tosyl  group instead faces away from the piperidine ring  135 
(Scheme 41). In all three pyrrolidines 130b-c and 131c, the trans relationship between the 
C2 and C3 substiuents is highlighted by an axial C2 group and an axial C3 group (Figures 
12 and 13). In both pyrrolidines that contain a 1-chloropropyl group 130b-c, the chlorine 
in the third stereocentre is introduced to same vertical face as the large C2 substituent. 
This is in keeping with the previous examples 119a,c,d derived from the (Z)-homoallyl 
tosylamine  116 and in contrast to  the example  125c derived from the (E)-homoallyl 
tosylamine 117, which is incorporated from the opposite face. It is felt that this supports 
the observation that the geometry of the double bond in the precursor has an effect on this 
third stereocentre. It is hypothesised that the chlorine attacks at the point of cyclisation 
and so can be included in a proposed transition state 136a-b (Scheme 42). 
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Scheme 42.  Proposed transition states for 3-(1-chloropropyl)-2-substituted-1-tosylpyrrolidine 
formation.
Based  on  the  regiochemical  outcome  of  the  indium  trichloride-mediated aza-Prins 
reaction when altering the olefin geometry, the effects of other substituents were studied, 
for example, using a tri-substituted double bond. Therefore 4-methyl-N-(4-methylpent-3-
enyl)benzenesulfonamide  139 was prepared in  two steps, starting from commercially 
available  4-methylpent-3-en-1-ol  137.  For  completeness,  4-methyl-N-(3-methylbut-3-
enyl)benzenesulfonamide  140 was  also  synthesised  from  commercially  available  3-
methylbut-3-en-1-ol 96 in two steps (Scheme 43). 
OH OTs NHTs
a b
OH OTs NHTs
a b
137 138 139
14096 97
Scheme 43. Reagents and conditions: (a) TsCl, DMAP, Et3N, DCM, 0 °C, 17 h & 48 h, 99% & 75%; (d) 
NaI, p-TsNH2, KOH, DMSO, 50 °C, 20 h & 18 h, 50% & 68%. 
The tosylate derivatives were obtained by the action of tosyl chloride on the commercially 
available alcohols 137 and 96. Each tosylate was prepared in excellent yield, 99% for 138 
and 75% for 97. Each tosylate was submitted to the sodium iodide-catalysed amination 
. 7Further Substituent  Effects  in  the  Aza-Prins 
Reaction
. aPrecursor Synthesis for the Aza-Prins Reaction 
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conditions as used previously to give moderate yields of the homoallylic tosylamines; 
50% for 139 and 68% for 140. 
With the precursor 139 containing a tri-subsituted double bond now available, the indium 
trichloride mediated aza-Prins  reactions  were performed on three aliphatic aldehydes. 
Surprisingly only two of these produced positive results (Table 22).  
Table 22. Further aza-Prins reactions involving tri-substituted olefin.
NHTs
N
Ts
R N
Ts
R
+
InCl3, DCM
rt
RCHO+
139 141a-c 142a-c
Entry R Time (h) %Yield of 141 
and 142 
Ratio
1 (CH2)2Ph 6 75      (a) 52:48
2 n-C7H15 6 60      (b) 58:42
3 c-Hex 144 Trace (c) 50:50
In each reaction, the tosylamine precursor was consumed and produced a mixture of 
pyrrolidine  isomers  141 and  142,  which  were  inseparable  by  flash  column 
chromatography. As in previous examples, the use of hydrocinnamaldehyde and octanal 
(Table 22, entry 1-2) produced good yields in short reaction times. The reaction times for 
these two aldehydes have been cut significantly on comparison to previous examples. It 
was assumed that the production of an intermediate tertiary carbocation 143 drives these 
reactions (Scheme 44).
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Scheme 44. Formation of stable tertiary carbo cation.
However,  on  use  of  cyclohexanecarboxaldehyde,  only  trace  quantities  of  cyclised 
pyrrolidine were identified on analysis of the GCMS and 1H NMR data (Table 22, entry 
3). Even though the reaction eventually went to completion, the majority of the product 
was  unidentifiable  material,  both  before  and  after  flash  column  chromatography. 
. b Aza-Prins  Cyclisations:  Effects  of 
Trisubstituted olefins.
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Interestingly, the product ratio of olefinic regioisomers was close to 1:1 in all cases and 
this ratio was maintained after chromatography. This is somewhat surprising, as the more 
substituted  olefinic  product  141 would  be  expected to  be  a  major  product.  It  was 
suggested  that  the  olefinic  products  were  formed  directly  from  elimination  of  the 
intermediate tertiary carbocation  143 and  not  from a  chlorinated  product,  since  no 
evidence for the presence of these products was observed. It seems that the reasoning for 
the  mixture  of  regioisomers  is  based  on  steric  effects  and  stability  of  reaction 
intermediates. Even though the fully substituted double bond would probably be the most 
stable  product  141,  any base-catalysed elimination is  more sterically viable from the 
unsubstituted position (Scheme 45). The competition between these pathways at room 
temperature leads to approximately a 1:1 mixture. Since it was assumed that this is an E1 
elimination process, a strong base is not required. Another hypothesis could be that the sp2 
centre of the fully substituted double bond  141 produces ring strain in the pyrrolidine 
core.
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Scheme 45. Steric and stability effects in E1 elimination. 
The next question to be answered is why 5-membered pyrrolidines are formed exclusively 
and not 6-membered piperidines. The explanation could be based upon the formation of a 
more stable tertiary carbocation 143 in a 5-membered intermediate against the formation 
of  a  less stable secondary carbocation in  a  6-membered intermediate  144.  It  is  also 
presumed that since a tri-substituted double bond was used, the disfavoured pseudo 1,3-
diaxial interactions in the chair transition state 145 are present leading to the 5-membered 
product (Scheme 46). 
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Scheme 46. Stability effects in carbocations. 
The relative stereochemistry of the 2-substituted-3-(prop-1-en-2-yl)-1-tosylpyrrolidines 
142a-b was suggested by NOESY experiments. This suggestion was not entirely accurate 
however, because of overlapping signals in the 1H NMR spectrum. The configuration of 
these products could not  be confirmed since no X-ray crystallographic data could be 
obtained. It was assumed that the relationship between the C2 and C3 substituents in the 
pyrrolidine products  142a-b was  trans, based on previous examples. Only small  nOe 
effects could be obtained and so this cannot accurately describe the relative configuration. 
However for the pyrrolidine 142b obtained from octanal, the trans relationship could be 
supported based on the small 0.1% enhancement of the C2 hydrogen on irradiation of the 
C3 hydrogen. This is further supported by the 0.6% enhancement of one of the olefinic 
hydrogens on irradiation of the C2 hydrogen (Figure 14).
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Figure 14. The nOe in 2-substituted-3-(prop-1-en-2-yl)-1-tosylpyrrolidines.
Now it was decided to perform indium trichloride-mediated aza-Prins reactions between 
two aliphatic aldehydes, ethyl glyoxylate and a homoallylic tosylamine 140 containing an 
external olefin. It was proposed that the positioning of this methyl group in the amine 
precursor would have a major affect on the stability of the intermediate carbocation and 
so possibly on the regiochemical outcome of the reaction (Table 23).
. c Aza-Prins  Cyclisations:  Effects  of 
Other Olefins
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Table 23. Further aza-Prins reactions involving di-substituted olefin.
NHTs
InCl3, DCM
rt
RCHO+
N
Ts
R N
Ts
R
+
140 146a-c 147a-c
Entry R Time(h) %Yield of 146 
and 147
Ratio
1 (CH2)2Ph 2 90 (a) 53:47
2 n-C7H15 2 73 (b) 53:47
3 CO2Et 1 0  (c) N/A
On use of the two aliphatic aldehydes (Table 23, entry 1-2), a mixture of regioisomers 
(146 and 147) of 4-methyltetrahydropyridine was formed, which was inseparable by flash 
column chromatography.  The ratio  of  regioisomers  was determined by analysing the 
intergration of  olefinic protons  in  the  1H NMR spectrum. The separation problem is 
highlighted by the fact that the gas chromatograph showed only one peak. Unfortunately 
when  using  ethyl  glyoxylate,  no  products  could  be  identified,  although  the  amine 
substrate  was  consumed.  Again  use  of  the  aliphatic  aldehydes,  octanal  and 
hydrocinnamaldehyde, have produced good yields of cyclised material and short reaction 
times (Table 23, entry 1-2). For these two aldehydes, this is the shortest time recorded for 
an  indium  trichloride  mediated  aza-Prins  reaction.  The  ratio  of  regioisomers  was 
approximately 1:1  in  each  case  and  this  ratio  was  maintained  after  flash  column 
chromatography. Again no traces of chlorinated species were identified by GCMS or 1H 
NMR analysis. It was assumed that the formation of a stable tri-substituted double bond 
formed via elimination from the intermediate tertiary carbocation 148 is more rapid than 
the  trapping by  chloride anions.  The formation  of  this  tertiary  carbocation  can also 
explain the regiochemical outcome of the reaction. The stability of this carbocation is 
much greater than a primary carbocation 149 that would be present if a five-membered 
intermediate had been produced (Scheme 47). 
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Scheme 47. Stability of tertiary carbo-cation.
The success found on use of 4-methyl-N-(3-methylbut-3-enyl)benzenesulfonamide 140 is 
unsurprising. This is based on the fact that the comparable N-benzyl substituted precursor 
98 screened in the initial studies (Scheme 27) was the only amine to produce positive 
results. Following this study our initial GCMS and 1H NMR data was reviewed so as to 
identify  any  tetrahydropyridine  products  formed on  use  of  the  N-benzyl  precursor. 
However, no positive results were identified and so it would seem that the N-tosyl group 
has a significant effect on the success of the aza-Prins reaction. It would seem that indium 
trichloride has  less  success on  promoting  the  aza-Prins reaction in  comparison with 
iron(III) halides with regards to yields and reaction times. However the mild nature of 
indium trichloride does have benefits with regards to handling. Also, perhaps the effect on 
reaction rates on use of this Lewis acid could affect the regiochemical outcome of the aza-
Prins reaction.
It is important to be able to utilise the aza-Prins reaction to form heterocycles substituted 
in all possible ring positions. With this in mind, it was proposed to synthesise homoallylic 
tosylamines that contained a C1 methyl group in order to functionalise the C6 position in 
the target piperidines (Scheme 47).
. 8Effects of the C1 Position in Homoallyl 
Amines
. aPrecursor Synthesis  for  the  Aza-Prins 
Reaction V
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Scheme 47. Proposed scheme for aza-Prins reaction of C1 susbtituted tosylamines.
In the past, utilising this position has allowed us to explore the diastereoselectivity of the 
silyl-Prins and aza-silyl-Prins reaction across the heteroatom in the formed heterocycle. In 
studies  on  the  aza-silyl-Prins  reaction  it  was  shown  that  the  2,6-disubstituted 
tetrahydropyridines formed had exclusive  trans geometry across the heteroatom. It has 
been proposed in previous work that the large N-substituent contributes to a steric effect 
known as A1,3 strain. It was believed that the same effect would be present in examples of 
the  aza-Prins  reaction  where  methyl  substituted  tosylamines  are  utilised.  Firstly 
synthesised was 4-methyl-N-(pent-4-en-2-yl)benzenesulfonamide 152 in two steps from 
the commercially available pent-4-en-2-ol 150 (Scheme 48).
OH NTs
OO
NHTs
a b
150 151 152
Scheme 48.  Reagents and conditions: (a)  N-Boc-TsNH, PPh3,  DIAD, THF, rt,  17h,  69%. (b) TFA, 
DCM, rt, 17h, quantitative.
Attempts  to  obtain  this  tosylamine  via the  sodium  iodide-catalysed  amination 
methodology were unsuccessful. Success was found following a literature procedure for 
two  steps.  Firstly  pent-4-en-2-ol  150 was  treated with  t-butyl  tosylcarbamate  under 
Mitsunobu conditions to  form the homoallylic tertiary amine  151 in  69% yield. The 
carbamate function was then cleaved by the action of TFA in DCM to give the required 
homoallylic tosylamine 152 in quantitative yield. 
To explore once again the regioselectivity of the aza-Prins reaction and introduce multiple 
substituents into the cyclised products, it was attempted to synthesise tosylamines with 
internal  olefins  and  a  C1  methyl  group.  Therefore  (E)-N-(hex-4-en-2-yl)-4-
methylbenzenesulfonamide 157 was synthesised in 4 steps from commercially available 
pent-4-yn-2-ol  153 (Scheme 49). The synthesis of the corresponding (Z)-N-(hex-4-en-2-
yl)-4-methylbenzenesulfonamide was unsuccessful.
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Scheme 49.  Reagents and conditions: (a)  n-BuLi, MeI, THF, -78  °C to rt, 53%. (b) LAH, triglyme, 
THF, 85 °C, 60%. (c) TsCl, Et3N, DMAP, 0 °C, 40 h, 25%. (d) TsNH2, KOH, NaI, DMSO, 50 °C, 20 h, 
31%. 
To synthesise the appropriate (E)-olefin, the alkyne methylation of pent-4-yn-2-ol  153 
was required. Deprotonation of the alkyne hydrogen with  n-butyllithium followed by 
treatment with iodomethane gave the methyl substituted alkyne  154 in a disappointing 
53% yield. To access the (E)-homoallylic alcohol, the alkyne 154 was treated with LAH 
in a mixture of triglyme and THF to give the required geometric isomer 155 in 60% yield. 
The alcohol was fully characterised as its tosyl activated alcohol 156 because even after 
distillation, it remains a mixture with triglyme. The homoallylic alcohol was transformed 
into  the  tosyl  activated alcohol   by  the  action  of  tosyl  chloride in  the  presence of 
triethylamine  and  4-dimethylaminopyridine  to  give  (E)-hex-4-en-2-yl  4-
methylbenzenesulfonate  156  in 25% yield. As in previous examples, this tosylate  156 
underwent sodium  iodide  catalysed amination to  give  the  required (E)-homoallylic 
tosylamine 157 in 31% yield. 
Next, aza-Prins reactions with 4-methyl-N-(pent-4-en-2-yl)benzenesulfonamide 152 were 
attempted with an aim to synthesise 2,4,6-trisubstituted piperidines 158. Various different 
aldehydes were screened, with  various temperatures, solvents  and  Lewis acid  being 
employed, but unfortunately, no positive results were found for generation of cyclised 
material (Table 24).
. bAza-Prins  Cyclisations:  Effects  of  the  C1  Position  in 
Homoallyl Amines
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Table 24. The aza-Prins reactions involving a C1 substituted tosylamine.
NHTs
1.5 eq.LA,
 solvent
RCHO+
N
Ts
R
Cl
152
158
Entry R LA solvent Temp. Time Comment
1 n-C7H15
2 (CH2)2Ph
3 c-Hex
InCl3
4 n-C7H15 TMSOTf
DCM Rt and 
reflux
48 h, then 
24 h reflux
No reaction, SM 
remained
Rt 48 h “       “
Rt 48 h “       “
Rt 48 h “       “
5 (CH2)2Ph InCl3 CH3CN Rt and 
reflux
48 h, then 
72 h reflux
“       “
6 (CH2)2Ph FeCl3 
anhydrous
DCM Rt 70 h 90% SM 
consumed, 
product trace
When the  three  aliphatic  aldehydes that  had  brought  the  most  success  in  previous 
examples were  screened in  the  presence of  indium trichloride  and  DCM at  room 
temperature, no reaction was observed (Table 24, entry 1-3). Even when more forcing 
conditions were attempted with DCM at reflux, still only starting material remained. Also 
when trimethylsilyl triflate was screened in comparative conditions, again the results were 
negative.  When the solvent  was altered for the higher boiling acetonitrile  and reflux 
conditions attempted, still only starting material remained and no trace of any type of 
cyclised product was observed. Finally it was decided to screen iron(III) chloride and 
after  70  hours  at  room  temperature, most  of  the  starting  material  was  consumed. 
However, only trace quantities of product were detected on analysis by GCMS and the 
rest of the crude mass was unidentifiable. It is highly disappointing that no success was 
found when this C1 methyl substituted tosylamine was screened as this potentially limits 
the use of the aza-Prins reaction in other fields such as pharmaceuticals. 
Next  to  be  attempted  were  aza-Prins  reactions  with  (E)-N-(hex-4-en-2-yl)-4-
methylbenzenesulfonamide 157. Even though it appears that the C1 methyl group hinders 
these cyclisation reactions, it was hoped that the internal olefin function would enhance 
the stability of reaction intermediates. If the six-membered carbocation intermediate 159 
is considered, then the  adjacent  methyl substituent would enhance the stability of the 
adjacent empty p-orbital via hyperconjugation and so promote the cyclisation step (Figure 
15). 
78
Chapter Two
N
O2S
R
159
Figure 15. Stabilisation of intermediate carbo cation by hyperconjugation.
This is comparable with the β-effect of silicon where there is sufficient overlap between 
the empty p-orbital and the polarised carbon-silicon σ-orbital to stabilise the intermediate. 
Our screening studies included alterations in temperature and solvents but no positive 
results for generation of cyclised material 160 and 161 were observed (Table 25). 
Table 25. The aza-Prins reactions involving C1 substituted tosylamine and other substituents.
NHTs
InCl3,
solvent
RCHO+
N
Ts
R
Cl
N
Ts
R
Cl
+
157
160 161
Entry R Solvent Temp. Time Comment
1 (CH2)2Ph DCM Rt and 
reflux
72 h, then 
72 h reflux
No reaction, SM 
remained
2 (CH2)2Ph DCM Rt and 
reflux
24 h, then 
24 h reflux
No reaction, SM 
remained
3 (CH2)2Ph CH3CN Reflux 72 h No reaction, SM 
remained
  
When the standard conditions of indium trichloride and DCM at room temperature were 
applied  to  the  (E)-isomer  157 and  hydrocinnamaldehyde (Table  25,  entry  1-2),  no 
progress was observed. When a more forcing reflux temperature was adopted, still only 
starting material remained (Table 25, entry 1-2). Even when the higher boiling acetonitrile 
was used at reflux, no positive results were obtained (Table 25, entry 3).  It would seem 
that again the issues surrounding the  C1 methyl group of the tosylamine substrate are 
responsible for the failure of these cyclisation reactions. Even the additional stabilisation 
that was proposed to be present adjacent to the carbocation intermediate has not aided the 
progress of the reaction. The failure of the C1 methyl substituted tosylamines has been 
unfortunate  as  it  limits  the  use  of  the  aza-Prins  reaction  in  other  fields  such  as 
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pharmaceuticals. However, heterocycles with fewer substituents are accessible using an 
aza-Prins reaction mediated by either iron(III) halides or indium trichloride. The use of 
indium  trichloride  has  identified  alternative  regioselective  routes  for  this  reaction, 
meaning that pyrrolidines as well as piperidines are accessible. 
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CHAPTER THREE: Formation of 6-
Trifluoromethyl-3,4-dihydropyrans and 6-
Trifluoromethyl-3,4-tetrahydropyridines
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. ILiterature Review for Formation of Trifluoromethyl Containing Heterocycles.
With a previous member of the Dobbs group having optimised silyl-Prins methodology in 
order  to  obtain  simple  heterocycles,  now  desired  was  the  incorporation  of  a 
trifluoromethyl substituent, to possibly enhance the biological interest in these studies. 
The substrates that were required for the silyl-Prins and aza-silyl-Prins reactions were 
silylated homoallylic alcohols and silylated N-protected homoallylic amines respectively. 
It  has  been  shown  that  it  is  possible  to  form  2,6-disubstituted  heterocycles  by 
incorporation of a substituent at C1 in the amine or its alcohol precursor. It occurred to the 
Dobbs  group  that  it  maybe possible  to  introduce a  trifluoromethyl group in  the  C6 
position  of  the  heterocycle  with  the  silyl-Prins  and  aza-silyl-Prins  reactions  by 
introducing this group adjacent to the hydroxyl or secondary amine function (Scheme 49). 
XH
CF3
XF3C R2
R2CHO, Lewis acid
(X = O,NR) (X= O, NR)
TMS
Scheme 49. Proposed scheme for silyl-Prins cyclisations with 2-trifluoromethyl substituted substrates.
Mechanistically,  both  cyclisations  involve attack by  the  oxygen or  nitrogen of  each 
substrate on a Lewis acid-activated aldehyde. If a highly electron withdrawing group is 
introduced on  the  adjacent  carbon,  then  the  nucleophilicity  of  the  heteroatom will 
presumably be reduced, thus affecting the kinetics of the reaction. These electronic effects 
may in turn also have an effect on synthesis of the precursor molecules. The following 
review cites examples of success in forming trifluoromethyl containing heterocycles as 
well as the appropriate substrates. 
The following review describes the synthesis of 6-trifluoromethyl-3,4-dihydropyrans and 
their precursors previously reported in the literature. 
An early article by Linn describes the use of acyclic fluoroketones in the hetero Diels-
Alder reaction. At the time, the use of carbonyl compounds in the Diels-Alder reaction 
was limited, although examples did include the reaction of formaldehyde with 2-methyl-
1,3-pentadiene at 185  °C. The same aldehyde did not however produce a Diels-Alder 
adduct on reaction with butadiene, although there were examples of extremely labile 
hexafluorocyclobutanone  reacting at  0  °C.  Linn describes the  successful  addition  of 
. 9Literature  Examples  of  Formation  of  Fluorinated 
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acyclic fluoro-ketones  163 such as hexafluoroacetone, decafluoro-3-pentanone and 1,3-
dichlorotetrafluoroacetone  to  dienes  162,  such  as  butadiene,  isoprene  and  2,3-
dimethylbutadiene. These reactions were performed at 100-200 °C without any solvent 
and produced dihydropyran products in good yields (Table 26). Although the Diels-Alder 
adducts  164 from these reactions  contain additional  fluorinated substituents to  those 
dihydropyrans targeted, it does show that these types of compounds may be synthesised 
and isolated.
Table 26. Formation of fluorinated oxa-cycles using the Diels-Alder reaction.
O X
X
R1
R2R1
R2 O
XX
+ 100-200°C
    neat
162 163 164
Entry R1 R2 X %Yield
1 Me Me CF3 92
2 Me Me CF2Cl 76
3 Me Me C2F5 95
4 H H CF2Cl 88
5 Me H CF3 83
The  next  example  by  Yamazaki  and  co-workers  includes  the  formation  of  a  6-
trifluoromethyl-3,4-dihydropyran and  also  the  corresponding  3,4-dihydroxy analogue 
which might also be accessed by our methodology. They emphasise the importance of the 
introduction  of  fluorine  for  enhanced  biological  activity,  namely  in  “sugar-type” 
molecules. At that time, the production of trifluoromethyl sugar analogues was rare and 
production  of  mono- or  di-fluorinated  sugars  was  more common.  For  example,  the 
reagent DAST has been utilised to transform carbonyl groups into difluoromethylene or 
difluoromethyl groups. The preparation of 6-deoxy-6,6,6-trifluoro-D-mannose and  D-
allose  from  the  same  key  intermediate,  anti-trifluoromethyl-2-butenolide  has  been 
described 168. This was obtained from a furan analogue 165, by deacetylation to give the 
alcohol 166, which could be separated from the acetylated enantiomer 167. This was then 
simply silyl-protected and then oxidised by a modified Kuwajima-Urabe procedure to 
give  the  desired trifluorinated 2-butenolide  as  a  1:1  mixture  of  diastereomers. The 
unwanted  syn product  169 could be epimerised to the desired  anti product  168 after 
treatment with LDA followed by quenching the reaction mixture with acetic acid. This 
butenolide  168 could be oxidised with potassium permanganate in  the presence of a 
crown ether to yield the di-hydroxylated species 170 which was produced face-selectively 
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due to the steric hindrance of the 1-t-butyldimethylsiloxy-2,2,2-trifluoroethyl group. The 
diol 170 was protected as its acetonide  and after DiBAL reduction a lactol was produced 
171. Base-promoted rearrangement/isomerisation conditions utilised the tautomeric forms 
of the cyclic hemi-acetal eventually to afford the tetrahydropyran 172 (Scheme 50).
O
AcO
F3C
TMS O
F3C
TMS O
F3C
TMS
HO AcO
O
F3C
O
TBSO
O
F3C
O
TBSO
O
F3C
O
TBSO
HO OH
O
F3C
OH
TBSO
O O
O OHF3C
TBSO
O
O
+
+
a
b, c
d
e, f
g
165 166 167
168 169170
171 172
Scheme 50.  Reagents and conditions: (a) lipase PS, 50% (98% ee); (b) TBSCl, imidazole, 93%; (c) 
MMPP, AcOH, 89%; (d) KMnO4, 18-crown-6, 42%; (e) Me2C(OMe)2, H+; (f) DiBAL; (g) KOt-Bu, 
35%. 
The preparation of 6-deoxy-6,6,6-trifluoro-D-mannose required di-hydroxylation from the 
opposite face of the olefin and so the order of the synthetic sequence was altered. The 
same butenolide  168 as previously employed was subjected firstly to DiBAL reduction 
and then potassium  t-butoxide effected the isomerisation pathway which yielded a 2-
hydroxy-5-siloxy-6-trifluoromethyl-3,4-dihydropyran  173.  The dihydropyran was  then 
converted into methyl glycoside and then di-hydroxylated with potassium permanganate 
on the less hindered  α-face to give a diol. This diol was then simply protected as the 
diacetate 174 (Scheme 51).
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O
F3C
O
TBSO
O OHF3C
TBSO
O OMeF3C
TBSO
OAc
OAc
a, b c, d, e
168 173 174
Scheme 51.  Reagents and conditions: (a) DiBAL; (b) KOtBu, 63%; (c) MeOH, H+; (d) KMnO4, 18-
crown-6, 55%; (e) Ac2O, pyridine.
Yoneda  describes  another  example involving  the  Diels-Alder  reaction  to  access  6-
trifluoromethyl-3,4-dihydropyrans.  In  this  case  however,  the  Lewis  acid-catalysed 
conditions also promoted the “ene” reaction. In this report the use of zinc(II) triflate and 
zinc(II) chloride was successful for the reaction between trifluoroacetaldehyde 175 and 
conjugated dienes 176 for producing both ene 177 and Diels-Alder products 178. It seems 
that the relatively low acidity of the zinc Lewis acids allows unwanted side reactions to be 
avoided, such as self-polymerisation of both starting materials. Optimal conditions for ene 
or Diels-Alder reactions were gained by use of DCM or nitromethane as solvent, mostly 
at room temperature. To favour the formation of 6-trifluoromethyl-3,4-dihydropyrans 178 
from the Diels-Alder reaction, it seemed that zinc(II) chloride must be adopted and this 
was  predominantly observed  in  the  reaction between trifluoroacetaldehyde and  2,3-
dimethylbuta-1,3-diene or  5,6-dimethyleneundecane. Zinc(II) triflate was insoluble in 
DCM which meant that it could be isolated by conventional filtration and also be re-used 
without  the  deterioration  of  catalytic  activity  (Table  27).  This  example has  perhaps 
highlighted that weakly acidic Lewis acids can be employed in the production of 6-
trifluoromethyl-3,4-dihydropyrans without the occurrence of unwanted side-reactions.
Table 27. Zinc mediated Diels-Alder reaction for formation of fluorinated oxa-cycles.
O
F3C
R1
R2
O
CF3
R1
OH
R1
R2
CF3
R2
++
ZnX2
175 176 177 178
Entry R1 R2 X Solvent Temp. (°
C)
%Yield of 
177
%Yield
of 178 
1 Me H OTf DCM 25 25 31
2 Me H OTf DCM 50 29 31
3 Me H Cl MeNO2 50 12 52
4 (CH2)3CH3 (CH2)3CH3 OTf DCM 25 7 48
5 (CH2)3CH3 (CH2)3CH3 Cl MeNO2 25 0 54
The next  literature example shows compounds of  biological  importance that  contain 
internal perfluoroalkane diyl  fragments (IPF) rather than the more common terminal 
perfluorinated moieties. This study focussed on incorporating IPF’s into carbohydrate or 
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glycoside molecules, which are comparable to  the pyran systems that  the silyl-Prins 
reaction affords (Figure 16). This work by Linclau follows on from work by DiMargo, 
focussing on enhancing polar hydrophobicity for molecular recognition by replacing polar 
hydrophilic groups such as hydroxyl groups with polar hydrophobic groups like fluorine 
and  difluoromethylene moieties.  Effects  of  these  replacements  include  the  10-fold 
increase in diffusion across red blood cell membranes with racemic hexafluoropyranose 
compared to 3-deoxy-3-fluoroglucose. 
O
HO
OH
F
F
F F
F
F
O
BnO
OH
F
F
F F
O
BnO
F
F
F F
O
F
F F
F
BnO OH
       racemic
hexafluoropyranose
tetrafluorofuranose tetrafluoropyranose protected glycal
Figure 16. Examples of carbohydrates and glycosides containing IPFs.
The precursor synthesis began with the Sharpless asymmetric dihydroxylation of allyl 
bis(difluoromethylene) bromide  179 to the dihydroxyl substrate 180 in 89% yield and in 
78% ee. Selective benzyl protection with benzyl bromide was performed to give 181 in 
96% yield and the secondary hydroxyl was coupled to formic acid with DCC and DMAP 
in 95% yield. The resulting fluorinated formic ester  182 underwent cyclisation to the 
furanose  185 via a lithium fluoromethylene species  183 in 78% yield with only trace 
amounts of a β-fluoride eliminated product  184.  A 2,4-dihydroxy-3,4-tetrafluoropyran 
186 was also accessible via hydrogenolysis of the benzyl group (Scheme 52).
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CF2CF2Br
OH
CF2CF2Br
OH
OBn
CF2CF2Br
OH
OBn
CF2CF2Br
O
OBn
CF2CF2Li
O
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O
F
F F
F
BnO OH
OBn
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OH
CF2
+
O OH
F F
F
FHO
a b c
d
e
179 180 181
182
183184185186
Scheme 52.  Synthesis  of  IPF containing furanose.  Reagents  and  conditions:  (a)  K2OsO4.2H2O (2 
mol%), (DHQ)2PYR (2 mol%), K3[Fe(CN)6], K2CO3, t-BuOH, H2O, 4 °C, 9 days; (b) Bu2SnO, toluene, 
reflux, 24 h, then BnBr, Bu4NI, reflux, 16 h; (c) DCC, DMAP, HCOOH, DCM, rt, 16 h; (d) MeLi (1 
equiv.), THF, -78 °C, 3 h; (e) Pd(OH)2/C, H2, rt, 16h.
Other IPF molecules were available by generating an intermediate α-bromoether  535 
from the monobenzylated hydroxyl bromide 181. The tetrafluoropyranose formed from 
cyclisation,  and  then  hydrogenolysis  was  given in  variable  yields  depending  on  the 
deprotection method. Furthermore the pyranose 536 could be converted into the glycal 
537 by Grieco elimination, via deprotection at the anomeric position (Scheme 53). 
OBn
CF2CF2Br
OH
OH
BnO
OR
F
F
F F
O
R'O
OR
F
F
F F
O
BnO
F
F
F F
Br
a b
181 535 536 537
Scheme 53.  Synthesis  of  IPF containing glycal.  Reagents  and  conditions:  (a)  Na2S2O4,  NaHCO3, 
DMSO, CH2CHOR, rt, 16 h; (b) o-NO2C6H4SeCN, PBu3, THF, rt, 1 h, then H2O2 (30% aq.), NaHCO3, 
rt, 1.5 h.
The  following  report  by  Billard  and  Langlois  focuses  on  the  use  of  ring-closing 
metathesis to furnish 6-trifluoromethyl-3,4-dihydropyrans. The precursor synthesis was 
designed to  incorporate easily used, commercially  available starting materials,  unlike 
gaseous trifluoroacetaldehyde, which has  been used in  other  strategies. The starting 
material  in  question,  a  fluoral  methyl  hemiacetal  187 is  essentially  equivalent  to 
trifluoroacetaldehyde and was used to access 1-trifluoromethyl homoallylic alcohols 189. 
This was done by treatment with allyl bromides 188 in the presence of one equivalent of 
indium metal in DMF. This methodology produced a range of homoallyic alcohols 189 in 
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good  to  moderate  yields  and  afterwards  these  alcohols  were  esterified.  This  was 
performed by the deprotonation of the alcohol with sodium hydride in DMF followed by 
the coupling to allylic halides to yield the RCM precursors 190 (Scheme 54).
OMe
F3C OH
Br
CF3
OH
R1
R
R1
R
OF3C
R2
R
R4
+ a b
10-90% 35-95%R = Ph 
R1 = Br, CO2Et R4 = Ph
R5 = Br, CO2Et
R5
187
188 189 190
Scheme 54. Precursor synthesis for RCM. Reagents and conditions : (a) 1 eq.In, DMF; (b) NaH, DMF, 
allylic halides.
The optimal conditions for the cyclisation pathway required the Grubbs II catalyst and 
gave dihydropyran products 191 in a few instances but frequently, a complex mixture of 
products. The enyne metathesis reaction was also attempted under the same conditions to 
achieve the synthesis of a conjugated diene 193 in only moderate yields. However under 
the same conditions, good yields were obtained for the corresponding nitrogen series to 
afford a 6-trifluoromethyl-3,4-tetrahydropyridine  195.  The improvement in yields was 
thought to originate from the use of a carbamate function on the nitrogen, which inhibits 
the nitrogen lone pair from chelating to the ruthenium carbene 194, as would be the case 
in the oxygen series 192 (Scheme 55).
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OF3C
R2
R3
R3 = tethered to R4
R4 = Ph, tethered to R3
R5 = Br
OF3C
R2
R3
R5
R4
R
R5 a
0 -70%
OF3C
Ph
OF3C
Ph
40%
a
N
CBz
F3C
N
CBz
F3C
a
75%
OF3C
Ph Ru
NF3C
Ph Ru
OBnO
191
192
193
194
195
Scheme 55. Ring-closing metathesis and enyne metathesis.  Reagents and conditions: (a) Grubbs II, 
DCM, 50 °C.
The  following  review  shows  examples  of  the  synthesis  of  6-trifluoro-3,4-
tetrahydropyridines or 6-trifluoromethyl piperidines and their precursors reported in the 
literature. The first example allowed the Dobbs group to make proposals for the synthesis 
of the trifluoromethyl amine substrate for the aza-silyl-Prins reaction. It is based on the 
synthesis of α-trifluoromethyl amines 197 via ring opening of optically active N-benzyl-
2-trifluoromethyl  aziridines  196.  The  author  reports  that  optically  active  N-benzyl 
trifluoromethyl aziridine  196 is  actually  afforded  via commercially  available  1,1,1-
trifluoromethyl-2,3-epoxypropane  (75%  ee)  in  good  yields.  The  opening  of 
trifluoromethylated aziridines using oxygen, sulfur nucleophiles or halogens has already 
been reported but opening with nitrogen or carbon nucleophiles was not possible. It is 
well documented that there is difficulty in opening the epoxide analogue with carbanions, 
probably owing to the electrostatic repulsion between lone pairs on the fluorines and the 
negative charge on the nucleophile. Karimova and co-workers reported the opening of the 
racemic trifluorinated aziridine with Brønsted acids such as thioacetic acid, sulfuric acid 
and  p-tosylic acid. Initially studied was acid catalysed ring opening with nucleophiles, 
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which proceeded regiospecifically  to  give  β  cleaved products  in  good yields.  These 
included using  halogenated Brønsted acids  as  well  as  water as  nucleophiles  (in  the 
presence of sulfuric  acid for the latter) resulting in α-trifluoromethyl amines in good 
yields at room temperature (Table 28). 
Table 28. Acid promoted ring-opening reactions of trifluoromethyl N-benzyl aziridine.
N
F3C
Ph
H Nu+ F3C
Nu
NHacid cat.
solvent
196 197
Ph
Entry %ee Temp. HNu Acid catalyst Solvent %Yield
1 94
2 94
3 unknown
4 >99
5 83
rt HCl
HBr
None H2O
94
93
H2O
CF3CO2H
H2SO4
EtOH
THF
64
98
88
6 unknown
7 unknown
90 °C
PhSH
CF3SO3H 85
None 40
8 92 rt
9 unknown 40 °C
PhSeH
CF3SO3H
None
10 unknown rt Ph2PH CF3SO3H
DCM
97
87
85
It is worth noting that the β-brominated amines could be possible building blocks for 
precursors  for  the  aza-silyl-Prins  reaction,  as  substitution  of  alkyl  bromides  with 
trimethylsilyl acetylides is well documented. 
Direct opening of  the  aziridine  196 under neutral  or  basic conditions  only  afforded 
starting material when using nucleophiles such as benzylamine, sodium cyanide, sodium 
azide, and diethylamine (Scheme 56).
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N
F3C
Ph
Nu
THF, r.t or
reflux
no reaction
196
Scheme 56. Un-successful opening of aziridine with nucleophiles.
Interestingly,  molecular orbital  calculations  suggested that  the  aziridine  should  have 
higher reactivity than its epoxide counterpart, as there is a higher positive charge on the 
methylene carbon (from a more polar β carbon-nitrogen bond) and a much lower LUMO 
than for non-fluorinated aziridines and epoxides. Also investigated, but with no success, 
was the Lewis acid-promoted ring-opening of the trifluoromethylated aziridine  196 at 
room  temperature  or  reflux  with  benzylamine  or  diethylamine  nucleophiles  using 
aluminium chloride, titanium(IV) chloride, boron trifluoride etherate or ytterbium triflate. 
It is assumed that it is the low co-ordinating ability of the lone pair on the nitrogen atom 
towards Lewis acids restricted the forward reaction whereas the epoxide equivalent is 
known to co-ordinate with success to Lewis acids. 
Langlois and Billard have published a paper related to their work on the synthesis of 6-
trifluoromethyl-3,4-dihydropyrans. In this case, they again used ring-closing metathesis to 
form 6-trifluoromethyl-3,4-tetrahydropyridines and  then  used  this  core  to  synthesise 
trifluoropipecoline  204.  They  targeted  a  homoallylamine  for  their  synthesis  201, 
beginning with  the commercially  available fluoral hemiacetal  187.  This  involved the 
coupling of  the  hemiacetal  187 to  an  imine  198 and the  resulting substituted imine 
protected as the trimethylsilyl ether  199.  This was then treated with allylsilane under 
Lewis acid conditions to furnish the allylimine  200,  and finally formation of the free 
amine under acid conditions, which was protected as the benzyl carbamate 201 in 65% 
overall yield over 5 steps (Scheme 57).
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Ph
TMS
F3C N
Ph
Ph
NHCBzF3C
+ a, b
c
d, e
198187
199
200201
Scheme 57. Reagents and conditions: (a) MS 4Å, DCM, 48 h, rt, 90%; (b) ImTMS, THF, 5 h, rt, 99%; 
(c)  BF3.Et2O, DCM, 50  °C, 24 h, 84%; (d)  2.0 M HCl(aq),  DCM, 50  °C, 24 h, 99%; (e)  CBzCl, 
NaHCO3, H2O, 12 h, rt, 88%.
The  protected homoallylamine  201 was  then alkylated  with  a  number of  ω-alkenyl 
bromides in the presence of sodium hydride in DMF (Scheme 58).
NHCBzF3C NCBz
F3C
n
a
Br
n
n = 1, 80%
n = 3, 56%
n = 4, 70%
n = 6, 71%
201
202
Scheme 58. Alkylation of protected homoallylamine. Reagents and conditions: (a) NaH, DMF, 0 °C to 
rt. 
These precursors  202 underwent ring-closing metathesis  in  the presence of Grubbs I 
catalyst at room temperature in DCM. Simple catalytic hydrogenation was performed on 
the six-membered heterocycle, 6-trifluoromethyl-3,4-tetrahydropyridine  203.  This was 
followed up by formation of the hydrochloride salt to give trifluoropipecoline 204 in 47% 
overall yield from fluoral hemiketal 187 (Scheme 59).
N
CBz
F3C
n
n = 1, 91%
n = 3, 80%
N
CBz
F3C
n
a
n = 1, 99%
N
H2
F3C
n
Cl
b, c
202
203 204
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Scheme 59. RCM and piperidine formation. Reagents and conditions: (a) Grubbs I (1 mol%), DCM, 
rt, 5 h; (b) Pd/C, H2, EtOH, rt, 24 h; (c) HCl. 
Bonnet-Delpon  has reported an  approach based on the  vinylogous  Mannich reaction 
between trimethylsiloxyfuran  206 and  fluorinated  aldimines  205.  The  lactones  207 
formed are a useful handle to synthesise trifluoromethylpiperidines. The key Mannich-
type reaction had optimal conditions using either TBS triflate or boron trifluoride etherate 
in  DCM  at  -78  °C.  The  reaction  proceeded  in  very  good  yields  and  excellent 
diastereoselectivity for benzyl, allyl or p-methoxyphenyl protected aldimines (Table 29).
Table 29. Mannich reaction of aldimines and trimethylsiloxyfuran.
N
F3C
R O OTMS O
O
NHR
F3C
H
+
0.5 eq. LA
DCM, -78 °C, 0.5 h
205 206 207
Entry R LA De(%) %Yield
1 Bn BF3.Et2O >98 90
2 Bn TBSOTf >98 97
3 Allyl BF3.Et2O >98 92
4 Allyl TBSOTf >98 95
5 PMP BF3.Et2O 80 87
6 PMP TBSOTf 36 80
The lactone resulting from the use of the benzyl protected aldimine was utilised to form 
3-hydroxy-2-trifluoromethylpiperidine 211 in excellent yields. Catalytic hydrogenation of 
208 removed the  olefin function  giving a  butyrolactone  209;  treatment of  this  with 
methanol or ethanol in the presence of a catalytic amount of sulfuric acid furnished the δ-
hydroxylactam  210,  which, after reduction, gave the desired trifluoromethylpiperidine 
211 (Scheme 60).
O O
NHBn
F3C
H
O O
NHBn
F3C
H
BnN
O
F3C
OH
BnN
F3C
OH
a b c
208 209 210 211
Scheme 60. Reagents and conditions: (a) Pd/C, H2, THF, 85%; (b) H2SO4, MeOH or EtOH, 80%; (c) 
LAH, AlCl3, THF, 90%. 
Kim has  reported upon  the  replacement  of  a  methyl  group in  the  natural  product 
monomorine with a trifluoromethyl group, with a view to enhancing biological activity. 
This indolizidine alkaloid is found as a trail pheromone of the Pharoah ant, Monomorium 
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pharaonis L. The synthesis begins with the condensation of carboxylic acid 212 with (S)-
(+)-phenylglycinol to  form a hexahydrooxazolopyridinone  213.  This bicycle  213 was 
converted to the enol triflate  215 by treatment with  N-(5-chloro-2-pyridinyl)triflimide 
214.  The enol triflate  215 was then coupled to 1-heptyne-3-ol  216 using a palladium 
catalysed Sonogoshira coupling to give the desired bicycle 217. Catalytic hydrogenation 
over platinum oxide  afforded an  epimeric  mixture  of  alcohols  218,  which could be 
separated. However, the mixture could be used for further synthesis by oxidation of the 
alcohol function with DMP to a ketone 219, which had an enantiomeric purity of greater 
than 98% by chiral HPLC.  From here the trifluoromethyl monomorine analogue could be 
obtained by catalytic hydrogenation of the ketone 219 (Scheme 61).
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def
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Scheme 61. Reagents and conditions: (a) (S)-(+)-phenylglycinol; (b) N-(5-chloro-2-pyridinyl)triflimide; 
(c) PdCl2(PPh3)2, CuI, THF, (i-Pr)2NH, rt, 65%; (d) H2 (50 psi), Pt2O, toluene, 68%; (e) DMP, DCM, 
91%; (f) H2, Pd(OH)2, EtOH, rt, 62%.
Bonnet-Delpin  and  co-workers  have  fashioned  a  simple  route  to  trifluoromethyl 
piperidines or tetrahydropyridines using either ring closing metathesis or the Pauson- 
Khand reaction on  doubly  unsaturated amines.  Previous work  using  a  Barbier-type 
allylation  reaction  reported  the  conversion  of  trifluoromethyl  aldimines  220 into 
homoallylic  or  homopropargylic  amines  221 using  activated  zinc  and  trimethylsilyl 
chloride as promoters (Scheme 62). 
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N
R
CF3 a
220
221NH
R
CF3R'
R = Bn or PMP
R' = vinyl or propargyl
Scheme 62. Barbier type allylation reaction of trifluoromethyl imines. Reagents and conditions: (a) 1.3 
eq.propargyl bromide, 1.1 eq.Zn, DMF, rt or THF, reflux.
Access to the doubly unsaturated amines 222 involved N-allylation of the homoallyl or 
homopropargylic amines 221 (Scheme 63).
NH
R
CF3R'
N
R
CF3R'
R = Bn or PMP
R' = vinyl or propargyl
a
221
222
Scheme 63. Synthesis of doubly unsaturated amines. Reagents and conditions: (a) 3 eq.vinyl or allyl 
bromide, 5 eq.NaHCO3, 0.1 eq.KI, CH3CN, reflux.
The doubly allylated amines  223 were then cyclised by ring closing metathesis using 
Grubbs II  catalyst  (5-10 mol%) to  furnish trifluoromethyl dehydropiperidines  224 in 
>89% yield (Scheme 64).
N
R
CF3
R3
R1 R2
N
R
F3C R3
R1 R2
a
223 224
Scheme 64. Cyclisation of doubly unsaturated amines by RCM. Reagents and conditions: (a) Grubbs 
II (5-10 mol%), DCM, rt.
 The enynes or allyl/propargyl amines 225 were also cyclised using the Pauson-Khand 
[2+2+1]  cycloaddition  to  226 with  NMO  and  stoichiometric  quantities  of  dicobalt 
octacarbonyl (Scheme 65).
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R = Bn or PMP
N
Bn
F3C
N
R
F3C
O
H
trans/cis, 85:15
a, b
225
226
Scheme 65. Synthesis of trifluoromethyl containing heterobicyclic compounds by the Pauson-Khand 
reaction. Reagents and conditions: (a) 1.2 eq.Co2(CO)8, DCM, 0.5 h; (b) 9 eq.NMO, 0 °C to rt, 3 h.
The next method by Bariau shows the formation of α-trifluromethyl piperidines but in this 
instance, with  more functionality  being introduced.  Condensation of  an α-chiral  1,3-
aminoketal 227 with various aldehydes formed intermediate imines 228 which, under acid 
catalysed conditions,  underwent  cyclisation to  form 2,6-disubstituted piperidines  229 
with exclusive cis stereoselectivity across the heteroatom (Scheme 66). 
O O
NH2
R
O O
N RR1
O O
H
N RR1
H++
de>95%
R1CHO
227
228
229
Scheme 66. Mannich type process yielding piperidines.
The fluorinated moiety may either be introduced via the aldehyde source, route A, or via a 
preformed fluorinated amine, route B. The first route generated trifluoroacetaldehyde in 
situ from  the  condensation  of  the  methylhemiacetal derivative  187 using  catalytic 
amounts of p-toluenesulfonic acid. This was coupled to the amine 230 in the same pot and 
also cyclised using the same acid to form the piperidine  231 in reasonable yields (35-
76%) and with high diastereoselectivity (Scheme 67).
O O
NH2
R
O O
H
N CF3R
F3C
OH
OMe+ a, b
187230
231
Scheme 67. Trifluoromethyl piperidines  via route A.  Reagents and conditions: (a)  p-TsOH, MgSO4, 
DCM, reflux; (b) p-TsOH, toluene, 70 °C.
Route B, although requiring a longer synthesis, utilizes a number of different aldehydes. 
First the N-hetero Michael acceptor 5,5,5-trifluoro-3-penten-2-one 233 was prepared from 
commercially available halotane® 232 and this was coupled to phthalimide in the presence 
of triton B® to give a phthalimido derivative  234.  Subsequent ketal  protection of the 
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ketone moiety gave 235 and then hydrazinolysis with hydrazine afforded the amines 236 
in >75% overall yield from the α,β-unsaturated ketone 233 (Scheme 68). 
CF3ClCHBr
O
CF3
O CF3
N
O
O
CF3
N
O
O
OO
n
CF3
NH2
OO
nHO
OH
n
a
b
c
232 233 234
236235
Scheme 68.  Precursor synthesis for route  B.  Reagents and conditions:  (a)  phthalimide,  Triton B, 
EtOAc, reflux; (b) p-TsOH, toluene, reflux; (c) NH2NH2.H2O, MeOH, reflux.
The cyclisations were then performed on a range of aromatic, or alkyl aldehydes giving 
yields between 70-80% and with exclusive cis stereoselectivity across the heteroatom. 
Canet has extended his work utilising the Mannich reaction of 1,3-aminoketals to form 
natural product analogues containing trifluoromethyl groups. In fact, their first target was 
pipecoline, the same compound targeted by Billard and Langlois, where the C2 methyl 
group of the piperidine is  substituted for a trifluoromethyl group. Using route A, the 
aminoketal 237 was treated with trifluoroacetaldehyde under acidic cyclisation conditions 
to afford the desired (trifluoromethyl)piperidine  238.  This piperidine was then treated 
with an excess of ethanedithiol in the presence of boron trifluoride etherate to yield the 
dithioketal derivative 239. Finally, hydrogenolysis of the thioketal function and treatment 
with acid afforded the pipecoline analogue 240 as its hydrochloride salt (Scheme 69). 
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Scheme 69.  Reagents and conditions: (a)  CF3CH(OH)OMe,  p-TsOH, MgSO4,  DCM, reflux; (b)  p-
TsOH, toluene, 80 °C, 71%; (c) ethanedithiol, BF3.OEt2, DCM, r.t, 88%; (d) Raney Ni, EtOH, reflux, 
then HCl, 90%.
Next, Canet utilised route B to synthesise trifluoromethyl analogues of some naturally 
occurring 2,6-disubstituted piperidines. The advantages of route B over route A are that 
alterations to the second ring substituent are easily obtained, as it  originates from an 
aldehyde. As with  the previous example, the cyclisation precursor (α-trifluoromethyl 
aminoketal)  236 was synthesised beginning with a 5,5,5-trifluoropent-3-en-2-one 233. 
Two different ketals  were submitted to  the acid-catalysed cyclisation pathway in the 
presence  of  different  aldehydes  to  afford  a  series  of  cis-2-substituted-6-
(trifluoromethyl)piperidines 241 in moderate to good yields (32-94%) and with exclusive 
cis diastereoselectivity in most cases. Following highly similar methods to the synthesis 
of 2-(trifluoromethyl)pipecoline,  the trifluoromethyl  analogues of dihydropinidine and 
isosolenopsin were isolated as their hydrochloride salts. This involved, in the case of 
dihydropinidine,  the  formation of  the  dithioketal  243 from  242,  followed by  global 
reduction  over  Raney Nickel  and  acid  treatment. In  the  case  of  isosolenopsin,  the 
unsaturated side chain of the ketalpiperidine precursor 244 was firstly reduced to 245 and 
then again dithioketal formation to  246 followed by hydrogenolysis and acid treatment 
afforded the desired analogue (Scheme 70). 
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N CF3CF3
n
R
n
R = (CH2)2CH3, n = 2, 32% (50% de)
R = (CH)2CH3, n = 2, 78% (95% de)
R = (CH)4(CH2)4CH3, n = 2, 71% (90% de)
R = Ph, n = 1, 66% (90% de)
R = p-F-Ph, n = 1, 70% (94% de)
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Cl
trifluoro-dihydropinidine
b c
a
O O
H
N CF3
O O
H
N CF3
S S
H
N CF3
H2
N CF3
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f
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Scheme 70.  Reagents and conditions:  (a)  (i)  RCHO,  p-TsOH, MgSO4,  DCM, reflux; (ii)  p-TsOH, 
toluene, 70-110 °C; (b) ethanedithiol, BF3.Et2O, DCM, rt, 77%; (c) Raney Ni, EtOH, reflux, then HCl, 
90%; (d) HCO2NH4, Pd(OH)2/C, MeOH, 60 °C, 92%; (e) ethanedithiol, BF3.Et2O, DCM, rt, 60%; (f) 
Raney Ni, EtOH, reflux, then HCl, 92%. 
. IIResults and Discussion: Studies into the Formation of Fluorinated Heterocycles
As  previously  discussed,  it  was  proposed  to  synthesise  dihydropyrans  and 
tetrahydropyridines that contain a trifluoromethyl group (CF3) in the C6 position, using 
the indium trichloride-mediated silyl-Prins and aza-silyl-Prins reactions. The reasoning 
behind this was to firstly synthesise heterocycles with interesting biological properties 
and secondly, to investigate the effects the strong electron withdrawing trifluoromethyl 
group may have on precursor synthesis and the kinetics of the cyclisation reactions.
Using the silyl-Prins reaction, the synthesis of trifluoromethyl-substituted dihydropyrans 
was attempted. These heterocycles should be a useful handle towards the total synthesis 
of  fluorinated  analogues  of  dihydropyran  containing  natural  products.  The  α-
trifluoromethyl group in the precursor 247 will be transferred to the C6 position in the 
. 11Synthesis  of  6-Trifluoromethyl-3,4-
dihydropyrans
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dihydropyran product, whereas the aldehyde source will  functionalise the C2 position 
(Scheme 71).
OH
CF3
O CF3R2
R2CHO, InCl3
TMS 247
Scheme 71. Proposed scheme for synthesis of 6-trifluoromethyl-3,4-dihydropyrans.
The  desired  substrate  for  this  silyl-Prins  reactions  was  (Z)-1,1,1-trifluoro-5-
(trimethylsilyl)pent-4-en-2-ol 247.  This was synthesised in 2 steps from commercially 
available 3,3,3-trifluoromethylpropylene oxide 248 (Scheme 72). 
O
F3C
OH
F3C
TMS OH
F3C
TMS
a b
248 249 247
Scheme 72. Reagents and conditions: (a) n-BuLi, TMS acetylene, Et2AlCl, hexane, -30 °C, 82%; (b) 
DiBAL, Et2O, reflux, 24 h, 61%. 
The silylated homopropargylic alcohol was prepared by the nucleophilic ring opening of 
the  commercially available  epoxide  248 using  a  metallated  trimethylsilyl  acetylide 
species, to afford the alcohol  249 in 82% yield, using a modified literature procedure. 
Next the  cis reduction of the alkynylsilane  249 by the action of DiBAL afforded the 
desired silylated homoallylic alcohol 247 in 61% yield. 
With the required trifluoromethyl-substituted alcohol 247 in hand, the silyl-Prins reaction 
was attempted with a range of commercially available aldehydes, initially using standard 
conditions previously described: dichloromethane at room temperature, with a 1:1:1 ratio 
of alcohol, aldehyde and indium trichloride. For the majority of aldehydes, there was no 
reaction at room temperature; on elevation of the temperature to reflux temperature, the 
formation of 6-trifluoromethyldihydropyran products 250 and 251 was observed for most 
aldehydes screened (Table 30).
. aPrecursor  Synthesis  I-  Formation  of  1-CF3-
Homoallylic Alcohol
. bSilyl-Prins  Reactions  of  1-CF3-
Homoallylic Alcohol
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Table 30. The silyl-Prins reactions of α-trifluoromethyl homoallyl alcohol.
OH
F3C
TMS
O RF3C O RF3C
InCl3, 
DCM
++ RCHO
cis trans
247 250a-e 251a-e
Entry R Temp Time (h) Total 
%Yield
Cis:trans
1 c-Hex Reflux 43 32       (a) 100:0
2 n-C7H15 Reflux 66 55       (b) 100:0
3 PhCH2 Reflux 44 42       (c) 100:0
4 Ph Reflux 42 25       (d) 60:40
5 CO2Et rt 24 Traces (e) N/A
Success was found in four of the five aldehydes screened (Table 30, entries 1-4) but these 
required longer reaction times than previously observed in the silyl-Prins reaction (42-66 
h, c.f. 5-12 h). The best yields were achieved on use of octanal and phenylacetaldehyde 
(Table 30, entries 2-3). Unfortunately, the dihydropyran formed from phenylacetaldehyde 
(Table 30, entry 3) was highly unstable and decomposed readily during purification by 
flash column chromatography and so a true yield could not be recorded. Therefore, only 
the 1H NMR spectra could be obtained rapidly enough and analysed accurately; however 
no mass spectra could be obtained. On use of cyclohexanecarboxaldehyde (Table 30, 
entry 1) the yield of dihydropyran product was disappointing. When using benzaldehyde 
(Table 30, entry 4), a lower yield was observed and this is comparable with previous 
examples. However,  unlike  previous  examples, here a  3:2  mixture of  cis and  trans 
dihydropyran products was formed. This is the only example where this occurred; for all 
other aldehydes only the  cis stereochemistry across the heteroatom was observed, in 
keeping with previous examples. It was assumed that the preference for these  cis-2,6-
dihydropyrans is to adopt a di-equatorial conformation 252 which keeps ring substituents 
facing away from one another (Figure 17). 
O
TMS
F3C R
H H
O
TMS
H H
CF3 R
252
Figure 17. Possible conformations of cis-2,6-disubstituted-3,4-dihydropyrans.
On use of ethyl glyoxylate, the starting material was consumed after 24 hours at room 
temperature.  The  temperature and  time  are  in  keeping  with  previous  use  of  ethyl 
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glyoxylate in Prins-type reactions, showing its high reactivity. Unfortunately, only trace 
amounts of product were observed on analysis of the GCMS data for the crude reaction 
material. This follows previous examples of the silyl-Prins reaction where a complicated 
mixture of unidentifiable products was observed. 
The relative stereochemistry of the cis-2,6-disubstituted dihydropyrans 250 was assigned 
by NOESY experiments. For the dihydropyran 250b derived from octanal there was a 
small 1.2% enhancement of the C2 hydrogen on irradiation of the C6 hydrogen. Similar 
nOe  effects  were  observed  for  the  dihydropyrans  250d and  250a derived  from 
benzaldehyde and cyclohexanecarboxaldehyde (Figure 18).  The decomposition of the 
dihydropyran 250c derived from phenylacetaldehyde meant that a NOESY experiment 
could not be completed.
OF3C C7H11
H H
1.2 & 0.9%
OF3C
H H
0.7 & 0.8%
OF3C
H H
0.9 & 1.0 %
250b 250d250a
Figure 18. The nOe effects in 6-trifluoromethyldihydropyrans.
Overall the yields are obviously quite disappointing and this is most probably attributable 
to the strong electron-withdrawing effects of the trifluoromethyl group. It was assumed 
that  this  decreases the nucleophilicity of  the alcohol precursor towards the activated 
aldehyde, thereby affecting yields and reaction times. 
A major advantage of the silyl-Prins reactions is the formation of an olefin, which is 
useful  for  further  functionalisation.  It  was  decided  to  dihydroxylate  the  6-
trifluoromethyldihydropyran  250b derived  from the  use  of  octanal  and  then  further 
elaborate the diol 253 and 254 (Scheme 73).
. cFurther  Functionalisation  of 
Dihydropyran olefin
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255 256
Scheme 73. Reagents and conditions: (a) OsO4 (1.0 M in H2O), NMO, THF, H2O, rt, 72 h, 83%; (b) p-
NO2C6H4COCl, DMAP, pyridine, DCM, rt, 24 h, 69%.
The exclusive  cis-2,6-disubstituted-3,4-dihydropyran  250b was reacted with a catalytic 
quantity of osmium tetraoxide in the presence of the co-oxidant NMO, a method taken 
from the thesis  of a previous group member.  Dihydroxylation occured predominantly 
from the  least hindered (bottom) face to  give a  94:6  mixture of  diols  253 and  254 
determined by GCMS analysis, in 83% yield. The diols 253 and 254 could not be fully 
purified or characterised and so were further elaborated to the di-p-nitrobenzoate esters 
255 and  256.  This  conversion  was  performed using  4-nitrobenzoyl chloride  in  the 
presence of pyridine and catalytic quantities of 4-dimethylaminopyridine. This gave the p-
nitrobenzoate esters in 69% yield and in the same ratio of diastereomers. 
The  relative  stereochemistry  of  these  compounds  was  also  proven  by  NOESY 
experiments and this further supported the observation that the silyl-Prins reaction for the 
α-trifluoromethyl  homoallyl  alcohol  247 produced exclusively  cis-2,6-dihydropyrans 
250.  On analysis of the major diastereomer  255,  a  3.6% enhancement of C2 and C6 
hydrogens  on  irradiation  of  each demonstrated the  cis relationship.  A smaller 1.6% 
enhancement of the C2 hydrogen on irradiation of the C3 hydrogen highlights a  trans 
relationship  between these  two  positions  and  showed that  the  di-hydroxylation  has 
occurred from the opposite face. The occurrence of the syn addition is suggested by the 
large 3.6% and 3.2% enhancement of  C3 and C4 hydrogens on irradiation  of  each. 
Conversely,  on  observation of  the  minor diastereomer  256,  there  was  a  large  3.2% 
enhancement of the C2 hydrogen on irradiation of the C3 hydrogen and also a 3.6% 
enhancement of the C2 hydrogen on irradiation of the C4 hydrogen. This demonstrates a 
cis relationship between the C2, C3, and C4 positions and that the syn hydroxylation and 
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has  occurred from the  more  hindered face  (Figure  19).  Although this  material  was 
crystalline, unfortunately an X-ray crystal  structure could not be obtained and so this 
assignment could not be confirmed.
OF3C C7H15
O
O
O
O
O2N
NO2
H H
H
H
3.6
& 3.6%
1.6%3.6
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O
O
O
O
O2N
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H H
3.0%
3.2%
H
H
3.6%
255 256
Figure 19. The nOe effects in p-nitrobenzoate esters.
Having  found  success  in  synthesising  6-trifluoromethyl-3,4-dihydropyrans,  attention 
turned to the synthesis  of their tetrahydropyridine analogues using the aza-silyl-Prins 
reaction  (Scheme  74).  Both  2-substituted-3,4-tetrahydropyridines  and  trans-2,6-
disubstituted-3,4-tetrahydropyridines were produced in good yields and short reaction 
times from coupling commercially available aldehydes to silicon-substituted homoallylic 
secondary  amines  under  indium  trichloride  mediated  conditions.  The  fluorinated 
precursors screened in the silyl-Prins reaction had a detrimental effect on reaction times 
and product yields and so it was predicted that similar effects would be observed in the 
aza-Silyl-Prins reaction. 
NHR
CF3
N
R
CF3R1
R1CHO, InCl3
TMS
Scheme 74. Proposed scheme for synthesis of 6-trifluoromethyl-3,4-tetrahydropyridines.
The precursor required for the aza-silyl-Prins reaction was (Z)-N-benzyl-1,1,1-trifluoro-5-
(trimethylsilyl)pent-4-en-2-amine  258.  As  before,  the  α-trifluoromethyl  group  would 
functionalise the C6 position in the tetrahydropyridine product and the aldehyde precursor 
would provide the substituent at C2. It was decided to synthesise the N-benzyl substituted 
. 12Synthesis  of  6-Trifluoromethyl-3,4-
tetrahydropyridines
. aPrecursor  Synthesis  II-  Formation  of  1-CF3-
Homoallylic Amine
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precursor as this gave the best yields in previous examples. The amine synthesis was not 
straightforward; it was first proposed that the amine could be obtained in 2 steps from the 
previously synthesised (Z)-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-ol 247. This route 
was similar to previous precursor syntheses for the aza-silyl-Prins reactions (Scheme 75). 
TMS
OH
CF3
TMS
OTs
CF3
TMS
NHBn
CF3
TMS
OTf
CF3
a b
c d
247 257 258
259
Scheme 75.  Reagents and conditions: (a) TsCl, Et3N, DMAP, DCM, 0  °C, 20 h, 50%; (b) BnNH2, 
EtOH, reflux or NaI,  i-Pr2EtN, BnNH2,  DMF, reflux; (c) Tf2O, pyridine, DCM, rt, 4 h, 66%; (d) 
BnNH2, EtOH, reflux or BnNH2, Et3N, CHCl3, reflux.
The homoallylic alcohol 247 was transformed into the corresponding tosylate 257 in 50% 
yield by the action of tosyl chloride in the presence of triethylamine and a  catalytic 
quantity of 4-dimethylaminopyridine. This was then subjected to previously successful 
conditions to allow substitution by benzylamine in ethanol. However, no reaction was 
observed and so more forcing conditions were attempted with Hunig’s base in DMF at 
reflux temperature and with a catalytic quantity of sodium iodide. Again no success was 
found and  so  it  was  decided to  employ a  better  leaving group on  the  alcohol  by 
transforming it into the triflate 259. This was achieved by the reaction of triflic anhydride 
in  the  presence of  pyridine  to  give  the desired triflate  259 in  66% yield.  This  was 
subjected to the same conditions for amine formation as the tosylate, but again with no 
success.  It  was  assumed that  the  strong  electron  withdrawing character  of  the  α-
trifluoromethyl group was inhibiting the SN2 reaction of either the tosylate or triflate by 
benzylamine. 
Success  for  formation  of  the  corresponding alcohol precursor  247 was  found when 
commercially available  3,3,3-trifluoromethylpropylene oxide  248 was  opened with  a 
metallated acetylide species. Therefore it was proposed that the corresponding aziridine 
could be manipulated in a similar manner. This pathway meant that no substitution of 
either a  tosylate or  triflate was required. This  route also had literature precedent, as 
described in the introduction to this chapter (Scheme 76).
105
Chapter Three
O
F3C
OH
NHBn
F3C
Bn
N
F3C
BnHN
Br
CF3
BnHN
CF3 TMS
a b
c
d
260248
261
262263
Scheme 76. Reagents and conditions: (a) BnNH2, CH3CN, rt, 48 h, 82%; (b) (Ph)3PCl2, Et3N, CH3CN, 
reflux, 24 h, 68%; (c) HBr(aq), rt, 16 h, 41%; (d) n-BuLi, TMS acetylene, HMPA, THF, -78 °C.
Formation of the aziridine 261 was completed in 2 steps from the commercially available 
epoxide 248. First, the epoxide 248 was opened by treatment with benzyamine to afford 
the  amino-alcohol  260 in  82%  yield.  The  alcohol  was  activated by  treatment with 
dichloro(triphenyl)phosphorane in the presence of triethylamine to promote ring closure 
and  form  the  aziridine  261 in  68%  yield.  Direct  ring-opening  of  aziridines  with 
carbanions has been proven to be unsuccessful due to the electronic repulsion from the 
trifluoromethyl group. Therefore, it was decided to ring open the aziridine with bromide 
under Brønsted acid conditions, using aqueous hydrogen bromide, to give the bromo-
amine 262 in 41% yield. It was assumed that the bromide function could be more readily 
substituted  by  carbanions such  as  trimethylsilyl  acetylide.  However,  even when the 
nucleophilicity of the carbanion was enhanced by the presence of HMPA, there was no 
substitution and only starting material 262 recovered, so the route was abandoned.
The next route involved the Barbier-type allylation of a trifluoromethyl imine 263 with 
propargyl bromide, followed by subsequent silylation and reduction. This methodology 
also had literature precedent as reviewed in the introduction and afforded the desired 
homoallylic amine 258 in 4 steps from a commercially available hemiacetal 187 (Scheme 
77).
106
Chapter Three
O
OHF3C
N Ph
F3C
HN
F3C
Ph
HN
F3C
Ph TMS
HN
F3C
Ph
TMS
HN
F3C
Ph
TMS
+
a b
c
d
or e
187 263 264
265258 266
Scheme 77. Reagents and conditions: (a) BnNH2, toluene, 140 °C, 2 h, 64%; (b) propargyl bromide, 
Zn, TMSCl, DMF, rt, 2 h, 59%; (c) n-BuLi, TMSCl, THF, -78 °C, 65%; (d) DiBAL, Et2O, reflux, 24 h, 
45% (Z:E; 50:50); (e) Ti(Oi-Pr)4, i-PrMgCl, Et2O, -60 °C, 5 h, 51% (Z:E; 100:0). 
First, the commercially available hemiacetal 187 was condensed with benzylamine using 
a  Dean and Stark apparatus to  afford the  imine  263 in  64% yield.  Then, using  the 
allylation conditions described in the introduction, propargyl bromide was coupled to the 
imine in the presence of zinc and TMSCl as promoters. The propargylic amine 264 that 
was  furnished  in  59%  yield  was  silylated  with  TMSCl,  using  n-butyllithium  to 
deprotonate the alkyne. This produced the alkynylsilane  265 in 65% yield, which was 
then subjected to DiBAL reduction conditions, as previously employed. However this 
produced a 1:1 inseparable mixture of olefinic isomers 258 and 266. This was unexpected 
when  considering  the  exclusive  production  of  (Z)-homoallylic  alcohols  previously 
(Scheme 72). It  was subsequently  found that  the  (Z)-isomer  258 could be generated 
exclusively,  in 51% yield, when the alkynylsilane was subjected to  a  hydrotitanation 
procedure  involving  the  use  of  titanium(IV)  isoproxide  and  iso-propylmagnesium 
chloride. This reaction only found moderate success on a small scale and so the product 
could not be used for further chemistry. 
Having successfully  synthesised  the  required homoallylic  amine,  the  aza-silyl-Prins 
reaction was attempted with a range of aldehydes. Since the amine precursor was only 
available as an inseparable 1:1 mixture of geometric isomers 258 and 266, it was decided 
to proceed with this mixture in the hope that it would allow us to quantify the reactivity of 
both isomers. It could also support past observations that the (Z)-isomer is required to 
maximise the  orbital  overlap present  in  the  β-effect  of  silicon  for  the  intermediate 
carbocation. The conditions required for the aza-silyl-Prins cyclisation reaction were use 
. bAza-silyl-Prins  Reactions  of  1-CF3-
Homoallylic Amine
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of acetonitrile at reflux temperature as well  as a 1:1:1 ratio of amine (258 and  266), 
aldehyde and indium trichloride (Table 31). 
Table 31. The aza-silyl-Prins reactions of α-trifluoromethyl homoallyl amines.
HN
F3C
Ph
TMS N
Bn
F3C R NBn
F3C R
+
RCHO
InCl3, 
CH3CN
refluxZ:E; 1:1 cistrans258 and 266
267a-e 268a-e
Entry R Time (h) Total 
%Yield
Trans:cis Comment
1 c-Hex 48 25 (a) 100:0 E-alkene remained
2 n-C7H15 48 43 (b) 100:0 E-alkene remained
3 PhCH2 48 55 (c) 85:15 E-alkene remained
4 CO2Et 17 69 (d) 85:15 Both alkenes consumed
5 p-NO2C6H4 48 Traces 
(e)
N/A Z-alkene consumed, E-
remained
The  aza-silyl-Prins reaction for  the  trifluoromethyl homoallyl  amine precursors was 
successful for 4 out of 5 aldehydes used (Table 31, entries 1-4). The use of aliphatic 
aldehydes (Table 31, entries 1-3), and also ethyl glyoxylate (Table 31, entry 4) produced 
positive  results.  The  greatest  yield  obtained  was  for  ethyl  glyoxylate,  where  both 
geometric isomers were consumed in the reaction and it was assumed this was due to the 
reactivity of the intermediate iminium ion in either form, 269 and 270 (Scheme 78). As 
with  previous  examples, the  reactivity  of  ethyl  glyoxylate contributes  to  the  shorter 
reaction time. 
258 and 266
HN
F3C
Ph
TMS
N
Bn
F3C CO2Et NBn
F3C CO2Et
+
Z:E; 1:1
N
F3C
TMS
Bn
85    :   15
O OEt
N
F3C
Bn
O OEt
TMS
267d 268d
269
270
Scheme 78. Formation of either form of iminium ion intermediates lead to heterocyclic product.
In the other aldehydes, only the  (Z)-alkene 258 was consumed and the  (E)-alkene 266 
remained in approximately the same amount as in the starting material on analysis of 
GCMS and 1H NMR data. From this, it can be assumed that the  (Z)-alkene 258 is the 
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more reactive isomer,  probably because it  maximises orbital  overlap in  the  β-effect. 
However,  the  (E)-alkene  266 is  capable of cyclisation due to its  consumption in  the 
example involving ethyl glyoxylate. It was assumed that even in the other examples, the 
(E)-alkene  266 must  be  consumed  to  a  certain  extent  because  on  use  of 
phenylacetaldehyde, a yield of over 50% was observed. It was also believed that some of 
the  (Z)-alkene  258 was  converted  to  the  (E)-isomer  266 via the  aza-Cope  [3,3] 
sigmatropic rearrangement (Scheme 79). The evidence for this is from previous examples 
of  the  aza-silyl-Prins  reaction  where  the  (E)-isomer  16 was  isolated  by  column 
chromatography (Scheme 6).
N
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N
PhRTMS
N
PhR
TMS
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CF3
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CF3
[3,3]
[3,3]
[3,3]
Scheme 79. The role of the aza-Cope rearrangement in the formation of reaction intermediates.
As with the previous examples, the reaction times for the fluorinated precursors were 
longer  than  before.  It  was  assumed  that  this  is  due  to  the  electronic  effect  the 
trifluoromethyl group has on the nucleophilicity of the amine precursor. The yields for 
phenylacetaldehyde and octanal are reasonably good based on the fact that the starting 
material was a geometric mixture (258 and 266). Unfortunately, the tetrahydropyridines 
267c and  268c derived  from  phenylacetaldehyde  were  relatively  unstable  and 
decomposed over time, comparable with the example from the silyl-Prins reaction. This 
meant that full characterisation could not be obtained for this compound as decomposition 
gave  inaccurate  analysis.  As  with  the  silyl-Prins  examples,  the  use  of 
cyclohexanecarboxaldehyde  (Table  31,  entry  1)  gave  lower  yields.  The 
diastereoselectivity of the reaction was still reasonably good when considering that two 
examples exclusively produced  trans-2,6-disubstituted-3,4-tetrahydropyridines  267 and 
the other two gave a high percentage of the  trans-diastereomer. It was not possible to 
separate the  mixtures  of  diastereomers  by  chromatography.   It  is  assumed that  the 
presence  of  the  large  N-substituent  favours  the  formation  of  the  trans-isomer,  a 
phenomenon known as A1,3 strain. For the time being, the relative stereochemistry could 
only be supported by the absence of any nOe effect between the C2 and C3 hydrogens. 
The aromatic example (Table 31, entry 5) was the only aldehyde that failed to produce 
any significant product. In this case, the (Z)-isomer 258 was consumed in the reaction but 
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only trace quantities of product were observed on analysis of the crude material. The 
majority of the product mass was attributed to unidentifiable species.
As  before,  the  formation  of  an  olefin  allowed further  functionalisation  of  the  2,6-
disubstituted-3,4-tetrahydropyridine. The use of ethyl glyoxylate in the aza-silyl-Prins 
reaction has the potential for the formation of pipecolate derivatives. These pipecolate 
esters are ideal precursors for the total synthesis of pipecolic acid analogues. Pipecolic 
acid is a nonproteinogenic amino acid, which is a precursor to a number of bioactive 
compounds such as synthetic peptides and local anesthetics. Therefore it was decided to 
functionalise the 6-trifluoromethyl pipecolate species 267d and 268d by dihydroxylation, 
followed by ester formation (Scheme 80).
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Scheme 80.  Reagents and conditions: (a) OsO4 (1.0 M in H2O), NMO, THF, H2O, rt, 48 h, 83%; (b) 
Ac2O, DMAP, DCM, rt, 20 h, 50%.
The 85:15 mixture of  trans/cis-2,6-disubstituted-3,4-tetrahydropyridine  267d and  268d 
was subjected to a dihydroxylation reaction using osmium tetroxide in the presence of 
NMO to give the diol 271 in 83% crude yield. The crude diol (included a major 271 and 
minor diastereomer, although the minor diastereomer could not be characterised) could 
not be purified or fully characterised in this form so was further functionalised. The diol 
was transformed into the di-acetate 272 in 50% yield by the action of acetic anhydride in 
the presence of 4-dimethylaminopyridine, using a method from the thesis of a previous 
group member. The di-acetate was an inseparable 86:14 mixture of diastereomers, but 
only the major diastereomer 272 could be characterised. It was assumed that the minor 
diastereomer was a  di-acetate of the  cis-2,6-disubstituted-3,4-tetrahydropyridine  268d, 
although this could not be confirmed by  1H NMR and NOESY experiments. NOESY 
experiments were used and supported the relative stereochemistry of the major di-acetate 
272. This study also allowed us to confirm the trans-diastereoselectivity of the aza-silyl-
Prins reaction for the fluorinated precursors. A 1.4 and 1.9% enhancement for C3 and C4 
hydrogens on irradiation of each confirmed the syn dihydroxylation. The absence of any 
. cFurther  Functionalisation  of 
Tetrahydropyridine Olefin
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significant nOe effect between the C2 hydrogen and the C3 or C4 hydrogens suggests that 
the dihydroxylation had occurred from the opposite face to the C2 substituent. Lastly, the 
1.4% enhancement of the C6 hydrogen on irradiation of the C4 hydrogen suggests the 
trans stereochemistry across the heteroatom (Figure 20). Although the di-acetate 272 was 
crystalline, unfortunately the X-ray crystal structure could not be obtained and so the 
relative stereochemistry could not be confirmed. 
272
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Figure 20. The nOe effects in 3,4-diacetylated-pipecolate. 
Based on the success found in the aza-Prins reaction of an N-tosyl amine, it was decided 
to incorporate this group into the α-trifluoromethyl homoallylic amine, for screening in 
the  aza-silyl-Prins reaction. Our  studies  into  the  aza-Prins reaction  showed that  the 
presence of the N-tosyl group enhanced the reactivity of the reaction intermediates. If this 
was utilised for the fluorinated precursor, perhaps greater yields of product and shorter 
reaction times could be obtained for the aza-silyl-Prins reaction. It was proposed to obtain 
the target precursor in 4 steps from the gaseous trifluoroacetaldehyde, generated in situ 
from commercially available  2-ethoxy-1,1,1-trifluoropropane  187 and then to use the 
same successful methodology that gave the α-trifluoromethyl-N-benzyl amine precursor 
using the Barbier-type allylation reaction (Scheme 81).
. dPrecursor Synthesis III – Formation of 1-CF3-Homoallylic 
Tosylamine
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Scheme 81. Reagents and conditions: (a) (i) 98% H2SO4 (aq), 80 °C, (ii) p-TsNH2, pyridine, THF, rt, 48 
h, (iii) SOCl2, C6H6, reflux, 5 h; (b) propargyl bromide, Zn, TMSCl, DMF, rt, 2 h, 22% for 2 steps; (c) 
n-BuLi, TMSCl, THF, -78 °C, 45%; (d) DiBAL, Et2O, reflux, 18 h. 
The commercial hemiacetal 187 was converted to trifluoroacetaldehyde by addition to 
sulfuric acid at 80 °C. The condensed gas was immediately transferred as an excess to a 
sealed vessel  containing 4-methylbenzenesulfonamide and pyridine.  After subsequent 
treatment with thionyl chloride, the N-tosyl imine 273 was afforded and used immediately 
as  it  is  reported to  be  highly  unstable. The  Barbier-type  allylation  procedure using 
propargyl bromide with zinc and TMSCl as promoters afforded the propargylic N-tosyl 
amine 274 in 22% overall yield for 3 steps. The low yield for these 3 steps could be based 
on the gaseous medium used and also the stability of the intermediate imine 273. The 
alkyne 274 was then silylated using TMSCl, with  n-butyllithium as base to afford the 
alkynylsilane 275 in 45% yield. Unfortunately, when the cis reduction with DiBAL was 
performed, only the related alkane  277,  produced by over-reduction, was observed on 
analysis by GCMS and 1H NMR. The other organic matter isolated after acidic work-up 
was insoluble in all tested organic solvents, including DMSO and methanol. Owing to this 
failure, this approach was abandoned. 
The use of the aza-silyl-Prins reaction has allowed access to heterocycles that are of 
biological interest as  they contain a trifluoromethyl group. This group has had major 
effects on the reactivity of substrates and reaction intermediates. The use of a geometric 
mixture of homoallyl amines has allowed us to suggest that (Z)-isomers are more reactive 
than the (E)-isomer based on our observations. Future studies could include targeting the 
trifluoromethyl-substituted homoallyl-N-tosyl amine 276 to improve reaction times and 
product yields;  it  is  possible that  an alternative route to  this  molecule could  be the 
hydrotitantion of the propargylic N-tosyl amine 275.
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CHAPTER FOUR: Towards the Synthesis of 
Pipecolic Acid Analogues and Pipecolates
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. ILiterature Review for Synthesis of Pipecolic Acid and Analogues
It  has  been  previously  shown  that  the  aza-silyl-Prins  reaction  may  be  utilized  to 
synthesize the racemic form of small natural products. For example, solenopsin A was 
obtained by using a simple long chain aliphatic aldehyde as the substrate for the aza-silyl-
Prins reaction and then, after hydrogenation of the product tetrahydropyridine species, the 
piperidine-containing natural product was produced (Scheme 2). 
It  has been proposed that pipecolic acid analogues or the ester-containing pipecolates 
could be prepared using ethyl glyoxylate as substrate in the aza-silyl-Prins reaction. To 
obtain the carboxylic acid function of the pipecolic acids, subsequent hydrolysis of the 
ester function is required, followed by the reduction step or vice versas (Scheme 82).
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Scheme 82. Proposal for access to pipecolates and pipecolic acid analogues.
It is also proposed that di-substituted or even tri-substituted analogues could be produced 
by simply varying the substituent on the  α and  β positions of the homoallylic amine 
precursor or even by functionalising the olefin on the tetrahydropyridine ring. The total 
synthesis of pipecolic acid itself has been completed on numerous occasions; therefore 
only analogues would be targetted. However to make observations on the efficiency of 
our route, comparisons were made with the syntheses of pipecolic acid in the literature. 
Examples of the synthesis of pipecolic acid reported are via enzyme-catalysed reactions, 
asymmetric hydrogenation, or by ring closing metathesis. 
One example by Hou involved treating (R)-2-cyano-6-phenyloxazolopiperidine 278 with 
acid,  followed  by  reduction  to  form  a  unknown  mixture  of  diastereomers  of  4-
phenylhexahydropyrido[2,1-c][1,4]-oxazin-1-ones 279.  These were then converted into 
(S)-pipecolic  acid  280 after  epimerisation  and  hydrogenation  (Scheme  83).  With 
replacement of  the  proton source with  an  alkyl  halide  in  the  epimerisation  step,  2-
substituted piperidines could also be formed.
. 13Formation  of  2-Substituted  Pipecolic 
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Scheme  83.  Hou’s  route  to  (S)-pipecolic  acid.  Reagents  and  conditions:  (a)  (i)  HCl,  EtOH, (ii) 
Zn(BH4)2; (b) (i) LDA, (ii) H+; (c) H2, Pd/C.
Biological studies have shown that the (R)-form of pipecolic acid 285 has a higher affinity 
towards muscarinic receptors in humans than the (S)-form 280. To synthesise the more 
active  form,  Hou  began  by  forming  a  chiral  glycine  enolate  282 synthon  from 
commercially available (R)-2-phenylglycinol  281.  Monoalkylation of  the  enolate  282 
with diiodobutane gave 283, followed by deprotection of the nitrogen substituent and then 
cyclisation under basic conditions, to provide the oxazinone 284. This was submitted to 
catalytic hydrogenation to afford the (R)-form 285 in good yield (Scheme 84).
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Scheme 84.  (R)-pipecolic acid accessed via chiral glycine enolate synthon.  Reagents and conditions: 
(a) (i) BrCH2CO2, (ii) Boc2O, (iii) PTSA, 34% for 3 steps; (b) NaN(SiMe3)2, I(CH2)4I, HMPA, THF, -78 
°C, 65%; (c) (i) TFA, (ii) EtNi-Pr2, 83 °C, 65% for 2 steps; (d) H2, Pd(OH)2, 99%.  
So, from this  example, it  has  been shown that  both forms of  pipecolic  acid can be 
obtained relatively easily. However racemic pipecolic acid could be obtained in a smaller 
number  of  steps  using  the  aza-silyl-Prins  reaction  and  more  importantly,  produce 
analogues of variable functionality by utilizing the olefin on the tetrahydropyridine ring 
and by introducing substitutents in the C6 position. If the aza-silyl-Prins reaction could be 
utilised to form tetrahydropyridines enantioselectively, then perhaps both enantiomers of 
pipecolic acid could be synthesised with relative ease.
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Next the synthesis of 6-substituted pipecolic acids will be reviewed, which could possibly 
be accessed via the aza-silyl-Prins reaction.
The first example by Shuman does not contain a cyclisation step but features the selective 
2-cyanation of pyridines and quinolines (286)  via the related  N-oxide  287,  utilising a 
modified Reissert-Henze reaction. The resulting nitriles 288 were simply hydrolysed to 
the corresponding 2-carboxylic acids  289 and hydrogenation of the pyridine ring over 
platinum oxide afforded various substituted pipecolic acids in good yields (Scheme 85). 
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Scheme 85.  Reagents and conditions: (a) H2O2,  HOAc; (b) TMSCN, DCM, (Me)2NCOCl; (c) HCl, 
H2O; (d) H2, PtO2, 60 psi.  
Lubell also focuses on the synthesis of 6-substituted pipecolic acid analogues but in high 
enantiopurity. The route employs an aldol condensation/reductive amination sequence to 
transform N-(PhF)aspartate β–aldehyde into alkylpipecolic acids. This route also offers 
the opportunity to introduce alkyl substituents into 4 of the 5 ring carbons by using β–
alkyl-branched aspartates and  alkyl-substituted  enolates.  In  the  first  step,  the  aldol 
. 14Formation of  2,6-Disubstituted  Pipecolic  Acids  and  Other 
Analogues
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condensation between the N-(PhF)aspartate β–aldehyde 291 and the lithium enolates of a 
variety of methyl alkyl ketones 290 gives the ε–oxo γ–hydroxy α–N-(PhF)amino esters 
292 in 61-93% yields.  After mesylate formation and in situ elimination to give 293, these 
were subjected to catalytic hydrogenation, which effected reduction of the double bond, 
the cleavage of the PhF group, iminium ion formation and reduction to afford t-butyl 6-
alkylpipecolates 294 in 86-91% yield. These were isolated quantitatively as hydrochloride 
salts  295 on treatment with HCl in DCM. Unfortunately the same hydrogenation of the 
enone directed towards a 6-arylpipecolate only gave a maximum 20% yield (Table 32). 
Table 32. Formation of 6-substituted pipecolic acids.  Reagents and conditions: (a)  nBuLi, (iPr)2NH, 
THF, -78 °C; (b) THF, -78 °C; (c) MsCl, Et3N, DCM, 0 °C; (d) H2, Pd/C, MeOH; (e) HCl, DCM.
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Entry Ketone R %Yield
of 292
% Yield
of 293
%Yield
of 294
%Yield
of 295
1 Pinacolone t-Bu 84 64 86 98
2 3-Methyl-2-
butanone
i-Pr 77 87 91 100
3 2-Pentanone n-Pr 72 91 86 97
4 Acetone Me 68 86 90 98
5 Acetophenone Ph 93 92 20 96
6 2-Acetylpyridine 2-Pyridyl 61 80 0 -
The enantiomeric purity of the 6-methylpipecolate  294d was determined by conversion 
into the N-benzylpipecolate and then coupling to a chiral amine, giving a diastereomeric 
excess of  >99%.
Davis has reported the asymmetric synthesis of proline and pipecolic acid derivatives via 
masked oxo sulfinimines. The general approach involved the synthesis of a masked oxo 
sulfinimine from a masked oxo aldehyde. The masked oxo aldehydes  297 were easily 
accessed by the DiBAL reduction of the corresponding esters 296. Then the sulfinimines 
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299 could be accessed by a one-pot procedure involving the treatment of these aldehydes 
297 with (1R,2S,5R)-(-)-menthyl (S)-p-toluenesulfinate  298 with LiHMDS at  -78  °C. 
From here, a sulfinimine-mediated asymmetric Strecker synthesis was used to generate an 
α–aminonitrile  230 with  the  desired  stereochemistry,  followed  by  hydrolysis  and 
reduction to give the cyclic amino acids. The asymmetric Strecker synthesis involves 
addition of isopropanol to diethylaluminium cyanide followed by the sulfinimine 299 to 
afford  amino  nitriles  230 in  good  yields  and  diastereoselectivity.  To  complete  the 
synthesis, the aminonitriles were treated with 6M HCl at reflux. This achieved essentially 
five  operations  in  one-pot:  first  hydrolysis  to  remove the  N-sulfinyl  auxilary  with 
concomitant conversion of the nitrile to the acid; then the oxo group was unmasked to 
give the intermediate oxo α–amino acid 231 which then cyclised to an iminium ion 232, 
isolated as an imine salt. The salt was then catalytically hydrogenated to afford proline 
233 and pipecolic  analogues  234,  235  and 236 in  good to excellent yields and high 
enantiomeric  excess  (Table  33).  The  geometry  of  the  disubstituted  species  was 
exclusively  cis across the heteroatom and the authors believe this had arisen from the 
hydrogenation of the least hindered face (Scheme 86).
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Scheme 86. Reagents and conditions: (a) DiBAL, -78 °C; (b) LiHMDS, -78 °C; (c) Ti(OEt)4, DCM; (d) 
Et2AlCN, i-PrOH; (e) 6 M HCl, reflux; (f) H2, Pd, MeOH.
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Table 33. Formation of proline and pipecolic acid derivatives by Davis.
Entry R R’ n %Yield 
of 299
%Yield of 230 %Yield of 233-
236
% ee
1 Me H 1 74 58 77 98
2 allyl Me 1 92 54 80 95
3 allyl Me 2 98 61 85 97
4 allyl Ph 2 65 80 48 95
Finally, Fleet has targeted the cyclic amino acid for screening as a potential inhibitor of 
HIV replication. The precursor for this synthesis was a protected xylose 238 which itself 
was generated in 3 steps from diacetone glucose. The free hydroxyl group of the xylose 
was converted to triflate 239 in the presence of trifluoromethanesulfonic anhydride. This 
was subsequently transformed into a nitrile 240 by substitution with potassium cyanide. 
Further treatment with methanolic hydrogen chloride gave the methyl furanosides 241 as 
a 3:4 mixture of α:β anomers. This mixture was converted into the corresponding triflates 
242,  which after treatment with borane-dimethyl  sulfide and work-up with potassium 
carbonate,  gave  the  bicyclic  piperidines  243.  These  were  protected  as  the  benzyl 
carbamates 244, the methoxy functions were hydrolysed with TFA to afford a mixture of 
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lactols  245. These lactols were oxidised with bromine to give the carbamate-protected 
lactones 246. From here the (2S,3R,4R)-3,4-dihydroxy pipecolic acid 247 was obtained in 
34% overall yield from the protected xylose 238 by the hydrogenolytic removal of both 
protecting groups as well as cleavage of the ester linkage (Scheme 87).
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Scheme 87. Reagents and conditions: (a) 3 steps; (b) Tf2O, pyridine, 94%; (c) KCN, DMF, 96%; (d) 
HCl/MeOH, 95%; (e) Tf2O, pyridine, 95%; (f) borane.Me2S, K2CO3, 96%; (g) CBzCl, NaHCO3, THF, 
H2O; (h) NaBH4, EtOH(aq), 97%; (i) Br2, Barium carbonate, dioxane(aq), 84%; (j) H2, Pd/C, 89%.
. IIResults and Discussion: Studies into the Formation of Pipecolic Acid Analogues 
and Pipecolates
Work in our group had already achieved the synthesis of the racemic forms of solenopsin 
A and epi-dihydropinidine using the aza-silyl-Prins reaction. 
It was envisaged that a similar synthetic sequence could afford the racemic form of an 
analogue  of  pipecolic  acid.  Also,  utilising  the  olefin  functionality  of  the 
tetrahydropyridine  core  would  allow  the  simple  synthesis  of  the  related  pipecolate 
analogues.
The  N-benzyl  (Z)-4-trimethylsilyl-1-ylamine starting  materials for  the  aza-silyl-Prins 
reaction  have  previously  been  prepared  from  the  commercially  available  starting 
materials, 3-butyn-1-ol and 4-pentyn-2-ol (Scheme 88). 
. 15Precursor Synthesis – Formation of Silylated Homoallylic 
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Scheme 88. Reagents and conditions: (a) n-BuLi, THF, - 78 °C, 2 h, followed by TMSCl, - 78 °C to rt, 1 
h, 1.0 M HCl, rt, 45 min, R=H, 61%; R=Me, 79%; (b) 1.0 M DiBAL in hexane, Et2O, 0 °C, 0 °C to rt 
and then reflux overnight, R=H, 65%, R=Me, 66%; (c) Et3N, TsCl, 4-DMAP, 0 °C, 4 h, R=H, 87%, 
R=Me, 57%; (d) EtOH, benzylamine, 80 °C, 5 h, R=H, 78%, R=Me, 100%.
Firstly the silylated homopropargylic alcohols were easily prepared in 61% (R=H, 250) 
and 79% (R=Me,  251)  yields  using literature methods,  using  two equivalents  of  n-
butyllithium, in THF at -78 °C, followed by addition of two equivalents of trimethylsilyl 
chloride and then quenching with hydrochloric acid. The alkyne function was then  cis 
reduced with DiBAL in diethyl ether at reflux to afford the homoallylic alcohols in 65% 
(R=H,  252)  and 66% (R=Me,  253)  yields respectively.  Displacement of  the  alcohol 
function was effected by tosylation and then subsequent amination. Tosylated alcohols 
were obtained in 87% (R=H,  254) and 57% (R=Me,  255) yields and the required  N-
benzyl Z-4-trimethylsilyl-1-ylamines in 78% (R=H, 256) and 100% (R=Me, 257) yields 
by the action of benzylamine.
Initially, the aim of this study was the total synthesis of simple analogues of (±)-pipecolic 
acid, and so the 6-methyl substituted derivative, (±)-6-methylpiperidine-2-carboxylic acid 
was targeted. In theory this could be obtained by the use of ethyl glyoxylate in the aza-
silyl-Prins reaction, hydrolysis of the ester function and reduction to the piperidine. The 
proposed three-step synthesis began with coupling in equimolar quantities, the silylated 
homoallylic  amine to ethyl  glyoxylate, activated by indium trichloride in  acetonitrile 
(Scheme 89). 
. 16Synthesis  of  6-Methyl 
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Scheme 89. Reagents and conditions: (a) InCl3, ethyl glyoxylate, CH3CN, rt, 48 h, 74%; (b) 1M LiOH, 
MeOH, 0 °C, overnight, 58%; (c) H2, Pd(OH)2/C (20%), EtOH, r.t, 5 h, quantitative; (d) 1M LiOH, 
MeOH, 0 °C, overnight.
The tetrahydropyridine 258 was obtained in 74% yield, and nOe studies confirmed mostly 
trans selectivity across the nitrogen with a large 3.4% enhancement of the C2 proton on 
irradiation of the 6-Me protons, and no enhancement of the C2 proton on irradiation of 
the C6 proton. Reflux temperatures were investigated for the aza-silyl-Prins reaction but 
were found to be detrimental to the product yields (c.f-8% for reflux). Next, instead of 
following the exact pathway that had been used in the (±)-solenopsin A and (±)-Epi-
dihydropinidine  synthesis,  it  was  proposed  to  hydrolyse  the  ester  function  before 
hydrogenation as reported by Gotor and co-workers in their attempts to make enantiopure 
(S)-pipecolic  acid.  The  action of  a  1M aqueous  solution  of  lithium hydroxide, with 
methanol at 0 °C overnight showed complete consumption of starting material by TLC. 
After GCMS and  1H NMR analysis  it  was found that  no  carboxylic  acid had been 
generated, but in fact the  α,β-unsaturated ester derivative  259 of the tetrahydropyridine 
had been formed in 58% yield. Instead of the hydroxyl anion attacking the ester carbonyl 
function, it had actually deprotonated the acidic C-2 proton and subsequent quenching 
with acid allowed the alkene migration. This had the effect of epimerising the C2 centre 
and therefore destroying the previously established diastereoselectivity. This species is a 
possible precursor to access enantiopure pipecolic acid analogues,  via the asymmetric 
hydrogenation of  this  2,3-tetrahydropyridine,  inducing chirality  in  the C2 position,  a 
method utilised by Comins. However, it was decided to continue with the synthesis of 
racemic pipecolic acid analogues.
It  was  now  proposed  to  firstly  remove  the  N-substituent  and  olefin  from  the 
tetrahydropyridine  259 by hydrogenation and then hydrolyse the ester function. Now, 
using hydrogen gas over catalytic quantities of palladium hydroxide on carbon in ethanol, 
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afforded  the  piperidine  2-ethyl  ester  260 in  quantitative  yield.  With  no  further 
purification, the crude extract was hydrolysed, as previously described, to afford the 6-
methyl derivative of pipecolic acid  261 (Scheme 38). This positive assumption is only 
based upon HRMS analysis with the presence of the [M+H]+ ion at 144.1026, with other 
data being inconclusive (Scheme 89). Some literature precedent for the formation of this 
pipecolic acid analogue shows that it is normally characterised as a hydrochloride salt, so 
the synthesis was modified. 
This proposal began with the pre-formed 87:13 mixture of trans and cis 2,6-disubstituted-
3,4-tetrahydropyridines  258 derived from the  aza-silyl-Prins reaction involving ethyl 
glyoxylate. It was proposed to use catalytic hydrogenation to remove the  N-substituent 
and the olefin, followed by the acid hydrolysis of the C2 ester substituent (Scheme 90). 
N
Bn O
OEt
N
H O
OEt
N
H2 O
OH
Cl
6-methylpipecolic acid
a b
87:13; trans:cis 63:37; trans:cis 66:34; trans:cis
258
264 :262 : 263 265
Scheme 90. Reagents and conditions: (a) H2, Pd(OH)2/C (20%), EtOH, r.t, 5 h, 87%; (b) 6.0M HCl(aq), 
reflux, 2 h, 83%.
Simultaneous removal of the  N-substituent and olefin was completed by the action of 
hydrogen over palladium hydroxide on carbon to give the piperidine-2-carboxylate in 
87% yield. Unfortunately, the hydrogenation step gave a 63:37 crude mixture of trans 262 
and cis piperidines 263 (c.f-started with 87:13). It was assumed that when catalytic de-
benzylation took place, there was partial formation of an intermediate iminium ion which 
racemised either the C2 (266) or C6 (267) centre. When the iminium ion was reduced, the 
hydrogenation took place from the least hindered face (Scheme 91). Therefore the cis-2,6-
disubstituted-3,4-tetrahydropyridine  263 was favoured, which  was reported by  Davis 
(Scheme 86). The synthesis was completed by acid hydrolysis of the ester substituent on 
treatment  of  hydrochloric  acid. This  afforded the  racemic  hydrochloride salt  of  6-
methylpipecolic acid as a 66:34 mixture of  trans 264 and  cis 265 diastereomers (c.f.-
started with 63:37). Overall this 6-methylpipecolic acid was obtained in 16% overall yield 
and in 7 steps, beginning with the commercially available 4-pentyn-2-ol.
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Scheme 91. De-benzylation and iminium ion formation leads to cis product.
Overall, the formation of a pipecolic acid analogue using the aza-silyl-Prins reaction has 
been successful and proves the usefulness of this cyclisation reaction in the total synthesis 
of  small  natural  products.  Unfortunately,  although  the  diastereoselectivity  of  the 
cyclisation  reaction  was  good,  the  de-benzylation  process  affords  a  mixture  of 
diastereomers.
To  demonstrate the  usefulness  of  the  olefin  functionality,  the  formation  of  a  3,4-
substituted pipecolate derivative was desired. In this instance, the aza-silyl-Prins reaction 
could be utilised to couple ethyl glyoxylate to the unsubstituted silylated-homoallylic 
amine. This amine was derived from 3-butyn-1-ol 248 as previously discussed and would 
form a  simple 2-substituted-3,4-tetrahydropyridine  268 (Scheme 92).  Then the olefin 
function  could  be  functionalised  for  example,  by  di-hydroxylation  as  previously 
employed (Scheme 73 and 80) to form 3,4-dihydroxypipecolate 269.
. 17Synthesis  of  3,4-Dihydroxy 
Pipecolates
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Scheme 92. Reagents and conditions: (a) InCl3, ethyl glyoxylate, CH3CN, reflux, 15 h, 70%; (b) OsO4 
(1.0 M in H2O), NMO, THF, H2O, rt, 72 h, 36%; (c) Ac2O, DMAP, DCM, rt, 24 h, 69%.
The aza-silyl-Prins reaction of the homoallylic amine 256 and ethyl glyoxylate proceeded 
smoothly  in  acetonitrile  at  reflux  temperature  to  give  the  2-substituted-3,4-
tetrahydropyridine  268 in 70% yield. This is in contrast to the  α-methyl homoallylic 
amine 257, which produced better yields at room temperature. The di-hydroxylation of 
the  tetrahydropyridine  was  then  performed by  treatment  with  osmium tetroxide  and 
NMO, which formed the diol 269 in a disappointing 36% crude yield. This diol could not 
be purified or characterised fully in this form so it was functionalised further. This was 
accomplished by transformation to the di-acetate 270 by treatment with acetic anhydride 
in the presence of 4-dimethylaminopyridine, as previously employed (Scheme 80). The 
di-acetate  270 was  formed in  69% yield  from the  crude  starting  material  and  the 
occurrence of the di-hydroxylation on the least hindered face was proven by NOESY 
experiments on this species. Small 0.9% and 0.5% enhancements of C2 and C3 hydrogens 
on  irradiation  of  either  confirmed this.  Unfortunately  the  occurrence of  the  syn di-
hydroxylation could not be confirmed as the C3 and C4 hydrogens occur too close to one 
another in the 1H NMR spectrum, but it is assumed based on previous examples (Scheme 
73 and 80). 
Again the usefulness of the olefin function from tetrahydropyridines has been proven by 
forming pipecolate molecules with  high  functional  diversity.  For  future work,  other 
substituents could be introduced into the 6-position of the piperidine core of pipecolic 
acids  and  pipecolates.  Also  worthy  of  future  study  would  be  an  attempt  to  form 
enantiopure analogues of  pipecolate molecules  using  enantiopure substrates  or  other 
asymmetric methods that will be discussed at a later stage in this thesis.
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CHAPTER FIVE: Formation of 1,2,5,6-
Tetrasubstituted-3,4-tetrahydropyridines
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. ILiterature Review on the Formation of Multi-substituted Tetrahydropyridines 
Past  work  by  the  group  has  utilized  the  silyl-Prins  reaction  to  synthesise  2,5,6-
trisubstituted  dihydropyrans  279 and  280 from  α,β-disubstituted  silicon-containing 
homoallylic  alcohols.  These  cyclisations  were  completely  diastereoselective  when 
beginning with either the syn or anti alcohols, which themselves were obtained via a short 
synthetic pathway beginning from commercially available symmetrical alkenes. Either 
the (Z) 271 or (E)-alkene 272 was transformed to the corresponding epoxide 273 and 274, 
each of which was opened with a trimethylsilyl aluminium acetylene species to yield the 
propargylic alcohols 275 and 276. These were reduced as with previous examples, to give 
the desired cyclisation substrates 277 and 278 (Scheme 93).
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trans 79%
syn 53%
anti 84%
syn 75%
anti 83%
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Ph
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Scheme 93.  Synthesis  of  2,5,6-trisubstituted dihydropyrans  via silyl-Prins  reaction.  Reagents and 
conditions: (a) 77% m-CPBA, H2O, NaHCO3, DCM, 0 °C; (b) (i) n-BuLi, toluene, TMS acetylene, -30 
°C, 30 min, (ii) Et2AlCl, -30 °C, 30 min; (c) (i) DiBAL, Et2O, 0 °C, (ii) reflux, 24 h, (iii) H2SO4(aq), 0 °
C; (d) PhCH2CHO, InCl3, DCM, 16 h, rt.
The proposal was to produce syn and anti α,β-disubstituted silylated homoallylic amines 
to  test  in  the  aza-silyl-Prins  reaction,  hopefully  to  furnish  tetrasubstituted 
tetrahydropyridines in synthetically useful yields (Scheme 94). This would allow us to see 
if  the  stereochemical  issues  follow the  same  pattern  as  previously  observed when 
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comparing the silyl-Prins and aza-silyl-Prins reactions. Also worthy of note is the fact that 
the precursor synthesis towards both stereoisomers of the allylic amine could be more 
challenging and so  literature examples  for  synthesising  α,β-disubstituted  homoallylic 
amines will  be reviewed, in addition to examples of the synthesis  of tetrasubstituted 
tetrahydropyridines.
RHN
R1
R1RHN
R1
R1
TMS TMS
syn anti
or
N
R
R1
R1 R2
R3CHO +
Scheme 94. Proposal for the formation of N,2,5,6-tetrasubstituted-3,4-tetrahydropyridines.
Firstly the diastereoselective production of α,β-disubstituted homopropargylic amines will 
be discussed.
The first example by Normant involves a novel coupling reaction between an allenyl zinc 
reagent and α-alkoxy (or siloxy) imines. Before this article, there was little known about 
the double  diastereoselection during addition of  chiral  allenyl zinc reagents to  chiral 
electrophiles such as aldehydes and imines. Addition of allenylzinc reagents to simple 
aldehydes has been studied extensively and Zweifel obtained an excellent anti:syn ratio 
(>96:4),  dependant on  the  allenyl  moiety  substitutent  groups.  The  proposal  was  to 
investigate  whether  carbozincation  using  allenylzinc  bromides  (derived  from  the 
corresponding lithium derivatives) would show the same reactivity as other allenylzinc 
reagents. Normant obtained his allenyl zinc species 282 via propargylic deprotonation of 
281 using  s-BuLi in THF at -40  °C; and this was followed by transmetallation of the 
lithium species  using  zinc(II)  bromide. On  coupling  these  species  to  α-oxygenated 
aldehydes 283, the corresponding trimethylsilyl propargylic alcohols  284 were obtained 
with low diastereoselectivity for a range of α-siloxy aldehydes (Scheme 95). 
TMS
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Ph
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OR' R
OH
Ph
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1) s-BuLi, THF,
-40 °C to 0 °C
2) ZnBr2 THF, -78 °C,
NH4Cl sat. 85-97% Yield
53-67% de
281
282
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284
Scheme 95. Synthesis of α-alkoxy (or siloxy) di-substituted alcohols.
It was assumed that the nucleophilicity of the allenylzinc bromides towards aldehydes 
was too great and so responsible for the low diastereoselection, therefore it was proposed 
to  use a  less  electrophilic  imine.  The use of  imines was highly  appropriate as  their 
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electrophilicity  may  be  fine  tuned  by  varying  nitrogen  substituents.  Interestingly, 
Yamamoto exclusively obtained  anti product  287 (Scheme 96) on addition of allenyl 
metals (Ti, B, Al, Li), derived from 1-(trimethylsilyl)-but-1-yne 286, to aliphatic imines 
285.
.
R''
TMS
M TMSNHR'
R''
R
N
R'
R''
+
H2O
M = Ti, B, Al, Li285
286 287
Scheme 96. Yamamoto found exclusive anti selectivity with imine addition.
This example would be particularly relevant for obtaining precursors for the aza-silyl-
Prins reactions, as it would allow us to have possibly identical alkyl substitutents in both 
the α and β positions as previously used for the examples of the silyl-Prins reaction. 
Normant initially screened benzyl imines of mandelic aldehyde, which were protected as 
silyl  derivatives  or  as  MOM  ethers.  At  -70  °C,  exclusive  diastereoselectivity  was 
observed for the addtion of the zinc reagents derived from 1-(trimethylsilyl)hex-1-yne 
with imines containing an α-hydroxy group bearing either a TIPS, TBS or benzyl group. 
Exclusive stereochemistry was also obtained at –35 °C on adding the TBS imine to the 
same zinc reagent although the yields were slightly lower (Table 33).
Table 33. Imine screening for allenyl zinc additions.
.
R2
TMS
ZnBr
TMSNHBn
R2
N
Bn
+
OR3
R1
OR3
R1
1) THF
2) NH3/NH4Cl aq.(1/2)
288 289 290
Entry R1 R2 R3 Temp.(°C) %Yield d.e (%)
1 Ph Pr TBDPS -70 90 93
2 Ph Pr TIPS -70 70 >99
3 Ph Pr TBS -70 85 >99
4 Ph Pr TBS -35 75 96
5 Ph Pr TBS 0 78 68
6 Me Pr Bn -70 80 >99
7 Ph Me TBS -70 68 >99
So it would seem feasible to be able to use Normant’s methodology to produce the α,β-
disubstituted homopropargylic amines which could later be used as substrates for the aza-
silyl-Prins reaction. Yamamoto does however report upon using simple aliphatic imines 
with other allenyl metal reagents. If either methodology could be incorporated into the 
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synthesisto of the desired substrate, then there would still be the problem of forming the 
syn product, as these methods report exclusive anti selectivity.
The next example by Panek is a route to highly enantioenriched tetrahydropyridines from 
chiral  organosilanes  291 and  the  methodology  was  applied  to  the  synthesis  of  the 
quinolizidine alkaloid (-)-217A. This study is important as there is little precedent in the 
literature for synthesis of tetrahydropyridines with high enantiopurity. They suggest that 
formation  of  2,6-tetrahydropyridines  with  use  of  allyl  and  vinylsilanes  as  the  π-
nucleophile  is  limited  due  to  the  competitive  aza-Cope  rearrangement  which  often 
compromises  reaction  diastereoselectivity.  Panek  reports  a  highly  stereoselective 
approach to both 2,6-cis and N,2,6-trans-3-trans-tetrasubstituted tetrahydropyridines  via 
intramolecular imine crotylation. This approach utilised the silicon-bearing centre as the 
dominant stereocontrol element leading to highly selective annulation. Initial screening 
used  ytterbium  triflate  to  activate  the  imines  generated  in  situ and  catalyse  an 
intramolecular  crotylation  to  provide  tetrahydropyridines  in  one  pot.  The  reaction 
proceeded under mild conditions but unfortunately, the diastereoselectivity was low. It 
seemed that the vinylglycine type moiety embedded in the annulation product was prone 
to epimerisation. Eventually titanium(IV) chloride was identified as the most general and 
effective Lewis  acid in  promoting annulation and provided an  efficient route to  the 
tetrahydropyridines. These were then protected as the trifluoroacetamides 292,  which 
could be isolated as single stereoisomers in up to 90% yield.  It  was  shown that the 
reactions involving imines isolated from aromatic aldehydes were more efficient than 
aliphatic examples with both  cis and  trans-2,6-disubstituted tetrahydropyridines being 
prepared with higher diastereoselectivities. It was also demonstrated that annulation could 
proceed with complete transfer of chirality from the chiral silane  291 to the product 
(Table 34).
Table 34. Aldehyde screening for asymmetric synthesis of 1,2,5,6-tetrahydropyridines.
CO2Me
SiMe2Ph
NH2
N
O CF3
MeO2C R
Me
HH
O
R H
1) MgSO4, DCM
2) TiCl4,-78 °C to rt
3) (CF3CO)2O,
pyridine, DCM
+
291
292
Entry R Chiral silane %Yield dr C2 to C6; 
cis:trans
1 i-Pr 2,3-anti 73 1:13
2 m-NO2Ph 2,3-anti 90 <1:30
3 2-furyl 2,3-anti 89 1:12
4 (trans)PhCHCH 2,3-anti 64 1:9
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5 C6H12 2,3-syn 78 10:1
6 4-BrPh 2,3-syn 82 >30:1
7 2-furyl 2,3-syn 75 8:1
The reaction products could also be converted into isomeric 1,4,5,6-tetrahydropyridines 
on treatment with DBU in THF, with both cis and trans isomers converted in >90% yield. 
The next example by Liebeskind is very different since it does not involve a cyclisation 
process.  It  is  the  enantiocontrolled  synthesis  of  N,2,3,6-tetrasubstituted 
tetrahydropyridines  using  (η3-dihydropyridinyl)  molybdenum  complexes  as  chiral 
scaffolds.  Complexes  with  molybdenum  centres  such  as  TpMo(CO)2(pyranyl)  and 
TpMo(CO)2(dihydropyridinyl) are excellent chiral scaffolds for enantioselective synthesis 
of  highly  functionalized  heterocycles.  They  have  reported  the  synthesis  of  N,2,3,6-
tetrasubstituted tetrahydropyridines using regiocontrolled abstraction of hydride from (3-
methoxy-η3-dihydropyridinyl)TpMo(CO)2 complexes  293.  Abstraction  of  the  hydride 
with Ph3CPF6 gave the η4-diene cation 294 and this reacted with several nucleophiles to 
provide the C2 substituent in  295.  After a second hydride abstraction and subsequent 
nucleophilic  addition,  the  (2,6-disubstituted-3-methoxy-dihydropyridinyl)molybdenum 
complex  296 was  obtained.  Decomplexation  gave  the  N,2,3,6-tetrasubstituted 
tetrahydropyridines 297, with poor regioselectivity for the first hydride abstraction except 
when the 3-substituent is a methoxy or phenoxy (Scheme 97).
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Scheme  97.  General  procedure  for  asymmetric  synthesis  of  N,2,3,6-tetrahydropyridines  by 
Liebeskind.
These few literature examples have shown us that multi-substituted tetrahydropyridines 
are obtainable, however controlling the relative stereochemistry is often challenging. 
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Using α,β-disubstituted homopropargylic amines in the aza-silyl-Prins reactions would 
give us a novel route to these highly functionalised heterocycles and hopefully in high 
diastereoselectivity.
. IIResults and Discussion: Studies into Synthesis of  N,2,5,6-Tetrasubstituted-3,4-
tetrahydropyridines
As previously discussed, the formation of tetrasubstituted-3,4-tetrahydropyridines via the 
aza-silyl-Prins reaction was to be attempted. This follows the success found in utilising 
the  silyl-Prins  reaction  to  form  2,5,6-trisubstituted-3,4-dihydropyrans  using  α,β-
disubstituted  silylated  homoallylic  alcohols.  Therefore,  coupling  α,β-disubstituted 
silylated homoallylic amines to aldehydes under indium trichloride mediated conditions 
was attempted. Although the first priority was to find conditions to form these multiply-
substituted tetrahydropyridines, attempts were also made to vary the substitution pattern 
of  the  α,β-disubstituted precursors  from  syn to  anti.  It  was interesting to  study the 
stereoselectivity of the aza-silyl-Prins reaction in comparison with the oxygen series and 
also to investigate the effect that the additional  N-substituent plays in controlling the 
selectivity.
The α,β-disubstituted amines were required for screening in the aza-silyl-Prins reaction 
and our first proposal was to use the same methodology with which our group previously 
accessed the alcohol precursors. Then the tosylation and amination methodology to access 
the required amines could be utilised. The previous synthesis began with (Z)-hex-3-ene 
271 and (E)-hex-3-ene  272.  Unfortunately these starting materials could no longer be 
obtained commercially so the synthesis began with the octene analogues. This meant that 
our  proposed  targets  were  syn 309 or  anti (4,5,Z)-N-benzyl-5-(2-
(trimethylsilyl)vinyl)octan-4-amine. It was decided to maintain the use of the  N-benzyl 
substituent as it had brought positive results in all other studies. Based on the studies into 
the aza-silyl-Prins reaction with fluorinated precursors, it was attempted to obtain strictly 
the (Z)-geometric isomers as it was felt that these would be the most reactive substrates. 
Using this methodology, it was possible to obtain the syn-α,β-dialkyl diastereomer 309 in 
5 steps from the commercially available alkene 299. However attempts to obtain the anti-
α,β-dialkyl diastereomer were unsuccessful (Scheme 98).
. 18Precursor Synthesis I:  Formation of  α,β-Disubstituted 
Amines
132
Chapter Five
O
O
TMS
HO
TMS
HO
HOHO
TMS TMS
cis 83% trans 67%
syn 20% anti 51%
syn 28%, Z:E; 43:57.
anti 70%
HO
TMS
+
TsO
TMS
anti 30%
TfO
TMS
anti 58%
BnHN
TMS
syn 17%
a a
b b
c c
d e
f g
298 299
300
301
302 303
304 305
306
307308
309
Scheme 98. Reagents and conditions: (a) 77% m-CPBA, H2O, NaHCO3, DCM, 0 °C, cis-83% & trans-
67%; (b)  n-BuLi, TMS acetylene, Et2AlCl, hexane, -30 °C, syn-20% & anti-51%; (c) DiBAL, Et2O, 
reflux, 48 h,  syn-28% (Z:E; 43:57) & anti-70%; (d) Tf2O, pyridine, DCM, 0  °C, 4 h,  anti-58%; (e) 
TsCl, Et3N, DMAP, DCM 0 °C, 48 h, anti-30%; (f) BnNH2, EtOH, reflux or BnNH2, Et3N, DCM, 0 °C; 
(g) BnNH2, EtOH, reflux, 20 h, syn-17%.
Following previous methodology for the first  two steps, firstly the epoxidation of the 
commercially available alkenes, (Z)-oct-3-ene 298 and (E)-oct-3-ene 299 was completed. 
This was performed by the treatment of the alkenes with  m-CPBA in the presence of 
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sodium hydrogen carbonate to give the  cis-epoxide 300 and  trans-epoxide  301 in 83% 
and 67% yields respectively. Again using previous methods, the epoxides were opened 
with  an aluminium TMS acetylide species to  give the  syn-  302 and  anti-α,β-dialkyl 
alkynylsilanes 303 in 20% and 51% yields respectively. These reactions were completed 
by  the  treatment  with  TMS  acetylene  in  the  presence  of  n-butyllithium  and 
diethylaluminium chloride. It is clear that the stereochemistry of the epoxide precursors 
had a large influence on the yield of product. Next the alkynylsilanes 302 and 303 were 
reduced by the treatment with DiBAL, which afforded exclusively the (Z)-alkene 306 for 
the  anti starting material  303 in 70% yield. However reduction of the  syn-α,β-dialkyl 
alkynylsilane 302 produced approximately a inseparable 1:1 mixture of (Z) 304 and (E) 
305 geometric isomers  in  28%  total  yield.  The  low  yield  and  the  poor  reduction 
stereoselectivity highlight the steric effects present due to the α and β substituents. The 
anti 306 and also the inseparable syn mixture of silylated homoallylic alcohols 304 and 
305 were then submitted to tosylation procedures using tosyl chloride. Product formation 
was only observed in the case of the  anti starting material. Even in  this example, a 
disappointing purified yield of 30% for the tosylated alcohol  307 was obtained, with 
mostly starting material remaining in the crude mixture after 48 hours. The amination of 
the anti-α,β-dialkyl tosylated alcohol 307 was completed by the action of benzylamine in 
refluxing ethanol to afford the syn-α,β-dialkyl homoallylic N-benzyl amine 309 in 17% 
yield. Complete inversion of configuration was assumed to have occurred by the SN2 
nucleophilic substitution of the anti-α,β-dialkyl tosylated alcohol 307 by benzylamine. It 
was not possible to accurately confirm the relative stereochemistry of all substrates by 
NOESY experiments for the 1H NMR spectra. However the large enhancements between 
olefinic hydrogens for both  syn 304 and anti-α,β-dialkyl 306 homoallylic alcohols and 
the  syn-α,β-dialkyl homoallylic amine  239 example confirm the presence of the (Z)-
isomer (Figure 21). Attempts to maximise the yield for the formation of the  syn-α,β-
dialkyl homoallylic amine 309 were performed first by employing a better leaving group 
by the formation of the anti-α,β-dialkyl triflate 308 in 58% yield. This was completed by 
the treatment of the anti-α,β-dialkyl homoallyic alcohol 306 with triflic anhydride in the 
presence of pyridine. Although this yield is an improvement in comparison to formation 
of the tosylate,  the amination of this  compound with benzylamine was unsuccessful. 
Attempts to also obtain the syn-α,β-dialkyl triflate from the inseparable mixture of 304 
and 305 were unsuccessful using the same methodology.
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Figure 21. The nOe effects in α,β-disubstituted homoallylic precursors.
The syn-α,β-dialkyl homoallylic N-benzyl amine 309 was now available for screening in 
the indium trichloride-mediated aza-silyl-Prins  reaction. At  this  stage, only  sufficient 
amine for one trial reaction was available and so it was decided to screen ethyl glyoxylate 
in 1:1:1 equivalents of amine, aldehyde and Lewis acid in acetonitrile. This was due to the 
high reactivity of ethyl glyoxylate in previous examples, suggesting this would give the 
greatest probability of a positive result (Scheme 99). Also, if the N,2,5,6-tetrasubstituted-
3,4-tetrahydropyridine 310 was formed, then this could be utilised in  the total synthesis 
of other pipecolic acid analogues (c.f-chapter 4).
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N
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310
Scheme 99. Reagents and conditions: (a) (i) InCl3,CH3CN, rt, 4 h, (ii) reflux, 48 h.
Initially the reaction was begun at room temperature, but no progress was observed after 4 
hours. Therefore, the conditions were changed to reflux temperature for 48 hours but still 
no progress or trace of product was observed on analysis by GCMS or 1H NMR. 
In order to screen other aldehydes or vary reaction conditions, more starting material was 
required and so a new precursor synthesis was proposed. Even if utilising the aza-silyl-
Prins reaction to form N,2,5,6-tetrasubstituted-3,4-tetrahydropyridines was unsuccessful, 
then at least there would have been a contribution towards new methodology for the 
synthesis of multi-substituted silylated-homoallylic amines. The new proposal was to use 
a coupling reaction between an allenyl zinc reagent and an imine to synthesise α,β-dialkyl 
silylated-homopropargylic  amines,  as  reported  in  the  literature  (Scheme  100).  As 
previously discussed, these reactions were exclusively diastereoselective under certain 
. 19Precursor Synthesis II- Zinc Bromide Mediated α,β-Dialkyl 
Amine Formation
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conditions. However,  the imines that were utilised in the literature examples were α-
alkoxy (or siloxy) imines, whereas the intention was to couple simple alkylated imines. 
This could alter the diastereoselectivity of the coupling reaction. If successful, simple cis 
reduction would hopefully give the required homoallylic amine.
TMS
.
TMS
ZnBr
TMSNHBn
N
Bn
NHBnNHBn
TMS
TMS
+
O
syn:anti; 82:18
Z:E 1:2
b
a
c
d
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Scheme 100. Reagents and conditions: (a) BnNH2, MgSO4, DCM, rt, 20 h, 19%; (b) (i) s-BuLi, THF, 0 
°C, 1h, (ii) ZnBr2, -20 °C; (c) THF, -70 °C, 1h, 65% over 2 steps; (d) DiBAL, Et2O, reflux, 48 h, 30% 
overall (Z:E; 1:2). 
The condensation of butyraldehyde 313 with benzylamine in the presence of magnesium 
sulfate  afforded the  desired  imine  314  in  a  disappointing  19% yield.  The  reported 
coupling  reaction  was  initiated  by  the  addition  of  s-butyllithium  to  commercially 
available 1-trimethylsilyl-1-hexyne 311. After treatment with anhydrous zinc bromide, the 
intermediate allenyl zinc compound 312 was formed, which was used immediately in the 
next step. When the pre-formed imine 314 was added at -70 °C, it generated the desired 
N-benzyl silylated-alkynyl amine 315 in an inseparable 82:18 mixture of  syn and  anti-
dialkylated amines. This inseparable mixture was then submitted to standard cis reduction 
by DiBAL to afford a 1:2 separable mixture of (Z) 316 and 317 (E)-geometric isomers in 
30% overall yield. These (Z) 316 and 317 (E) alkenes were also separable from the minor 
anti-dialkyl diastereomers. This mixture of geometric isomers was comparable with the 
poor stereoselectivity observed for formation of the α-trifluoromethyl homoallylic amine 
precursors from the related alkynylsilanes (Scheme 77). It seems that the Lewis acid-
Lewis base compatibility required for selectivity in the cis reduction is poor on the use of 
136
Chapter Five
amines rather than alcohols. The spectral analysis of the (Z)-alkene 316 was identical to 
that found for the syn-dialkylated homoallylic amine 309 derived from the amination of 
the related tosylated alcohol 307.
With  the  desired  syn precursor obtained,  the  (Z)-homoallylic  amine  316 was  again 
screened in the aza-silyl-Prins reaction. It was also decided to introduce the pre-separated 
(E)-alkene 317 to indium trichloride mediated Prins conditions. If success was found with 
either geometric isomer, then again, conclusions could be drawn upon the requirement for 
the (Z)-geometry to  maximise the  stability  of  important  intermediates. Unfortunately 
when using ethyl glyoxylate or phenylacetaldehyde, there was no positive progress for 
either geometric isomer at room temperature or reflux temperatures. When all substrates 
were submitted for up to 120 hours at reflux, only starting material remained and any 
trace quantities of product were not identifiable (Scheme 101). It was assumed that the 
negative results for the formation of tetrasubstituted tetrahydropyridine product 318 were 
based upon the presence of an N-substituent in comparison with the oxygen series. 
BnHN
TMS
N
Bn
R
a
BnHN
TMS
or
316 317 318
Scheme 101. Reagents and conditions: (a) (i) InCl3, CH3CN, RCHO (R=CO2Et or PhCH2), rt, 8 h, (ii) 
reflux, 120 h.
Even  though  synthesising  tetrasubstituted  tetrahydropyridines  via the  aza-silyl-Prins 
reaction was unsuccessful, new methodology for precursor formation has been introduced 
and perhaps could be adapted for other studies. For future work, it would be beneficial to 
complete thorough screening of all variables involved in the cyclisation reaction, such as 
the Lewis acid, solvent, aldehyde or  N-substituent adopted. Perhaps then if success is 
found for the formation of multi-substituted nitrogen heterocycles, then the methodology 
could be adapted towards the formation of natural product analogues, such as pipecolic 
acid.
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CHAPTER SIX: Towards the Synthesis of 
Enantiopure 2-Substituted-3,4-
tetrahydropyridines
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. IIILiterature Review Towards Formation of Enantiopure Tetrahydropyridines
The  next  evolution  of  the  aza-silyl-Prins  methodology  would  be  to  utilise  these 
cyclisation  reactions  to  form  enantiopure  2-substituted-3,4-tetrahydropyridines.  The 
initial proposals included the use of chiral auxillaries and also chiral Lewis acids. The 
later example would involve the formation of a complex between chiral ligands and a 
Lewis acid, which could then activate substrates in the aza-silyl-Prins reaction. If this 
theory is applied then the chiral Lewis acid could activate the aldehyde substrate  319, 
which would subsequently undergo condensation with the silylated-homoallylic amine 
precursor to form an intermediate iminium ion 320. Unfortunately, this leaves an achiral 
intermediate, which at the point of cyclisation, is likely to be un-bound to the chiral Lewis 
acid (Scheme 102). This is required to induce enantioselectivity at the C2 position of the 
3,4-tetrahydropyridine product.  
TMS
NHR
N
R
R1
O
R1
+
LA*
LA* = chiral Lewis acid
TMS
NR
R1
LA*OH+ LA*OH+
319 320
Scheme 102. Formation of achiral intermediates in aza-silyl-Prins reaction.
Therefore an alteration was required to this methodology, and it was proposed that the 
iminium ion intermediate could be replaced with an imine. The imine could then be 
activated by the chiral Lewis acid  321 and remain datively bound when the cyclisation 
step occurred, therefore hopefully inducing enantioselectivity (Scheme 103).
N
H
R1
LA* = chiral Lewis acid
TMS
N
R1
LA*+
LA*
321
Scheme 103. Asymmetric imine-vinylsilane cyclisation, promoted by chiral Lewis acid.
With this proposal in hand, examples of imine-vinylsilane cyclisations in the literature, as 
well as examples of the use of chiral Lewis acids, will now be reviewed.   
Overman has examined the reactions of vinylsilanes in the regiocontrolled synthesis of 
tetrahydropyridines and related heterocycles. This includes the preparation of free amine 
. 20Vinylsilane  Cyclisations:  Formation  of  Racemic 
Tetrahydropyridines
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tetrahydropyridines  324 via a  protic  acid  promoted cyclisation  of  imine precursors. 
Several imines  323 were prepared by the condensation of an amine  322 with various 
commercially available aldehydes. These imines 323 were then treated with an excess of 
trifluoroacetic acid to promote the cyclisation in moderate yields (26-55%). Surprisingly, 
five equivalents of protic acid gave greater yields than one equivalent, in spite of the 
greater  opportunity  for  protodesilyation.  Similar  conditions  were  unsuccessful  in 
promoting the cyclisation in cases where the imine was derived from aldehydes with α-
hydrogens,  where it  was  assumed that  self-condensation between the  imine and the 
enamine tautomer occurred (Table 35).  
Table 35. Protic acid mediated imine-vinylsilane cyclisations.
TMS
NH2
TMS
N
R NH
R
RCHO, MgSO4, 
Et2O
5eq.TFA, 
CH3CN,
322 323 324
Entry R Temp. (°C) Time (h) %Yield
1 3-bromophenyl 55 48 55
2 3-pyridinyl 60 40 33
3 C(CH3)2CH2Ph 120 24 66
4 C(CH3)2CH2Ph 60 40 26
5 (CH2)2Ph - - 0
Next Overman reported the formation of 2,6-disubstituted tetrahydropyridines  via the 
same imine-vinylsilane cyclisations. The imine precursor 331 required for the study was 
taken from the condensation of  benzaldehyde and an  α–substituted chiral vinyl-silyl 
amine 330. This amine was derived in 7 steps from commercially available L-alanine 325. 
Firstly,  the  amino acid  325 was  converted into  an  N-tosylaziridine  327 by  known 
procedures,  and  it  was  then  opened  in  the  least  hindered  position  by 
(trimethylsilyl)alkynyllithium. The resulting alkynylsilane 328 was cis reduced to the (Z)-
alkene  329 using dicyclohexylborane, followed by protonolysis. The stereochemically 
pure sulfonamide  329 was deprotected by  the  action  of  sodium naphthalide  in  1,2-
dimethoxyethane to give the required amine 330 in >96% ee. After the condensation of 
the  amine  330 with  benzaldehyde,  the  resulting  imine  331 was  introduced  to  the 
previously employed conditions of  TFA in  acetonitrile  at  60  °C.  The results  of  this 
cyclisation were the production of a 1:1 mixture of separable  cis-  332 and  trans-2,6-
tetrahydropyridines  333 in 85% yield (Scheme 104). This is  surprising as you would 
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presume that a di-equitorial conformation or  cis geometry would be highly favoured to 
reduce steric strain between ring substituents.
The enantiopurity of the 2,6-tetrahydropyridine products 332 and 333 were investigated 
by Overman in a later article. On use of chiral HPLC analysis, the previously separated 
diastereomers each had an enantiopurity of 85%. This shows partial racemisation of a 
iminium-ion intermediate via the intermediate aza-Cope rearrangement.
TMS
N
Ph
N
H
Ph
CO2H
NH2
H
CH2OTs
NHTs
H TsN
TMS
TsHNTsHN
TMS
H2N
TMS
N
H
Ph
+
85% ee 85% ee
a b
c
de
f
g
325 326
327
328329330
331
332 333
Scheme 104.  Reagents and conditions: (a) (i) LAH, (ii) TsCl, pyridine, 58% for 2 steps; (b) KOH, 
MeOH, 72%. (c) Lithium TMS acetylide, TMEDA, 92%. (d) (i) (c-Hex)2BH, (ii) Acetic acid, NaOH, 
H2O2, 83% for 2 steps; (e) Na, naphthalene, 1,2-dimethoxyethane, 68%; (f) PhCHO, MgSO4/Na2SO4, 
DCM, 62%; (g) 3 eq.TFA, CH3CN, 60 °C, 85%.
The next example by Tanner again shows high similarities with our work on the aza-silyl-
Prins reaction, with various examples of iminium-ion vinyl-silane cyclisations. Based on 
the  previous  example by  Overman,  which  is  cited in  this  article,  they  attempted a 
ketimine cyclisation. This was performed firstly by the formation of an  α–substituted 
primary amine  335 which was derived in five steps from the commercially available 
epoxide  334. After condensation with cyclopentanone, the resulting imine  336 did not 
undergo cyclisation to 337 on treatment with TFA in acetonitrile at reflux. However under 
the same cyclisation conditions, the imine 338, derived from the same primary amine 335 
and benzaldehyde, did yield success. The resulting 2,6-disubstituted tetrahydropyridine 
339 interestingly produced a 1:1 diastereomeric mixture, comparable with Overman’s 
studies. Further attempts to cyclise the ketimine 336 to the corresponding spirocycle were 
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unsuccessful  on  treatment with  Lewis  acids, TMS triflate, boron trifluoride etherate, 
titanium(IV) chloride or titanium(IV) isopropoxide (Scheme 105).
TMS
NH2 NH
OBn
TMS
N
OBn
BnO
TMS
N
OBn
Ph
O
OBn
N
H
BnO Ph
 5 steps
a b
c
d
334
335
336 337
338 339
Scheme 105. Reagents and conditions: (a) cyclopentanone, 4Ǻ mol sieves, Et2O, 92%; (b) no reaction; 
(c) PhCHO, 4 Ǻ mol sieves, Et2O; (d) TFA, CH3CN, 80 °C, 37% (2 steps).
There are no examples in the literature that involve Lewis acids in imine-vinylsilane 
cyclisations, only protic acids. Therefore our initial screening towards the synthesis of 
enantiopure 2-substituted-3,4-tetrahydropyridines would involve testing Lewis acids for 
racemic examples.
Previously discussed, is the proposal of synthesising 2-substituted tetrahydropyridines via 
a Lewis acid-mediated cyclisation of imine-vinylsilanes. In the literature, this has been 
reported under protic acid conditions. This section will examine examples where Lewis 
acids have been used to activate imines, so that a list of azaphilic Lewis acids may be 
identified for screening.
Aube examined Lewis acid-mediated imine-olefin cyclisations in order to produce 2-aryl-
4-chloropiperidines (Table 7). The use of titanium(IV) chloride to activate the imine 340, 
produced piperidine products 341 in reasonably low yields of 18-52% (Scheme 106). It is 
uncertain whether it was the low reactivity of the imine precursor 340 (containing an un-
activated olefin  nucleophile)  or  the  stability  of  the  intermediate carbocation  which 
contributes to the low yields. It could also be due to the use of the titanium Lewis acid, 
. 21Activation of Imines with Lewis 
Acids
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since this is very moisture-sensitive. However, the Lewis acid is, at least to some extent, 
compatible with the imine precursor.
R3
R1
N
R2
R3
R1
N
H
Cl
R2
TiCl4, DCM, reflux
340 341
Scheme 106. The titanium mediated imine-olefin cyclisations.
Lectka has reported the extensive screening of Lewis acids for the synthesis of β-lactams 
via the activation of imines. Initial screening was perfomed with a variety of Lewis acids 
for the coupling of phenylacetyl chloride 342 with an imino ester 343. Most success was 
found using metal triflates of Sc(III), Al(III), Zn(II) and In(III). More specifically, the 
metal triflates of Zn(II) and In(III) resulted in the greatest yields of 345 of 85% and 95% 
respectively (Scheme 107).
O
Ph
Cl N
Ts
EtOOC
N
OTs
N
N
O
Ph
O
EtOOC PhOMe
+
LA (10mol %), toluene, 
-78 °C
342 343
344
345
Scheme 107. Lewis acid mediated coupling of imino ester to phenylacetyl chloride.
The Lewis acids reviewed here are some of the very few examples of imine activation 
discussed in the literature.
In order for the aza-silyl-Prins reaction to be a short novel route to natural product cores, 
then there is a desire to control the absolute stereochemistry of the tetrahydropyridine 
product. The Dobbs group has already described the diastereoselectivity of the aza-silyl-
Prins reaction as being exclusively  trans across the nitrogen atom but the products are 
still racemic. Attempts to make the reaction asymmetric have proved unsuccessful to date 
with the use of chiral auxillaries on the  N-substituted moiety giving poor to moderate 
enantiomeric excesses. Other possibilities  for  enhancing the  enantioselectivity  of  the 
. 22Utilisation of Chiral Lewis 
Acids
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reaction include using chiral Lewis acids or chiral ligand-Lewis acid complexes and so 
the use of these species will be reviewed.
Loh and co-workers have reported the synthesis of enantiomerically enriched homoallylic 
alcohols  347.  This  area  is  of  great  requirement  as  these  alcohols  are  versatile 
intermediates for synthesis. Work has already been undertaken using chiral Lewis acid 
catalysed additions of allyl moieties to carbonyl function. These include ligands attached 
to metals such as Zn, Ti and Rh. Loh first reported the use of chiral In(III)-PYBOX 
complexes to  catalyse the addition  of  allyltributylstannanes  346 to  aldehydes.  Initial 
studies  involved  complexation using  a  catalytic  amount  of  indium triflate  and  also 
PYBOX ligands. These were stirred together at  room temperature for 2 hours in the 
presence of molecular sieves. Then addition of excess allylstannane 346 and TMSCl as 
well as an aldehyde derivative gave homoallylic alcohols 347 in varying yields and % ee. 
First the reaction was studied at room temperature using the solvents DCM, toluene, ethyl 
cyanide, and also a 1:1 mixture of DCM/toluene, with DCM proving the superior solvent, 
giving 59% ee.  Various  temperatures were used and -60  °C proved to  be  the  most 
effective giving 80% yield and 85% ee (Table 36). 
Table 36. Ligand screening for enatioselective alcohol synthesis.
O
H
SnBu3
OH
NO
N N
OPh
Ph
Ph
Ph
PYBOX-In(III) complex (20 mol%)
MS 4Å/ DCM, 
TMSCl, -60 °C, 30 hrs
NO
N N
O
(S)-(i-Pr)-(Ph)4 -PYBOX (S)-(i-Pr)-PYBOX
+
*346 347
348 349
Entry Chiral ligand Indium salt %Yield %ee
1 (S)-(i-Pr)PYBOX In(OTf)3 80 85
2 (S)-(i-Pr)PYBOX In(OTf)3 81 22 (TMSCl 
absent)
3 (S)-(i-Pr)PYBOX InBr3 12 31
4 (S)-(i-Pr)PYBOX InCl3 84 40
5 (S)-(i-
Pr)(Ph)4PYBOX
In(OTf)3 81 92
Other In(III) salts were screened and proved unsuccessful. Different PYBOX and also 
BOX ligands were screened in the presence of indium triflate, with the (S)-(i-Pr)-PYBOX 
349 complex yielding 80% and 85% ee. With the same ligand 349, InCl3 produced an 
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increase in yield to 85% but with a reduction in enantioselectivity to 40%. The best results 
were obtained for the tetraphenyl substituted (S)-(i-Pr)-PYBOX ligand 348, giving 81% 
yield and 92% ee. Observations from these results were that tridentate PYBOX ligands 
gave the best yields and ee and that these results were further dependent on the In(III) 
salt, with the order of improvement being Br<Cl<OTf (Table x). Also TMSCl was found 
to be the superior promoter over other silyl chlorides such as TESCl, TBSCl, and TIPSCl. 
With the most beneficiary conditions in hand, aldehydes were screened and after 30 hours 
at  -60  °C,  the  best  results  were  obtained  from  aromatic  aldehydes,  notably  2-
naphtylaldehyde giving 86% yield and 94% ee.
Loh’s work progresses, to allow the recyclability of the chiral Lewis acid complex in 
order to make the reaction truly catalytic. The use of ionic liquids allows immobilisation 
of chiral catalysts and allows re-use with comparable enantioselectivity and yields, up to 
4 times in this case. The optimal conditions for the same addition of allyltributylstannanes 
346 to aldehydes used a mixture of [hmim]PF6 351 and DCM to give the best yield of 
88% and also 94% ee for homoallylic alcohol product 350. This was with the use of a 
bis(tricyclic-oxazolinyl) pyridine ligand 352 and indium(III) triflate (Scheme 108).
O
R H
SnBu3
R
OH
*
PYBOX-In(OTf)3 (20 mol%)
MS 4Å, DCM/[hmim]PF6, 
TMSCl,
+
N N
PF6
[hmim]PF6
NO
N N
O
bis(tricyclic-oxazolinyl)PYBOX
346
350
351 352
Scheme 108. Enantioselective alcohol formation with ionic liquid.
Shibasaki has further evolved the use of chiral ligand–Lewis acid complexation by using 
a ligand system where both Lewis acid, Lewis base and other substrates are all held in 
close proximity. Here, addition of ketones to TMSCN can allow the formation of chiral 
quaternary  α–hydroxy carbonyl derivatives  353 with a novel titanium promoter being 
utilised for the transformation. The screening of the multi-functional ligand  354 with 
several Lewis acids to promote addition of TMSCN to acetophenone led to the optimal 
conditions of using titanium(IV) isopropoxide, at < -20 °C with THF to give for example, 
high yields of 85% and 92% ee (Table 37). 
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Table 37. Ketone screening in asymmetric cyanosilation.
O
RL RS RL RS
CNTMSO
TMSCN+
Ti(Oi-Pr)4 (10 mol%)
ligand (10 mol%), THF
O
P
O
Ph
Ph
O
HO
HO
RL= large group
RS= small group
353
354
Entry Ketone Temp. (°C) Time (h) %Yield %ee
1 O
Ph Me
-30 36 85 92
2 O
Me
-40 80 82 95
4 O
Ph Et
-20 64 89 91
5 O
Me
-50 88 72 91
6 O
Me
-50 36 86 90
7 O
Me
-50 36 92 85
The mechanism for the use of this ligand and promoter system is as thus. The titanium 
Lewis acid transforms to include a monocyano and monoisopropoxide function via ligand 
exchange and is  then bound in a tridentate fashion to the ligand. This complex then 
activates the ketone substrate, which is also held above the plane of the pyran ring. A 
phosphine oxide of the ligand is bound to the silane function of the cyanide, which allows 
it to be held in close proximity to the ketone (Figure 22).
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Figure 22. Mechanistic model of enantioselective cyanosilation.
It seems feasible that this system could be applied to the aza-silyl-Prins reaction since the 
silylated homoallylic amine could be held in close proximity to the aldehyde Lewis base 
via the co-ordinating phosphine oxide-silane system. 
Another  literature example of  interest  is  the  asymmetric alkynylation  of  aldehydes 
catalysed by a In(III)-BINOL complex. This study is important due to the versatility of 
the corresponding propargylic alcohol products 356 and is highly relevant to our work as 
it ultilises In(III) salts, which are present in our cyclisation reactions. These systems are 
fashioned on the bifunctional character of In(III) salts which act as hard Lewis acids and 
activators of alkynyl groups 355. Initial studies showed the use of BINOL, which gives 
high  enantioselectivity  for  the  addition  of  phenylacetylene  to 
cyclohexanecarboxaldehyde. These reactions required 10 mol% of indium bromide, 10 
mol% of (R)-BINOL, and 50 mol% of (i-Pr)2NEt in DCM at 40 °C and afforded the 
product in 96% ee and 46% yield after 7 hours. This was further improved by altering the 
promoter to Cy2NMe to give the yield as 84% and 98% ee (Table 38).
Table 38. Aldehyde screening for asymmetric alkynylation using (R)-BINOL.
O
R1 H
H R2 R1
R2
OH
+
InBr3 (10 mol%),
(R)-BINOL (10 mol%),
Cy2NMe (50 mol%),
DCM (2.0 M), 40 °C355 356
Entry Aldehyde R2 Time (h) %Yield %ee 
1
2 CHO
Ph 9 95 98
(CH2)2Ph 36 77 >99
3
CHO
(CH2)2Ph 48 46 98
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4
CHO
Ph 24 85 98
5
CHO
Ph 24 70 98
6
CHOF
(CH2)2Ph 24 61 99
7
O
CHO Ph 20 84 98
This review shows that chiral-Lewis acids can be utilised in many organic transformations 
to form desired products with high enantioselectivity. Some of the ligands reviewed are 
either commercially available or synthesised easily. The Lewis acids discussed are also 
readily available  and some have been shown to  be  compatible  with  our  cyclisation 
reactions in previous screening studies.   
. IVResults and Discussion: Studies Towards Asymmetric Imine-vinylsilane Reaction
Previous work in group had already examined an asymmetric version of the aza-silyl-
Prins reaction  using chiral auxillaries on  the  nitrogen atom.  A range of  enantiopure 
primary  amines  357 were  coupled  to  the  tosyl  activated  alcohol  254 to  produce 
enantiomerically pure silylated homoallylic amines  358. Coupling of these amines to a 
range of aldehydes in the aza-silyl-Prins reaction using indium trichloride produced N-
substituted 2-substituted tetrahydropyridines  359 and  360 in moderate yields and poor 
diastereomeric excesses (Table 39). The only combination that gave moderate success 
was the use of ethyl glyoxylate with a chiral ether auxiliary to give tetrahydropyridines in 
62% yields and 76% diastereomeric excess. 
Table 39. Utilisation of chiral auxillaries in the aza-silyl-Prins reaction.
N R'
InCl3, R'CHO
CH3CN, reflux
24 hours Ph R
+
N R'
Ph R
H2N
TMS
OTs
+ TMS
N
H
(i-Pr)2NEt
CH3CN, reflux
48 hours
Ph
R
Ph
R254
357
358
359 360
Entry R %Yield of 
358
R’ %Yield of 
359 and 360
%De
1
2
3
Me 65 n-Pn 36 26
Bn 53 12
Ph 45 31
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4 Et 66 Ph 23 18
5 OMe 80 CO2Et 62 76
As an alternative to a chiral auxillary, it was proposed to develop an asymmetric aza-silyl-
Prins reaction using a chiral Lewis acid, formed from the complexation of a Lewis acid 
and a chiral ligand. However, as previously discussed, this proposal was not be utilised 
with any success since the aza-silyl-Prins reaction proceeds via an achiral iminium ion 
intermediate. The chiral Lewis acid would be present initially when either the aldehyde or 
secondary amine is activated. When the iminium ion is formed however, the Lewis acid-
Lewis base interaction would be dissociated.
Therefore the  proposal  was  to  examine  the  cyclisation  of  imine-vinylsilanes.  This 
involved the cyclisation of imines derived from the condensation of silylated-homoallylic 
primary  amines  and  simple  aldehydes  to  form  2-substituted-3,4-tetrahydropyridines. 
However it was proposed to form 2-substituted tetrahydropyridines in high enantiopurity 
using chiral Lewis acids. It was hoped that the chiral Lewis acid would remain complexed 
to the imine-vinylsilane  321 at the point of cyclisation (Scheme 109). If this were the 
case,  then  perhaps  asymmetry  could  be  induced  at  the  C2  position  in  the 
tetrahydropyridine product. To date, only protic acids such as TFA have been used to 
promote these  types  of  cyclisation.  Therefore, before  screening chiral  Lewis  acids, 
standard Lewis  acids  would  have  to  be  screened in  a  racemic  example of  imine-
vinylsilane cyclisations.
N
H
R1
LA* = chiral Lewis acid
TMS
N
R1
LA*+
LA*
321
Scheme 109. Proposal for the use of chiral Lewis acids in imine-vinylsilane cyclisations. 
First,  it  was  necessary to  develop  a  route  to  the  pre-requisite  silylated homoallylic 
primary amine. This  could then be condensed with aldehydes to  afford the required 
imines. The silylated primary amine  322 was obtained in 5 steps from commercially 
available  3-butyn-1-ol  248 (Scheme  110).  This  synthetic  pathway had  already been 
completed in the Dobbs group.
. 23Lewis Acid Mediated Imine-vinylsilane  Cyclisations  for Racemic 
Products
. aPrecursor Synthesis: Synthesis of Imine-vinylsilanes
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c
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TMS
NH2
f
R=Ph    
R=2-napthyl    
R=p-NO2Ph
R=(CH2)2Ph
R=n-C7H15
R=c-Hex
R=i-Bu
248 250 252
254
361322
362
363
364
365
366
367
368
Scheme 110.  Reagents and conditions:  (a)  n-BuLi, TMSCl, THF,  -78  °C, 61%; (b) DiBAL, Et2O, 
reflux, 24 h, 65%; (c) TsCl, Et3N, DMAP, DCM, 0 °C, 5 h, 87%; (d) NaN3, DMF, 60 °C, 4 h, 82%; (e) 
LAH, THF, 0 °C, 67%; (f) RCHO, MgSO4, DCM, rt, 20 h, R=Ph, quant.; R=2-napthyl, quant.; R=p-
NO2Ph, quant.; R=(CH2)2Ph, 96%; R= n-C7H15, 87%; R=c-Hex, quant.; R=i-Bu, quant.; 
The 5-step synthesis begins with the silylation of 3-butyn-1-ol  248 by the action of  n-
butyllithium followed by TMSCl, to give the alkynylsilane 250 in 65% yield. This was 
then submitted to cis reduction by treatment with DiBAL to give the homoallylic alcohol 
252 in 65% yield. After reaction with tosyl chloride in the presence of triethylamine and 
4-dimethylaminopyridine,  the  tosylated alcohol  254 was afforded in  87% yield.  The 
corresponding azide 361 was prepared in 82% yield via nucleophilic substitution of the 
tosylated alcohol  254 by sodium azide. This was then simply reduced to the desired 
primary amine 322 in 67% yield by LAH and in 19% overall yield for 5 steps from 248. 
The primary amine 322 could then be condensed with a range of commercially available 
aldehydes to give imines 362 to  368, mostly in quantitative yields. These imines could 
then be used in the following step without further purification and were identified by the 
analysis of the 1H NMR of the crude extract.
With the desired imines in hand, different Lewis acids were screened with 1 equivalent of 
Lewis acid in acetonitrile as solvent firstly with the imine 362 derived from benzaldehyde 
(Table 40). The solvent acetonitrile was chosen based on the success found with TFA by 
Overman. Lewis acids were chosen based on literature precedent for the activation of 
imines as previously discussed and also for their compatibility with chiral ligands that 
have previously been successfully employed to induce asymmetry.  Other Lewis acids 
. b Cyclisations  Reactions  for 
Racemic Products
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were  chosen based  on  their  availability  commercially  or  their  reported affinity  for 
nitrogen. No progress was observed at room temperature, so the temperature was raised to 
reflux; this is comparable with the higher temperatures required on use of TFA.
Table 40. Lewis acid screening in imine-vinylsilane cyclisations
TMS
N
N
H
1.equiv LA
CH3CN, reflux
369362
Entry Lewis acid Time(h) % Completion* %Yield
1 TiCl4 72 100% Trace
2 AlCl3 72 0% 0%
3 Cu(OTf)2 72 2% Trace
4 Yb(OTf)3 240 81% 35%
5 InCl3 240 100% 15%
6 In(OTf)3 240 100% 32%
7 Sc(OTf)3 240 100% 50%
8 La(OTf)3 240 100% 25%
* = based on consumption of starting material
The yields of product 369 were calculated from the LCMS and 1H NMR analysis of the 
crude  material  after  aqueous  work-up. In  general,  these  reactions  were  difficult  to 
monitor,  as  the  use  of  TLC or  analysis  by  LCMS could  not  be  utilised effectively. 
Therefore small  extractions  were  made  at  regular  intervals  and  1H  NMR  analysis 
performed on the crude material. In the reaction mediated by titanium(IV) chloride, the 
starting material was consumed fairly rapidly in comparison with others, but only trace 
quantities  of  2-substituted-3,4-tetrahydropyridine  369 were  observed.  The  use  of 
aluminium(III) chloride and copper(II) triflate failed to promote this reaction adequately. 
When the  triflate salts  of  Yb(III),  In(III),  Sc(III)  and La(III),  together with  indium 
trichloride were used to promote this reaction, the starting material was consumed after 
240 hours at reflux temperature. While the reaction times for these Lewis acids were very 
long, it may be that the imine 362, derived from benzaldehyde, is of low reactivity. This is 
comparable with other studies involving iminium ion-vinylsilane cyclisations, where the 
phenyl group is adjacent to the iminium ion. The greatest yields were obtained on use of 
scandium(III) triflate, with the triflate salts of Yb(III) and In(III) also giving respectable 
yields.
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Therefore it  was decided to take the triflate salts  of Sc(III), In(III)  and  also  indium 
trichloride and screen different solvents while using an excess of the Lewis acid. Both 
triflate salts gave reasonably good yields and all three had literature precedent for the co-
ordination to chiral ligands in asymmetric synthesis. In this instance the imine starting 
material was altered to that derived from 2-napthylaldehyde 363 (Table 41). The greater 
absorption of this chromophore made analysis based on UV detection such as that used in 
TLC and LCMS more efficient. This chromophore also made UV detection more feasible 
in chiral HPLC analysis and purification by preparative HPLC. It was hoped that  an 
excess of Lewis acid would shorten the reaction times and make this methodology more 
synthetically viable. Although using an excess of reagents is a disadvantage to cost, the 
use of scandium(III) triflate, which can be recycled from an aqueous work-up, overcomes 
this. It  was also hoped that the screening of higher boiling solvents and hence higher 
reaction temperature might also allow shorter reaction times. 
Table 41. Solvent screening in imine-vinylsilane cyclisations.
TMS
N
N
H
2 or 5.equiv LA
solvent, reflux
363 371a
Entry Lewis acid Equiv. Solvent Time (h) %Yield
1
2
3
4
5
6
InCl3 2 CH3CN 72 37
Toluene 48 47
DMF 24 0
5 CH3CN 72 26
Toluene 48 38
DMF 24 0
7
8
9
10
11
In(OTf)3 2 CH3CN 72 17
Toluene 48 0
DMF 24 0
5 CH3CN 72 12
toluene 48 0
12
13
14
15
Sc(OTf)3 2 CH3CN 72 58
Toluene 48 0
5 CH3CN 72 27
Toluene 48 0
The  yields  of  product  371a were  calculated as  isolated  yields  after  purification  by 
preparative HPLC. Again monitoring these reactions was difficult and to monitor the 
consumption of starting material, 1H NMR analysis of crude extracts was required. The 
use of acetonitrile, toluene or DMF allowed the reactions to be complete in 72, 48, or 24 
hours respectively.  In general, the use of toluene or DMF at  reflux temperature was 
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detrimental to the isolated yields of products. It was assumed that in these cases the imine 
starting material 363 was decomposing at the high boiling temperatures. This assumption 
is  supported by  observations  during distillation  under reduced pressure of  the imine 
starting material. During attempts to purify the imines, the neat crude extract went from 
light yellow to a very dark brown in colour. However, in one instance, using toluene as 
solvent with indium trichloride in 2 or 5 equivalents, the yield of product was greater than 
on use of acetonitrile. It was discovered that this was based on the solubility of the Lewis 
acid in the solvent media. When other Lewis acids were used with toluene, the mixture 
remained a  suspension,  even after  warming to  reflux temperature, perhaps  allowing 
decompostition over cyclisation. Overall scandium(III) triflate (2 eq.) proved to be the 
Lewis acid of choice, with acetonitrile as solvent, as this produced the greatest product 
yields. The use of 2 equivalents of Lewis acid also seemed more viable than the use of 1 
equivalent as the reaction times were much shorter than in our initial screening (Table 
40). 
With  these  optimised  reaction  conditions,  different  imine  substrates  363-368 were 
screened  in  the  scandium(III)  triflate  mediated  imine-vinylsilane  cyclisations.  This 
included imines derived from aliphatic (cyclic and non-cyclic) and aromatic aldehydes. 
This is particularly relevant as the TFA mediated imine-vinylsilane cyclisations completed 
by Overman were attempted on imines that contained no  α-hydrogens because those 
imines containing α-hydrogens underwent self-condensation via an enamine intermediate. 
The purification of the 2-substituted-3,4-tetrahydropyridine products 371 by flash column 
chromatography was made difficult by the lack of chromophores for visualisation by UV 
or  other  TLC  visualisation  techniques.  Therefore  most  examples  were  further 
functionalised using methods used previously by the group, to the  N-benzyl carbamate 
tetrahydropyridines 372 and these were purified and fully characterised. The yields for the 
free amine tetrahydropyridines 371 were calculated by analysis of GCMS or LCMS and 
1H NMR data for the crude organic material. The yields for the  N-benzyl carbamate 
derivatives 372 were calculated as isolated yields after the purification by flash column 
chromatography.  For  completeness,  some examples of  the  cyclisation  reaction  were 
performed at room temperature. The products from the cyclisation reactions completed at 
room  temperature  were  not  further  elaborated  to  the  N-benzyl  carbamate 
tetrahydropyridines 372 (Table 42).
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Table 42. Imine screening in imine-vinylsilane cyclisations and further functionalisation.
TMS
N
R NH
R N R
OO
2 equiv.Sc(OTf)3,
CH3CN
CBzCl, NaHCO3,
THF, H2O, rt
363-368 371a-f
372a-f
STEP A STEP B
Entry R Temp. Time (h) %Yield 
(Step A)
%Yield 
(Step B)
1 2-napthyl Reflux 72 58 (a) 43
2
3
p-NO2Ph Rt 120 13 (b) N/A
Reflux 17 86 (b) 62
4
5
(CH2)2Ph Rt 120 36 (c) N/A
Reflux 17 57 (c) 55
6
7
n-C7H15 Rt 120 42 (d) N/A
Reflux 17 83 (d) 50
8
9
c-Hex Rt 120 66 (e) N/A
Reflux 17 88 (e) 44
10 i-Bu Reflux 17 0   (f) N/A
In general, all reactions attempted at room temperature had long reaction times and poor 
to moderate product yields (Table 42, entries 2,4,6,8). Significant improvements were 
found when the reaction was attempted at reflux temperature with most reactions being 
completed  overnight  and  the  yields  being  moderate  to  good  (Table  42,  entries 
1,3,5,7,9,10). In general,  the functionalisation of the free amines  371 to the  N-benzyl 
carbamates 372 was completed in disappointing yields but this step was mainly required 
for analytical purposes. Interestingly, good yields of products were obtained from the use 
of imines with α-hydrogens, proving that the use of a Lewis acid is more advantageous 
than  using  protic  acids.  The  use  of  the  imine  derived  from  the  condensation  of 
isobutyraldehyde  368 (Table  42,  entry  10)  showed  that  the  starting  material  was 
consumed overnight but unfortunately, no cyclised product could be identified on analysis 
by GCMS or 1H NMR.
After optimising the conditions required for the racemic synthesis of 2-substituted-3,4-
tetrahydropyridines, attention was focussed on turning this into an asymmetric synthesis. 
As previously discussed, it was proposed to investigate the use of chiral Lewis acids, 
specifically chiral ligands, co-ordinated to a promoter Lewis acid. Before any screening 
. 24Imine-vinylsilane  Reactions:  Formation  of  Enantiopure 
Products 
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could begin, it was necessary to synthesise PYBOX ligands, which were either expensive 
or not commercially available. These ligands were chosen for their compatibility, based 
on literature precedent, with the Lewis acids that found success in the racemic series.
The first ligand to be synthesised was the 2,6-bis((S)-4-isopropyl-4,5-dihydrooxazol-2-
yl)pyridine ligand [(S)-(i-Pr)-PYBOX]  349 which is available in three steps from the 
commercially available pyridine-2,6-dicarboxylic acid 373. Initially the dicarboxylic acid 
was converted into the diacid chloride 374 in quantitative yield by the action of thionyl 
chloride. This acid chloride was then coupled to the amino alcohol (S)-valinol 376, which 
was the source of chirality. The amino alcohol  376 was easily obtained in 77% yield 
directly from the amino acid (S)-valine 375 by reduction using lithium aluminium hydride 
in THF (Scheme 111). The chiral ligand 349 was afforded after further treatment with 
thionyl chloride and sodium hydroxide stepwise and all  data were in agreement with 
literature values.
N
N
OO
N
(S)-(i-Pr)-(PYBOX)
N
OO
OHHO
N
OO
ClCl
N
HN
OO
NHHO OH
OH
H2N
OH
H2N
O
a
b
c
d
373 374
375 376
377
349
Scheme 111.  Reagents and conditions: (a) SOCl2,  85 °C, 15 h,  quantitative; (b) (S)-Valinol,  Et3N, 
CHCl3, 0 °C, 1 h, r.t, 24 h; (c) (i) SOCl2, 85 °C, 2 h, (ii) NaOH, H2O, MeOH, 72 h, 22%; (d) LAH, 
THF, 0 °C, 70 °C, 15 h, 77%.
The second ligand required for synthesis was the tetra-phenyl substituted derivative of the 
(S)-(i-Pr)-PYBOX ligand, [(S)-(i-Pr)-(Ph)4-PYBOX] 348. This was obtained, again in 3 
steps, from the pyridine-2,6-dicarboxylic acid 373. After generation of the acid chloride 
. aChiral 
ligand Synthesis
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374 as previously described, the preformed amino alcohol 379 was coupled under base-
catalysed conditions to generate the di-amide intermediate 380 in 38% yield. The amino 
alcohol 379 was again formed from (S)-valine 375 but in 2 steps. Initially the methyl ester 
hydrochloride salt 378 was formed in 69% yield by the treatment of the amino acid 375 
with thionyl chloride and methanol. Addition of 2 equivalents of the preformed Grignard 
reagent to the ester function furnished the diphenyl substituted amino alcohol 379 in 76% 
yield.  When  the  di-amide  intermediate  380 was  treated  with  calcium hydride  and 
methanesulfonic acid, the desired chiral ligand 348 was obtained in 75% yield (Scheme 
112). 
373 374
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ClH3N
O
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Ph Ph
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HNNH
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HOOHPh
Ph Ph
Ph
N
N
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N Ph
PhPh
Ph
c
d
e
(S)-(i-Pr)-(Ph)4-PYBOX
375
378379
380
348
Scheme 112. Reagents and conditions: (a) SOCl2, 85 °C, 15 h, quantitative; (b) (S)-(Ph)2-Valinol, Et3N, 
DCM, rt, 20 h, 38%; (c) CaH2, MeSO3H, DCM, reflux, 6 h, 75%; (d) SOCl2, MeOH, 85 °C, 20 h, 69%; 
(e) Mg, PhBr, 65 °C, 24 h, 76%.
It  was  now  proposed  to  attempt  the  asymmetric  synthesis  of  2-substituted-3,4-
tetrahydropyridines via chiral Lewis acid-mediated imine-vinylsilane cyclisation. For the 
initial screening, the ligands  (S)-(i-Pr)-PYBOX 349, (S)-(i-Pr)-(Ph)4-PYBOX 348, (R)-
BINOL  and  (S)-BINOL would  be  used.  These  were  reported  to  co-ordinate  to 
scandium(III) triflate or indium trichloride in the literature and also these Lewis acids 
have produced good yields of products in the racemic examples (Table 41, entries 1-6 and 
12-15). These combinations would be utilised in either acetonitrile or toluene as these 
. bImine-vinylsilane  Cyclisations:  Towards 
Enantiopure Products
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solvents have also had success in the racemic examples. Finally, the use of 2 equivalents 
of Lewis acid would be maintained from the initial studies and therefore an equal quantity 
of chiral ligand would be used. 
The  imine  derived  from  2-naphthylaldehyde  363 was  screened  initially  because 
purification by flash column chromatography and preparative HPLC of the product 2-
substituted-3,4-tetrahydropyridine was more efficient. Unfortunately, the free secondary 
amine tetrahydropyridine product  381 could not be analysed by chiral HPLC, as these 
species were not compatible with the chiral column. Therefore the free amine 381 was 
further functionalised  to  the  N-benzyl  carbamate  382 by  treatment with  CBzCl  and 
sodium  hydrogen  carbonate. The  N-protected species  were  more  easily  purified  by 
preparative HPLC, due to ease of UV detection and they gave good separation on the 
chiral column. Yields were therefore calculated over two steps (it was assumed that the 
yields would remain reasonably constant for the second N-protection step in all examples; 
this was because all major contaminants were removed by passing the crude extract of the 
cyclisation reactions through a short silica plug).
Before the imine 363 was added to the reaction mixtures, flame-dried flasks were charged 
with the Lewis  acid and the chiral ligand. Anhydrous  THF was added, the resulting 
mixture stirred, and the solvent removed under vacuum to azeotropically remove any 
residual moisture. This process was repeated and then anhydrous DCM was added and the 
mixture stirred overnight to allow complexation to occur between the Lewis acid and the 
ligand.  The  DCM was  removed under  vacuum and  then  the  cyclisation  procedure 
commenced. Again  the  use  of  reflux temperature  was  required  as  no  progress was 
monitored at room temperature (Table 43).
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Table 43. Chiral ligand screening in imine-vinylsilane cyclisations.
TMS
N
N
H
N
OO
2 equiv.LA, solvent, reflux
2 equiv.chiral ligand, 120 h
CBzCl, NaHCO3,
THF, H2O, rt
363 381
382  
Entry Lewis acid Chiral ligand Solvent %Yield for
2 steps
%ee
1
2
3
4
5
6
InCl3 (R)-BINOL CH3CN 0 N/A
Toluene 0 N/A
(S)-(i-Pr)-
PYBOX
CH3CN 3 0
Toluene 0 N/A
(S)-(i-Pr)-
(Ph)4-
PYBOX
CH3CN 0 N/A
Toluene 0 N/A
7
8
9
10
11
12
Sc(OTf)3 (S)-BINOL CH3CN 13 0
Toluene 5 0
(S)-(i-Pr)-
PYBOX
CH3CN 37 0
Toluene 13 0
(S)-(i-Pr)-
(Ph)4-
PYBOX
CH3CN 10 0
Toluene 8 0
As with previous examples, it was difficult to monitor the reactions with LCMS analysis. 
Even the analysis by 1H NMR of crude extracts became difficult due to the presence of 
excess amounts of the chiral ligand. Therefore the time of 5 days at reflux temperature 
was approximate for each reaction, although trial reactions of shorter and longer reaction 
times allowed this approximation to be reached. Overall, the use of indium trichloride 
with all ligands and either solvent gave very poor yields. It is assumed this is based on 
solubility problems identified for the chiral Lewis acid complex in either solvent. Only 
one instance of the use of this Lewis acid gave positive results, when it  was used in 
conjuction with the (S)-(i-Pr)-PYBOX ligand  349 and acetonitrile as solvent.  Clearly 
from these results, scandium(III) triflate is a more efficient promoter of these reactions 
when  considering  product  yield,  since  in  all  examples   some  of  the  desired 
tetrahydropyridine was formed (Table 43, entries 7-12). This was also the case when 
acetonitrile  was  replaced with  toluene, which is  in  contrast to  previous  examples. A 
possible reason for this could be that the chiral Lewis acid complexes are more soluble in 
refluxing toluene than the Lewis acid used independently. However, in general, the yields 
of the reactions in acetonitrile were greater than the corresponding transformations in 
toluene. The greatest product yields were obtained for the combination of scandium(III) 
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triflate, the (S)-(i-Pr)-PYBOX ligand 349 and acetonitrile. Unfortunately, in all cases, the 
enantiomeric excess was negligible and so  each chiral Lewis  acid did  not  promoted 
enantioselectivity in the imine-vinylsilane reactions. Possible reasons for the failure to 
induce enantioselectivity could be the raised temperatures, on comparison with examples 
of  asymmetric  reactions  in  the  literature,  which  take  place  mostly  at  sub-zero 
temperatures. Other possibilities could be that the chiral ligand had not coordinated to the 
Lewis acid metal or that there is negligible difference in the energy of the two possible 
diastereomeric transition states between the substrate and the chiral Lewis acid.
Therefore, it was attempted to lower the temperature of our imine-vinylsilane reactions, 
perhaps to induce some enantioselectivity in the reaction. To lower the temperature, the 
use of imines that furnished higher product yields was required. In our imine screening, it 
was shown that more reactive imines did react at room temperature, albeit with long 
reaction times and  low product yields.  However the  use  of  the  imine  derived from 
cyclohexanecarboxaldehyde 367 did produce adequate product yields and so this reaction 
was the next to be investigated. In this instance, (S)-(i-Pr)-PYBOX 349, (S)-(i-Pr)-(Ph)4-
PYBOX 348 and (R)-BINOL chiral ligands were used. Again reactions were attempted 
using scandium(III) triflate and indium trichloride but only using acetonitrile as solvent. 
Once again it  was  required to functionalise further the free amine tetrahydropyridine 
product 383 to the N-benzyl carbamate 384 (Table 44). As before, this made purification 
by flash column chromatography more efficient and allowed analysis by chiral HPLC.
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Table 44. Chiral ligand screening in imine-vinylsilane cyclisations at room temperature. 
2 equiv.LA, solvent, reflux
2 equiv.chiral ligand, 168 h
CBzCl, NaHCO3,
THF, H2O, rtTMS
N
N
H
N
OO383
384
367
 
Entry Lewis acid Chiral ligand %Yield 
for 2 steps
%ee
1
2
3
InCl3 (R)-BINOL 0 unknown
(S)-(i-Pr)-PYBOX 0 unknown
(S)-(i-Pr)-(Ph)4-
PYBOX
0 unknown
4
5
6
Sc(OTf)3 (R)-BINOL 11 unknown
(S)-(i-Pr)-PYBOX 28 unknown
(S)-(i-Pr)-(Ph)4-
PYBOX
25 unknown
Again these reactions were difficult to monitor but it seems that the reaction times were 
longer  when  using  chiral  Lewis  acid  complexes on  comparison with  the  racemic 
examples.  Again,  the  use  of  indium  trichloride  proved  to  be  totally  unsuccessful. 
However, on use of scandium(III) triflate with any chiral ligand, generation of the desired 
tetrahydropyridine  was  observed.  Unfortunately,  analysis  by  chiral  HPLC  was 
unsuccessful  for  the  calculation  of  enantiomeric excess  as  the  resolution  for  this 
compound was poor. Other methods for analysing the samples using NMR experiments, 
such as the use of chiral shift reagents or chiral solvents were also unsuccessful.
In general, the use of scandium(III)  triflate  in  acetonitrile profited the production of 
tetrahydropyridines  in  racemic  examples  of  imine-vinylsilane  cyclisations.  This 
combination also allowed the formation of product in conjunction with chiral ligands. At 
this  stage,  it  is  unknown  whether  the  combination  could  be  employed  to 
enantioselectively form tetrahydropyridines, as these compounds are incompatible with 
standard analytical techniques. 
The future work for this study will focus around the protection of the free secondary 
amine of  the  tetrahydropyridine  product with  different  substituents  in  order  to  find 
efficient resolution in chiral HPLC.  
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CHAPTER SEVEN: Towards the Total Synthesis 
of Cannabisativine
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. ILiterature  Review  for  Total  Synthesis  of  Cannabisativene  and  Spermidine 
Alkaloids
The  tetrahydropyridine  ring  system  is  a  common motif  found in  numerous natural 
products, drugs and drug candidates. Essential to the structure-activity relationships of 
natural  products  containing  these  motifs  is  the  position  of  the  double  bond,  the 
stereochemistry across the heteroatom and also the stereochemistry between other ring 
substituents.  Studies  within  our  group  have focussed  on  utilising  the  aza-silyl-Prins 
reaction to generate exclusively trans-2,6-disubstituted-3,4-tetrahydropyridines (Scheme 
113). 
NHR
TMS
+
O
R1 N
R
R1
InCl3
CH3CN, reflux
Scheme 113.  The  aza-silyl-Prins  reaction  produces  trans-2,6-disubstituted-3,4-tetrahydropyridines 
exclusively.
With  these results  in  hand, our  group successfully  completed the  total  synthesis  of 
racemic  solenopsin  A,  a  constituent  of  fire-ant venom from  Solenopsis species and 
racemic  Epi-dihydropinidine,  isolated  from  pine  and  spruce  species  such  as  Picea 
pungens or  Pinus  ponderosa (Figure  23).  These  trans-2,6-disubstituted  piperidine 
alkaloids were prepared by reduction of the related tetrahydropyridine cores, prepared by 
the aza-silyl-Prins reaction.
N
H 10
solenopsin A
N
H 2
epi-dihydropinidine
Figure 23. Structures of solenopsin A and epi-dihydropinidine.
Also, within this thesis, it has been shown how the aza-silyl-Prins reaction can be utilised 
to form 6-methylpipecolic acid. On coupling an α-methyl substituted homoallylic amine 
257 to  ethyl  glyoxylate, the desired  trans-2,6-disubstituted-3,4-tetrahydropyridine  258 
was  formed.  This  pipecolate  species  could  then  easily  be  reduced  and  then  acid 
hydrolysed to afford an analogue of the natural product pipecolic acid 264/265 (Scheme 
114).
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Scheme 114.  Reagents and conditions:  (a)  ethyl glyoxylate,  InCl3,  CH3CN, rt,  48 h, 74%; (b)  H2, 
Pd(OH)2/C, EtOH, rt, 5 h, 87%; (c) 6.0 M HCl (aq), reflux, 2 h, 83%. 
It was now desired to use the aza-silyl-Prins reaction towards a more complicated target, 
to prove that it can be utilised to form larger natural products. Our target molecule was 
cannabisativene, a  macrocyclic spermidine alkaloid isolated from the marijuana plant 
Cannabis sativa. It is part of a family of macrocyclic polyamine alkaloids which contain 
the biogenetic base spermidine. This family includes anhydrocannabisativine, paulustrine 
and  dihydropalustrine.  These  related  species  each  have  the  same  13-membered 
macrocyclic lactam ring which is tethered between the C2 position and the nitrogen of the 
azacyclic  core.  Both  cannabisativine  and  anhydrocannabisativine  have  a  trans-2,6-
disubstituted-4,5-tetrahydropyridine  moiety,  with  only  the  6-substitutent  defining  the 
different structure. However the 2,6-disubstituted tetrahydropyridine containing palustrine 
and  the  related  2,6-disubstituted  piperidine-containing  dihydropalustrine  are  each  cis 
across the nitrogen of the aza-cyclic core (Figure 24). If it were possible to utilise the aza-
silyl-Prins reaction to synthesise cannabisativene where the 6-substituent was derived 
from the coupled aldehyde, then it could be assumed that anhydrocannabisativine would 
also be obtained from the same aza-silyl-Prins amine precursor.
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Figure 24. The macrocyclic spermidine family.
The following literature review will focus on both racemic and enantioselective syntheses 
of members of the macrocyclic spermidine alkaloid family. This will hopefully allow a 
more comprehensive understanding of how to fashion a more efficient  route to these 
molecules, for  example,  how to  prepare the  13-membered macrocyclic  lactam ring. 
Another advantage of this review might be to recognise targets that might constitute a 
formal synthesis. 
Weinreb has described the racemic synthesis of anhydrocannabisativine, focussing on an 
intramolecular imino-Diels-Alder cycloaddition to fashion the trans-2,6-disubstituted-4,5-
tetrahydropyridine  core.  The  required  starting  material  for  the  imino-Diels-Alder 
approach was a diene alcohol 387. This was efficiently prepared from pentadienylsilane 
386 by treatment with hexanal and titanium tetrachloride, using a method described by 
Seyferth  and  Sakurai. This,  in  turn,  was  fashioned from pentadienyllithium  385 by 
treatment with  trimethylsilyl  chloride.  The alcohol  387 was  then  converted into  the 
related carbamate 388 using the cyanate method devised by Loev and Kormendy. This 
then was treated with methyl glyoxylate in acetone at reflux to give an intermediate that 
was then acetylated to afford an acetate 389, as a mixture of stereoisomers. This mixture 
was treated with diisopropylethylamine in toluene at 215 °C in a sealed vessel, to afford a 
single bicyclic adduct 391, the relative stereochemistry of which was established by X-ray 
crystallography.  The  trans configuration  of  the  2-carboxylate-tetrahydropyridine core 
could be rationalised by assuming that an intermediate N-acylimine was formed which 
underwent  an  in  situ intramolecular  Diels-Alder  reaction  390 (Scheme  115).  The 
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stereochemistry was assumed to be generated from an (E) acyl imine in the transition 
state, which holds the nitrogen carbonyl endo to the diene moiety. 
Li
TMS C5H11
OH
O
OH2N
C5H11
O
OHN
C5H11
CO2Me
OAc
O
ON
C5H11
CO2R
H
H
H
H
N
C5H11
CO2Me
O
H
a b
c
de
R = Me
R = H
f
O
385 386 387
388389
390
391
392
Scheme 115.  Reagents and conditions: (a) TMSCl; (b) TiCl4,  n-C5H11CHO, DCM, -45  °C, 69%; (c) 
NaOCN, TFA, Et2O, rt, 24 h, 95%; (d) methyl glyoxylate, acetone, reflux, 72 h, 82%; (e) (iPr)2EtN, 
toluene, sealed vessel, 215 °C, 3 h, 83%; (f) 5% NaOH (aq), MeOH, rt, 2 h, 96%.
The hydrolysed 2-carboxylate-tetrahydropyridine moiety 392 was then further elaborated 
by Arndt-Eistert chain elongation of the acid using methanol to generate the methyl ester 
393.  The bicycle  393 was then cleaved by hydrolysis of the carbamate functionality, 
which was then re-esterified and the alcohol  394 protected as the  t-butyldimethylsilyl 
ether 395 (Scheme 116).
O
ON
C5H11
CO2H
H
H
H
O
ON
C5H11
H
H
H
CO2Me
OR
NH
C5H11
H
H
H
CO2Me
a b
R = H
R = t-BuMe2Si
c
392 393
394
395
Scheme 116. Reagents and conditions: (a) (i) (COCl)2, toluene, rt, 3 h, (ii) CH2N2, Et2O, 1 h. (iii) Ag2O, 
MeOH, rt, 78%; (b) (i) Ba(OH)2.(H2O)8, glyme, water, reflux, 48 h, (ii) SOCl2, MeOH, reflux, 12 h, 
78%; (c) TBSOTf, 2, 6-lutidine, DCM, 0 °C, 4 h, 91%.
The free trans-2,6-disubstituted-4,5-tetrahydropyridine 395 could be a possible target to 
potentially constitute a formal synthesis of anhydrocannabisativine from this publication. 
This intermediate could be obtained via the aza-silyl-Prins reaction.
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To furnish the  macrocycle it  was  first  necessary to  mono-tosylate  3-aminopropanol, 
followed by triflate activation of the alcohol terminus. This species was then coupled to 
the tetrahydropyridine 395 to give an amino ester 398 which could be base hydrolysed to 
the corresponding acid 399. This acid 399 was then activated as the 2,4,5-trichlorophenyl 
ester, which was then coupled to 4-aminobutanol to give the amide alcohol  400. This 
alcohol was activated as the mesylate 401 and cyclisation of the macrocycle was effected 
by treating with a suspension of potassium carbonate in acetonitrile at reflux under dilute 
conditions. The N-tosyl function of 402 was then removed with sodium in liquid ammonia 
to give the secondary amine 403 and the alcohol was deprotected with boron trifluoride 
etherate to afford the amino alcohol  404. Finally, oxidation of the alcohol with Jones’ 
reagent  afforded racemic  anhydrocannabisativine  405 in  17  steps,  starting  from  the 
silylpentadiene (Scheme 117).
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Scheme 117. Reagents and conditions: (a) TfO(CH2)3NHTs, DCM, rt, 4h, 99%; (b) 1.0 M aq. LiOH, 
MeOH,  0  °C,  15  h,  100%;  (c)  (i)  2,4,5-trichlorophenol,  1-cyclohexyl-3-(2-
morpholinoethyl)carbodiimide methyl-p-toluenesulfonate, rt, 45 h, (ii) 4-Aminobutanol, DMF, -20°C, 
18 h, 82%; (d) MsCl, Et3N, DCM, -15 °C to 5 °C, 1 h, 80%; (e) K2CO3, MeCN, reflux, 24 h, 58%; (f) 
Na, NH3, THF, -60 °C, 90%; (g) BF3.OEt2, rt, 1h; (h) Jones’ reagent, acetone, rt, 30 mins, 54%.
Wasserman synthesised a compound with a palustrine structure (eventually concluded to 
be the incorrect structure with regard to the position of the tetrahydropyridine olefin), but 
this  was utilised as an intermediate towards the total synthesis of a racemic form of 
dihydropalustrine (Figure 25). 
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Figure 25. Structures of (i) naturally occuring palustrine, (ii) Watsume’s compound with a palustrine 
structure, (iii) dihydropalustrine.
Wasserman’s synthesis began with a nine-membered lactam 406, which was also used 
previously towards the synthesis of alkaloids chaenorhine and verbascenine. This lactam 
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406 was  then  converted  into  a  methyl  imino  ether  407 using  trimethyloxonium 
tetrafluoroborate. The species  407 was then coupled to a  β-lactam  408 at  145 °C in 
mesitylene  to  give  409.  This  coupled  product  409 was  reduced  using  sodium 
cyanoborohydride  in  acetic  acid  to  form the  13-membered  lactam  410.  The  newly 
generated amino group was  then  protected as  the  trichloroethoxycarbamate and  the 
terminal acetate 411 was converted into the alcohol  412 using sodium methoxide. The 
alcohol was then converted into the bromide 413 using triphenylphosphite dibromide and 
then treated with triphenylphosphine to furnish the phosphonium salt 414 (Scheme 118).
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Scheme  118.  Reagents  and  conditions:  (a)  Me3O+BF4-,  97%;  (b)  mesitylene,  145°C,  65%;  (c) 
NaBH3CN,  AcOH,  90%;  (d)  ClCOOCH2CCl3,  DMAP,  90%;  (e)  NaOMe,  95%;  (f)  (i) 
triphenylphosphite dibromide; (ii) PPh3, heating, 50% for 2 steps.
The other precursor required was an epoxy aldehyde 417, which was prepared from an 
allylic alcohol  415 via a Sharpless epoxidation procedure, followed by oxidation with 
PDC (Scheme 119).
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Scheme  119.  Synthesis  of  aldehyde  Wittig  precursor.  Reagents  and  conditions:  (a)  t-BuOOH, 
VO(acac)2; (b) PDC.
 The Wittig reaction using NaH as the base gave  418 via an unstabilised ylid which 
afforded the desired  cis double bond. Removal of  the  trichloroethoxycarbonyl  group 
allowed formation of a separable mixture of two diastereomeric tetrahydropyridines, 420 
and  421 (47:53)  via ring opening of the epoxide  419 by the secondary amine. After 
removal of the Boc group from the  cis diastereomer 421, the product with a palustrine 
structure was obtained. Analysis of this product on comparison with a sample of naturally 
occurring palustrine  showed that  the  tetrahydropyridine  olefin  was  in  the  incorrect 
position. The palustrine type product was then converted to racemic dihydropalustrine 
422 by hydrogenation over a poisoned palladium catalyst (Scheme 120).
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Scheme 120. Completion of synthesis of racemic dihydropalustrine. Reagents and conditions: (a) NaH, 
THF/DMSO; (b) Zn, THF/H2O, pH 5.5; (c) HCl/DCM; (d) H2, Pd/C, BaSO4.
Even though no targets could be identified in this publication that would constitute a 
formal synthesis, it encouraged consideration of fashioning the 13-membered macrocyclic 
lactam before synthesising the tetrahydropyridine core via the aza-silyl-Prins reaction. 
Wuts  has  described a  synthetic  pathway to  2,6-disubstituted tetrahydropyridines that 
possess  the  cannabisativine  skeleton,  using  an  intramolecular  allylsilane-nitrone 
cycloaddition.  The design of the synthesis  relies on an allylboronate  to  establish the 
relative stereochemistry at three chiral centres. Asymmetric induction in the addition of 
the  allylboronate to  an  oxime is  likely  to  produce two possible  diastereomers.  The 
resulting hydroxlamines can then be converted to the nitrone which is then cyclised to the 
desired tetrahydropyridine. 
The oxime was obtained in six steps from 2-octynoic acid 423. First the acid  423 was 
esterified with diazomethane, followed by hydrogenation over Lindlar’s catalyst to give a 
mixture of cis and trans unsaturated esters 424  in a 9.8:1 ratio. The desired cis isomer 
was isolated by flash chromatography and next treated with osmium tetroxide and the 
resulting diol protected as the acetonide  425. This was then reduced with DiBAL and 
further treated with hydroxylamine hydrochloride in pyridine to afford an (E/Z) mixture 
(1.9:1)  of  oximes  426 and  427.  The  mixture  of  oximes  was  then  treated  with 
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[(trimethylsilyl)allyl]boronate 428 to give two isomers 429 and 430 with a ratio of 1.7:1 
after  purification.  The  relative  stereochemistry of  these  isomers was  determined by 
conversion into bicyclic isooxazolidines  432 and  433 by a thermal [3+2] cycloaddition 
and analysing the  1H NMR spectra of the resulting products. The thermally promoted 
nitrone  cyclisation  favoured the  cis-2,6-isooxazolidine  433.  Treating  the  mixture  of 
isomers 429 and 430 with 3-(benzyloxy)propanal furnished the nitrone 431. Treatment of 
the intermediate nitrone 431 with TMS triflate gave exclusively, a trans-2,6-disubstituted 
N-hydroxytetrahydropyridine  434.  The hydroxylamine was then reduced with aqueous 
zinc and acetic acid followed by hydrolysis  of the acetonide to furnish the diol  435 
(Scheme 121).
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Scheme 121. Reagents and conditions: (a) (i) CH2N2, Et2O, 95%, (ii) Lindlar catalyst, quinoline, 91%; 
(b)  (i)  OsO4,  NMO,  85%,  (ii)  (CH3)2C(OMe)2/H+,  97%;  (c)  (i)  DiBAL,  -78  °C,  78%,  (ii) 
NH2OH.HCl/pyridine,  97%; (d)  CCl4,  heat,  55%; (e)  2 eq.BnOCH2CH2CHO, toluene,  -20  °C; (f) 
toluene,  reflux,  2  h,  100%;  (g)  TMSOTf, -40  °C,  18  h,  79%;  (h)  (i)  Zn,  HOAc/H2O, (ii)  TFA, 
THF/H2O, 73%.  
Potentially the tetrahydropyridine  435 could also be accessed using the aza-silyl-Prins 
reaction and then the product further elaborated to synthesise racemic cannabisativine or 
another member of the macrocyclic spermidine family. 
Comins has described the asymmetric total synthesis of (+)-cannabisativine in 19 steps 
and in 7% overall yield. The synthesis began with the addition of a zinc enolate  438, 
prepared from 2,2-diethyl-1,3-dioxolan-4-one, to a chiral 1-acylpyridinium salt 437. This 
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furnished the dihydropyridone 439 as the major diasteromer in a high yield with the anti 
conformation confirmed by  the  X-ray structure. The dihydropyridone  439 was  then 
transformed into a Weinreb amide  440 by treatment with  N,O-dimethylhydroxylamine 
hydrochloride. The amide 440 was then treated with pentynyllithium to give the alkynyl 
ketone 441. This was then transformed under Luche conditions to a diol  442 with high 
diastereoselectivity. The authors used Cram’s rule to explain why the reduction occured 
from the least sterically demanding side of the intermediate. When the diol  442 was 
treated with sodium hydride, the chiral auxillary was released on formation of the 5-
membered chiral oxazolidinone 443. After protection of the free hydroxyl group as the 
benzyl ether 445, the alkyne was catalytically reduced over Pt/C to give the desired side-
chain  446. The dihydropyridone was then activated by removal of the TIPS group  via 
protodesilylation with TFA to give 447. The C2 dihydropyridone 447 proton was removed 
with LiHMDS and treated with phenylselenyl chloride to afford an inseparable mixture 
(3.5:1) of diastereomeric selenides 448. Treatment of this mixture with o-silyl ketal acetal 
449 under Lewis acidic conditions, gave the Mukaiyama-Michael product, which under 
acidic work-up afforded the ketones 450 as an inseparable diastereomeric mixture. These 
ketones 450 were reduced to alcohols  451, again under Luche conditions. The mixture 
was converted into thiocarbamates  453 on treatment with 1,1’-thiocarbonyldiimidazole 
452 followed by reduction with tributyltin hydride to give a single trans-2,6-disubstituted 
tetrahydropyridine diastereomer 454 (Scheme 122).
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Scheme 122. Reagents and conditions: (a) n-BuLi, (i-Pr)2NH, THF, -78 °C, 85%; (b)MeONHMe.HCl, 
AlMe3,  DCM, rt,  1.5 h,  97%; (c) 0.5 M 1-pentynyllithium, THF, -78  °C, 96%; (d)  CeCl3.(H2O)7, 
NaBH4, MeOH, -50 °C, 96%; (e) NaH, THF, rt, 3h, 88%; (f) TfOH, Et2O, rt, 5 h, 86%; (g) H2, 5% 
Pt/C, Li2CO3, EtOAc, rt, 12 h, 97%; (h) TFA/CHCl3 (1:1), reflux, 12 h, 77%; (i) LiHMDS, PhSeCl, -78 
°C, 73%; (j) BF3.OEt2, DCM, 100%; (k) CeCl3.(H2O)7, NaBH4, MeOH, rt, 85%; (l) DMAP, toluene, 
reflux, 3 h, 91%; (m) Bu3SnH, AIBN, toluene, reflux, 95%.   
This tetrahydropyridine product  454 could be targeted towards an asymmetric formal 
synthesis of (+)-cannabisativine using the aza-silyl-Prins reaction. 
The synthesis was completed by converting the trans-2,6-disubstituted tetrahydropyridine 
454 into  the carboxylic  acid  455 by base hydrolysis.  From here, after acid chloride 
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formation 456, this was coupled to an N-benzyl protected amino alcohol 457 to afford the 
amide 458. The oxazolidinone function was then cleaved under basic conditions to afford 
the aminodiol  459 and the core tetrahydropyridine N-alkylated on treatment with an N-
tosylamino triflate  460 to  afford the  tertiary amine  461.  Conversion  of  the terminal 
alcohol into the mesylate, followed by treatment with potassium carbonate, furnished the 
desired  macrocyclic  lactam  462.  After  global  deprotection  using  sodium  in  liquid 
ammonia, the synthesis of the natural product  463 was complete (Scheme 123).
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Scheme 123. Reagents and conditions: (a) KOH, H2O, MeOH, rt, 2 h, 100%; (b) (COCl)2, DMF, DCM, 
rt, 1 h; (c) 10% aq.NaOH, DCM, rt, 1.5 h, 82%; (d) 50% KOH (aq), MeOH, reflux, 18 h, 88%; (e) (i-
Pr)2EtN, DCM, rt, 3 h, 84%; (f) (i) MsCl, Et3N, DCM, -20 °C, 95%, (ii) K2CO3, MeCN, reflux, 24 h, 
70%; (g) Na, NH3, THF, reflux, 76%.   
Hamada has described the total synthesis of the unnatural product, (-)-cannabisativine. 
The retrosynthetic strategy towards this compound was to utilise a hetero Diels-Alder 
reaction between an optically active diene and an N-tosylimine (Scheme 124).
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Scheme 124. Retrosynthetic strategy utilising a hetero Diels-Alder reaction.
The chiral diene 468 was accessed in several steps starting from a chiral epoxide  465, 
formed by Sharpless asymmetric epoxidation of  trans-2-octenol  464 using (+)-diethyl 
tartrate.  This  epoxide  465 was  opened also  using  a  Sharpless method  involving  a 
titanium(IV) alkoxide  species,  directly  followed by  tritylation,  benzylation  and  acid 
hydrolysis. The alcohol product 466 was then oxidised under Swern conditions, followed 
by Wittig olefination with a stable phosphorane to give the (E)-alkene  467.  The ester 
function was then reduced with DiBAL to the desired allyl alcohol, which underwent 
Swern  oxidation.  The  resulting  aldehyde underwent  Wittig  olefination  to  yield  the 
required optically active diene 468 in 12 steps and 21% overall yield, starting from n-
hexanal 464 (Scheme 125).
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Scheme 125. Reagents and conditions: (a) (EtO)2P(O)CH2CO2Et, NaH, Et2O, 88%; (b) DiBAL, DCM, 
78%; (c) Ti(Oi-Pr)4,  tBuOOH, (+)-DET, DCM, 68%; (d) Ti(OBn)4, BnOH, 82%; (e) TrCl, DMAP, 
NEt3;  (f)  NaH,  BnCl,  THF-DMSO(1:2);  (g)  4M  HCl-THF,  3  steps,  96%; (h)  (COCl)2,  DMSO, 
NEt3/DCM; (i) (EtO)2P(O)CH2CO2Et, NaH, Et2O, 2 steps, 96%; (j) DiBAL, DCM, 90%. (k) PDC, 
DMF; (l) Ph3PCH2, THF, 2 steps, 75%.
This diene 468 was used in the hetero Diels-Alder reaction with an N-tosylimine 469 to 
furnish the N-tosyl-2,6-disubstituted tetrahydropyridine 470 with cis geometry across the 
heteroatom. The carboxylate side chain of this species was then reduced with LAH to the 
aldehyde, followed by a Wittig reaction with methoxymethylene phosphorane to give an 
enol ether that was elaborated further by acetalisation to give 471. The tosyl function of 
the tetrahydropyridine core was then deprotected by sodium-naphthalenide reduction, and 
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the  resulting  free  amine was  acrylated with  N-tosyl  alanyl  chloride, followed by  a 
reduction with LAH to furnish the tertiary amine  472.  The acetal function was later 
converted into an aldehyde by acetal exchange and on treatment with potassium carbonate 
in methanol, the C6 centre was epimerised to the desired  trans diastereomer (Scheme 
126). From here the construction of the macrocyclic lactam followed a similar pattern to 
previous literature examples. 
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Scheme 126. Reagents and conditions: (a) neat, 40 °C, 6 days, 81%; (b) LAH, Et2O, 92%; (c) (COCl)2, 
DMSO, NEt3, DCM, -60 °C; (d) MeOCH-P+Ph3, THF, 2 steps, 72%; (e) CSA, MeOH, 93%; (f) Na, 
C10H8, THF, 86%; (g) TsNH(CH2)2COCl, K2CO3, C6H6, toluene, H2O, 94%; (h) LAH, THF, reflux, 
94%. 
. IIResults and Discussion: Studies Towards the Total Synthesis of Cannabisativine
Attempts at utilising the aza-silyl-Prins reaction in the total synthesis of cannabisativine 
are now discussed. In previous examples, the aza-silyl-Prins reaction produced trans-2,6-
disubstituted-3,4-tetrahydropyridines exclusively and our natural product target contains 
an azacyclic core with this configuration. The spermidine alkaloid cannabisativine occurs 
naturally  as  the  (+)-enantiomer but  initially  the  synthesis  of  a  racemic mixture was 
studied. If  successful, the route  could hopefully  be  adapted towards the asymmetric 
synthesis of the natural product. An attractive option would be to exploit previous studies 
into the asymmetric imine-vinylsilane cyclisations or the use of chiral auxillaries in the 
aza-silyl-Prins reaction. While the diastereoselectivity of the aza-silyl-Prins reaction is 
attractive, it was considered that the use of complex starting materials in the aza-silyl-
Prins reaction  may negatively  affect  this  selectivity.  If  this  were the  case,  then this 
177
Chapter Seven
methodology could be adapted to synthesise other members of the spermidine family such 
as anhydrocannabisativine, paulustrine and dihydropalustrine.
In order to identify an appropriate synthetic target for a formal synthesis of a member of 
the spermidine family,  intermediates from selected literature examples were analysed 
retrosynthetically. Although cannabisativine was our priority target, problems that may 
arise during the synthesis may allow us to direct our efforts towards other spermidine 
alkaloids.  
The first example to be analysed was from the total synthesis of anhydrocannabisativine 
by Weinreb. The intermediate free amine  trans-2,6-disubstituted-4,5-tetrahydropyridine 
476 is the desired target and this could also be adapted with a different aldehyde  474 
towards the synthesis of cannabisativine. The homoallylic amine precursor 473 that would 
be required for the aza-silyl-Prins reaction needs a α-methylenecarboxylate functionality 
as well as an easily  removed protecting group on the nitrogen, such as a carbamate 
function (Scheme 127).
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Scheme 127. Retrosynthetic analysis of possible formal synthesis, via Weireb’s intermediate.
The next publication analysed is based on the synthesis of a compound with a palustrine 
structure (eventually concluded to be the incorrect structure with regards to the position of 
the olefin) by Wasserman. This article does not contain an intermediate that would be 
ideal for a formal synthesis. However, it allowed us to ponder the possibility of fashioning 
the 13-membered macrocyclic lactam before the synthesis of the tetrahydropyridine core 
479 via the aza-silyl-Prins reaction. The aldehyde precursor to the cyclisation would be a 
simple protected-α-hydroxy aliphatic  aldehyde  478.  However,  the homoallylic  amine 
precursor  477 required,  would  have  the  13-membered lactam tethered  between the 
. 25Retrosynthetic Analysis of Literature Examples, Towards the 
Formal Synthesis of Spermidine Alkaloids
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nitrogen  and  the  α-position.  This  could  alter  the  stereochemical  outcome  of  the 
cyclisation, as perhaps the A1,3 strain between ring substituents would be altered with the 
tethered macrocycle. With all other nitrogen-bearing substituents used in the aza-silyl-
Prins reaction such as  benzyl,  phenyl and alkyl,  the  tetrahydropyridine product  was 
exclusively trans across the heteroatom (Scheme 128).  
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Scheme 128. Retrosynthetic analysis of possible palustrine analogue.
The next example from the literature is based on the formation of the tetrahydropyridine 
skeleton of cannabisativine by Wuts. Even though this does not allow a formal synthesis, 
access to this tetrahydropyridine using the aza-silyl-Prins reaction with further elaboration 
might  allow  the  synthesis  of  racemic  cannabisativine  or  another  member  of  the 
macrocyclic spermidine family. The condensation between a di-protected α,β-dihydroxy 
aliphatic aldehyde and a homoallylic amine would be required. The amine would require 
a  protected-α-ethanol  substituent  and  perhaps a  carbamate function  on  the  nitrogen, 
which could be easily removed without reducing the double bond (Scheme 129).
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Scheme 129. Retrosynthetic analysis of possible target molecule for cannabisativine synthesis.
If  the  studies  towards  the  synthesis  of  the  racemic  form  of  cannabisativine  were 
successful,  then  work  could  progress  towards  an  asymmetric  synthesis.  Comins 
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completed  the  synthesis  of  naturally  occurring  (+)-cannabisativine  and  again  a 
tetrahydropyridine intermediate 482 could be targeted using the aza-silyl-Prins reaction. 
The precursors required for the cyclisation would be one enantiomer of a di-protected α,
β-dihydroxy aliphatic  aldehyde  481,  accessed perhaps from Sharpless  asymmetric di-
hydroxylation. Also, required would be a homoallylic amine 480 with an  α-methylene 
carboxylate  function  and  also  a  nitrogen-bearing  carbamate  function.  Such  an 
intermediate might be utilised as a single enantiomer (Scheme 130). 
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Scheme 130. Retrosynthetic analysis of possible asymmetric formal synthesis target.
This  section has not  only allowed us to  target intermediate compounds for a  formal 
synthesis of spermidine alkaloids but also to design new targets based on the different 
methodologies utilised.
In the majority  of  total  syntheses of  cannabisativine  and also other  members of  the 
macrocyclic spermidine family, the 13-membered macrocyclic lactam, tethered between 
the tetrahydropyridine nitrogen and the adjacent C6 position, is  constructed after the 
azacyclic core has been prepared. Many macrocyclic lactam ring closures are fashioned 
by nucleophilic attack by a primary or secondary amine on an activated ester function. 
Similarly, this can also be effected by the coupling of carboxylic acids and amines to give 
the amide function by treatment with coupling reagents such as DCC. At  this  stage, 
macrocycle formation would not be a concern as very similar methodology has been used 
each time in the literature examples. However, such an approach requires the presence of 
the ester  function or  similar tethered to  the C6 position of  the azacyclic core.  Also 
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required  is  an  N-substituent  that  can  easily  be  removed  without  affecting  other 
functionality  on  the  ring  such  as  an  N-Boc  or  N-CBz  substituent;  if  an  N-benzyl 
subsitituent were to be employed, as in previous examples, then removal by catalytic 
hydrogenation would also reduce the 3,4-olefin function.
Disconnection of the  trans-2,6-disubstituted-3,4-tetrahydropyridine core  494 gives the 
aza-silyl-Prins precursors, a homoallylic secondary amine 489 and an  α,β-disubstituted 
aldehyde 490. The amine precursor 489 requires an α-methylene-carboxylate moiety to 
functionalise the C6 position of the 3,4-tetrahydropyridine core. It also contains the  N-
carbamate function, which has provided success in previous aza-silyl-Prins examples. The 
aldehyde component 490 functionalises the C2 position of the 3,4-tetrahydropyridine and 
the 2,3-dihydroxy function contained within this is required to be protected throughout 
the synthesis of the 13-membered macrocycle, as in previous literature examples. The 
protected 2,3-dihydroxyaldehyde 490 may be obtained from the corresponding ester 491. 
The desired 2,3-dihydroxy diastereomer 492 is taken from the syn di-hydroxylation of the 
(Z)-alkene 493. The silylated-homoallylic secondary amine precursor could be obtained 
by using methods already discussed in this thesis (Scheme 131).
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Scheme 131. Retrosynthetic analysis of racemic cannabistavine.
The amine required for the aza-silyl-Prins  reaction  via this  route  was  (Z)-methyl  3-
(carbamate)-6-(trimethylsilyl)hex-5-enoate 489. It was proposed that either the N-Boc or 
N-CBz analogue could be obtained in 7 steps from the commercially available but-3-
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enoic acid  496 (Scheme 132).  This  pathway would proceed  via the  amination of  a 
tosylated alcohol 488, comparable with our previous methodology. 
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Scheme 132. Reagents and conditions: (a) SOCl2, 40 °C, 3 h; (b) MeOH, rt, 1 h, 43% for 2 steps; (c) 
77% m-CPBA in H2O, DCM, 0 °C, 24 h, 88%; (d) n-BuLi, TMS acetylene, Et2AlCl, toluene, -30 °C, 
52%; (e) Ti(Oi-Pr)4,  i-PrMgCl, Et2O, -60 °C, 3 h, 41%; (f) TsCl, Et3N, DMAP, DCM, 0 °C or TsCl, 
pyridine, DMAP, 0 °C; 
The action of thionyl chloride on the commercially available carboxylic acid 496 afforded 
the acid chloride 497, which was treated with methanol immediately to give the methyl 
ester 484 in 43% over 2 steps. The olefin function of this β,γ-unsaturated methyl ester 484 
was then oxidised to the epoxide 485 in 88% yield by the action of m-CPBA. The epoxide 
485 was then opened using the TMS-acetylide-diethyl aluminium species to give the 
alkynylsilane  486 in 52% yield. This propargylic species was then reduced to the  cis 
olefin 487 using the hydrotitanation procedure to give the homoallylic alcohol 487 in 41% 
yield. The exclusive generation of the (Z)-alkenylsilane was confirmed using NOESY 
experiments, with a 1.9 and 1.5% reciprocal enhancement of the olefinic hydrogen on 
irradiation of each. Unfortunately, all attempted methods for tosyl activation 488 of the 
alcohol were unsuccessful. A variety of conditions were surveyed, such as the use of 
DMAP with either triethylamine or pyridine, where all starting material was consumed 
but only the α,β-unsaturated methyl ester 500 was identified as the major product. After 
initial tosylation, it is assumed that one of the acidic α-hydrogens is removed 498 and 
subsequent elimination from the enolate 499 leads to the double bond 500 (Scheme 133).
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Scheme 133. Formation of α,β-unsaturated methylester.
Owing to the acidity of the α-hydrogens adjacent to the methyl ester, it was decided to 
reduce the ester to the primary alcohol  501 and then protect this function selectively. It 
was proposed to protect this alcohol as the TBS ether 502 (Scheme 134). 
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Scheme 134.  Reagents and conditions: (a) LAH, THF, 0  °C to rt, 2 h, 81%; (b) TBSCl, imidazole, 
DMF, rt. 
The methyl ester  487 was therefore reduced with 2 equivalents of LAH to the primary 
alcohol  to give the 1,3-diol 501 in 81% yield. The protection of the primary alcohol as 
the TBS ether 502 was unsuccessful using standard conditions with the starting material 
being consumed but with no recognisable products being isolated. 
While the idea of maintaining a TBS-protected alcohol through the synthesis remained 
attractive, a new approach to the protected alcohol-containing amine was clearly required. 
The new route involved starting with a homoallylic alcohol 85 and introducing the amine 
via an azide 508 (Scheme 135).
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Scheme 135. Retrosynthetic analysis of new amine precursor synthesis.
Before the amine precursor synthesis began, it was deemed essential to also trial the (Z)-
homoallylic  alcohol  502 in  an  indium trichloride-mediated silyl-Prins  reaction.  This 
would allow us to study how the siloxy α-substituent would respond in the presence of a 
Lewis acid. Also, in our previous studies, only simple α-substituents had been utilised to 
form cis-2,6-disubstituted-3,4-dihydropyrans. This trial could also give us precedent for 
the  formation of  natural  products  containing  cis-2,6-disubstituted-3,4-dihydropyrans. 
Using standard silyl-Prins reaction conditions of indium trichloride in DCM with a 1:1:1 
ratio of Lewis acid, aldehyde and alcohol 502 precursor and using hydrocinnamaldehyde, 
the 2,6-disubstituted-3,4-dihydropyran product  515 was obtained in 79% yield (Scheme 
136).
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Scheme 136. Reagents and conditions: (a) InCl3, Ph(CH2)2CHO, DCM, rt, 20 h, 79%.
However,  the TBS ether had also been cleaved to the free hydroxyl function. It  was 
assumed that this has occurred in the presence of indium trichloride. There are examples 
in the literature where other Lewis acids such as boron trifluoride etherate have cleaved 
silyl ethers. It was clear from GCMS and  1H NMR that one diastereomer was formed 
exclusively.  On the basis  of  previous  work,  it  was assumed that  this  is  the  cis-2,6-
disubstituted-3,4-dihydropyran but unfortunately this could not be proved using NOESY 
experiments as too many of the signals in the 1H NMR overlapped.
It was assumed from this that the silyl ether function would probably be cleaved to the 
alcohol when the amine precursor was screened in an indium trichloride mediated aza-
silyl-Prins reaction. This  is  fortunate  however  since  it  was  proposed  to  cleave this 
immediately after the formation of the azacyclic core anyway in the total synthesis of 
racemic cannabisativine. 
The  amine  precursor  that  was  desired  was  (Z)-1-(t-butyldimethylsilyloxy)-6-
(trimethylsilyl)hex-5-en-3-ylcarbamate and it was proposed that either the N-Boc 511 or 
N-CBz  510 derivative could be obtained in 7 or 8 steps from commercially available 3-
buten-1-ol 503 (Scheme 137).
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Scheme 137. Reagents and conditions: (a) TBSCl, imidazole, DCM, rt, 2 h, 90%; (b) 77% m-CPBA in 
H2O, DCM, rt, 72 h, 88%; (c) n-BuLi, TMS acetylene, BF3.Et2O, THF, -78 °C, 92%. (d) Ti(Oi-Pr)4, i-
PrMgCl, Et2O, -60 °C, 4 h, 60%; (e) DPPA, DIAD, PPh3, THF, rt, 1 h, 91%; (f) PPh3, THF, H2O, 60 °
C, 20 h, quantitative; (g) R=Bn, CBzCl, NaHCO3, THF, H2O, rt, 72 h, 64%; R=t-Bu, Boc2O, Et3N, 
DCM, rt, 1 h, 72%; 
The commercially available 3-buten-1-ol 85 was first converted into the TBS ether 504 in 
90% yield using TBSCl in the presence of imidazole. Epoxidation with m-CPBA gave the 
protected epoxy alcohol 505 in 88% yield. Ring-opening with lithium TMS acetylide and 
boron trifluoride etherate gave the alkynylsilane 506 in 92% yield. The triple bond was 
cis-reduced using the previously employed hydrotitanation procedure to give the (Z)-
homoallylic alcohol  502 in 60% yield. An azide 508 could be directly obtained in 91% 
yield  by a  Mitsunobu reaction  involving  the allylic alcohol  502,  triphenylphosphine, 
DIAD  and  diphenylphosphoryl  azide.  This  was  then  reduced  by  the  use  of 
triphenylphosphine and water to afford the primary amine 509 in quantitative yield. 
The desired aza-silyl-Prins precursors could now be obtained by  N-protection of  the 
primary amine 509. The benzyl carbamate derivative 510 was obtained in 64% yield by 
treatment of the primary amine with CBzCl and sodium hydrogen carbonate, using a 
method previously employed by the group. The t-butyl carbamate 511 was derived in 72% 
yield  by  treatment of  the  amine  509 with  di-t-butyl  dicarbonate and  triethylamine. 
Unfortunately, the benzyl carbamate precursor 510 decomposed readily and could not be 
forwarded for screening in the aza-silyl-Prins reaction. The HRMS data could not be 
obtained for this compound and decomposition occurred even when frozen as a solution 
in benzene.
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Now required was the synthesis of the protected α,β-dihydroxyaldehyde 490 for coupling 
to the Boc-amine 511 in the aza-silyl-Prins reaction. If our proposal was correct, then the 
diastereomer required would be obtained from the syn di-hydroxylation of (Z)-ethyl oct-2-
enoate  493 by  an  oxidant  such as  osmium tetroxide.  However,  since  only  the  (E)-
geometric isomer  516 is available commercially,  this was utilised initially in order to 
firstly optimise the conditions of the aza-silyl-Prins reaction for these substrates (Scheme 
138). If  the 2,6-disubstituted-3,4-tetrahydropyridine were formed,  then the use of the 
correct diastereomer  490 of the protected  α,β-dihydroxy aldehyde substrate could be 
explored. 
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Scheme 138. Reagents and conditions: (a) 0.1M OsO4 (aq), NMO, THF, H2O, rt, 72 h, quantitative; (b) 
TBDPSCl, imidazole, DMF, rt, 20 h, 81%; (c) DiBAL, toluene, -78 °C, 2 h, 88%; (d) PCC, 4Å MS, 
DCM, rt, 3 h, 64%; (e) BnBr, NaH, TBAB, 16-crown-6, THF, rt, 1 h, 36%; (f) DiBAL, toluene, -78 °C, 
2 h, 64%; (g) PCC, 4Å MS, DCM, rt, 4 h, 39%; 
The commercially available unsaturated ethyl ester 516 was first converted into the syn-
2,3-diol  517 in  quantitative  yield  via  syn-dihydroxylation  by  the  action  of  osmium 
tetroxide in the presence of NMO as previously employed. This diol 517 was protected as 
the di-silyl ether  518 in 81% yield by the treatment with TBDPSCl and imidazole. It 
could also be protected as the di-benzyl compound  521 in 36% yield by the treatment 
with benzyl bromide in the presence of TBAB and 16-crown-6. The protected diols were 
then submitted to hydride reduction by DiBAL to give the primary alcohols in 88% and 
64% yields for the di-silyl ether 519 and di-benzylate 522 respectively. Initially the aim 
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was to  partially  reduce to  the  desired aldehydes, but  both  substrates underwent  full 
reduction  even at  low temperatures. The primary  alcohol  522,  derived from the  di-
benzylated diol, was a partial mixture with the desired aldehyde 523 and so was only 
characterised fully after the subsequent oxidation step. This oxidation step required the 
use of PCC and gave the desired aldehydes in 64% and 39% yields for the di-silyl ether 
520 and di-benzyl 523 compounds respectively.
With  both  amine and  aldehyde precursors  available,  it  was  now possible  to  begin 
screening for the aza-silyl-Prins reaction. Initially, the coupling of the N-Boc homoallylic 
amine  511 to  either  the  di-silyl  ether  aldehyde  520 or  hydrocinnamaldehyde was 
attempted. It  was expected that the TBS silyl  ether would be cleaved to the primary 
alcohol in the presence of the Lewis acid, based on the previous results with the silyl-
Prins reaction. However,  the di-TBDPS ether was expected to remain intact because 
harsher conditions  are required to cleave this.  The reaction  was attempted using the 
standard conditions for the cyclisation reaction of 1:1:1 ratio of aldehyde: amine: Lewis 
acid, in acetonitrile at reflux temperature (Scheme 139). 
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Scheme 139. Reagents and conditions: (a) InCl3, CH3CN, reflux, 20 h. 
After 20 hours at reflux, TLC and GCMS analysis showed full consumption of starting 
material. Unfortunately,  it  seemed that  the amine precursor  511 had decomposed on 
heating, comparable with the decomposition witnessed for the  N-CBz amine precursor 
510. Only unreacted aldehyde was recovered in both cases.
Fortunately,  there  was  a  second  proposal  to  form  the  core  2,6-disubstituted-3,4-
tetrahydropyridine  of  racemic  cannabisativine.  It  was  proposed  to  utilise  the 
scandium(III) triflate-mediated imine-vinylsilane cyclisations introduced in chapter 6. All 
. dAza-silyl-
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of  the  required  precursors for  this  pathway are  already available. This  includes the 
homoallylic primary amine 509, derived from reduction of the corresponding azide 508, 
and also  both diol-protected aldehydes.  Previously,  the  primary amine and aldehyde 
precursors were condensed in the presence of a dehydrating agent and then the imine was 
exposed  to  the  scandium(III)  triflate-mediated  conditions.  However,  all  previous 
examples  have  contributed  towards  the  synthesis  of  monosubstituted-3,4-
tetrahydropyridines.  In  this  case,  the  amine  precursor  509 has  an  α-TBS  ether 
functionality, which would give a 2,6-disubstituted-3,4-tetrahydropyridine (Scheme 140). 
There was no precedent in our studies to date for the diastereoselectivity of this imine-
vinylsilane cyclisation. 
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Scheme 140.  Reagents and conditions: (a) MgSO4,  DCM, reflux, 4 h,  94%; (b) Sc(OTf)3,  CH3CN, 
reflux, 20 h, 55%;
Following  previous  methodology,  condensation  of  the  primary amine  509 with  the 
aldehyde 523 in the presence of magnesium sulphate, at reflux, gave the desired imine 
526 in 94% crude yield, which was used immediately in the next step. The imine 526 was 
treated with 2 equivalents of scandium(III) triflate in acetonitrile at reflux temperature for 
20  hours.  This  afforded  an  inseparable  mixture  of  2,6-disubstituted-3,4-
tetrahydropyridines 527 in 55% yield as a 1.24:1 mixture of two diastereomers (Scheme 
141). It  was believed that  these diastereomers,  were a  mixture of  cis and  trans-2,6-
disubstituted-3,4-tetrahydropyridines.  The evidence supporting this  assumption  is  that 
there were two signals for the C2 proton separated clearly in the  1H NMR spectrum. 
Unfortunately  the  relative  stereochemistry  could  not  be  confirmed  by  NOESY 
experiments as many signals in the 1H NMR spectra overlapped. 
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Scheme 141.  Reagents and conditions: (a) MgSO4, DCM, reflux, 20 h, 82%; (b) Sc(OTf)3, CH3CN, 
reflux, 17 h, 38%; 
Then the same primary amine 509 was condensed with the di-silyl protected compound 
520, in the presence of magnesium sulphate, to yield the desired imine 528 in 82% yield. 
This imine was again used immediately in the next step. The cyclisation of this imine 528 
required overnight stirring at reflux temperature when treated with scandium(III) triflate 
and afforded the  2,6-disubstituted-3,4-tetrahydropyridine  529 in  38% yield  and as  a 
1.25:1 mixture of diastereomers. Again these diastereomers were inseparable by flash 
column chromatography  and the  relative  stereochemistry could  not  be  confirmed by 
NOESY experiments. Also, there was only a single signal for the C2 proton, perhaps 
suggesting that the mixture included exclusively, either cis or trans-2,6-disubstituted-3,4-
tetrahydropyridines.
The imine-vinylsilane cyclisation has been utilised to form compounds containing the 
cannabisativine skeleton. Unfortunately the diastereoselectivity of this reaction for the 
substrates studied was poor. In order for this methodology to contribute towards a total 
synthesis of cannabisativine, then this selectivity issue must be resolved. To date, two 
different types of protecting group chemistry on the aldehyde substrate have been studied 
and this produced approximately a 1:1 mixture of tetrahydropyridine diastereomers in 
each case. For the  future work, it  would seem necessary to  use  different protecting 
groups, perhaps less bulky, in order to improve selectivity. Eventually, when this issue has 
been resolved, then the correct configuration for the α,β–disubstituted aldehyde 490 must 
be obtained, starting from a (Z)-alkene 493 (Scheme 142). 
190
Chapter Seven
C5H11
OPG
OPG
O
TMS
NH2
OTBS
+
TMS
N
OTBS
C5H11
OPG
OPGN
H
OH
C5H11
OPG
OPG
CO2Et
C5H11
H
493
490
509
530531
Scheme 142. Study on protecting group chemistry for imine-vinylsilane cyclisations.
It would also seem worthwhile to revise the use of the aza-silyl-Prins reaction for this 
total synthesis.  Previously the amine substrates synthesised were highly unstable, and 
these included the N-benzyl carbamoyl 510 and N-t-butyl carbamoyl 511 amines. The N-t-
butyl carbamoyl amine 511 seemed to be relatively stable at room temperature so perhaps 
conditions  suited  to  lower  temperatures would  be  beneficial, rather  than  the  reflux 
temperature attempted in the indium trichloride-mediated aza-silyl-Prins reaction. Other 
Lewis acids or solvents could also promote the cyclisation of these substrates at lower 
temperatures. To improve stability issues, perhaps different N-substituents could also be 
utilised. These substituents should be available to be cleaved under conditions that will 
not effect other protecting group moieties (Scheme 143).
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Scheme 143. Study on N-substituent and Lewis acid/solvent/temperature screening.
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Finally,  in  our  initial  retrosynthetic  analysis,  it  was  proposed  that  the  core 
tetrahydropyridine should be obtained followed by the lactamisation of the 13-membered 
macrocycle. However, perhaps it would be possible to synthesise first the macrocycle 477 
and  then  perform  an  aza-silyl-Prins  reaction  in  order  to  afford  the  desired 
tetrahydropyridine 534 (Scheme 144).
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Scheme 144. Study on pre-macrocycle formation and subsequent aza-silyl-Prins reaction.
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Firstly, the previous optimisation of the silyl-Prins and aza-silyl-Prins reactions to form 
dihydropyrans and tetrahydropyridines respectively had allowed us to make several new 
proposals for further studies. This included using this initial methodology as precedent to 
fashion a new coupling reaction, the aza-Prins reaction. Unfortunately the initial studies 
failed when screening several different Lewis acids, aldehydes and homoallyic amines 
and when altering other variables such as temperature, reaction time and solvent. Success 
in the literature, showed that the reactivity of the amine precursor was of considerable 
importance and so our studies were adjusted. Using an N-tosylamine precursor, success 
was found in forming 2,3,4-trisubstituted-4-chloropiperidines using indium trichloride as 
promoter. Reaction times were longer than the examples in the literature using ferric(III) 
halides,  although it  was  felt  that  our  promoter was  easier to  use.  Using  differently 
substituted homoallylic  amines, including the use of internal double bonds, produced 
regiochemical effects and so allowed the formation of pyrrolidines as well as piperidines.
With  the  optimisation  of  the  silyl-Prins  and  aza-silyl-Prins  reactions  using  simple 
substrates, our new studies focussed on using these cyclisation reactions to form oxa- and 
azacycles with  more  challenging  functionality.  This  included the  introduction  of  6-
trifluoromethyl groups  to  these  six-membered heterocycles. The  precursor synthesis 
towards the  formation of  the  dihydropyran system was simple and involved use  of 
methodology previously utilised by the group. However,  the formation of the desired 
amine precursor for the nitrogen series was far more challenging, but an efficient pathway 
was fashioned nonetheless. Success was found for the formation of 6-trifluoromethyl 
heterocycles, although  reaction  times  were longer  and yields  lower than  for  simple 
precursors. As well as utilising the olefin function of the unsaturated heterocycles, it was 
also possible to qualitatively conclude that (Z)-vinylsilanes are more reactive than their 
(E) counterparts. 
Also shown in these studies, was the fact that the aza-silyl-Prins reaction can be adapted 
to form analogues of natural products such as pipecolic acid in an efficient manner and in 
good yields. However, further studies are required to see if this reaction can be adapted to 
form larger, more complex natural products such as cannabisativine and this would be an 
ideal future project. It was shown however that an imine-vinylsilane reaction mediated by 
scandium(III) triflate allowed us to afford the core cannabisativine tetrahydropyridine 
skeleton, although the diastereoselectivity of this reaction was poor. This same reaction 
was optimised to form simple 2-substituted free amine tetrahydropyridines in racemic 
form.  With future work, this reaction could be adapted to form these azacycles in high 
enantiopurity using, for example, chiral Lewis acids. 
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EXPERIMENTAL
All  chemicals  were  purified  by  distillation  where  appropriate.  Diethyl  ether  and 
tetrahydrofuran were  predried  over  sodium  wire  and  distilled  from  sodium  under 
nitrogen, with  benzophenone ketyl  as  indicator.  Dichloromethane was  distilled  from 
calcium hydride and kept under nitrogen. All reactions were carried out under anhydrous 
conditions and in an atmosphere of nitrogen unless otherwise stated, using flame-dried 
glassware with all transfers performed using plastic syringes and needles.
All column chromatography was carried out using Fluka Silica Gel 60 (220-440 mesh) 
(Brockmann 2-3). TLC analysis was carried out using aluminium-backed plates coated 
with Merck Kieselgel 60 GF254. Plates were visualised by ultraviolet light and aqueous 
potassium  permanganate  spray  (KMnO4:K2CO3:water  6:1:100,  w/w/v).  Another 
purification technique involved the use of Mass-Directed-Auto-Prep (MDAP), a form of 
preparative  HPLC,  performed  in  the  laboratories  at  GlaxoSmithKline,  Harlow 
(confidential).
Melting points were determined using a Gallenkamp melting point apparatus.
Optical rotations were measured on an Optical Activity Ltd. AA-1000 polarimeter, values 
are quoted in 10-1 cm2 g-1.
Infrared spectra were recorded in the range 4000-600 cm-1 on a Nicolet MAGNA 550 FT-
IR spectrometer with internal calibration. Spectra were recorded as thin films between 
NaCl plates, as KBr disks or as Nujol pastes.
Proton (1H) and carbon (13C) NMR spectra were recorded at 300 MHz or at 400 MHz and 
at 75.5 MHz or 100.6 MHz respectively on JNM-LA300 (300 MHz and 75.5 MHz) and 
on a Bruker ACF-300 or a Advance DRX 400 spectrometers. Chemical shift values (δH 
and δC) are reported as values in parts per million (ppm) from the residual protic solvent 
as the internal standard reference for 1H NMR spectra and from the solvent peaks for 13C 
NMR.  1H NMR spectra are  recorded in  the form (integration;  multiplicity;  coupling 
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constants; assignment). Multiplicities are given as s-singlet, d-doublet, t-triplet, q-quartet, 
m-multiplet and bs-broad signal. Coupling constants (J values) are quoted to one decimal 
place with values in Hz. 13C NMR spectra are recorded in the form δC (assignment).
High and low resolution mass spectra were recorded on a Kratos profile instrument or on 
a VG Analytical ZAB-E instrument (EPSRC Mass Spectrometry Service, Swansea) or on 
a ThermoQuest Trace GC 2000 series and Agilent 6890 Series GC system, Micromas 
GCT. Mass spectrometric data were also acquired using LCMS analysis, performed in the 
laboratories at GlaxoSmithKline, Harlow (confidential). 
Full characterisation of a compound within this experimental includes, but is not limited 
to, data on IR, 1H NMR, 13C NMR, low-resolution mass spectra and high-resolution mass 
spectra. Compounds that have been characterised fully in the literature contain two or 
more from the previous list. On some occasions, it was not possible to obtain all required 
data; the reasons for this have been alluded to in the main body of this thesis. 
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General procedure A: alcohol tosylation on 69.73 mmol scale. A round-bottomed flask 
was charged with homoallylic alcohol (69.73 mmol, 1.00 eq.) and dichloromethane (140 
mL). The resulting solution was stirred and cooled to 0 °C before adding sequentially 4-
dimethylaminopyridine (5.08 g, 41.84 mmol, 0.60 eq.) and  p-toluenesulfonyl  chloride 
(15.96 g, 83.68 mmol, 1.20 eq.) portionwise and dropwise triethylamine (9.82 mL, 69.73 
mmol, 1.00 eq.). The resulting solution was stirred at 0 °C until TLC showed complete 
consumption of starting material. The resulting suspension was diluted with diethyl ether 
(150 mL), stirred for a further 30 minutes and the precipitate removed by filtration. The 
solution was then washed sequentially with 10% aqueous copper sulfate (2 x 75 mL), 
10% aqueous sodium hydrogen carbonate (2 x 75 mL) and a saturated aqueous sodium 
chloride solution (60 mL). The combined organic layers were dried over magnesium 
sulfate, filtered, and concentrated in vacuo.
4-(Toluene-1-sulfonyloxy)-but-3-ene (86).
OS
O
O
C11H14O3S
Mol. Wt.: 226.29
4
1
9
Following the general procedure A, 3-buten-1-ol 85 (3.35 g, 46.40 mmol) gave after 22 
hours of stirring, a yellow oil which was purified by flash column chromatography (50% 
petroleum ether 50% diethyl ether) to give the title compound 86 (8.22 g, 36.30 mmol, 
78%) as a colourless oil.
δH (300 MHz; CDCl3) 7.80 (2H, d, J 8.3, H-C6), 7.36 (2H, d, J 8.3, H-C7), 5.75-5.61 (1H, 
m, H-C3), 5.13-5.07 (2H, m, H-C4), 4.07 (2H, t, J 6.7, H-C1), 2.45 (3H, s, H-C9), 2.44-
2.39 (2H, m, H-C2); δC (75.5 MHz; CDCl3) 145.2 (C8), 133.5 (C5), 132.8 (C3), 130.3 
(C7), 128.3 (C6), 118.7 (C4), 69.8 (C1), 33.6 (C2), 22.1 (C9); m/z (CI) 227 (MH+, 100), 
173 (95), 155 (55). Data in agreement with literature values.
General procedure B: amination or tosyl displacement by primary amine on 18.00 
mmol scale.  A round-bottomed flask  equipped with  a  condenser was  charged with 
primary amine (90 mmol, 5.00 eq.), tosylated alcohol (18 mmol, 1.00 eq.), and ethanol 
(18ml).  The  resulting  solution  was  stirred  at  reflux  temperature  until  TLC showed 
complete consumption of starting material. The solution was cooled to room temperature, 
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the ethanol removed in vacuo and the excess of primary amine carefully distilled under 
reduced pressure unless otherwise stated. The resulting residue was partitioned between 
dichloromethane (60 mL) and 1.0 M aqueous sodium hydroxide solution (40mL). The 
organic layer was separated, the aqueous layer extracted with dichloromethane (3 x 10 
mL),  the  combined  organic  layers  dried  over  magnesium  sulphate,  filtered  and 
concentrated in vacuo.
N-Benzyl-N-(3-butenyl)amine (87).
N
H
Ph
C11H15N
Mol. Wt.: 161.24
1
4
5
Following the general procedure B, 4-(toluene-4-sulfonyloxy)-but-1-ene 86 (4.07 g, 18.00 
mmol), in the presence of benzylamine (9.65 g, 90.00 mmol), was consumed based on 
analysis by TLC after 20 hours of stirring and heating. The excess of benzylamine was 
distilled (104 °C, 245 mmHg) and the work-up gave a yellow oil, which was purified by 
flash column chromatography (75% petroleum ether 24% ethyl acetate 1% triethylamine) 
to give the title compound 87 (2.29 g, 14.00 mmol, 50%) as a colourless oil.
δH (300 MHz; CDCl3) 7.38-7.24 (5H, m, ArH) 5.88-5.74 (1H, m, H-C3), 5.15-5.03 (2H, 
m, H-C4), 3.82 (2H, s, H-C5), 2.73 (2H, t, J 6.0, H-C1), 2.31 (2H, dt, J 6.0, 6.0  
H-C2),  1.66 (1H, bs,  H-NH);  δC (75.5 MHz; CDCl3)  140.5 (ArC),  136.8 (C3), 128.9 
(ArC), 128.5 (ArC), 127.2 (ArC), 116.9 (C4), 54.2 (C5), 48.6 (C1), 34.6 (C2). Data in 
agreement with literature values.
General procedure C: iodine catalysed synthesis of  homoallylic  amines on 15.00 
mmol scale. A round-bottomed flask was charged with aldehyde (15.00 mmol, 1 eq.) and 
acetonitrile (15 ml). To the resulting solution at room temperature was added sequentially 
iodine (0.38 g, 1.5 mmol, 0.10 eq.), benzyl carbamate (2.38 g, 15.75 mmol, 1.05 eq.) 
portionwise,  and  dropwise  allyltrimethylsilane  (2.38  mL,  15  mmol,  1.00  eq.).  The 
resulting  suspension  was  stirred  at  room  temperature until  TLC  showed  complete 
consumption of starting material. To the solution was added sodium thiosulfate (0.90 g), 
distilled water (10 mL) and the reaction mixture was stirred for a further 20 minutes. The 
biphasic solution was diluted with diethyl ether (30 mL), the organic layer washed with 
saturated aqueous sodium chloride (2 x 25 mL) and combined aqueous layers extracted 
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with diethyl ether (2 x 25 mL). The combined organic layers were dried over sodium 
sulfate, filtered, and concentrated in vacuo.
N-Benzyloxycarbonyl-(±)-1-benzylbut-3-enylamine (89).
N
H
O
O
Ph
Ph
C19H21NO2
Mol. Wt.: 295.38
1
4
5
11
Following the general procedure C, phenylacetaldehyde (1.80 g, 15.00 mmol), gave after 
overnight stirring a yellow oil which was purified by flash column chromatography (90% 
petroleum ether 10% ethyl acetate) to give the  title compound 89 (2.00 g, 6.76 mmol, 
45%) as a colourless oil.
δH (300 MHz; CDCl3) 7.42-7.18 (10H, m, ArH), 5.88-5.74 (1H, m, H-C3), 5.14-5.07 (2H, 
m, H-C4), 5.08 (2H, s, H-C11), 4.67-4.64 (1H, m, H-NH), 4.04-3.97 (1H, m, H-C1), 2.89-
2.76 (2H, m, H-C2), 2.35-2.28 (1H, m, H-C5), 2.20-2.07 (1H, m, H-C5); δC (75.5 MHz; 
CDCl3) 156.2 (C10), 138.3 (ArC), 137.0 (C3), 134.6 (ArC), 129.8 (ArC), 129.0 (ArC), 
128.7 (ArC), 128.5 (ArC), 128.4 (ArC), 126.9 (ArC), 118.7 (C4), 67.4 (C11), 52.1 (C5), 
40.8 (C1), 38.6 (C2). Data in agreement with literature values.
N-Benzyloxycarbonyl-(±)-1-heptylbut-3-enylamine (90).
N
H
O
O
Ph
C19H29NO2
Mol. Wt.: 303.44
1
4
5
11
13
Following the general procedure C, octanal (1.80 g, 15.00 mmol) gave, after overnight 
stirring,  a  yellow  oil  which  was  purified  by  flash  column  chromatography (90% 
petroleum ether 10% ethyl acetate) to give the  title compound 90  (1.53 g, 5.03 mmol, 
34%) as a white solid.
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M.p. 52-53°C (Lit.: 51-52°C); δH (300 MHz; CDCl3) 7.38-7.34 (5H, m, ArH), 5.82-5.71 
(1H, m, H-C3), 5.10-5.05 (2H, m, H-C4), 5.10 (2H, s, H-C13), 4.57-4.54 (1H, m, H-NH), 
3.73-3.71 (1H, m, H-C1), 2.31-2.15 (2H, m, H-C2), 1.32-1.25 (12H, m, H-C5 to C10), 
0.89 (3H, t, J 6.0, H-C11); δC (75.5 MHz; CDCl3) 156.5 (C12), 137.2 (ArC), 134.8 (C3), 
128.9 (ArC), 128.4 (ArC), 118.16 (C4), 66.9 (C13), 51.1 (C5), 39.9 (C1), 35.0 (C2), 32.2 
(C6), 29.8 (C7 and C8), 26.3 (C9), 23.1 (C10), 14.5 (C11); m/z (CI) 304 (MH+, 100), 196 
(28), 172 (18). Data in agreement with literature values.
3-Methylbut-3-enyl 4-methylbenzenesulfonate (97).
O S
O
O
1
3
6
7
7
8
8
9
10
5
C12H16O3S
Mol. Wt.: 240.32
Following the general procedure A, 3-methylbut-3-en-1-ol 96 (6.01 g, 69.73 mmol) was 
consumed based on analysis by TLC after 48 hours of stirring at 0 °C. The work-up gave 
the title compound 97 (12.63 g, 52.55 mmol, 75%) as a yellow oil which was used in the 
next step without any further purification.
δH (300 MHz; CDCl3) 7.77 (2H, d, J  8.3, H-C7), 7.33 (2H, d, J  8.3, H-C8), 4.77 (1H, s, 
H-C4), 4.66 (1H, s, H-C4), 4.10 (2H, t, J  6.8, H-C1), 2.43 (3H, s, H-C10), 2.33 (2H, t, J 
6.8, H-C2), 1.64 (3H, s, H-C5); m/z (CI) 241 (MH+, 90), 173 (72), 137 (100). Data in 
agreement with literature values.
Benzyl-(3-methyl-but-3-enyl)-amine (98).
N
H
Ph
C12H17N
Mol. Wt.: 175.27
1
4
5
6
Following  the  general  procedure B,  2-methyl-4-(toluene-4-sulfonyloxy)-but-1-ene 97 
(2.88 g, 12.00 mmol), in the presence of benzylamine (6.43 g, 60 mmol), was consumed 
based on analysis by TLC after 18 hours of stirring and heating. The work-up gave a 
yellow oil, which was purified by flash column chromatography (75% petroleum ether 
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24% ethyl acetate 1% triethylamine) to give the title compound 98 (2.55 g, 14.55 mmol, 
97%) as a colourless oil.
δH (300 MHz; CDCl3) 7.37-7.23 (5H, m, ArH), 4.79 (1H, s, H-C5), 4.75 (1H, s, H-C5), 
3.81 (2H, s, H-C6), 2.76 (2H, t, J 6.3, H-C1), 2.26 (2H, t, J 6.3, H-C2), 1.72 (3H, s, H-
C4);  δC (75.5 MHz; CDCl3) 143.9 (C3), 140.5 (ArC), 128.8 (ArC), 128.6 (ArC), 127.4 
(ArC), 112.0 (C5), 54.2 (C6), 47.1 (C1), 38.3 (C2), 22.6 (C4); m/z (CI) 176 (MH+, 100), 
120 (93). Data in agreement with literature values.
(Z)-Pent-3-en-1-ol (112).
OH
13
5
C5H10O
Mol. Wt.: 86.13
A solution of pent-3-yn-1-ol 111 (5.00 g, 59.44 mmol) in methanol (85 mL) was injected 
into a hydrogenation flask containing a prehydrogenated suspension of Lindlar’s catalyst 
(425 mg) in  methanol (10 mL). The  hydrogenation  was complete in  17  hours.  The 
mixture was filtered through celite, which was washed with diethyl ether (10 mL) and the 
filtrate was concentrated in vacuo. This gave a pale yellow oil, which was purified by 
distillation at atmospheric pressure (50 °C, 760 mmHg) to give the title compound 112 
(4.02 g, 46.69 mmol, 79%) as a colourless oil.
δH (300 MHz; CDCl3) 5.66-5.53 (1H, m, H-C3), 5.43-5.31 (1H, m, H-C4), 3.61 (2H, t, J 
6.6, H-C1), 2.34-2.26 (2H, m, H-C2), 2.11 (1H, bs, H-OH), 1.64-1.59 (3H, m, H-C5); δ
C (75.5 MHz; CDCl3) 126.9 (C3), 126.0 (C4), 62.0 (C1), 30.3 (C2), 12.8 (C5). Data in 
agreement with literature values. 
General  Procedure  D:  trans reduction  of  propargylic  alcohols  with  lithium 
aluminium hydride on 59.44 mmol scale.  A three-necked round-bottomed flask fitted 
with a reflux condenser, a dropping funnel and a thermometer was charged with lithium 
aluminium  hydride  (5.86  g,  153.90  mmol,  2.59  eq.),  triglyme  (46  mL)  and 
tetrahydrofuran (9 mL). The resulting suspension was cooled to 0  °C and a propargylic 
alcohol derivative (59.44 mmol, 1.00 eq.) in tetrahydrofuran (10 mL) added dropwise 
whilst maintaining a temperature below 25 °C. The mixture was then heated to 85 °C and 
stirred for 72 hours and then cooled to room temperature. To the mixture was added ice 
(100 g) and a 1.0 M solution of hydrochloric acid (300 mL) with stirring. The resulting 
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biphasic solution was diluted with diethyl ether (100 mL) and the organic layer separated. 
The aqueous layer was extracted with diethyl  ether (2 x 100 mL) and the combined 
organic layers were dried over magnesium sulfate, filtered and concentrated in vacuo. 
(E)-Pent-3-en-1-ol (113).
OH
13
5
C5H10O
Mol. Wt.: 86.13
Following the general procedure D, 3-pentyn-1-ol 111 (5.00 g, 59.44 mmol) gave a pale 
yellow oil,  which  was  purified  by  distillation  under reduced pressure (100 °C,  114 
mmHg) to give the title compound 113 (3.33 g, 38.64 mmol, 65%) as a colourless oil.
δH (300 MHz; CDCl3) 5.64-5.49 (1H, m, H-C3), 5.46-5.33 (1H, m, H-C4), 3.65-3.57 (2H, 
m, H-C1), 2.29-2.19 (2H, m, H-C2), 1.89 (1H, bs, H-OH), 1.71-1.65 (3H, m, H-C5). Data 
in agreement with literature values.
(Z)-Pent-3-enyl 4-methylbenzenesulfonate (114).
O S
O
O
13
7
7
8
8
9
10
5
C12H16O3S
Mol. Wt.: 240.32
Following the general procedure A, (Z)-pent-3-en-1-ol  112 (3.99 g, 46.32 mmol) was 
consumed based on analysis by TLC after 20 hours of stirring at 0  °C. The work-up 
afforded  a  yellow oil,  which  was  purified  by  flash  column chromatography (90% 
petroleum ether, 10% ethyl acetate) to give the title compound 114 (9.78 g, 40.71 mmol, 
88%) as a colourless oil.
δH (300 MHz; CDCl3) 7.79 (2H, d, J  8.3, H-C7), 7.34 (2H, d, J  8.3, H-C8), 5.62-5.49 
(1H, m, H-C3), 5.31-5.19 (1H, m, H-C4), 4.01 (2H, t, J  7.0, H-C1), 2.45 (3H, s, H-C10), 
2.44-2.35 (2H, m, H-C2), 1.59-1.54 (3H, m, H-C5); m/z (CI) 241 (MH+, 17), 213 (20), 
173 (100). Data in agreement with literature values.
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(E)-Pent-3-enyl 4-methylbenzenesulfonate(115).
O S
O
O
13
6
7
7
8
8
9
10
5
C12H16O3S
Mol. Wt.: 240.32
Following the general procedure A, (E)-pent-3-en-1-ol  113 (2.10 g, 24.38 mmol) was 
consumed based on analysis by TLC after 20 hours of stirring at 0  °C. The work-up 
afforded  a  yellow oil,  which  was  purified  by  flash  column chromatography (90% 
petroleum ether, 10% ethyl acetate) to give the title compound 115 (3.32 g, 13.82 mmol, 
57%) as a colourless oil.
δH (300 MHz; CDCl3) 7.77 (2H, d, J  8.3, H-C7), 7.33 (2H, d, J  8.3, H-C8), 5.55-5.40 
(1H, m, H-C3), 5.30-5.17 (1H, m, H-C4), 3.99 (2H, t, J  6.8, H-C1), 2.44 (3H, s, H-C10), 
2.34-2.26 (2H, m, H-C2), 1.63-1.57 (3H, m, H-C5); m/z (CI) 241 (MH+, 15), 213 (20), 
173 (100). Data in agreement with literature values.
General  Procedure  E:  Amination  of  tosylated  alcohol  with  4-
methylbenzenesulfonamide, catalysed by sodium iodide on a 69.73 mmol scale. A 
round-bottomed  flask  fitted  with  a  reflux  condenser  was  charged  with  4-
methylbenzenesulfonamide (27.98 g, 160.38 mmol, 2.30 eq.), finely powdered potassium 
hydroxide (5.06 g, 90.65 mmol, 1.30 eq.) and dimethylsulfoxide (87 mL). The resulting 
suspension was heated to 50 °C and stirred for 2 hours. The resulting solution was cooled 
to  room temperature and  a  tosylated alcohol  derivative  (69.73 mmol,  1.00  eq.)  in 
dimethylsulfoxide (10 mL) added dropwise, followed by sodium iodide (3.15 g, 20.92 
mmol, 0.30 eq.) in one portion. The mixture was heated to 50 °C and stirred until TLC 
showed  full  consumption  of  starting  material.  The  mixture  was  cooled  to  room 
temperature, ice-cold water (100 mL) added, the organic layer separated, and the aqueous 
layer extracted with dichloromethane (3 x 50 mL). The combined organic layers were 
washed with a 15 % aqueous solution of potassium hydroxide (100 mL), water (100 mL) 
and a saturated aqueous solution of sodium chloride (100 mL). The organic layer was 
dried over magnesium sulfate, filtered and concentrated in vacuo. 
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(Z)-4-Methyl-N-(pent-3-enyl)benzenesulfonamide (116).
N
H
S
O
O
13
6
7
7
8
8
9
10
5
C12H17NO2S
Mol. Wt.: 239.33
Following the general procedure E, (Z)-pent-3-enyl 4-methylbenzenesulfonate 114 ( 1.00 
g, 4.16 mmol) was consumed based on analysis by TLC after 20 hours of stirring at 50 °
C.  The  work-up  afforded  a  yellow  oil,  which  was  purified  by  flash  column 
chromatography (80% hexane, 20% ethyl acetate) to give the title compound 116 (0.93g, 
3.89 mmol, 94%) as a colourless oil.
νmax(neat)/cm-1 3282, 2924, 1598; δH (300 MHz; CDCl3) 7.74 (2H, d, J  8.3, H-C7), 7.31 
(2H, d, J  8.3, H-C8), 5.64-5.50 (1H, m, H-C3), 5.25-5.13 (1H, m, H-C4), 4.49-4.39 (1H, 
m, H-NH), 3.01-2.93 (2H, m, H-C1), 2.43 (3H, s, H-C10), 2.25-2.16 (2H, m, H-C2), 1.59-
1.54 (3H, m, H-C5); δC (75.5 MHz; CDCl3) 143.3 (C9), 136.8 (C6), 129.7 (C8), 127.7 
(C3), 127.1 (C7), 125.5 (C4), 42.6 (C1), 27.0 (C2), 21.5 (C10), 12.9 (C5); m/z (CI) 240 
(MH+, 100), 184 (65), 172 (26); HRMS (ES) Found [M+NH4]+ 257.1315, C12H21N2O2S 
requires 257.1318.
(E)-4-Methyl-N-(pent-3-enyl)benzenesulfonamide (117).
N
H
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O
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5
C12H17NO2S
Mol. Wt.: 239.33
Following the general procedure E, (E)-pent-3-enyl 4-methylbenzenesulfonate 115 (1.00 
g, 4.16 mmol) was consumed based on analysis by TLC after 20 hours of stirring at 50 °
C.  The  work-up  afforded  a  yellow  oil,  which  was  purified  by  flash  column 
chromatography (80% hexane, 20% ethyl acetate) to give the title compound 117 (0.97g, 
4.04 mmol, 97%) as a colourless oil.
νmax(neat)/cm-1 3284, 3035, 2918, 1816, 1598; δH (300 MHz; CDCl3) 7.74 (2H, d, J  8.4, 
H-C7), 7.31 (2H, d,  J  8.4, H-C8), 5.52-5.38 (1H, m, H-C3), 5.25-5.13 (1H, m, H-C4), 
4.47-4.37 (1H, m, N-NH), 2.96 (2H, dd, J  12.7, 6.4, H-C1), 2.43 (3H, s, H-C10), 2.15-
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2.07 (2H, m, H-C2), 1.64-1.60 (3H, m, H-C5); δC (75.5 MHz; CDCl3) 143.3 (C9), 136.9 
(C6), 129.6 (C8), 128.9 (C3), 127.1 (C7), 126.6 (C4), 42.5 (C1), 32.4 (C2), 21.4 (C10), 
17.9 (C5); m/z (CI) 240 (MH+,  100), 184 (35), 111 (18); HRMS (ES) Found [M+H]+ 
240.1050, C12H18NO2S requires 240.1053.
General procedure F: aza Prins reaction on 1.97 mmol scale.
A round-bottomed flask was charged with indium trichloride (642 mg, 2.96 mmol, 1.50 
eq.) and dichloromethane (5 mL). To the resulting suspension was added an aldehyde 
derivative (2.96 mmol, 1.50 eq.) in dichloromethane (1.5 mL). After stirring the mixture 
for  15  minutes  at  room temperature,  an  amine derivative  (1.97 mmol,  1.00 eq.)  in 
dichloromethane (1.5 mL) was added and the resulting mixture stirred until TLC showed 
complete  consumption  of  starting  material.  The  mixture  was  diluted  with 
dichloromethane (10 mL) and water (10 mL) and stirred for 30 minutes. The organic layer 
was separated and the aqueous layer was extracted with dichloromethane (3 x 10 mL). 
The  combined  organic  layers  were  dried  over  magnesium  sulfate,  filtered  and 
concentrated in vacuo. 
(2R*,3R*,4S*)-4-Chloro-2-heptyl-3-methyl-1-tosylpiperidine  (118a),  (2S*,3R*)-3-
((S)-1-Chloroethyl)-2-heptyl-1-tosylpyrrolidine (119a).
2
19
15
N
S OO
Cl
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4
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16
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C20H32ClNO2S
Mol. Wt.: 385.99
4
7
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Following the general procedure F, (Z)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 116 
(150 mg, 0.62 mmol), in the presence of octanal (120 mg, 0.94 mmol), was consumed 
based on analysis by TLC after 17 hours of stirring at room temperature. The work-up 
afforded a yellow oil, which was purified by flash column chromatography (90% hexane, 
10% ethyl  acetate) to  give the  title  compound 118a (84 mg,  0.22 mmol, 35%) as  a 
colourless oil.
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νmax(neat)/cm-1 2928, 1729, 1598; δH (300 MHz, CDCl3) 7.67 (2H, d, J  8.2, H-C15), 7.27 
(2H, d, J  8.2, H-C16), 4.31 (1H, td, J  12.6, 4.6, H-C4), 3.96-3.88 (1H, m, H-C2), 3.78-
3.69 (1H, m, H-C6), 2.94 (1H, td, J  13.6, 3.2, H-C6), 2.41 (3H, s, H-C18) 2.16-2.05 (1H, 
m, H-C3), 2.01-1.84 (1H, m , H-C5), 1.84-1.74 (1H, m, H-C5), 1.66-1.33 (2H, m, H-C7), 
1.32-1.11 (10H, m, H-C8 to H-C12), 1.08 (3H, d, J  6.9, H-C19), 0.87 (3H, t, J  6.8, H-
C13); δC (75.5 MHz; CDCl3)  143.1 (C17), 138.1 (C14), 129.5 (C16), 126.9 (C15), 60.1 
(C2), 57.4 (C4), 40.6 (C6), 37.3 (C3), 31.7 (C11), 30.0 (C5), 29.4 (C9 and C10), 26.8 
(C12), 22.6 (C8), 21.5 (C18), 14.1 (C13), 12.7 (C19); m/z (CI) 386 (MH+, 100), 350 (60), 
286 (42); HRMS (ES) Found (35Cl) [M+H]+ 386.1910, C20H33ClNO2S requires 386.1915.
Further elution (90% hexane 10% ethyl acetate) provided the other title compound 119a 
(84 mg, 0.22 mmol, 35%) as a colourless oil.
νmax(neat)/cm-1 2927, 1598; δH (300 MHz; CDCl3) 7.75 (2H, d, J 8.3, H-C15), 7.32 (2H, d, 
J 8.3, H-C16), 3.80 (1H, ddd, J  7.6, 4.9, 2.9, H-C2), 3.36 (1H, ddd, J  10.7, 7.3, 5.7, H-
C5), 3.25 (1H, td, J  10.7, 7.3, H-C5), 3.09 (1H, qd, J  8.8, 6.5, H-C6), 2.43 (3H, s, H-
C18), 2.13-2.01 (1H, m, H-C3), 1.93 (1H, dt, J  14.6, 7.3, H-C4), 1.79-1.66 (1H, m, H-
C7), 1.66-1.51 (1H, m, H-C7), 1.48-1.31 (1H, m, H-C4), 1.27 (3H, d, J 6.5, H-C19), 1.33-
1.19 (10H, m, H-C8 to H-C12), 0.88 (3H, t, J  6.6, H-C13); δC (75.5 MHz; CDCl3) 143.4 
(C17), 135.0 (C14), 129.6 (C16), 127.5 (C15), 63.7 (C1), 59.2 (C6), 52.5 (C3), 47.3 (C5), 
37.0 (C7), 31.8 (C11), 29.4 (C9 and C10), 27.8 (C4), 25.8 (C8), 23.1 (C19), 22.6 (C12), 
21.5 (C18), 14.1 (C13); m/z (CI) 386 (MH+, 100), 350 (25), 286 (27); HRMS (ES) Found 
(35Cl) [M+NH4]+ 403.2185, C20H36ClN2O2S requires 403.2181.
(2S*,3R*,4S*)-4-Chloro-3-methyl-2-phenyl-1-tosylpiperidine (118a).
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Following the general procedure F, (Z)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 116 
(150  mg,  0.62  mmol)  in  the  presence of  benzaldehyde  (99  mg,  0.94  mmol),  was 
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consumed based on analysis by TLC after 144 hours of stirring at room temperature. The 
work-up afforded a yellow oil, which was purified by flash column chromatography (90% 
hexane, 10% ethyl acetate) to give the title compound 118a (34 mg, 0.09 mmol, 15%) as a 
white solid.
M.p. 112-114 °C;  νmax(neat)/cm-1 3029, 2940, 2344, 1596;  δH (300 MHz; CDCl3)  7.70 
(2H, d, J  7.8, H-C8), 7.45-7.27 (5H, m, Ar-H), 7.21 (2H, d, J  7.8, H-C9), 5.19 (1H, s, H-
C2), 4.09 (1H, td, J  11.8, 4.1, H-C4), 3.97-3.80 (1H, m, H-C6), 3.27 (1H, ddd, J  13.9, 
11.8, 3.5, H-C6), 2.88-2.72 (1H, m, H-C3), 2.47 (3H, s, H-C11), 2.07-1.91 (1H, m, H-C5) 
1.85-1.78 (1H, m, H-C5),  1.16 (3H, d,  J  6.9, H-C12);  δC (75.5 MHz; CDCl3)  143.8 
(C10), 137.8 (C7), 137.7 (ArC), 129.6 (ArC), 128.7 (ArC), 127.2 (ArC), 127.1 (C8), 
126.8 (C9), 62.5 (C2), 57.5 (C4), 41.8 (C6), 39.3 (C3), 29.8 (C5), 21.5 (C11), 13.0 (C12); 
m/z (CI) 364 (MH+, 64), 328 (30), 210 (55); HRMS (ES) Found (35Cl) [M+H]+ 364.1135, 
C19H23ClNO2S requires 364.1133.
(2R*,3R*,4S*)-4-Chloro-3-methyl-2-phenethyl-1-tosylpiperidine (118c), (2S*,3R*)-3-
((S)-1-Chloroethyl)-2-phenethyl-1-tosylpyrrolidine (119c).
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Following the general procedure F, (Z)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 116 
(150 mg, 0.62 mmol) in the presence of 3-phenylpropanal (126 mg, 0.94 mmol), was 
consumed based on analysis by TLC after 17 hours of stirring at room temperature. The 
work-up afforded a yellow oil, which was purified by flash column chromatography (90% 
hexane, 10% ethyl acetate) to give the title compound 118c (98 mg, 0.25 mmol, 40%) as a 
colourless oil.
νmax(neat)/cm-1 3063, 2938, 1598; δH (300 MHz; CDCl3) 7.66 (2H, d, J  8.3, H-C10), 7.34-
7.13 (5H, m, Ar-H), 7.08 (2H, d, J  8.3, H-C11), 4.32 (1H, td, J  12.3, 4.6, H-C4), 4.01 
(1H, m, H-C2), 3.80 (1H, dd, J  13.3, 4.5, H-C6), 2.99 (1H, td, J  13.3, 3.3, H-C6), 2.66-
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2.47 (2H, m, H-C8), 2.42 (3H, s, H-C13), 2.22-2.13 (1H, m, H-C3), 2.02-1.88 (1H, m, H-
C5), 1.89-1.77 (1H, m, H-C5), 1.78-1.52 (2H, m, H-C7), 1.07 (3H, d, J  6.9, H-C14); δ
C (75.5 MHz; CDCl3)  143.2 (C12), 140.9 (ArC), 138.0 (C9), 129.7 (C11), 128.5 (ArC), 
128.2 (ArC), 126.9 (C10), 126.1 (ArC), 59.6 (C2), 57.2 (C4), 40.7 (C6), 37.4 (C3), 33.1 
(C8), 31.8 (C5 or C7), 30.0 (C5 or C7), 21.5 (C13), 12.7 (C14); m/z (CI) 392 (MH+, 100), 
356  (18),  238  (48); HRMS (ES)  Found  (35Cl)  [M+NH4]+ 409.1716,  C21H30ClN2O2S 
requires 409.1711.
Further elution (90% hexane 10% ethyl acetate) provided the other title compound 119c 
(88 mg, 0.22 mmol, 36%) as a white solid.
M.p. 122-123 °C;  νmax(KBr)/cm-1 3062, 2955, 1664, 1594;  δH (300 MHz; CDCl3) 7.81 
(2H, d, J  8.3, H-C10), 7.39 (2H, d, J  8.3, H-C11), 7.36-7.24 (5H, m, Ar-H), 3.94 (1H, 
ddd, J  6.7, 5.8, 3.2, H-C2), 3.55-3.31 (2H, m, H-C5), 3.18 (1H, qd, J  9.1, 6.6, H-C6), 
2.82 (2H, t, J  8.3, H-C8), 2.50 (3H, s, H-C13), 2.25-2.17 (1H, m, H-C3), 2.18-2.08 (2H, 
m, H-C7), 2.19-1.95 (1H, m, H-C4), 1.45 (1H, dt, J  13.0, 6.2, H-C4), 1.34 (3H, d, J  6.6, 
H-C14); δC (75.5 MHz; CDCl3) 143.6 (C12), 141.6 (ArC), 134.8 (C9), 129.6 (C11), 128.4 
(ArC), 128.3 (ArC), 127.5 (C10), 125.7 (ArC), 63.4 (C2), 59.2 (C6), 52.9 (C3), 47.6 (C5), 
38.6 (C7), 32.1 (C8), 27.9 (C4), 23.1 (C14), 21.5 (C13); m/z (CI) 392 (MH+, 100), 356 
(12), 238 (58); Anal. Calcd. for C21H26ClNO2S requires C, 64.35; H, 6.69; N, 3.57%. 
Found: C, 64.47; H, 6.58; N, 3.54%.
(2R*,3R*,4S*)-4-Chloro-2-cyclohexyl-3-methyl-1-tosylpiperidine  (118d),  (2S*,3R*)-
3-((S)-1-Chloroethyl)-2-cyclohexyl-1-tosylpyrrolidine (119d).
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Following the general procedure F, (Z)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 116 
(150 mg, 0.62 mmol) in the presence of cyclohexanecarbaldehyde (105 mg, 0.94 mmol), 
was consumed based on analysis by TLC after 144 hours of stirring at room temperature. 
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The work-up afforded a yellow oil, which was purified by flash column chromatography 
(90% hexane, 10% ethyl acetate) to give the  title compound 118d (60 mg, 0.16 mmol, 
26%) as a white solid.
M.p. 89-91 °C; νmax(KBr)/cm-1 3044, 2923, 1597; δH (300 MHz; CDCl3) 7.70 (2H, d,  J 
8.4, H-C12), 7.27 (2H, d, J  8.4, H-C13), 4.34-4.24 (1H, m, H-C4), 3.76-3.64 (2H, m, H-
C2 and H-C6), 2.98-2.83 (1H, m, H-C6), 2.42 (3H, s, H-C15), 2.39-2.28 (1H, m, H-C3), 
1.85-1.71 (2H, m, H-C5), 1.77-1.53 (5H, m, H-C7 and H-C8), 1.27-0.99 (6H, m, H-C9 
and H-C10), 0.95 (3H, d,  J  6.9, H-C16);  δC (75.5 MHz; CDCl3) 142.9 (C14), 138.3 
(C11), 129.4 (C13), 127.1 (C12), 65.8 (C2), 57.6 (C4), 41.0 (C6), 36.1 (C3), 34.7 (C7), 
31.0 (C8), 30.2 (C8), 29.5 (C5), 26.3 (C10), 26.2 (C9), 26.1 (C9), 21.5 (C15), 13.2 (C16); 
m/z (CI) 370 (MH+, 100), 334 (12), 286 (10); Anal. Calcd. for C19H28ClNO2S requires C, 
61.68; H, 7.63; N, 3.79%. Found: C, 61.44; H, 7.72; N, 3.76%.
Further elution (90% hexane 10% ethyl acetate) provided the other title compound 119d 
(115 mg, 0.31 mmol, 50%) as a white solid.
M.p. 109-112 °C; νmax(KBr)/cm-1 2918, 1670, 1597; δH (300 MHz; CDCl3) 7.74 (2H, d, J 
8.1, H-C12), 7.30 (2H, d, J  8.1, H-C13), 3.69 (1H, dd, J  4.3, 2.5, H-C2), 3.38-3.30 (1H, 
m, H-C5), 3.28-3.19 (1H, m, H-C5), 3.02 (1H, qd, J  8.8, 6.5, H-C6), 2.41 (3H, s, H-C15), 
2.17-2.09 (1H, m, H-C3), 1.98-1.83 (1H, m, H-C4), 1.78-1.58 (5H, m, H-C7 and H-C8), 
1.38 (1H, ddd, J  16.8, 8.1, 4.8, H-C4),  1.16 (3H, d, J  6.5, H-C16), 1.22-0.76 (6H, m, H-
C9 and H-C10);  δC (75.5 MHz; CDCl3) 143.4 (C14), 134.8 (C11), 129.5 (C13), 127.6 
(C12), 68.1 (C2), 59.5 (C6), 49.6 (C3), 48.0 (C5), 43.3 (C7), 29.8 (C8), 28.5 (C8), 27.9 
(C4), 26.4 (C10), 26.3 (C9), 26.2 (C9), 22.7 (C16), 21.5 (C15); m/z (CI) 370 (MH+, 100), 
334 (28), 286 (20); Anal. Calcd. for C19H28ClNO2S requires C, 61.69; H, 7.63; N, 3.79%. 
Found: C,  61.65; H,  7.84;  N,  3.66%;  HRMS (ES)  Found (35Cl)  [M+H]+ 370.1602, 
C19H29ClNO2S requires 370.1599.
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(2S*,3R*,4S*)-Ethyl-4-chloro-3-methyl-1-tosylpiperidine-2-carboxylate (118e).
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Following the general procedure F, (Z)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 116 
(40 mg, 0.17 mmol), in the presence of a pre-heated 33% solution of ethyl 2-oxoacetate in 
toluene (76 mg, 0.25 mmol, 1.50 eq.), was consumed based on analysis by TLC after 1 
hour of stirring at  room temperature. The work-up afforded a  yellow oil,  which was 
purified by flash column chromatography (90% hexane, 10% ethyl acetate) to give the 
title compound  118e (12 mg, 0.03 mmol, 20%) as a pale yellow oil.
νmax(neat)/cm-1 2927, 1736, 1598; δH (300 MHz; CDCl3) 7.66 (2H, d, J  8.3, H-C8), 7.29 
(2H, d, J  8.3, H-C9), 4.54 (1H, d, J  1.2, H-C2), 4.13-4.02 (1H, m, H-C4), 4.04-3.94 (2H, 
m, H-C13), 3.79-3.70 (1H, m, H-C6), 3.31 (1H, td, J  12.4, 3.4, H-C6), 2.69-2.58 (1H, m, 
H-C3), 2.42 (3H, s, H-C11), 2.13-1.97 (1H, m, H-C5), 1.94-1.82 (1H, m, H-C5), 1.25 
(3H, d, J  6.9, H-C15), 1.16 (3H, t, J  7.1, H-C14); δC (75.5 MHz; CDCl3) 169.9 (C12), 
143.4 (C10), 136.3 (C7), 129.4 (C9), 127.2 (C8), 61.6 (C13), 61.0 (C2), 57.2 (C4), 42.3 
(C6), 37.2 (C3), 29.3 (C5), 21.5 (C11), 13.9 (C14), 11.9 (C15); m/z (CI) 360 (MH+, 90), 
286 (45), 206 (100); HRMS (ES) Found (35Cl) [M+H]+ 360.1027, C16H23ClNO4S requires 
360.1031.
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(2R*,3S*,4S*)-4-Chloro-2-heptyl-3-methyl-1-tosylpiperidine (124a).
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Mol. Wt.: 385.99
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Following the general procedure F, (E)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 117 
(150 mg, 0.62 mmol) ), in the presence of octanal (120 mg, 0.94 mmol), was consumed 
based on analysis by TLC after 17 hours of stirring at room temperature. The work-up 
afforded a yellow oil, which was purified by flash column chromatography (90% hexane, 
10% ethyl acetate) to give the title compound 124a (159 mg, 0.41 mmol, 66%) as a white 
solid.
M.p. 56-57 °C; νmax(neat)/cm-1 2925, 1712, 1461; δH (300 MHz; CDCl3)  7.69 (2H, d,  J 
8.4, H-C15), 7.27 (2H, d, J  8.4, H-C16), 3.98 (1H, td, J  9.7, 4.4, H-C2), 3.84-3.82 (1H, 
m, H-C4), 3.81-3.75 (1H, m, H-C6), 2.99 (1H, td,  J  15.1, 2.7, H-C6), 2.40 (3H, s, H-
C18), 2.03-1.93 (1H, m, H-C5), 1.83-1.69 (1H, m, H-C3), 1.67-1.50 (1H, m, H-C5), 1.47-
1.34 (2H, m, H-C7), 1.33-1.10 (10H, m, H-C8 to H-C12), 1.01 (3H, d, J 6.9, H-C19), 0.86 
(3H, t,  J  6.8, H-C13);  δC (75.5 MHz; CDCl3) 143.1 (C17), 138.4 (C14), 129.7 (C16), 
126.8 (C15), 60.6 (C4), 58.8 (C2), 42.1 (C3), 39.9 (C6), 35.9 (C5), 31.7 (C11), 29.2 (C9 
and C10), 26.2 (C8), 24.4 (C7), 22.6 (C12), 21.4 (C18), 16.4 (C19), 14.0 (C13); m/z (CI) 
386 (MH+,  100), 350 (42), 286 (40); HRMS (ES) Found (35Cl) [M+NH4]+ 403.2176, 
C20H36ClN2O2S requires 403.2181.
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(2R*,3S*,4S*)-4-Chloro-3-methyl-2-phenethyl-1-tosylpiperidine (124b).
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Following the general procedure F, (E)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 117 
(150 mg, 0.62 mmol) in the presence of 3-phenylpropanal (126 mg, 0.94 mmol), was 
consumed based on analysis by TLC after 17 hours of stirring at room temperature. The 
work-up afforded a yellow oil, which was purified by flash column chromatography (90% 
hexane, 10% ethyl acetate) to give the title compound 124b (157 mg, 0.40 mmol, 64%) as 
a white solid.
M.p. 105-106 °C; νmax(KBr)/cm-1 3030, 2955, 1596; δH (300 MHz; CDCl3) 7.83 (2H, d, J 
8.1, H-C10), 7.39 (2H, d, J  8.1, H-C11), 7.36-7.18 (5H, m, Ar-H), 4.26-4.15 (1H, m, H-
C2), 3.97 (1H, dd, J  15.0, 4.9, H-C6), 3.85 (1H, td, J  11.6, 4.5, H-C4), 3.25-3.11 (1H, m, 
H-C6),  2.79-2.66 (1H, m, H-C8),  2.65-2.52 (1H, m, H-C8), 2.51 (3H, s, H-C13), 2.13-
2.00 (1H, m, H-C5), 1.95-1.71 (1H, m, H-C3), 1.87-1.63 (2H, m, H-C7), 1.74-1.56 (1H, 
m, H-C5), 1.09 (3H, d, J  6.8, H-C14); δC (75.5 MHz; CDCl3) 143.4 (C12), 141.6 (ArC), 
138.3 (C9), 129.9 (C11), 128.4 (ArC), 128.3 (ArC), 126.9 (C10), 125.9 (ArC), 60.4 (C4), 
58.8 (C2), 41.9 (C3), 40.1 (C6), 35.7 (C5), 32.7 (C8), 26.9 (C7), 21.5 (C13), 16.4 (C14); 
m/z (CI) 392 (MH+, 40), 238 (20), 202 (74); Anal. Calcd. for C21H26ClNO2S requires C, 
64.35; H, 7.08; N, 3.57%. Found: C, 64.15; H, 6.70; N, 3.50%; HRMS (ES) Found (35Cl) 
[M+H]+ 392.1446, C21H27ClNO2S requires 392.1444.
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(2S*,3R*)-3-((S)-1-Chloroethyl)-2-cyclohexyl-1-tosylpyrrolidine (125c).
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Following the general procedure F, (E)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 117 
(150 mg, 0.62 mmol) in the presence of cyclohexanecarbaldehyde (105 mg, 0.94 mmol), 
was consumed based on analysis by TLC after 240 hours of stirring at room temperature. 
The work-up afforded a yellow oil, which was purified by flash column chromatography 
(90% hexane, 10% ethyl acetate) to give the title compound 125c (162 mg, 0.44 mmol, 
70%) as a white solid.
M.p. 116-118 °C; νmax(neat)/cm-1 2927, 1669, 1599; δH (300 MHz; CDCl3) 7.73 (2H, d, J 
8.4, H-C12), 7.31 (2H, d, J  8.4, H-C13), 3.45-3.41 (1H, m, H-C2), 3.38-3.28 (3H, m, H-
C6 and H-C5), 2.43 (3H, s, H-C15), 2.23-2.14 (1H, m, H-C3), 1.91-1.63 (7H, m, H-C4, 
H-C7 and H-C8), 1.32 (3H, d,  J  6.6, H-C16), 1.28-0.81 (6H, m, H-C9 and H-C10); δ
C (75.5 MHz; CDCl3) 143.5 (C14), 134.9 (C11), 129.5 (C13), 127.7 (C12), 67.2 (C2), 59.4 
(C6), 49.1 (C3), 48.1 (C5), 43.3 (C7), 30.1 (C8), 28.0 (C8), 27.3 (C4), 26.5 (C10), 26.3 
(C9), 26.2 (C9), 23.9 (C16), 21.5 (C15); m/z (CI) 370 (MH+, 100), 334 (55), 286 (62); 
HRMS (ES) Found (35Cl) [M+NH4]+ 387.1871, C19H32ClN2O2S requires 387.1868.
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(2S*,3S*,4S*)-Ethyl-4-chloro-3-methyl-1-tosylpiperidine-2-carboxylate (124d).
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Following the general procedure F, (E)-4-methyl-N-(pent-3-enyl)benzenesulfonamide 117 
(150 mg, 0.62 mmol) ), in the presence of a pre-heated 33% solution of ethyl 2-oxoacetate 
in toluene (287 mg, 0.94 mmol, 1.50 eq.), was consumed based on analysis by TLC after 
1 hour of stirring at room temperature. The work-up afforded a yellow oil, which was 
purified by flash column chromatography (90% hexane, 10% ethyl acetate) to give the 
title compound  124d (47 mg, 0.13 mmol, 21%) as a pale yellow oil.
νmax(neat)/cm-1 2980, 1733, 1598; δH (300 MHz; CDCl3) 7.62 (2H, d, J  8.4, H-C8), 7.27 
(2H, d, J  8.4, H-C9), 4.59 (1H, d, J  5.8, H-C2), 4.01 (1H, td, J  11.6, 4.4, H-C4), 3.93-
3.81 (1H, m, H-C6), 3.81-3.66 (2H, m, H-C13), 3.49 (1H, td,  J  12.8, 2.8, H-C6), 2.41 
(3H, s, H-C10), 2.26 (1H, tdd, J  9.5, 5.1, 2.8, H-C5), 2.14-2.01 (1H, m, H-C3), 2.01-1.85 
(1H, m, H-C5), 1.14 (3H, t, J  7.2, H-C14), 1.08 (3H, d, J  6.9, H-C15); δC (75.5 MHz; 
CDCl3) 168.9 (C12), 143.7 (C10), 135.6 (C7), 129.5 (C9), 127.1 (C8), 60.8 (C13), 59.6 
(C2), 59.2 (C4), 42.1 (C6), 41.0 (C3), 36.0 (C5), 21.5 (C11), 15.2 (C15), 13.9 (C14); m/z 
(CI) 360 (MH+, 100), 286 (65), 206 (87); HRMS (ES) Found (35Cl) [M+H]+ 360.1029, 
C16H23ClNO4S requires 360.1031.
(Z)-Hex-3-enyl 4-methylbenzenesulfonate (127).
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C13H18O3S
Mol. Wt.: 254.35
Following the general procedure A, (Z)-hex-3-en-1-ol 126 (5.00 g, 49.90 mmol) was 
consumed based on analysis by TLC after 20 hours of stirring at 0 °C. The work-up gave 
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the title compound 127 (10.67 g, 41.96 mmol, 84%) as a yellow oil which was used in the 
next step without any further purification.
δH (300 MHz; CDCl3) 7.77 (2H, d, J  8.2, H-C8), 7.33 (2H, d, J  8.2, H-C9), 5.52-5.40 
(1H, m, H-C3), 5.23-5.12 (1H, m, H-C4), 3.98 (2H, t, J  7.0, H-C1), 2.43 (3H, s, H-C11), 
2.42-2.33 (2H, m, H-C2), 2.02-1.90 (2H, m, H-C5), 0.91 (3H, t, J  7.5, H-C6); m/z (CI) 
255 (MH+, 15), 213 (30), 173 (100). Data in agreement with literature values.
 (Z)-N-(Hex-3-enyl)-4-methylbenzenesulfonamide (128).
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C13H19NO2S
Mol. Wt.: 253.36
Following the general procedure E, (Z)-hex-3-enyl 4-methylbenzenesulfonate 127 (10.67 
g, 41.96 mmol) was consumed based on analysis by TLC after 17 hours of stirring at 50 °
C.  The  work-up  afforded  a  yellow  oil,  which  was  purified  by  flash  column 
chromatography (80% hexane, 20% ethyl acetate) to give the title compound 128 (6.64g, 
26.21 mmol, 62%) as a colourless oil.
δH (300 MHz; CDCl3) 7.74 (2H, d, J  8.3, H-C8), 7.30 (2H, d, J  8.3, H-C9), 5.53-5.42 
(1H, m, H-C3), 5.18-5.07 (1H, m, H-C4), 4.55 (1H, t, J  5.4, H-NH), 3.00-2.90 (2H, m, 
H-C1), 2.42 (3H, s, H-C11), 2.24-2.15 (2H, m, H-C2), 2.02-1.89 (2H, m, H-C5), 0.92 
(3H, t, J  7.5, H-C6); δC (75.5 MHz; CDCl3) 143.3 (C10), 136.8 (C7), 135.4 (C3), 129.6 
(C9), 127.1 (C8), 123.9 (C4), 42.7 (C1), 27.2 (C2), 21.5 (C5), 20.6 (C11), 14.2 (C6). Data 
in agreement with literature values.
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(2R*,3R*,4S*)-4-Chloro-3-ethyl-2-heptyl-1-tosylpiperidine  (129a),  (2S*,3R*)-3-((S)-
1-Chloropropyl)-2-heptyl-1-tosylpyrrolidine (130a).
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C21H34ClNO2S
Mol. Wt.: 400.02
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Following the general procedure F, (Z)-N-(hex-3-enyl)-4-methylbenzenesulfonamide 128 
(500 mg, 1.97 mmol), in the presence of octanal (379 mg, 2.96 mmol), was consumed 
based on analysis by TLC after 17 hours of stirring at room temperature. The work-up 
afforded a yellow oil, which was purified by flash column chromatography (90% hexane, 
10% ethyl acetate) to give the  title compound 129a (323 mg, 0.81 mmol, 41%) as a 
colourless oil.
νmax(neat)/cm-1 2957, 1729, 1598; δH (300 MHz; CDCl3) 7.66 (2H, d, J  8.4, H-C15), 7.26 
(2H, d, J  8.4, H-C16), 4.37-4.28 (1H, m, H-C4), 4.11-4.03 (1H, m, H-C2), 3.79-3.69 (1H, 
m, H-C6), 3.01-2.87 (1H, m, H-C6), 2.40 (3H, s, H-C18), 1.91-1.74 (2H, m, H-C5), 1.75-
1.63 (1H, m, H-C3), 1.59-1.29 (2H, m, H-C7), 1.32-1.23 (8H, m, H-C8 to H-C11), 1.23-
1.16 (4H, m, H-C19 and H-C12), 0.94 (3H, t, J  7.3, H-C20), 0.87 (3H, t, J  6.8, H-C13); 
δC (75.5 MHz; CDCl3) 143.0 (C17), 138.1 (C14), 129.5 (C16), 126.8 (C15), 58.1 (C4), 
55.8 (C2), 44.7 (C3), 40.6 (C6), 31.7 (C11), 30.9 (C5), 29.1 (C9 and C10), 26.7 (C8), 
22.6 (C12), 22.6 (C7), 21.4 (C18), 17.4 (C19), 14.0 (C13), 12.3 (C20);  m/z (CI) 400 
(MH+,  100),  364  (78),  300  (42); HRMS  (ES)  Found  (35Cl)  [M+H]+ 400.2073, 
C21H35ClNO2S requires 400.2072.
Further elution (90% hexane 10% ethyl acetate) provided the other title compound 130a 
(339 mg, 0.85 mmol, 43%) as a colourless oil.
νmax(neat)/cm-1 2954, 1597, δH (300 MHz; CDCl3) 7.73 (2H, d, J  8.3, H-C15), 7.30 (2H, 
d, J  8.3, H-C16), 3.83-3.77 (1H, m, H-C2), 3.39-3.20 (2H, m, H-C5), 2.78 (1H, td, J  9.1, 
2.8, H-C6), 2.41 (3H, s, H-C18), 2.16-2.05 (1H, m, H-C3), 1.96-1.82 (1H, m, H-C4), 
1.73-1.54 (2H, m, H-C7), 1.60-1.39 (2H, m, H-C19), 1.43-1.29 (1H, m, H-C4), 1.31-1.19 
(10H, m, H-C8 to H-C12), 0.86 (3H, t,  J  6.5, H-C13), 0.83 (3H, t,  J  7.2, H-C20); δ
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C (75.5 MHz; CDCl3) 143.4 (C17), 135.0 (C14), 129.5 (C16), 127.5 (C15), 66.7 (C6), 
63.7 (C2), 50.7 (C3), 47.4 (C5), 36.9 (C7), 31.8 (C11), 29.3 (C9 and C10), 28.5 (C19), 
27.8 (C4), 25.8 (C8), 22.6 (C12), 21.4 (C18), 14.0 (C20), 10.5 (C13); m/z (CI) 400 (MH+, 
100), 364 (40), 300 (25); Anal. Calcd. for C21H34ClNO2S requires C, 63.05; H, 8.57; N, 
3.50%. Found: C, 62.99; H, 8.83; N, 3.50%.
(2R*,3R*,4S*)-4-Chloro-3-ethyl-2-phenethyl-1-tosylpiperidine  (129b),  (2S*,3R*)-3-
((S)-1-Chloropropyl)-2-phenethyl-1-tosylpyrrolidine (130b).
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Following the general procedure F, (Z)-N-(hex-3-enyl)-4-methylbenzenesulfonamide 128 
(500 mg, 1.97 mmol), in the presence of 3-phenylpropanal (398 mg, 2.96 mmol), was 
consumed based on analysis by TLC after 17 hours of stirring at room temperature. The 
work-up afforded a pale yellow oil, which was purified by flash column chromatography 
(90% hexane, 10% ethyl acetate) to give the title compound 129b (328 mg, 0.81 mmol, 
41%) as a white solid.
M.p. 95-97 °C; νmax(neat)/cm-1 3032, 1941, 1598;  δH (300 MHz; CDCl3)  7.58 (2H, d,  J 
8.3, H-C10), 7.29-7.11 (5H, m, Ar-H), 7.04 (2H, d, J  8.3, H-C11), 4.35-4.25 (1H, m, H-
C4), 4.11-4.04 (1H, m, H-C2), 3.81-3.70 (1H, m, H-C6), 2.99-2.85 (1H, m, H-C6), 2.64-
2.39 (2H, m, H-C8), 2.37 (3H, s, H-C13), 1.88-1.73 (2H, m, H-C5), 1.73-1.62 (1H, m, H-
C3), 1.73-1.50 (2H, m, H-C7), 1.30-1.11 (1H, m, H-C14), 0.84 (3H, t, J  7.3, H-C15); δ
C (75.5 MHz; CDCl3)  143.2 (C12), 140.6 (ArC), 137.9 (C9), 129.6 (C11), 128.4 (ArC), 
128.3 (ArC), 126.8 (C10), 126.1 (ArC), 57.9 (C4), 55.2 (C2), 44.8 (C3), 40.7 (C6), 33.0 
(C8), 31.2 (C5 or C7), 30.9 (C7 or C5), 21.4 (C13), 17.4 (C14), 12.2 (C15); m/z (CI) 406 
(MH+,  20),  216  (90),  111  (100); HRMS  (ES)  Found  (35Cl)  [M+H]+ 406.1606, 
C22H29ClNO2S requires 406.1602.
217
Experimental
Further elution (90% hexane 10% ethyl acetate) provided the other title compound 130b 
(392 mg, 0.97 mmol, 49%) as a white solid.
M.p. 69-71 °C; νmax(neat)/cm-1 3088, 2936, 1598;  δH (300 MHz; CDCl3) 7.75 (2H, d,  J 
8.3, H-C10), 7.35-7.16 (5H, m, Ar-H), 7.23 (2H, d, J  8.3, H-C11), 3.89 (1H, td, J  6.2, 
3.1, H-C2), 3.45-3.30 (2H, m, H-C5), 2.84 (1H, td, J  9.1, 2.9, H-C6), 2.80-2.71 (2H, m, 
H-C8), 2.43 (3H, s, H-C13), 2.24-2.14 (1H, m, H-C3), 2.09-1.84 (2H, m, H-C7), 1.97-
1.85 (1H, m, H-C4), 1.59-1.44 (1H, m, H-C14), 1.44-1.29 (2H, m, H-C14 and H-C4), 
0.85 (3H, t, J  7.2, H-C15); δC (75.5 MHz; CDCl3) 143.6 (C12), 141.7 (ArC), 135.0 (C9), 
129.6 (C11), 128.4 (ArC), 128.3 (ArC), 127.6 (C10), 125.8 (ArC), 66.7 (C6), 63.6 (C2), 
51.2 (C3), 47.7 (C5), 38.6 (C7), 32.2 (C8), 28.6 (C14), 28.0 (C4), 21.5 (C13), 10.6 (C15); 
m/z (CI)  406  (MH+,  92),  252  (52),  216  (100);
HRMS (ES) Found (35Cl) [M+H]+ 406.1602, C22H29ClNO2S requires 406.1606.
(2R*,3R*,4S*)-4-chloro-2-cyclohexyl-3-ethyl-1-tosylpiperidine  (129c),  (2S*,3R*)-3-
((S)-1-chloropropyl)-2-cyclohexyl-1-tosylpyrrolidine  (130c),  (2S*,3S*,E)-2-
cyclohexyl-3-(prop-1-enyl)-1-tosylpyrrolidine (131c).
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Following the general procedure F, (Z)-N-(hex-3-enyl)-4-methylbenzenesulfonamide 128 
(500 mg, 1.97 mmol), in the presence of cyclohexanecarbaldehyde (332 mg, 2.96 mmol), 
was consumed based on analysis by TLC after 72 hours of stirring at room temperature. 
The work-up afforded a yellow oil, which was purified by flash column chromatography 
(90% hexane, 10% ethyl acetate) to give the  title compounds 129c and  131c (182 mg, 
0.47 mmol, 24%) as a white solid.
Data for 129c: M.p. 151-153°C (mixture); νmax(neat)/cm-1 3035, 2928, 1815 (mixture); δH 
(300 MHz; CDCl3) 7.68 (2H, d, J 8.3, H-C12), 7.27 (2H, d, J  8.3, H-C13), 4.37-4.28 (1H, 
m, H-C4), 3.84 (1H, d, J 10.5, H-C2), 3.76-3.65 (1H, m, H-C6), 2.99-2.85 (1H, m, H-C6), 
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2.42 (3H, s, H-C15), 1.94-1.84 (1H, m, H-C3), 1.85-1.51 (5H, m, H-C7 and H-C8), 1.75-
1.54 (2H, m, H-C5), 1.29-0.88 (6H, m, H-C9 and H-C10), 1.09-0.82 (2H, m, H-C16), 
0.97-0.92 (3H, m, H-C17); δC (75.5 MHz; CDCl3) 142.9 (C14), 138.4 (C11), 129.4 (C13), 
126.9 (C12), 61.4 (C2), 58.5 (C4), 43.8 (C3), 41.1 (C6), 35.9 (C7), 31.0 (C8), 30.4 (C8), 
28.3 (C5), 26.5 (C10), 26.4 (C9), 26.2 (C9), 21.5 (C15), 17.2 (C16), 12.2 (C17); m/z (CI) 
384 (MH+, 100), 348 (78), 300 (22); Anal. Calcd. for C20H30ClNO2S requires C, 62.56; H, 
7.88; N, 3.65%. Found: C, 62.66; H, 8.01; N, 3.69%.
Data for 131c: δH (300 MHz; CDCl3) 7.73 (2H, d, J  8.2, H-C12), 7.31 (2H, d, J  8.2, H-
C13), 5.25-5.11 (1H, m, H-C16), 4.66-4.55 (1H, m, H-C6), 3.40-3.30 (1H, m, H-C5), 
3.31-3.25 (1H, m, H-C5), 3.27-3.21 (1H, m, H-C2), 2.62-2.51 (1H, m, H-C3), 2.43 (3H, s, 
H-C15), 1.84-1.68 (5H, m, H-C7 and H-C8), 1.69-1.56 (2H, m, H-C4), 1.41 (3H, dd, J 
6.4, 1.3, H-C17), 1.29-1.03 (6H, m, H-C9 and H-C10);  δC (75.5 MHz; CDCl3) 143.2 
(C14), 135.1 (C6), 133.0 (C11), 129.5 (C13), 127.7 (C12), 124.7 (C16), 70.7 (C2), 48.5 
(C5), 43.4 (C3), 42.0 (C7), 31.7 (C8), 30.2 (C8), 26.6 (C4), 26.4 (C10), 26.3 (C10), 26.1 
(C9), 21.5 (C15), 17.7 (C17); m/z (CI) 348 (MH+, 100), 264 (10), 194 (35).
Further elution (90% hexane 10% ethyl acetate) provided the other title compound 130c 
(470 mg, 1.22 mmol, 62%) as a white solid.
M.p. 102-103 °C; νmax(neat)/cm-1 3034, 2927, 1597; δH (300 MHz; CDCl3) 7.75 (2H, d, J 
8.3, H-C12), 7.31 (2H, d, J  8.3, H-C13), 3.70 (1H, dd, J  4.8, 2.3, H-C2), 3.40-3.20 (2H, 
m, H-C5), 2.67 (1H, td, J  9.2, 2.6, H-C6), 2.42 (3H, s, H-C15), 2.29-2.19 (1H, m, H-C3), 
1.96-1.82 (1H, m, H-C4), 1.83-1.71 (4H, m, H-C8), 1.71-1.60 (1H, m, H-C7), 1.54-1.37 
(2H, m, H-C4 and H-C16), 1.37-1.24 (1H, m, H-C16), 1.28-0.96 (6H, m, H-C9 and H-
C10), 0.81 (3H, t, J 7.2, H-C17); δC (75.5 MHz; CDCl3) 143.4 (C14), 135.0 (C11), 129.5 
(C13), 127.6 (C12), 68.4 (C2), 67.1 (C6), 48.1 (C3), 48.0 (C5), 43.4 (C7), 29.7 (C8), 28.9 
(C8), 28.2 (C16), 27.9 (C4), 26.4 (C10), 26.3 (C9), 26.3 (C9), 21.4 (C15), 10.7 (C17); 
m/z (CI) 384 (MH+,  100), 348 (45),  300  (25); HRMS (ES) Found (35Cl)  [M+NH4]+ 
401.2021, C20H34ClN2O2S requires 401.2024.
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4-Methylpent-3-enyl 4-methylbenzenesulfonate (138).
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Mol. Wt.: 254.35
Following the general procedure A, 4-methylpent-3-en-1-ol 137 (250 mg, 2.50 mmol) 
was consumed based on analysis by TLC after 20 hours of stirring at 0 °C. The work-up 
gave the title compound 138 (630 mg, 2.48 mmol, 99%) as a yellow oil which was used in 
the next step without any further purification.
δH (300 MHz; CDCl3) 7.78 (2H, d, J  8.3, H-C8), 7.34 (2H, d, J  8.3, H-C9), 4.99-4.91 
(1H, m, H-C3), 3.97 (2H, t, J  7.1, H-C1), 2.45 (3H, s, H-C11), 2.37-2.28 (2H, m, H-C2), 
1.65 (3H, s, H-C6), 1.55 (3H, s, H-C5);  m/z (CI) 255 (MH+, 30), 173 (100), 155 (20). 
Data in agreement with literature values.
4-Methyl-N-(4-methylpent-3-enyl)benzenesulfonamide (139).
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C13H19NO2S
Mol. Wt.: 253.36
Following the general procedure E, 4-methylpent-3-enyl 4-methylbenzenesulfonate 138 
(630 mg, 2.48 mmol) was consumed based on analysis by TLC after 20 hours of stirring 
at  50  °C.  The work-up  afforded a  yellow oil,  which was purified by  flash column 
chromatography (80% hexane, 20% ethyl acetate) to give the  title compound 139  (317 
mg, 1.25 mmol, 50%) as a colourless oil.
νmax(neat)/cm-1 3521, 3281, 2926, 1598; δH (300 MHz; CDCl3) 7.74 (2H, d, J  8.3, H-C8), 
7.30 (2H, d, J  8.3, H-C9), 4.95-4.87 (1H, m, H-C3), 4.48 (1H, t, J  5.8, H-NH), 2.93 (2H, 
dd, J  13.1, 6.6, H-C1), 2.42 (3H, s, H-C11), 2.19-2.09 (2H, m, H-C2), 1.66 (3H, s, H-
C6), 1.55 (3H, s, H-C5); δC (75.5 MHz; CDCl3) 143.3 (C10), 136.8 (C7), 135.6 (C3), 
129.6 (C9), 127.1 (C8), 119.6 (C4), 42.9 (C1), 28.1 (C2), 25.7 (C6), 21.5 (C10), 17.8 
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(C5); m/z (CI) 254 (MH+, 100), 184 (38), 155 (12); HRMS (ES) Found [M+H]+ 254.1207, 
C13H20NO2S requires 254.1209.
4-Methyl-N-(3-methylbut-3-enyl)benzenesulfonamide (140).
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Mol. Wt.: 239.33
Following  the  general procedure E,  3-methylbut-3-enyl  4-methylbenzenesulfonate  97 
(12.63 g, 52.55 mmol) was consumed based on analysis by TLC after 20 hours of stirring 
at  50  °C.  The work up afforded a  yellow oil,  which was purified by flash column 
chromatography (80% hexane, 20% ethyl acetate) to give the title compound 140 (8.59 g, 
35.89 mmol, 68%) as a white solid.
M.p. 38-39 °C; δH (300 MHz; CDCl3) 7.70 (2H, d, J  8.4, H-C7), 7.25 (2H, d, J  8.4, H-
C8), 4.89-4.78 (1H, m, N-NH), 4.73-4.69 (1H, m, H-C4), 4.59-4.56 (1H, m, H-C4), 2.98 
(2H, dd, J  12.9, 6.8, H-C1), 2.36 (3H, s, H-C10), 2.09 (2H, t, J  6.8, H-C2), 1.53 (3H, s, 
H-C5); m/z (CI) 240 (MH+, 62), 184 (100), 157 (18). Data in agreement with literature 
values.
(2S*,3S*)-2-Phenethyl-3-(prop-1-en-2-yl)-1-tosylpyrrolidine  (142a),  and  (±)-2-
Phenethyl-3-(propan-2-ylidene)-1-tosylpyrrolidine (141a).
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Mol. Wt.: 369.52
Following  the  general  procedure  F,  4-methyl-N-(4-methylpent-3-
enyl)benzenesulfonamide 139 (100 mg, 0.39 mmol), in the presence of 3-phenylpropanal 
(80 mg, 0.59 mmol), was consumed based on analysis by TLC after 6 hours of stirring at 
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room temperature. The work-up afforded a  yellow oil,  which was purified by  flash 
column chromatography (90% hexane, 10% ethyl acetate) to give the  title compounds 
141a and 142a (108 mg, 0.29 mmol, 75%) as a colourless oil.
Data for 141a:  νmax(neat)/cm-1 3026, 2925, 1644, 1599 (mixture);  δH (300 MHz; CDCl3) 
7.69-7.61 (2H, m, H-C10), 7.30-7.24 (2H, m, H-C11), 7.27-7.13 (5H, m, Ar-H), 4.46-4.40 
(1H, m, H-C2), 3.47-3.32 (2H, m, H-C5), 2.71-2.58 (2H, m, H-C8), 2.40 (3H, s, H-C13), 
2.28-2.10 (1H, m, H-C4), 2.09-1.94 (1H, m, H-C4), 1.95-1.81 (2H, m, H-C7), 1.39 (3H, s, 
H-C15), 1.37 (3H, s, H-C14); δC (75.5 MHz; CDCl3)  143.2 (C12), 142.1 (ArC), 135.2 
(C9),  132.2 (C3), 129.3 (C11), 128.4 (ArC), 128.2 (ArC), 127.4 (C10), 125.6 (ArC), 
123.8 (C6), 62.0 (C2), 48.7 (C5), 37.2 (C4), 36.4 (C7), 31.7 (C8), 21.4 (C13), 21.0 (C15), 
19.9 (C15); m/z (CI) 370 (MH+, 100), 264 (18), 216 (35); HRMS (ES) Found [M+H]+ 
(mixture) 370.1837, C22H28NO2S requires 370.1835.
Data for 142a:  δH (300 MHz; CDCl3)  7.69-7.61 (2H, m, H-C10), 7.30-7.24 (2H, m, H-
C11), 7.30-7.24 (5H, m, Ar-H), 4.59-4.56 (1H, m, H-C14), 4.41-4.39 (1H, m, H-C14), 
3.51-3.41 (1H, m, H-C2), 3.54-3.38 (2H, m, H-C5), 2.83-2.65 (2H, m, H-C8), 2.66-2.50 
(1H, m, H-C3), 2.40 (3H, s, H-C13), 2.28-2.10 (1H, m, H-C4), 2.09-1.94 (1H, m, H-C4), 
1.87-1.70 (2H, m, H-C7), 1.51 (3H, s, H-C15); δC (75.5 MHz; CDCl3) 143.9 (C6), 143.3 
(C12), 141.7 (ArC), 134.9 (C9), 129.5 (C11), 128.5 (ArC), 128.2 (ArC), 127.5 (C10), 
125.7 (ArC), 111.9 (C14), 62.3 (C2), 51.7 (C3), 46.8 (C5), 31.4 (C8), 29.7 (C7), 28.2 
(C4), 21.4 (C13), 20.9 (C15); m/z (CI) 370 (MH+, 100), 264 (15), 216 (40).
(2S*,3S*)-2-Heptyl-3-(prop-1-en-2-yl)-1-tosylpyrrolidine (142b), and (±)-2-Heptyl-3-
(propan-2-ylidene)-1-tosylpyrrolidine (141b).
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Mol. Wt.: 363.56
Following  the  general  procedure  F,  4-methyl-N-(4-methylpent-3-
enyl)benzenesulfonamide 139 (100 mg, 0.39 mmol), in the presence of octanal (76 mg, 
222
Experimental
0.59 mmol), was consumed based on analysis by TLC after 6 hours of stirring at room 
temperature. The work-up afforded a yellow oil, which was purified by flash column 
chromatography (90% hexane, 10% ethyl acetate) to give the title compounds 141b and 
142b (85 mg, 0.23 mmol, 60%) as a colourless oil.
Data for 141b: νmax(neat)/cm-1 2926, 1735, 1645, 1598 (mixture); δH (300 MHz; CDCl3) 
7.72 (2H, d, J  8.3, H-C15), 7.29 (2H, d, J  8.3, H-C16), 4.39-4.33 (1H, m, H-C2), 3.52-
3.37 (2H, m, H-C5), 2.42 (3H, s, H-C18),  1.86-1.70 (2H, m, H-C4), 1.70-1.57 (2H, m, H-
C7), 1.43 (3H, s, H-C20), 1.39 (3H, s, H-C19), 1.37-1.17 (10H, m, H-C8 to H-C12), 0.91-
0.84 (3H, m, H-C13); δC (75.5 MHz; CDCl3) 143.0 (C17), 135.5 (C14), 132.5 (C3), 129.2 
(C16), 127.4 (C15), 123.3 (C6), 62.3 (C2), 46.6 (C5), 34.7 (C4), 31.8 (C11), 29.6 (C7), 
29.4 (C9 and C10), 25.4 (C8),  22.6 (C12), 21.5 (C18), 21.0 (C20), 20.2 (C19), 14.1 
(C13);  m/z (CI) 364 (MH+,  100), 264 (40), 210 (38);  HRMS (ES) Found [M+NH4]+ 
(mixture) 381.2569, C21H37N2O2S requires 381.2570.
Data for 142b: δH (300 MHz; CDCl3) 7.65 (2H, d, J  8.4, H-C15), 7.24 (2H, d, J  8.4, H-
C16), 4.56-4.52 (1H, m, H-C19), 4.43-4.37 (1H, m, H-C19), 3.52-3.39 (1H, m, H-C2), 
3.40-3.25 (2H, m, H-C5), 2.49 (1H, dd, J  13.2, 6.8, H-C3), 2.40 (3H, s, H-C18), 2.27-
2.12 (1H, m, H-C4), 2.08-1.94 (1H, m, H-C4), 1.55 (3H, s, H-C20), 1.54-1.43 (2H, m, H-
C7),  1.37-1.17 (10H, m, H-C8 to H-C12), 0.91-0.84 (3H, m, H-C13);  δC (75.5 MHz; 
CDCl3) 144.2 (C6), 143.2 (C17), 135.4 (C14), 129.5 (C16), 127.5 (C15), 111.4 (C19), 
63.2 (C2), 51.2 (C3), 48.5 (C5), 35.8 (C4), 31.8 (C11), 29.7 (C7), 29.3 (C9), 28.2 (C10), 
25.1 (C8), 22.6 (C12), 21.5 (C18), 21.0 (C20), 14.1 (C13); m/z (CI) 364 (MH+, 100), 264 
(30), 210 (44).
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(±)-4-Methyl-2-phenethyl-1-tosyl-1,2,3,6-tetrahydropyridine  (146a)  and  (±)-4-
Methyl-2-phenethyl-1-tosyl-1,2,5,6-tetrahydropyridine (147a).
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Mol. Wt.: 355.49
Following the general procedure F, 4-methyl-N-(3-methylbut-3-enyl)benzenesulfonamide 
140 (250 mg, 1.04 mmol), in the presence of 3-phenylpropanal (210 mg, 1.56 mmol), was 
consumed based on analysis by TLC after 2 hours of stirring at room temperature. The 
work-up afforded a yellow oil, which was purified by flash column chromatography (90% 
hexane, 10% ethyl acetate) to give the  title compounds 146a  and  147a (331 mg, 0.93 
mmol, 90%) as a pale yellow oil.
Data for 146a:  νmax(neat)/cm-1 3026, 2929, 1736, 1598 (mixture);  δH (300 MHz; CDCl3) 
7.82-7.79 (2H, m, H-C10), 7.44-7.39 (2H, m, H-C11), 7.39-7.23 (5H, m, Ar-H), 5.48-5.42 
(1H, m, H-C3), 4.50-4.37 (1H, m, H-C2), 3.98 (1H, dd, J 14.6, 6.1, H-C6), 3.28 (1H, ddd, 
J 14.6, 11.8, 4.8, H-C6), 3.07 (1H, t, J  7.5, H-C8), 2.95-2.86 (1H, m, H-C8), 2.51 (3H, s, 
H-C13), 2.00-1.89 (2H, m, H-C7),  1.87-1.72 (2H, m, H-C5), 1.64 (3H, s, H-C14);  δ
C (75.5 MHz; CDCl3)  142.9 (C12), 141.9 (ArC), 138.4 (C9), 132.7 (C4), 129.4 (C11), 
128.3 (ArC), 128.3 (ArC), 127.0 (C10), 125.7 (ArC), 121.5 (C3), 53.6 (C2), 40.4 (C6), 
36.8 (C5), 32.8 (C8), 28.1 (C7), 23.2 (C14), 21.5 (C13); m/z (CI) (mixture) 356 (MH+, 
100), 250 (25), 202 (37); HRMS (ES) Found [M+H]+ (mixture) 356.1682, C21H26NO2S 
requires 356.1679.
Data for 147a:  δH (300 MHz; CDCl3)  7.79-7.75 (2H, m, H-C10), 7.38-7.34 (2H, m, H-
C11), 7.39-7.23 (5H, m, Ar-H), 5.40-5.35 (1H, m, H-C5), 4.31-4.23 (1H, m, H-C2), 4.26-
4.18 (1H, m, H-C6), 3.77-3.62 (1H, m, H-C6), 2.88-2.70 (2H, m, H-C8), 2.51 (3H, s, H-
C13), 2.24-2.12 (1H, m, H-C3), 1.87-1.71 (2H, m, H-C7), 1.77-1.65 (1H, m, H-C3), 1.60 
(3H, s, H-C14); δC (75.5 MHz; CDCl3) 142.9 (C12), 141.7 (ArC), 137.9 (C9), 131.0 (C4), 
129.5 (C11), 128.4 (ArC), 128.3 (ArC), 126.9 (C10), 125.9 (ArC), 116.0 (C5), 50.7 (C2), 
45.3 (C6), 38.5 (C3), 32.7 (C8), 27.5 (C7), 23.4 (C14), 21.5 (C13). 
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(±)-2-Heptyl-4-methyl-1-tosyl-1,2,3,6-tetrahydropyridine (146b) and (±)-2-Heptyl-4-
methyl-1-tosyl-1,2,5,6-tetrahydropyridine (147b).
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Mol. Wt.: 349.53
and
Following the general procedure F, 4-methyl-N-(3-methylbut-3-enyl)benzenesulfonamide 
140 (250 mg, 1.04 mmol), in the presence of octanal (200 mg, 1.56 mmol), was consumed 
based on analysis by TLC after 2 hours of stirring at room temperature. The work-up 
afforded a yellow oil, which was purified by flash column chromatography (90% hexane, 
10% ethyl acetate) to give the title compounds 146b and 147b (265 mg, 0.76 mmol, 73%) 
as a pale yellow oil.
Data for  146b:  νmax(neat)/cm-1 2927, 1598 (mixture);  δH (300 MHz; CDCl3)  7.73-7.68 
(2H, m, H-C15), 7.27-7.23 (2H, m, H-C16), 5.36-5.30 (1H, m, H-C3), 4.31-4.16 (1H, m, 
H-C2), 3.82 (1H, dd, J  14.6, 6.2, H-C6), 3.11 (1H, ddd, J  14.6, 11.9, 4.7, H-C6), 2.40 
(3H, s, H-C18), 1.77-1.58 (1H, m, H-C5), 1.58-1.44 (1H, m, H-C5), 1.55 (3H, s, H-C19), 
1.46-1.34 (2H, m, H-C7), 1.38-1.11 (10H, m, H-C8 to H-C12), 0.91-0.84 (3H, m, H-
C13);  δC (75.5 MHz; CDCl3) 142.8 (C17), 138.6 (C14), 132.1 (C4), 129.3 (C16), 127.0 
(C15), 121.9 (C3), 53.8 (C2), 38.4 (C6), 32.7 (C5), 31.8 (C11), 31.6 (C7), 29.5 (C9), 29.2 
(C10), 26.2 (C8), 23.2 (C19), 22.6 (C12), 21.5 (C18), 14.1 (C13); m/z (CI) (mixture) 350 
(MH+,  100),  250  (12),  196  (40); HRMS (ES)  Found  [M+H]+ (mixture)  350.2148, 
C20H32NO2S requires 350.2149.
Data for 147b:  δH (300 MHz; CDCl3)  7.68-7.64 (2H, m, H-C15), 7.23-7.19 (2H, m, H-
C16), 5.29-5.22 (1H, m, H-C5), 4.14-4.03 (1H, m, H-C6), 4.09-4.01 (1H, m, H-C2), 3.58-
3.46 (1H, m, H-C6), 2.40 (3H, s, H-C18), 2.16-1.98 (1H, m, H-C3), 1.58-1.47 (1H, m, H-
C3), 1.49 (3H, s, H-C19), 1.55-1.41 (2H, m, H-C7), 1.38-1.11 (10H, m, H-C8 to H-C12), 
0.91-0.84 (3H, m, H-C13); δC (75.5 MHz; CDCl3) 142.8 (C17), 138.0 (C14), 131.1 (C4), 
129.4 (C16), 126.9 (C15), 116.0 (C5), 50.9 (C2), 40.3 (C6), 35.2 (C3), 31.8 (C11), 31.2 
(C7), 29.3 (C9), 29.2 (C10), 26.4 (C8), 23.5 (C19), 22.7 (C12), 21.5 (C18), 14.1 (C13).
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(±)-tert-Butyl pent-4-en-2-yl(tosyl)carbamate (151).
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Mol. Wt.: 339.45
A round-bottomed flask was charged with  (±)-pent-4-en-2-ol  150 (1.00 g, 11.61 mmol, 
1.00 eq.)  and  tetrahydrofuran (160  mL). The resulting  solution  was stirred at  room 
temperature and triphenylphosphine (9.07 g, 34.83 mmol, 3.00 eq.) added portionwise 
followed by  tert-butyl tosylcarbamate (4.72 g, 17.38 mmol, 1.50 eq.) portionwise and 
diisopropyl azodicarboxylate (5.67 mL, 28.62 mmol, 2.47 eq.) dropwise. The resulting 
solution was stirred overnight, filtered through a pad of celite and concentrated in vacuo. 
This afforded a pale yellow oil which was purified by flash column chromatography (90% 
hexane 10% ethyl acetate) to afford the title compound 151 (2.72 g, 8.01 mmol, 69%) as a 
sticky colourless oil.
δH (300 MHz; CDCl3) 7.78 (2H, d, J 8.4, H-C7), 7.28 (2H, d, J  8.4, H-C8), 5.74 (1H, tdd, 
J  17.2, 10.0, 7.2, H-C4), 5.13-5.00 (2H, m, H-C5), 4.69-4.56 (1H, m, H-C2), 2.78-2.66 
(1H, m, H-C3), 2.52-2.42 (1H, m, H-C3), 2.43 (3H, s, H-C10), 1.46 (3H, d, J  6.8, H-C1), 
1.35 (9H, s, H-C13); δC (75.5 MHz; CDCl3) 150.6 (C11), 143.7 (C9), 137.9 (C4), 135.2 
(C6), 129.1 (C8), 127.8 (C7), 117.6 (C5), 83.9 (C12), 54.9 (C2), 39.4 (C3), 27.9 (C13), 
21.6 (C10), 19.4 (C1). Data in agreement with literature values.
(±)-4-Methyl-N-(pent-4-en-2-yl)benzenesulfonamide (152).
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Mol. Wt.: 239.33
A round-bottomed flask was charged with  (±)-tert-butyl pent-4-en-2-yl(tosyl)carbamate 
151 (2.13 g, 6.27 mmol, 1.00 eq.) and dichloromethane (43 mL). The resulting solution 
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was stirred at room temperature and trifluoroacetic acid (3.61 g, 31.66 mmol, 5.00 eq.) 
added dropwise. The mixture was stirred at room temperature overnight and water (50 
mL) was added. The organic layer was separated and the aqueous layer was extracted 
with  dichloromethane (3  x  30  mL).  The  combined organic  layers  were  dried  over 
magnesium sulfate, filtered, and concentrated in vacuo.  This afforded a pale yellow oil 
which was purified by flash column chromatography (80% hexane 20% ethyl acetate) to 
afford the title compound 152 (1.50 g, 6.27 mmol, quantitative) as a colourless oil.
δH (300 MHz; CDCl3) 7.75 (2H, d, J 8.3, H-C7), 7.29 (2H, d, J  8.3, H-C8), 5.56 (1H, tdd, 
J  17.4, 10.3, 7.2, H-C4), 5.06-4.95 (2H, m, H-C5), 4.53 (1H, d, J  7.1, H-NH), 3.43-3.29 
(1H, m, H-C2), 2.42 (3H, s, H-C10), 2.14-2.08 (2H, m, H-C3), 1.06 (3H, d, J  6.6, H-C1); 
m/z (CI) 240 (MH+, 45), 198 (100), 155 (10). Data in agreement with literature values.
(±)-Hex-4-yn-2-ol (154).
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Mol. Wt.: 98.14
A round-bottomed flask was wrapped in aluminium foil and equipped with a dropping 
funnel and a thermometer. The flask was charged with  (±)-pent-4-yn-2-ol 153  (5.00 g, 
59.43 mmol, 1.00 eq.) and tetrahydrofuran (96 mL). The resulting solution was cooled to 
–78 °C and a 2.5 M solution of n-butyllithium in hexane (47 mL, 118.86 mmol, 2.00 eq.) 
was added dropwise over 30 minutes. The mixture was stirred at -78 °C for a further 90 
minutes and iodomethane (18.6 mL, 297.15 mmol, 5.00 eq.) was added dropwise. The 
mixture was allowed to warm to room temperature for 1 hour and 1.0 M hydrochloric 
acid (100 mL) was added dropwise over 30 minutes. The mixture was stirred for a further 
30  minutes  at  room temperature,  the  organic layer  separated and the  aqueous layer 
extracted with diethyl ether (3 x 100 mL). The combined organic layers were dried over 
magnesium sulfate, filtered and concentrated in vacuo. This afforded a yellow oil, which 
was purified by distillation under reduced pressure (125 °C, 226 mmHg) to give the title 
compound 154 (3.10 g, 31.59 mmol, 53%) as a colourless oil.
δH (300 MHz; CDCl3) 3.88-3.77 (1H, m, H-C2), 2.37 (1H, bs, H-OH), 2.28-2.18 (2H, m, 
H-C3), 1.75 (3H, t, J 2.2, H-C6), 1.17 (3H, d, J  6.2, H-C1); δC (75.5 MHz; CDCl3) 78.2 
(C4),  75.3 (C3),  66.4 (C2), 29.2 (C3), 22.1 (C1),  3.4 (C6).  Data in  agreement with 
literature values.
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(±)-(E)-Hex-4-en-2-ol (155).
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Mol. Wt.: 100.16
Following the general procedure D, (±)-hex-4-yn-2-ol 154 (966 mg, 9.84 mmol) gave a 
pale yellow oil, which was purified by distillation under reduced pressure (120 °C, 213 
mmHg) to give the title compound 155 (590 mg, 5.89 mmol, 60%) as a colourless oil.
δH (300 MHz; CDCl3) 5.62-5.48 (1H, m, H-C4), 5.47-5.35 (1H, m, H-C5), 3.82-3.70 (1H, 
m, H-C2), 2.24-2.12 (1H, m, H-C3), 2.12-1.99 (1H, m, H-C3), 1.74 (1H, bs, H-OH), 1.70-
1.65 (3H, m, H-C6), 1.17 (3H, d, J  6.2, H-C1). Data in agreement with literature values.
(±)-(E)-Hex-4-en-2-yl 4-methylbenzenesulfonate (156).
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Mol. Wt.: 254.35
Following the general procedure A, (±)-(E)-hex-4-en-2-ol 155 (590 mg, 5.90 mmol) was 
consumed based on analysis by TLC after 40 hours of stirring at 0  °C. The work-up 
afforded a yellow oil, which was purified by flash column chromatography (90% hexane, 
10% ethyl acetate) to  give the  title  compound 156  (374 mg,  1.47 mmol, 25%) as a 
colourless oil.
δH (300 MHz; CDCl3) 7.78 (2H, d, J  8.2, H-C8), 7.33 (2H, d, J  8.2, H-C9), 5.49-5.35 
(1H, m, H-C4), 5.20-5.07 (1H, m, H-C5), 4.61-4.50 (1H, m, H-C2), 2.44 (3H, s, H-C11), 
2.32-2.12 (2H, m, H-C3), 1.58-1.53 (3H, m, H-C6), 1.25 (3H, d, J  6.3, H-C1);
δC (75.5 MHz; CDCl3)  144.3 (C10), 134.4 (C7), 129.6 (C9),  128.3 (C4), 127.7 (C8), 
124.7 (C5), 80.1 (C2), 39.6 (C3), 21.6 (C11), 20.4 (C1), 17.9 (C6).  Data in agreement 
with literature values.
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(±)-(E)-N-(Hex-4-en-2-yl)-4-methylbenzenesulfonamide (157).
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Mol. Wt.: 253.36
Following the general procedure E, (±)-(E)-hex-4-en-2-yl 4-methylbenzenesulfonate 156 
(350 mg, 1.38 mmol) was consumed based on analysis by TLC after 20 hours of stirring 
at  50  °C.  The work-up  afforded a  yellow oil,  which was purified by  flash column 
chromatography (80% hexane, 20% ethyl acetate) to give the  title compound 157  (107 
mg, 0.42 mmol, 31%) as a colourless oil.
δH (300 MHz; CDCl3) 7.66 (2H, d, J  8.3, H-C8), 7.22 (2H, d, J  8.3, H-C9), 5.36-5.23 
(1H, m, H-C4), 5.08-4.95 (1H, m, H-C5), 4.66 (1H, d, J  7.2, H-NH), 3.24-3.11 (1H, m, 
H-C2), 2.33 (3H, s, H-C11), 1.96-1.89 (2H, m, H-C3), 1.50-1.46 (3H, m, H-C6), 0.97 
(3H, d, J  6.6, H-C1); m/z (CI) 254 (MH+, 100), 198 (70), 172 (22). Data in agreement 
with literature values.
General procedure G: epoxide opening with diethylaluminium chloride on 23.20 
mmol scale.
A 2.5 M solution of n-butyllithium in hexane (21.26 mL, 53.15 mmol, 2.2 eq.,) was added 
dropwise to a solution of trimethylsilylacetylene (6.65 mL, 46.40 mmol, 2.00 eq.) in 
hexane (46 ml) at –30 °C and stirred at this temperature for 30 min.  After this time, a 1.0 
M solution of diethylaluminium chloride in hexane (51.04 mL, 51.04 mmol, 1.00 eq.) was 
added and the solution was stirred for a further 1 hour, while being allowed to warm to 0 °
C.  The reaction mixture was then cooled again to –30 °C before adding a solution of the 
epoxide  (1.00 eq.)  in  hexane (10  mL).   The  reaction  was  slowly  warmed to  room 
temperature and stirred for 3 hours.  The reaction was cooled to 0 °C before adding a 2.0 
M solution of dilute sulfuric acid (15 ml) and stirring at room temperature for 30 minutes. 
The reaction mixture was then further diluted with water (100 ml) and diethyl ether (100 
ml), filtered through celite, the layers separated and aqueous layer further extracted with 
ether (2×100 mL).  The combined organic layers were washed with brine (100 ml), water 
(100 ml), dried over magnesium sulfate and concentrated in vacuo.
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(±)-1,1,1-Trifluoro-5-(trimethylsilyl)pent-4-yn-2-ol (249).
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Mol. Wt.: 210.27
Following the general procedure G, (±)-2-(trifluoromethyl)oxirane 248 (2.00 mL, 23.20 
mmol) afforded a colourless oil, which was purified by flash column chromatography 
(75% hexane, 25% diethyl ether) to give the  title compound 249 (3.99 g, 19.02 mmol, 
82%) as a colourless oil.
νmax(neat)/cm-1 3435, 2962, 2360, 2183; δH (300 MHz; CDCl3) 4.06-3.95 (1H, m, H-C2), 
2.63 (1H, dd,  J  17.2, 4.5, H-C3), 2.52 (1H, dd,  J  17.2, 7.6, H-C3), 0.07 (9H, s, H-
CTMS); δC (75.5 MHz; CDCl3) 99.1 (C5), 89.3 (C4), 68.5 (q, J  31.5, C2), 22.4 (q, J  2.4, 
C3), 0.1 (CTMS); δF (282 MHz, CDCl3) -79.88 (d, JH-F  6.4); m/z (CI) 211 (MH+, 10), 171 
(100),  119  (90);  HRMS  (ES)  Found  [M+NH4]+ 228.1023,  C8H17F3NOSi  requires 
228.1026. Data in agreement with literature values.
General  procedure  H:  cis reduction of  alkynylsilanes  with  diisobutylaluminium 
hydride on 19.27 mmol scale. A round-bottomed flask equipped with a reflux condenser 
was charged with a 1.0 M solution of diisobutylaluminum hydride in hexane (57.80 mL, 
57.80 mmol, 3.00 eq.) and diethyl ether (86 mL). The resulting solution was stirred and 
cooled to 0 °C before adding dropwise a solution of alkynylsilane (19.27 mmol, 1.00 eq.) 
in  diethyl ether (9.50 mL).  The reaction was then allowed to  slowly warm to  room 
temperature and then heated at  reflux temperature overnight.  After cooling  to  room 
temperature and then to 0 °C, a 2.0 M solution of dilute sulfuric acid (78 mL) was added 
dropwise to the reaction mixture, which was stirred for a further 45 minutes whilst being 
allowed to warm to room temperature. The mixture was then filtered through a pad of 
celite, diluted with additional diethyl ether (43 mL), the organic layer separated and the 
aqueous layer extracted with diethyl ether (3 x 25 mL). The combined organic layers were 
washed  with  ice  cold  water  (86  mL),  dried  over  magnesium sulfate,  filtered  and 
concentrated in vacuo.
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(±)-(Z)-1,1,1-Trifluoro-5-(trimethylsilyl)pent-4-en-2-ol (247).
1
3
5
TMS
OH
CF3
C8H15F3OSi
Mol. Wt.: 212.28
Following  the  general procedure H,  (±)-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-yn-2-ol 
249 (4.87g, 23.2 mmol) afforded a pale yellow oil, which was purified by flash column 
chromatography (75% hexane, 25% diethyl ether) to give the title compound 247 (3.00 g, 
14.15 mmol, 61%) as a colourless oil.
νmax(neat)/cm-1 3428, 2958, 1610 ; δH (300 MHz; CDCl3) 6.17 (1H, td, J  14.4, 7.4, H-C4), 
5.66 (1H, d, J  14.4, H-C5), 3.95-3.75 (1H, m, H-C2), 2.63-2.51 (1H, m, H-C3), 2.46 (1H, 
dd, J  15.1, 8.3, H-C3), 2.16 (1H, d, J  5.6, H-OH), 0.15 (9H, s, H-CTMS); δC (75 MHz; 
CDCl3) 140.5 (C4), 135.1 (C5), 70.0 (q, J  31.0, C2), 33.4 (q, J  1.6, C3), 0.0 (CTMS); δF 
(282 MHz, CDCl3) -80.04 (d,  JH-F  6.6);  m/z (CI) 197 ((M-OH)H+, 100), 171 (50), 121 
(18); HRMS (CI) Found [M+NH4]+ 230.1184, C8H19F3NOSi requires 230.1183.
General procedure I: the silyl-Prins reaction on 1.92 mmol scale. Unless otherwise 
stated, a  round-bottomed flask equipped with  a  condenser  was charged with indium 
trichloride (406 mg, 1.96 mmol, 1.00 eq.), an aldehyde derivative (1.96 mmol, 1.00 eq.) 
and dichloromethane (10 mL). The resulting suspension was stirred at room temperature 
for  15  minutes  and  a  solution  of  a  homoallylic  alcohol  (1.96  mmol,  1.00  eq.)  in 
dichloromethane (2 mL) was added dropwise. The reaction was then heated to reflux 
temperature. Once TLC showed full consumption of starting material, the solution was 
cooled to room temperature, poured into dichloromethane (10 mL), water (10 mL) added 
and the resulting biphasic solution stirred for a further 30 minutes at room temperature. 
The  organic  layer  was  separated  and  the  aqueous  layer  was  extracted  with 
dichloromethane (3 x 2 mL). The combined organic layers were washed with a saturated 
aqueous solution of sodium chloride (10 mL), dried over magnesium sulfate, filtered and 
concentrated in vacuo.
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(±)-cis-2-Cyclohexyl-6-(trifluoromethyl)-3,6-dihydro-2H-pyran (250a).
7
82
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OF3C
8
9
9
10
C12H17F3O
Mol. Wt.: 234.26
Following the general procedure I, (±)-(Z)-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-ol 
247 (44 mg,  0.21 mmol),  in  the presence of  cyclohexanecarbaldehyde (24 mg, 0.21 
mmol), was consumed based on analysis  by TLC after 43 hours of stirring at  reflux 
temperature.  The  work-up  gave  a  yellow  oil,  which  was  purified  by  flash  column 
chromatography (90% hexane 10% ethyl acetate) to give the title compound 250a (6 mg, 
0.03 mmol, 12%) as a pale yellow oil.
νmax(neat)/cm-1 2928, 1658;  δH (300 MHz; CDCl3) 5.90-5.78 (1H, m, H-C4), 5.74-5.66 
(1H, m, H-C3), 4.09-4.02 (1H, m, H-C6), 4.01-3.89 (1H, m, H-C2), 2.36-2.21 (1H, m, H-
C5), 2.12-2.01 (1H, m, H-C5), 1.79-1.61 (4H, m, H-C8), 1.61-1.47 (1H, m, H-C7), 1.31-
1.01 (6H, m, H-C9 and H-C10); δC (75.5 MHz; CDCl3) 128.6 (C3), 122.7 (C4), 79.4 (C2), 
71.9 (q, J  30.6, C6), 42.3 (C7), 28.2 (C8), 27.6 (C8), 26.5 (C10), 26.2 (C9), 26.1 (C9), 
24.0 (q, J  2.0, C5); δF (282 MHz, CDCl3) -79.80 (d, JH-F   6.3); m/z (CI) 235 (MH+, 100), 
233 (80), 151 (86); HRMS (EI) Found [M+H]+ 234.1227, C12H18F3O requires 234.1226.
(±)-cis-2-Heptyl-6-(trifluoromethyl)-3,6-dihydro-2H-pyran (250b).
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OF3C
C13H21F3O
Mol. Wt.: 250.3
Following the general procedure I, (±)-(Z)-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-ol 
247 (407  mg,  1.92 mmol), in  the  presence of   octanal  (247 mg,  1.92 mmol),  was 
consumed based on analysis by TLC after 66 hours of stirring at reflux temperature. The 
work-up gave a yellow oil, which was purified by flash column chromatography (98% 
hexane 2% ethyl acetate) to give the title compound 250b (264 mg, 1.06 mmol, 55%) as a 
colourless oil.
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νmax(neat)/cm-1 2929, 1656;  δH (300 MHz; CDCl3) 5.85-5.77 (1H, m, H-C4), 5.67 (1H, 
tdd, J  10.3, 2.5, 1.2, H-C3), 4.26-4.17 (1H, m, H-C2), 4.04-3.91 (1H, m, H-C6), 2.40-
2.25 (1H, m, H-C5), 2.15-1.99 (1H, m, H-C5), 1.62-1.52 (2H, m, H-C7), 1.47-1.34 (2H, 
m, H-C8), 1.33-1.23 (8H, m, H-C9 to H-C12), 0.88 (3H, t, J  6.6, H-C13); δC (75.5 MHz; 
CDCl3) 130.2 (C3), 122.1 (C4), 75.5 (C2), 72.0 (q, J  31.9, C6), 35.0 (C7), 31.8 (C11), 
29.5 (C9), 29.2 (C10), 24.7 (C8), 23.9 (q,  J  1.9, C5), 22.6 (C12), 14.1 (C13); δF (282 
MHz, CDCl3) -79.70 (d, JH-F   6.4); m/z (CI) 251 (MH+, 100), 187 (55), 139 (20); HRMS 
(EI) Found [M]+ 250.1541, C13H21F3O requires 250.1539.
(±)-cis-2-Benzyl-6-(trifluoromethyl)-3,6-dihydro-2H-pyran (250c).
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OF3C
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C13H13F3O
Mol. Wt.: 242.24
Following the general procedure I, (±)-(Z)-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-ol 
247 (92 mg, 0.43 mmol), in the presence of  phenylacetaldehyde (52 mg, 0.43 mmol), was 
consumed based on analysis by TLC after 44 hours of stirring at reflux temperature. The 
work-up gave a yellow oil, which was purified by flash column chromatography (88% 
hexane 12% diethyl ether) to give the title compound 250c (44 mg, 0.18 mmol, 42%) as a 
yellow oil.
νmax(neat)/cm-1 2924, 1742, 1604; δH (300 MHz; CDCl3)  7.33-7.18 (5H, m, ArH), 5.85-
5.77 (1H, m, H-C4), 5.69-5.62 (1H, m, H-C3), 4.51-4.41 (1H, m, H-C2), 4.00 (1H, dtd, J 
16.7, 6.4, 3.6, H-C6), 3.05 (1H, dd, J 13.6, 6.3, H-C7), 2.77 (1H, dd, J  13.6, 7.3, H-C7), 
2.40-2.23 (1H, m, H-C5), 2.14-1.90 (1H, m, H-C5).
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(±)-cis-2-Phenyl-6-(trifluoromethyl)-3,6-dihydro-2H-pyran  (250d)  and  (±)-trans-2-
Phenyl-6-(trifluoromethyl)-3,6-dihydro-2H-pyran (251d).
2
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O PhF3C
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O PhF3C
C12H11F3O
Mol. Wt.: 228.21
Following the general procedure I, (±)-(Z)-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-ol 
247 (150 mg, 0.71 mmol), in the presence of benzaldehyde (72 μL, 0.71 mmol), was 
consumed based on analysis by TLC after 42 hours of stirring at reflux temperature. The 
work-up gave a yellow oil, which was purified by flash column chromatography (88% 
hexane 12% diethyl ether) to give the title compounds 251d and 250d (41 mg, 0.18 mmol, 
25%) as a colourless oil.
 Data for 251d: νmax(neat)/cm-1 (mixture) 3066, 2924, 1663; δH (300 MHz; CDCl3) 7.48-
7.20 (5H, m, ArH), 6.16-6.05 (2H, m, H-C3 and H-C4), 5.43 (1H, s, H-C2), 4.00-3.89 
(1H, m,  H-C6),  2.55-2.40 (1H, m,  H-C5),  2.26-2.08 (1H, m,  H-C5);  δC (75.5 MHz; 
CDCl3)  139.2 (ArC), 128.5 (ArC), 128.3 (ArC), 127.9 (C3), 127.3 (ArC), 123.5 (C4), 
74.3 (C2), 66.5 (q, J  32.1, C6), 23.6 (C5); δF (282 MHz, CDCl3) -79.14 (d, JH-F   6.4); m/z 
(CI) 229 (MH+, 100), 228 (70), 151 (60); m/z (CI) (mixture) 229 (MH+, 100), 228 (95), 
151  (100); HRMS (ES)  Found [M+NH4]+ (mixture) 246.1100,  C12H15F3NO requires 
246.1100.
Data for 250d: δH (300 MHz; CDCl3) 7.48-7.20 (5H, m, ArH), 5.97-5.91 (1H, m, H-C4), 
5.80 (1H, d, J 10.3, H-C3), 5.30 (1H, s, H-C2), 4.27-4.16 (1H, m, H-C6), 2.55-2.40 (1H, 
m, H-C5), 2.26-2.08 (1H, m, H-C5); δC (75.5 MHz; CDCl3)  139.8 (ArC), 130.1 (ArC), 
128.6 (ArC), 128.2 (C3), 127.0 (ArC), 122.0 (C4), 77.9 (C2), 72.3 (q, J 32.2, C6), 23.6 
(C5); δF (282 MHz, CDCl3) -79.55 (d, JH-F   6.1).
General procedure J: syn di-hydroxylation of olefins on 29.37 mmol scale.
An olefin derivative (29.37 mmol, 1.00 eq.) was placed into a round-bottomed flask and 
dissolved in tetrahydrofuran (195 mL) and water (83 mL). The resulting solution was 
stirred at room temperature and 4-methylmorpholine N-oxide (9.74 g, 58.73 mmol, 2 eq.) 
added in one portion, followed by a 0.1 M aqueous solution of osmium tetroxide (14.68 
mL, 1.47 mmol, 0.05 eq.). The reaction was then stirred at room temperature for 72 hours, 
allowed to cool to 0 °C, a saturated aqueous solution of sodium bisulfite (190 mL) added 
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slowly and after 10  minutes of  stirring  at  0  °C,  the  solution  was warmed to  room 
temperature while being stirred for  30  minutes. The  solution was diluted with  ethyl 
acetate (190 mL), the organic layer separated,  the aqueous layer extracted with ethyl 
acetate (3 x 80 mL), the combined organic layers were washed with a saturated aqueous 
solution  of  sodium chloride  (2  x  200  mL),  dried  over  sodium sulfate,  filtered  and 
concentrated in vacuo.
(2S*,3R*,4R*,6S*)-2-Heptyl-6-(trifluoromethyl)-tetrahydro-2H-pyran-3,4-diol (253).
6
7 13OF3C
OH
OH
C13H23F3O3
Mol. Wt.: 284.32
14
Following the general procedure J,  (±)-cis-6-heptyl-2-(trifluoromethyl)-3,6-dihydro-
2H-pyran 250b (175 mg, 0.70 mmol) afforded the title compound  253 (165 mg, 0.58 
mmol, 83%) as a colourless oil  which was used in the next step without any further 
purification.
νmax(neat)/cm-1 3401, 2928, 1709, 1637; δH (300 MHz; CDCl3) 4.19-4.13 (1H, m, H-C2), 
4.14-4.05 (1H, m, H-C6), 3.60-3.51 (1H, m, H-C4), 3.40-3.32 (1H, m, H-C3), 2.86 (1H, 
bs, H-OH), 2.61 (1H, bs, H-OH), 2.08-1.99 (1H, m, H-C5), 1.87-1.75 (1H, m, H-C5), 
1.82-1.71 (1H, m, H-C7), 1.63-1.46 (1H, m, H-C7), 1.45-1.17 (10H, m, H-C8 to H-C12), 
0.87 (3H, t,  J  6.6, H-C13); δC (75.5 MHz; CDCl3) 124.3 (q, J  279.1, C14), 75.7 (C3), 
71.0 (C4), 69.7 (q, J  32.0, C6), 66.5 (C2), 31.8 (C9), 31.8 (C7), 31.1 (C5), 29.5 (C9), 
29.2 (C10), 25.2 (C8), 22.6 (C12), 14.0 (C13); δF (282 MHz, CDCl3) -79.01 (d, JH-F  6.4); 
m/z (CI) 285 (MH+, 20), 267 (100), 249 (22).
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(2S*,3R*,4S*,6S*)-2-Heptyl-6-(trifluoromethyl)-tetrahydro-2H-pyran-3,4-diyl bis(4-
nitrobenzoate)  (255),  (2S*,3S*,4R*,6S*)-2-Heptyl-6-(trifluoromethyl)-tetrahydro-
2H-pyran-3,4-diyl bis(4-nitrobenzoate) (256).
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C27H29F3N2O9
Mol. Wt.: 582.52
A round-bottomed flask was charged with  (2S,3R,4R,6S)-2-heptyl-6-(trifluoromethyl)-
tetrahydro-2H-pyran-3,4-diol  253 and  (2R,3S,4S,6R)-2-Heptyl-6-(trifluoromethyl)-
tetrahydro-2H-pyran-3,4-diol 253 (81 mg, 0.30 mmol, 1.00 eq.), pyridine (4.5 mL) and 4-
dimethylaminopyridine (4 mg, 0.03 mmol, 0.1 eq.). The resulting solution was cooled to 0 
°C and 4-nitrobenzoyl chloride (1.17 g, 6.28 mmol, 21.00 eq.) in dichloromethane (1.5 
mL) was added dropwise. The resulting solution was warmed to room temperature and 
stirred for 24 hours. To this solution was added water (0.3 mL) and dichloromethane (90 
mL) and the resulting mixture was washed with water (3 x 90 mL), a saturated aqueous 
solution of sodium hydrogen carbonate (90 mL), and water (90 mL). The organic layer 
was dried over sodium sulfate and concentrated in vacuo to afford a yellow solid which 
was purified by flash column chromatography (90% hexane 10% ethyl acetate) to give the 
title compound 255 and 256 (120 mg, 2.06 mmol, 69%) as a yellow solid.
Data for 255: M.p. 87-90 °C (mixture); νmax(neat)/cm-1 (mixture) 2927, 1736, 1608, 1530; 
δH (300 MHz; CDCl3) 8.38-8.32 (2H, m, ArH), 8.25-8.20 (2H, m, ArH), 8.20-8.14 (2H, 
m, ArH), 8.08-8.00 (2H, m, ArH), 5.99-5.94 (1H, m, H-C4), 5.08 (1H, dd, J  10.1, 2.9, H-
C3), 4.37-4.24 (1H, m, H-C6), 4.11-4.01 (1H, m, H-C2), 2.34-2.19 (2H, m, H-C5), 1.76-
1.48 (2H, m, H-C7), 1.44-1.16 (10H, m, H-C8 to H-C12), 0.85 (3H, t, J  6.7, H-C13); δ
C (75.5 MHz; CDCl3) 163.5 (C14), 163.4 (C15), 150.9 (ArC), 150.7 (ArC), 134.5 (ArC), 
134.4 (ArC), 130.7 (ArC), 130.7 (ArC), 123.9 (ArC), 123.6 (ArC), 77.2 (C3), 74.5 (C2), 
70.8 (q, J  33.1, C6), 67.8 (C4), 31.7 (C11), 31.6 (C7), 29.5 (C5), 29.4 (C9), 29.1 (C10), 
24.8 (C8), 22.6 (C12), 14.1 (C13); δF (282 MHz, CDCl3) -78.89 (d, JH-F  5.9);  m/z (CI) 
(mixture) 600 ((M+NH4)+, 100), 540 (40), 404 (50); HRMS (EI) Found [M+H]+ (mixture) 
582.1816, C27H30F3N2O9 requires 582.1820.
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 Data for 256:  δH (300 MHz; CDCl3) 8.38-8.33 (2H, m, ArH), 8.25-8.21 (2H, m, ArH), 
8.20-8.14 (2H, m, ArH), 8.05-8.00 (2H, m, ArH), 5.64 (1H, d,  J  2.8, H-C3), 5.43 (1H, 
ddd, J  10.2, 7.7, 2.8, H-C4), 4.09-4.02 (1H, m, H-C6), 3.77 (1H, dd, J  7.7, 4.7, H-C2), 
2.34-2.23 (2H, m, H-C5), 1.87-1.51 (2H, m, H-C7), 1.45-1.22 (10H, m, H-C8 to H-C12), 
0.92-0.84 (3H, m, H-C13); δF (282 MHz, CDCl3) -79.13 (d, JH-F  5.7).
(±)-(Z)-1,1,1-Trifluoro-5-(trimethylsilyl)pent-4-en-2-yl-4-methylbenzenesulfonate 
(257).
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C15H21F3O3SSi
Mol. Wt.: 366.47
Following the general procedure A, (±)-(Z)-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-
ol 247 (3.50 g, 16.48 mmol) was consumed based on analysis by TLC after 20 hours of 
stirring at 0  °C. The work-up afforded a pale yellow oil, which was purified by flash 
column chromatography (75% hexane, 25% diethyl ether) to give the title compound 257 
(3.01 g, 8.21 mmol, 50%) as a colourless oil.
νmax(neat)/cm-1 3036, 2956, 1960, 1815, 1599; δH (300 MHz; CDCl3) 7.79 (2H, d, J  8.4, 
H-C7), 7.34 (2H, d, J  8.4, H-C8), 6.12 (1H, td, J  14.2, 7.2, H-C4), 5.69-5.62 (1H, m, H-
C5), 4.94-4.82 (1H, m, H-C2), 2.66-2.58 (2H, m, H-C3), 2.45 (3H, s, H-C10), 0.08 (9H, s, 
H-CTMS);  δC (75.5 MHz; CDCl3) 145.4 (ArC), 138.4 (C4), 135.0 (ArC), 133.1 (C5), 
129.8 (ArC), 128.0 (ArC),  76.6 (q,  J  32.7, C2), 32.3 (q,  J  1.3, C3), 21.7 (C10), -0.1 
(CTMS); δF (282 MHz, CDCl3) -76.74 (d, JH-F  6.0); m/z (CI) 367 (MH+, 100), 245 (65), 
155 (40); HRMS (ES) Found [M+NH4]+ 384.1268, C15H25F3NO3SSi requires 384.1271.
General Procedure K: Triflate protection of an alcohol on 3.41 mmol scale. 
A round-bottomed flask was charged with pyridine (6.8 mL) and dichloromethane (25 
mL). The mixture was stirred and cooled to 0 °C and trifluoromethanesulfonic anhydride 
(861 µl, 5.12 mmol, 1.50 eq.) added dropwise followed by an alcohol derivative (3.41 
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mmol, 1.00 eq.) in dichloromethane (3 mL). The resulting solution was stirred at 0 °C for 
4 hours and 15% hydrochloric acid (10 mL) was added dropwise, followed by ice-water 
(20 mL). The organic layer was separated and the aqueous layer was extracted with 
dichloromethane (3 x 10 mL). The combined organic layers were washed with water until 
a  neutral  pH  was  reached  and  then  dried  over  magnesium sulfate,  filtered,  and 
concentrated in vacuo.
(±)-(Z)-1,1,1-Trifluoro-5-(trimethylsilyl)pent-4-en-2-yl  trifluoromethanesulfonate 
(259).
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Mol. Wt.: 344.35
Following the general procedure K, (±)-(Z)-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-
ol 247 (724 mg, 3.41 mmol) afforded a pale pink oil, which was purified by flash column 
chromatography (75% hexane, 25% diethyl ether) to give the  title compound 259 (774 
mg, 2.25 mmol, 66%) as a colourless oil.
νmax(neat)/cm-1 2960, 1614, 840; δH (300 MHz; CDCl3) 6.19 (1H, td, J  14.3, 7.2, H-C4), 
5.95-5.87 (1H, m, H-C5), 5.09-4.98 (1H, m, H-C2), 2.84-2.75 (2H, m, H-C3), 0.15 (9H, s, 
H-CTMS); δC (75.5 MHz; CDCl3) 137.4 (C4), 136.4 (C5), 122.1 (q, J  254.4, C1), 81.1 
(q, J  34.0, C2), 32.1 (q, J  0.9, C3), -0.2 (CTMS);  δF (282 MHz, CDCl3) -74.56 (d, JH-F  
3.0).
(±)-3-(Benzylamino)-1,1,1-trifluoropropan-2-ol (260).
41 3
N
H
PhF3C
OH
 C10H12F3NO
Mol. Wt.: 219.2
A round-bottomed flask was charged with benzylamine (2.08 g, 19.40 mmol, 0.97 eq.) 
and acetonitrile (5 mL). The resulting solution was stirred, cooled to 0  °C and  (±)-2-
(trifluoromethyl)oxirane  248 (1.72 mL, 20.00 mmol, 1.00 eq.)  added dropwise.  The 
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mixture was warmed to room temperature and stirred for 48 hours, concentrated in vacuo, 
filtered and the precipitate washed with ice-cold hexane (20 mL).  This gave the  title 
compound 260 (3.59 g, 16.40 mmol mmol, 82%) as a white solid which was used in the 
next step without any further purification.
M.p. 94-96 °C (Lit.: 78°C in diethyl ether); δH (300 MHz; CDCl3) 7.38-7.22 (5H, m, Ar-
H), 4.03-3.91 (1H, m, H-C2), 3.79 (2H, s, H-C3), 3.50 (2H, bs, H-OH and H-NH), 2.90 
(1H, dd,  J  12.8, 6.9, H-C4), 2.83 (1H, dd,  J  12.8, 4.5, H-C4);  δC (75.5 MHz; CDCl3) 
138.6 (ArC), 128.7 (ArC), 128.2 (ArC), 127.5 (ArC), 124.9 (q, J  282.1, C1), 67.6 (q, J 
30.6, C2), 53.6 (C4), 46.8 (q, J  1.7, C3); δF (282 MHz, CDCl3) –78.95 (d, JH-F  7.1). Data 
in agreement with literature values.
(±)-1-Benzyl-2-(trifluoromethyl)aziridine (261).
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 C10H10F3N
Mol Wt.: 201.19
A  round-bottomed  flask  equipped  with  a  reflux  condenser  was  charged  with 
dichlorotriphenylphosphorane (4.39 g, 13.57 mmol, 1.00 eq.) and acetonitrile (3 mL). The 
resulting  solution  was  stirred  at  room  temperature  and  (±)-3-(benzylamino)-1,1,1-
trifluoropropan-2-ol 260  (2.98 g, 13.57 mmol, 1.00 eq.) in acetonitrile (2 mL) added 
dropwise. The mixture was then heated at reflux temperature for 30 minutes and then 
cooled to 0 °C. To the mixture was added triethylamine (2.35 mL, 16.96 mmol, 1.25 eq.) 
dropwise and then the reaction mixture was slowly warmed to reflux temperature and 
stirred overnight. The mixture was then cooled to room temperature and concentrated in 
vacuo.  This afforded a white solid, which was purified by distillation under reduced 
pressure (120 °C, 20 mmHg) to give the title compound 261 (1.86 g, 9.23 mmol, 68%) as 
a colourless oil. 
δH (300 MHz; CDCl3) 7.43-7.27 (5H, m, Ar-H), 4.00 (1H, d, J 13.1, H-C4), 3.93 (1H, d, J 
13.1, H-C4), 3.78 (1H, dd, J 11.9, 3.9, H-C3), 3.64 (1H, dd, J  11.9, 6.4, H-C3), 3.45-3.33 
(1H, m, H-C2); δF (282 MHz, CDCl3) -73.41 (d, JH-F  7.0); m/z (ES) 202 (MH+, 100), 133 
(30), 124 (18). Data in agreement with literature values.
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(±)-N-Benzyl-3-bromo-1,1,1-trifluoropropan-2-amine (262).
4
1
3
CF3
N
H
PhBr
 C10H11BrF3N
Mol. Wt.: 282.1
A round-bottomed flask was charged with a 48% hydrobromic acid (3.70 mL, 33.67 
mmol, 20.41 eq.) and the solution was cooled to 0 °C. To this was added (±)-1-benzyl-2-
(trifluoromethyl)aziridine  261 (333 mg,  1.65 mmol, 1.00 eq.)  dropwise,  the  mixture 
warmed to room temperature and stirred for 16 hours. After this, a saturated aqueous 
solution of sodium hydrogen carbonate (10 mL) and diethyl ether (10 mL) was added. 
The organic layer was separated, the aqueous layer extracted with diethyl ether (2 x 10 
mL), the combined organic layers dried over magnesium sulfate, filtered and concentrated 
in  vacuo.  This  afforded  a  pale  yellow  oil  which  was  purified  by  flash  column 
chromatography (83% hexane 17% diethyl ether) to afford the title compound 262 (189 
mg, 0.67 mmol, 41%) as a colourless oil.
δH (300 MHz; CDCl3) 7.46-7.27 (5H, m, Ar-H), 4.06 (1H, d, J  13.1, H-C4), 3.98 (1H, d, 
J  13.1, H-C4), 3.65 (1H, dd, J  11.0, 3.8, H-C2), 3.56-3.38 (2H, m, H-C3), 1.94 (1H, bs, 
N-NH); δF (282 MHz, CDCl3) -68.89 (d, JH-F  6.6); m/z (ES) 283 (MH+, 55), 282 (100), 
204 (50). Data in agreement with literature values.
(E)-Phenyl-N-(2,2,2-trifluoroethylidene)methanamine (263).
1
3
N
CF3
Ph
C9H8F3N
Mol. Wt.: 187.16
2
A round-bottomed  flask  equipped  with  a  dropping  funnel  and  a  Dean  and  Stark 
distillation apparatus fitted with a reflux condenser was charged with a 90% aqueous 
solution of (±)-1-ethoxy-2,2,2-trifluoroethanol 187 (4.25 mL, 32.95 mmol, 1.00 eq.) and 
toluene (27 mL). The resulting solution was stirred at room temperature and benzylamine 
(3.53 g, 32.95 mmol, 1.00 eq.) was added dropwise. The mixture was then heated slowly 
to 140 °C for 2 hours so that the distillate was trapped and the aqueous layer separated. 
The mixture was then dried over 4Å molecular sieves, filtered and concentrated in vacuo. 
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This afforded a pale yellow oil, which was purified by distillation under reduced pressure 
(45 °C, 1.25 mmHg) to give the  title compound 263 (3.93 g, 20.97 mmol, 64%) as a 
colourless oil.
δH (300 MHz; CDCl3) 7.61-7.55 (1H, m, H-C1), 7.36-7.25 (3H, m, Ar-H), 7.24-7.18 (2H, 
m, Ar-H), 4.77 (2H, s, H-C3); δC (75.5 MHz; CDCl3) 150.0 (q, J 38.2, C1), 139.5 (ArC), 
128.5 (ArC), 128.1 (ArC), 127.2 (ArC), 63.5 (C3); δF (282 MHz, CDCl3) -71.93 (d, JH-F  
1.7). Data in agreement with literature values.
(±)-N-Benzyl-1,1,1-trifluoropent-4-yn-2-amine (264).
6
1
3
5
N
H
CF3
Ph
C12H12F3N
Mol. Wt.: 227.23
A  round-bottomed  flask  was  charged  with  (E)-phenyl-N-(2,2,2-
trifluoroethylidene)methanamine  263 (2.00 g,  10.69 mmol, 1.00  eq.),  an  80  %  w/v 
solution  of  3-bromoprop-1-yne in  toluene (2.06 g,  13.92 mmol,  1.30 eq.)  and  N,N-
dimethylforamide (19 mL). The resulting solution was cooled to 0  °C and coarse zinc 
powder  (911  mg)  added  portionwise,  followed by  chlorotrimethylsilane  (10  drops) 
dropwise. The resulting suspension was warmed to room temperature and stirred for 2 
hours.  The  mixture  was  then  cooled to  0  °C  and  a  saturated  aqueous  solution  of 
ammonium chloride (40 mL) was added dropwise followed by diethyl ether (40 mL). The 
organic layer was separated and the aqueous layer was extracted with diethyl ether (3 x 20 
mL). The combined organic layers were washed with a saturated aqueous solution of 
sodium chloride (60 mL), dried over magnesium sulfate, filtered and concentrated in 
vacuo. This afforded a yellow oil which was purified by flash column chromatography 
(90% hexane 10% ethyl acetate) to afford the  title compound 264 (1.44 g, 6.35 mmol, 
59%) as a colourless oil.
δH (300 MHz; CDCl3) 7.41-7.26 (5H, m, ArH), 4.04 (1H, dd, J 13.2, 4.8, H-C6), 3.96 (1H, 
dd, J 13.2, 4.4, H-C6), 3.34-3.19 (1H, m, H-C2), 2.65 (1H, ddd, J 17.2, 4.6, 2.7, H-C3), 
2.50 (1H, ddd, J 17.2, 7.6, 2.7, H-C3), 2.07 (1H, t, J  2.7), 1.82 (1H, bs, H-NH); δC (75.5 
MHz; CDCl3) 139.1 (ArC), 128.5 (ArC), 128.3 (ArC), 127.4 (ArC), 78.6 (C4), 71.3 (C5), 
57.42 (q, J  28.0, C2), 52.38 (C6), 19.85 (q, J  3.0, C3); δF (282 MHz, CDCl3) -75.12 (d, 
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JH-F  7.0); m/z (CI) 228 (MH+, 100), 188 (82), 158 (34). Data in agreement with literature 
values.
(±)-N-Benzyl-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-yn-2-amine (265).
6
1
3
5
N
H
CF3
Ph
TMS
C15H20F3NSi
Mol. Wt.: 299.41
Following the general procedure O,  (±)-N-benzyl-1,1,1-trifluoropent-4-yn-2-amine  264 
(1.44  g,  6.35  mmol)  afforded  a  yellow  oil,  which  was  purified  by  flash  column 
chromatography (95% hexane, 5% ethyl acetate) to give the title compound  265 (1.24 g, 
4.13 mmol, 65%) as a colourless oil.
νmax(neat)/cm-1 3352, 3089, 2960, 2181, 1924, 1890; δH (300 MHz; CDCl3) 7.33-7.14 (5H, 
m, ArH), 3.84 (1H, d, J  13.1, H-C6), 3.76 (1H, d, J  13.1, H-C6), 3.24-3.10 (1H, m, H-
C2), 2.60 (1H, dd, J  17.3, 4.3, H-C3), 2.43 (1H, dd, J  17.3, 8.5, H-C3), 1.72 (1H, bs, H-
NH), 0.09 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 139.2 (ArC), 128.5 (ArC), 128.3 
(ArC), 127.3 (ArC), 100.9 (C5), 88.1 (C4), 57.19 (q, J  28.0, C2), 52.21 (C6), 20.76 (q, J 
3.0, C3), -0.1 (CTMS); δF (282 MHz, CDCl3) -75.36 (d, JH-F   6.9);  m/z (CI) 300 (MH+, 
100), 226 (44), 188 (43); HRMS (ES) Found [M+H]+ 300.1380, C15H21F3NSi requires 
300.1390.
 
(±)-(Z)-N-Benzyl-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-amine  (258)  and  (±)-
(E)-N-Benzyl-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-amine (266).
1
3
5
6
TMS
N
H
CF3
Ph
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H
CF3
PhTMS
C15H22F3NSi
Mol. Wt.: 301.42
Following the general procedure H, N-benzyl-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-yn-
2-amine  265 (0.62 g, 2.07 mmol) afforded a yellow oil, which was purified by flash 
column chromatography (98% hexane, 1% ethyl acetate, 1% triethylamine) to give the 
title compound  258 and 266 (280 mg, 0.93 mmol, 45%) as a colourless oil. 
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Data for  266: νmax(neat)/cm-1 (mixture) 3359, 3091, 2956, 1924, 1889, 1607;  δH (300 
MHz; CDCl3) 7.36-7.23 (5H, m, ArH), 5.89-5.78 (2H, m, H-C4 and H-C5), 3.99 (1H, d, J 
13.3, H-C6), 3.82 (1H, d, J  13.3, H-C6), 3.19-3.02 (1H, m, H-C2), 2.60-2.48 (1H, m, H-
C3), 2.25 (1H, ddd,  J  14.5, 9.7, 6.7, H-C3), 0.07 (9H, s,  H-CTMS); δC (75.5 MHz; 
CDCl3)  140.7 (C4), 139.5 (ArC), 135.6 (C5), 128.5 (ArC), 128.3 (ArC), 127.3 (ArC), 
57.4 (q, J  27.4, C2), 52.2 (C6), 36.1 (q, J  2.1, C3), -1.4 (CTMS); δF (282 MHz, CDCl3) 
-75.21 (d,  JH-F  7.2);  m/z (CI) 302 (MH+, 100), 228 (40), 188 (55); HRMS (ES) Found 
[M+H]+ (mixture) 302.1548, C15H23F3NSi requires 302.1546.
Data for 258:  δH (300 MHz; CDCl3) 7.38-7.22 (5H, m, ArH), 6.25-6.14 (1H, m, H-C4), 
5.73-5.67 (1H, m, H-C5), 4.01 (1H, d, J 13.3, H-C6), 3.83 (1H, d, J  13.3, H-C6),  3.17-
3.03 (1H, m, H-C2), 2.58-2.48 (1H, m, H-C3), 2.32 (1H, dddd, J  14.8, 9.5, 8.0, 1.2, H-
C3), 0.12 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 142.3 (C4), 139.5 (ArC), 133.7 (C5), 
128.4 (ArC), 128.2 (ArC), 127.2 (ArC), 58.2 (q, J  27.3, C2), 52.3 (C6), 32.5 (q, J  2.1, 
C3), 0.1 (CTMS); δF  (282 MHz, CDCl3) -75.09 (d, JH-F  7.1); m/z (CI) 302 (MH+, 64), 228 
(25), 188 (100).
General procedure L: hydrotitanation of alkynylsilanes on 3.57 mmol scale.
A three-necked flask fitted with a dropping funnel and a thermometer, was charged with 
an alkynylsilane (3.57 mmol, 1.00 eq.) and diethyl ether (70 mL). The solution was then 
cooled to  -78 °C before adding dropwise titanium(IV) isopropoxide (5.36 mL, 18.11 
mmol, 5.07 eq.), and a 2.0 M solution of isopropylmagnesium chloride in diethyl ether 
(18.12 mL, 36.19 mmol, 10.13 eq.). The resulting solution was then warmed slowly to -60 
°C until GCMS showed complete consumption of starting material. To this solution was 
added dropwise, a saturated aqueous solution of ammonium chloride (150 mL) and ethyl 
acetate (150 mL) and the reaction mixture was slowly warmed to room temperature. The 
organic layer was separated and the aqueous layer was extracted with ethyl acetate (2 x 50 
mL). The combined organic layers were washed with brine, dried over sodium sulfate, 
filtered and concentrated in vacuo.
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(±)-(Z)-N-Benzyl-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-en-2-amine (258).
1
3
5
6
TMS
N
H
CF3
Ph
C15H22F3NSi
Mol. Wt.: 301.42
Following the general procedure L,  N-benzyl-1,1,1-trifluoro-5-(trimethylsilyl)pent-4-yn-
2-amine 265 (22 mg, 0.073 mmol) afforded a yellow oil, which was purified by flash 
column chromatography (95% hexane, 5% ethyl acetate) to give the title compound 258 
(11 mg, 0.037 mmol, 51%) as a colourless oil.
νmax(neat)/cm-1 3359, 2958, 1924, 1889, 1607; HRMS (ES) Found [M+H]+ 302.1548, 
C15H23F3NSi requires 302.1546.
General  procedure  M:  the  Aza-silyl-Prins  reaction on  0.70  mmol  scale. Unless 
otherwise stated, a round-bottomed flask equipped, with a condenser, was charged with 
indium trichloride (145 mg, 0.70 mmol, 1.00 eq.), an aldehyde derivative (0.70 mmol, 
1.00  eq.)  and  acetonitrile  (2.5  mL).  The  resulting  suspension  was  stirred  at  room 
temperature for 15 minutes and a solution of a homoallylic amine (0.70 mmol, 1.00 eq.) 
in  acetonitrile  (1  mL) was added dropwise.  The  reaction  was then heated to  reflux 
temperature. Once TLC showed full consumption of the starting material, the solution 
was cooled to room temperature, poured into dichloromethane (5 mL), 1.0 M aqueous 
sodium hydroxide (5 mL) added and the resulting biphasic solution stirred for a further 30 
minutes at room temperature. The organic layer was separated and the aqueous layer was 
extracted with dichloromethane (3 x 2 mL). The combined organic layers were washed 
with a saturated aqueous solution of sodium chloride (10 mL), dried over sodium sulfate, 
filtered and concentrated in vacuo.
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(±)-trans-1-Benzyl-2-cyclohexyl-6-(trifluoromethyl)-1,2,3,6-tetrahydropyridine 
(267a).
9
7
2
4
6
12
NF3C
Ph
8
9
10
10
11
C19H24F3N
Mol. Wt.: 323.4
Following the general procedure M, A 1:1 mixture of (±)-(Z)-N-benzyl-1,1,1-trifluoro-5-
(trimethylsilyl)pent-4-en-2-amine  258 and  (±)-(E)-N-benzyl-1,1,1-trifluoro-5-
(trimethylsilyl)pent-4-en-2-amine  266 (150  mg,  0.50  mmol),  in  the  presence  of 
cyclohexanecarbaldehyde (56 mg, 0.50 mmol), was consumed based on analysis by TLC 
after 48 hours of stirring at reflux temperature. The work-up gave a yellow oil, which was 
purified by flash column chromatography (99% hexane 1% ethyl acetate) to give the title 
compound 267a (24 mg, 0.07 mmol, 15%) as a colourless oil.
νmax(neat)/cm-1 3032, 2925, 1604; δH (300 MHz; CDCl3) 7.37-7.19 (5H, m, ArH), 5.92-
5.84 (1H, m, H-C4), 5.83-5.76 (1H, m, H-C3), 3.94 (1H, d, J  13.7, H-C7), 3.64-3.50 (1H, 
m, H-C6), 3.48 (1H, d, J  13.7, H-C7), 2.66-2.59 (1H, m, H-C2), 2.45-2.32 (1H, m, H-
C5), 2.17-2.05 (1H, m, H-C5), 2.06-1.95 (1H, m, H-C9), 1.75-1.53 (3H, m, H-C9), 1.49-
1.31 (1H, m, H-C8), 1.22-0.94 (3H, m, H-C9), 0.93-0.70 (2H, m, H-C9 and H-C10), 0.62-
0.44 (1H, m, H-C10); δC (75.5 MHz; CDCl3) 139.4 (ArC), 129.1 (C3), 128.3 (ArC), 128.0 
(ArC), 126.8 (ArC), 123.5 (C4), 62.8 (C2), 54.7 (q, J  29.4, C6), 51.8 (q, J  2.2, C7), 41.6 
(C8), 30.3 (C9), 29.7 (C9), 26.4 (C11), 26.2 (C10), 26.1 (C10), 20.2 (q, J  1.6, C5); δF 
(282 MHz, CDCl3)  -70.2 (d,  JH-F   8.9);  m/z (CI) 324 (MH+, 43), 240 (100), 133 (43); 
HRMS (ES) Found [M+H]+ 324.1931, C19H25F3N requires 324.1934.
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(±)-trans-1-Benzyl-2-heptyl-6-(trifluoromethyl)-1,2,3,6-tetrahydropyridine (267b).
14
7
2
4
6
15 NF3C
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8
C20H28F3N
Mol. Wt.: 339.44
Following the general procedure M, A 1:1 mixture of (±)-(Z)-N-benzyl-1,1,1-trifluoro-5-
(trimethylsilyl)pent-4-en-2-amine  258 and  (±)-(E)-N-benzyl-1,1,1-trifluoro-5-
(trimethylsilyl)pent-4-en-2-amine 266 (92 mg, 0.43 mmol), in the presence of octanal (43 
mg, 0.14 mmol), was consumed based on analysis by TLC after 48 hours of stirring at 
reflux temperature. The work-up gave a yellow oil, which was purified by flash column 
chromatography (99% hexane 1% ethyl acetate) to give the title compound 267b (63 mg, 
0.18 mmol, 43%) as a colourless oil.
νmax(neat)/cm-1 3032, 2955, 1741;  δH (300 MHz; CDCl3) 7.39-7.20 (5H, m, ArH), 5.86-
5.78 (1H, m, H-C4), 5.69-5.60 (1H, m, H-C3), 3.93 (1H, d, J 13.8, H-C7), 3.58 (1H, d, J 
13.8, H-C7), 3.56-3.46 (1H, m, H-C6), 3.07 (1H, s, H-C2), 2.45-2.28 (1H, m, H-C5), 
2.20-2.08 (1H, m, H-C5), 1.47-1.35 (2H, m, H-C8), 1.33-1.19 (4H, m, H-C9 and H-C10), 
1.20-0.95 (6H, m, H-C11 to H-C13), 0.86 (3H, t, J  6.9, H-C14); δC (75.5 MHz; CDCl3) 
139.4 (ArC), 130.1 (C2), 128.8 (ArC), 128.1 (ArC), 126.9 (ArC), 122.8 (C4), 57.2 (C2), 
54.5 (q, J  26.1, C6), 52.0 (q, J 2.2, C7), 33.5 (C8), 31.8 (C12), 29.3 (C10), 29.2 (C11), 
25.4 (C9), 22.6 (C13), 21.2 (q, J 1.7, C5), 14.1 (C14); δF (282 MHz, CDCl3) -69.60 (d, JH-
F   9.0); m/z (CI)  340  (MH+,  55),  240 (100), 133  (50); HRMS (ES) Found  [M+H]+ 
340.2247, C20H29F3N requires 340.2247.
(±)-trans-1,2-Dibenzyl-6-(trifluoromethyl)-1,2,3,6-tetrahydropyridine (267c).
7
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C20H20F3N
Mol. Wt.: 331.37
Following the general procedure M, A 1:1 mixture of (±)-(Z)-N-benzyl-1,1,1-trifluoro-5-
(trimethylsilyl)pent-4-en-2-amine  258 and  (±)-(E)-N-benzyl-1,1,1-trifluoro-5-
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(trimethylsilyl)pent-4-en-2-amine  266 (29  mg,  0.09  mmol),  in  the  presence  of 
phenylacetaldehyde (12 mg, 0.09 mmol), was consumed based on analysis by TLC after 
48 hours of stirring at reflux temperature. The work-up gave a yellow oil, which was 
purified by flash column chromatography (99% hexane 1% ethyl acetate) to give the title 
compound 267c (16 mg, 0.05 mmol, 50%) as a yellow oil.
νmax(neat)/cm-1 3028, 2924, 1889, 1729; δH (300 MHz; CDCl3) 7.22-6.96 (10H, m, Ar-H), 
5.92-5.79 (1H, m, H-C4), 5.65-5.57 (1H, m, H-C3), 3.95 (1H, d, J 14.1, H-C7), 3.73-3.60 
(1H, m, H-C6), 3.61 (1H, d,  J  14.1, H-C7), 3.33-3.24 (1H, m, H-C2), 2.84 (1H, dd,  J 
13.5, 7.5, H-C8), 2.63 (1H, dd, J 13.5, 6.9, H-C8), 2.48-2.26 (1H, m, H-C5), 2.24-2.10 
(1H, m, H-C5); δF (282 MHz, CDCl3) -69.59 (d, JH-F  8.9); m/z (CI) 332 (MH+, 100), 240 
(70), 133 (36); HRMS (ES) Found [M+H]+ 332.1618, C20H21F3N requires 332.1621.
(±)-trans-Ethyl-1-benzyl-6-(trifluoromethyl)-1,2,5,6-tetrahydropyridine-2-
carboxylate (267d).
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C16H18F3NO2
Mol. Wt.: 313.31
Following the general procedure M, A 1:1 mixture of (±)-(Z)-N-benzyl-1,1,1-trifluoro-5-
(trimethylsilyl)pent-4-en-2-amine  258 and  (±)-(E)-N-benzyl-1,1,1-trifluoro-5-
(trimethylsilyl)pent-4-en-2-amine 266 (150 mg, 0.50 mmol), in the presence of a pre-
heated 38% solution of ethyl 2-oxoacetate in toluene (127 mg, 0.50 mmol, 1.00 eq.), was 
consumed based on analysis by TLC after 17 hours of stirring at reflux temperature. The 
work-up gave a yellow oil, which was purified by flash column chromatography (95% 
hexane 5% ethyl acetate) to give the title compound 267d (101 mg, 0.32 mmol, 65%) as a 
pale yellow oil.
νmax(neat)/cm-1 3031, 2928, 1748, 1668; δH (300 MHz; CDCl3) 7.47-7.40 (2H, m, Ar-H), 
7.37-7.22 (2H, m, Ar-H), 7.20-7.14 (1H, m, Ar-H), 6.01-5.82 (1H, m, H-C3), 5.79-5.72 
(1H, m, H-C4), 4.24-4.13 (2H, m, H-C9), 4.14-4.07 (1H, m, H-C2), 3.97 (1H, d, J  13.5, 
H-C7), 3.81 (1H, d, J  13.5, H-C7), 3.71-3.57 (1H, m, H-C6), 2.54-2.18 (2H, m, H-C5), 
1.26 (3H, t, J  7.1, H-C10); δC (75.5 MHz; CDCl3) 171.8 (C8), 137.7 (ArC), 128.9 (C3), 
128.4 (ArC), 127.4 (ArC), 125.1 (ArC), 123.7 (C4), 61.1 (C2), 58.5 (C9), 54.5 (q, J  1.8, 
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C7), 53.3 (q, J  27.8, C6), 23.3 (q, J 2.1, C5), 14.2 (C10); δF (282 MHz, CDCl3) -68.20 (d, 
JH-F   8.6);  m/z (CI) 314 (MH+,  96), 240 (100), 133 (40);  HRMS (ES) Found [M+H]+ 
314.1363, C16H19F3NO2 requires 314.1362.
(2S*,3R*,4S*,6S*)-Ethyl-1-benzyl-3,4-dihydroxy-6-(trifluoromethyl)piperidine-2-
carboxylate (271).
N
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F3C
 C16H20F3NO4
Mol. Wt.: 347.33
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Following the general procedure J, (±)-trans-ethyl-1-benzyl-6-(trifluoromethyl)-1,2,5,6-
tetrahydropyridine-2-carboxylate 267d (64 mg, 0.20 mmol) afforded the title compound 
271 (58 mg, 0.17 mmol, 83%) as a pale yellow oil  which was used in the next step 
without any further purification.
νmax(neat)/cm-1 3393, 2955, 2854, 1732; δH (300 MHz; CDCl3)  7.40-7.24 (5H, m, ArH), 
4.20 (2H, ddd, J 14.0, 6.9, 3.7, H-C9), 4.19-4.13 (1H, m, H-C3), 4.10-4.03 (1H, m, H-
C6), 4.01 (1H, d, J  13.0, H-C7), 3.82 (1H, d, J  13.0, H-C7), 3.74-3.68 (1H, m, H-C4), 
3.70-3.64 (1H, m, H-C2), 2.06-1.93 (1H, m, H-C5), 1.84-1.68 (1H, m, H-C5), 1.32-1.25 
(3H, m, H-C10); δF (282 MHz, CDCl3) -69.39 (d, JH-F  7.1); m/z (CI) 346 ((M-H)+, 5), 304 
(100), 214 (7).
General procedure N: di-acetylation of diols on 0.06 mmol scale.
A round-bottomed flask was charged with a diol derivative (0.06 mmol, 1.00 eq.) and 
dichloromethane (300 µL) and the resulting solution stirred at room temperature. Acetic 
anhydride  (27  µL,  0.29  mmol,  5.00  eq.)  was  added  dropwise,  followed  by  4-
dimethylaminopyridine (1 mg, 0.006 mmol, 0.10 eq.) in one portion and the reaction was 
allowed to  stir  for  24  hours at  room temperature. After this  time, the  reaction was 
quenched  by  adding  a  saturated  solution  of  sodium  hydrogen  carbonate  (2  mL), 
dichloromethane (2 mL) was added and the resulting biphasic solution stirred for 15 
minutes at  room temperature. The organic layer was separated and the aqueous layer 
extracted with dichloromethane (3 x 2 mL). The combined organic layers were washed 
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with  a  saturated solution of  sodium chloride (4  mL),  dried over  magnesium sulfate, 
filtered and concentrated in vacuo.
(2S*,3R*,4S*,6S*)-Ethyl-3,4-diacetoxy-1-benzyl-6-(trifluoromethyl)piperidine-2-
carboxylate (272).
13
15
9
7
26
11
NF3C
Ph
8
O
O 10
O
O
O
O
C20H24F3NO6
Mol. Wt.: 431.4
Following  the  general  procedure  N,  (2S,3R,4S,6S)-ethyl-1-benzyl-3,4-dihydroxy-6-
(trifluoromethyl)piperidine-2-carboxylate  271 and  (2R,3S,4R,6R)-ethyl-1-benzyl-3,4-
dihydroxy-6-(trifluoromethyl)piperidine-2-carboxylate 271 (20 mg, 0.06 mmol) afforded 
a yellow oil, which was purified by preparative TLC (90% hexane, 10% ethyl acetate) to 
give the title compound 272 (13 mg, 0.03 mmol, 50%) as a pale yellow solid.
M.p. 84-86 °C; νmax(neat)/cm-1 3030, 2926, 1791, 1749; δH (300 MHz; CDCl3) 7.32-7.24 
(5H, m, Ar-H), 5.36-5.32 (1H, m, H-C3), 5.02 (1H, ddd, J  10.7, 4.4, 3.2, H-C4), 4.28-
4.14 (2H, m, H-C9), 4.14 (1H, d, J  14.3, H-C7), 4.04-3.93 (1H, m, H-C6), 3.74-3.72 (1H, 
m, H-C2), 3.74 (1H, d,  J  14.3, H-C7), 2.19-2.04 (2H, m, H-C5), 2.03 (3H, s, H-C13), 
1.96 (3H, s, H-C15), 1.22 (3H, t,  J  7.2, H-C10); δC (75.5 MHz; CDCl3)  169.9 (C12), 
169.9 (C14), 169.6 (C8), 137.7 (ArC), 128.4 (ArC), 128.3 (ArC), 127.6 (ArC), 67.9 (C3), 
66.7 (C4), 61.4 (C2), 61.2 (C9), 60.4 (C7), 53.9 (C6), 25.6 (q, J  2.4, C5), 20.8 (C13 and 
C15), 14.2 (C10); δF (282 MHz, CDCl3) -68.61 (d, JH-F 6.8); m/z (CI) 432 (MH+, 100), 358 
(30), 298 (62); HRMS (ES) Found [M+H]+ 432.1626, C20H25F3NO6 requires 432.1628.
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2,2,2-Trifluoroacetaldehyde  (535)  and  (E)-4-Methyl-N-(2,2,2-
trifluoroethylidene)benzenesulfonamide  (273)  and  (±)-4-Methyl-N-(1,1,1-
trifluoropent-4-yn-2-yl)benzenesulfonamide (274).
6
7
9
1
3
5
10
NH
CF3
S OO
88
7
C12H12F3NO2S
Mol. Wt.: 291.29
3
4
6
2
7
N
CF3
S OO
55
4
 C9H8F3NO2S
Mol. Wt.: 251.23
and
CF3
O
and
2
 C2HF3O
Mol. Wt.: 98.02
A round-bottomed flask was equipped with a dropping funnel and a reflux condenser 
fitted with a collection flask immersed in a –78 C° cold bath. The flask was charged with 
a 90% aqueous solution of (±)-1-ethoxy-2,2,2-trifluoroethanol 187 (3.3 mL, 25.58 mmol, 
2.19 eq.) and heated to 80 °C. To this solution was added a 98% sulphuric acid (6.2 mL) 
dropwise and the mixture stirred for 30 minutes at 80 °C. This process produced a grey 
gas, which was condensed to afford the title compound 535 as a colourless oil which was 
used  in  the  next  step  immediately.  A  sealed  vessel  was  charged  with  4-
methylbenzenesulfonamide (2.00 g, 11.70 mmol, 1.00 eq.), tetrahydrofuran (10 mL) and 
pyridine (45 µL). The resulting solution was stirred at room temperature and an excess 
amount of  2,2,2-trifluoroacetaldehyde  535 added dropwise. The vessel was sealed and 
stirred at room temperature for 48 hours. The mixture was concentrated in vacuo and 
thionyl chloride (2 mL) and benzene (5 mL) added. A reflux condenser was fitted to the 
flask  and  the  mixture  heated  at  reflux  temperature  for  5  hours.  The  mixture  was 
concentrated in vacuo to afford the title compound 273 (2.64 g, 10.55 mmol, 90%) as a 
sticky yellow oil which was used in the next step immediately. A round-bottomed flask 
was  charged  with  (E)-4-methyl-N-(2,2,2-trifluoroethylidene)benzenesulfonamide 273 
(2.64 g, 10.55 mmol, 1.00 eq.), a 80 % w/v solution of 3-bromoprop-1-yne in toluene 
(2.06 g,  13.76 mmol, 1.30 eq.)  and  N,N-dimethylformamide (19 mL).  The resulting 
solution was cooled to 0  °C and coarse zinc powder (899 mg) was added portionwise, 
followed by  chlorotrimethylsilane (4  drops)  dropwise.  The resulting  suspension  was 
warmed to room temperature and stirred for 2 hours. The mixture was then cooled to 0 °C 
and a saturated aqueous solution of ammonium chloride (40 mL) was added dropwise 
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followed by diethyl ether (40 mL). The organic layer was separated and the aqueous layer 
was extracted with diethyl ether (3 x 20 mL). The combined organic layers were washed 
with a saturated aqueous solution of sodium chloride (60 mL), dried over magnesium 
sulfate, filtered and concentrated in vacuo. This afforded a yellow oil which was purified 
by flash column chromatography (90% hexane 10% ethyl  acetate) to afford the  title 
compound 274 (757 mg, 2.60 mmol, 22%) as a white solid.
M.p. 108-111 °C;  νmax(KBr)/cm-1 3296, 3296, 3043, 2930, 2359, 1598;  δH (300 MHz; 
CDCl3) 7.77 (2H, d, J  8.4, H-C7), 7.31 (2H, d, J  8.4, H-C8), 5.30 (1H, d, J  9.9, H-NH), 
4.11-3.99 (1H, m, H-C2), 2.57 (2H, dd, J  5.4, 2.7, H-C3), 2.43 (3H, s, H-C10), 2.04 (1H, 
t, J  2.7, H-C5); δC (75.5 MHz; CDCl3) 144.1 (C9), 137.2 (C6), 129.7 (C8), 127.1 (C7), 
76.0 (C4), 73.0 (C5), 52.9 (q, J  31.4, C2), 21.6 (C10), 19.9 (q, J  2.3, C3); δF (282 MHz, 
CDCl3) -75.43 (d, JH-F  6.9); m/z (CI) 292 (MH+, 100), 252 (13), 138 (34); HRMS (ES) 
Found [M+NH4]+ 309.0881, C12H16F3N2O2S requires 309.0879.
General procedure O: alkyne silylation on 25.00 mmol scale.  To a stirred solution of 
an alkyne derivative (25.00 mmol, 1.00 eq.) in tetrahydrofuran (40 mL) at – 78 °C was 
added dropwise, a 2.5 M solution of n-butyllithium in hexane (20 mL, 50.00 mmol, 2.00 
eq.) over 30 minutes. The resulting solution was stirred at –78 °C for a further 1 hour and 
30 minutes. After this time, trimethylsilyl chloride (6.35 mL, 50.00 mmol, 2.00 eq.) was 
added dropwise to the solution, the cold bath removed and the reaction stirred for 1 hour 
while being allowed to warm to room temperature. A 1.0 M solution of hydrochloric acid 
(50 mL) was then added and the reaction was stirred at room temperature for a further 45 
minutes. The aqueous layer was then extracted with  diethyl  ether (3  x  25 mL), the 
combined organic layers were washed with ice cold water (50 mL), dried over magnesium 
sulfate, filtered and concentrated in vacuo.
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(±)-4-Methyl-N-(1,1,1-trifluoro-5-(trimethylsilyl)pent-4-yn-2-yl)benzenesulfonamide 
(275).
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7
C15H20F3NO2SSi
Mol. Wt.: 363.47
Following  the  general  procedure  O,  (±)-4-methyl-N-(1,1,1-trifluoropent-4-yn-2-
yl)benzenesulfonamide  274 (857  mg,  2.94 mmol)  afforded a  brown oil,  which was 
purified by flash column chromatography (80% hexane, 20% ethyl acetate) to give the 
title compound  275 (485 g, 1.33 mmol, 45%) as a white solid.
M.p. 128-129 °C; νmax(nujol)/cm-1 3314, 3278, 2954; δH (300 MHz; CDCl3) 7.77 (2H, d, J 
8.3, H-C7), 7.32 (2H, d, J  8.3, H-C8), 5.10 (1H, d, J  9.7, H-NH), 4.08-3.94 (1H, m, H-
C2), 2.62-2.58 (2H, m, H-C3), 2.44 (3H, s, H-C10), 0.17 (9H, s, H-CTMS); δC (75.5 
MHz; CDCl3) 144.1 (C9), 137.2 (C6), 129.8 (C8), 127.0 (C7), 99.9 (C5), 97.6 (C4), 53.0 
(q,  J  32.5, C2), 21.6 (C10), 21.4 (q,  J  2.0, C3),  -0.2 (CTMS); δF  (282 MHz, CDCl3) 
-75.18 (d,  JH-F  6.9);  m/z (CI) 364 (MH+, 100), 209 (35), 125 (44); HRMS (ES) Found 
[M+NH4]+ 381.1273, C15H24F3N2O2SSi requires 381.1274.
4-(Trimethylsilyl)but-3-yn-1-ol (250).
OH
TMS
C7H14OSi
Mol. Wt.: 142.27
1
4
Following the general procedure O, 3-butyn-1-ol 248 (1.75 g, 25.00 mmol) gave a pale 
yellow oil, which was purified by distillation under reduced pressure (29 °C, 0.2 mmHg) 
to give the title compound  250 (2.16 g, 14.90 mmol, 61%) as a colourless oil.
δH (300 MHz; CDCl3) 3.73 (2H, t, J 9.2, H-C1), 2.52 (2H, t, J 9.2, H-C2), 1.31 (1H, bs, 
H-OH), 0.17 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 103.2 (C3), 87.0 (C4), 60.8 (C1), 
24.2 (C2), 0.0 (CTMS). Data in agreement with literature values.
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(±)-5-Trimethylsilyl-4-pentyn-2-ol (251).
OH
TMS
C8H16OSi
Mol. Wt.: 156.30
1
5
Following the general procedure O, (±)-4-pentyn-2-ol  249 (2.10 g, 25.00 mmol) gave a 
pale yellow oil,  which was purified  by  distillation  under reduced pressure (70°C,  5 
mmHg) to give the title compound 251 (3.10 g, 19.27 mmol, 79%) as a colourless oil.
δH (300 MHz; CDCl3) 3.99-3.89 (1H, m, H-C2), 2.44 (1H, dd,  J 5.1, 16.8, H-C3), 2.35 
(1H, dd, J 6.6, 16.8, H-C3), 1.82 (1H, bs, H-OH), 1.26 (3H, d, J 6.0, H-C1), 0.16 (9H, s, 
H-CTMS); δC (75.5 MHz; CDCl3) 103.3 (C4), 87.7 (C5), 66.2 (C2), 30.4 (C3), 22.2 (C1), 
0.0 (CTMS). Data in agreement with literature values.
(Z)-4-Trimethylsilyl-3-buten-1-ol (252).           
OH
TMS
C7H16OSi
Mol. Wt.: 144.29
1
4
Following  the  general procedure H,  4-trimethylsilyl-3-butyn-1-ol  249  (2.12 g,  14.90 
mmol) afforded a  pale  yellow oil,  which was purified by  distillation  under  reduced 
pressure (64 °C, 0.7 mmHg) to give the title compound 252 (1.39 g, 9.62 mmol, 65%) as 
a colourless oil.
δH (300 MHz; CDCl3) 6.30 (1H, td, J 7.5, 15.0, H-C3), 5.70 (1H, d, J 15.0, H-C4), 3.69 
(2H, t, J 7.5, H-C1), 2.42 (2H, dt, J 7.5, 7.5, H-C2), 1.43 (1H, bs, H-OH), 0.14 (9H, s, H-
CTMS);  δC (75.5  MHz;  CDCl3)  143.9  (C3),  132.8  (C4),  61.9  (C1),  36.4  (C2),  0.0 
(CTMS). Data in agreement with literature values.
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(±)-(Z)-5-Trimethylsilyl-4-penten-2-ol (253).
OH
TMS
C8H18OSi
Mol. Wt.: 158.31
1
5
Following the general procedure H, (±)-5-trimethylsilyl-4-pentyn-2-ol 251 (3.01 g, 19.27 
mmol) gave a pale yellow oil, which was purified by distillation under reduced pressure 
(24 °C, 0.15 mmHg) to give the  title compound 253 (2.00 g, 12.64 mmol, 66%) as a 
colourless oil.
δH (300 MHz; CDCl3) 6.33 (1H, ddd, J 7.0, 7.0, 14.1, H-C4), 5.70 (1H, ddd, J 1.2, 1.2, 
14.1, H-C5), 3.91-3.82 (1H, m, H-C2), 2.33-2.28 (2H, m, H-C3), 1.54 (1H, bs, H-OH), 
1.23 (3H, d,  J 6.2, H-C1), 0.14 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 144.2 (C4), 
132.8 (C5),  67.5 (C2),  43.0  (C3),  22.9 (C1),  0.3  (CTMS). Data in  agreement with 
literature values.
(Z)-4-(Trimethylsilyl)but-3-enyl 4-methylbenzenesulfonate (254).
OS
O
O
TMS
C14H22O3SSi
Mol. Wt.: 298.47
1
4
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Following the general procedure A, (Z)-4-trimethylsilyl-3-buten-1-ol  252 (1.39g, 9.62 
mmol) gave after 5 hours of stirring, a yellow oil which was purified by flash column 
chromatography (90% petroleum ether 10% ethyl acetate) to give the title compound 254 
(2.50 g, 8.39 mmol, 87%) as a colourless oil.
δH (300 MHz; CDCl3) 7.80 (2H, d, J 8.3, H-C6), 7.36 (2H, d, J 8.3, H-C7) 6.12 (1H, td, J 
7.2, 14.4, H-C3), 5.65 (1H, td, J 1.3, 14.3, H-C4), 4.04 (2H, t, J 7.2, H-C1), 2.48 (2H, ddt, 
J 1.3, 7.2, 7.2 H-C2), 2.45 (3H, s, H-C9), 0.07 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 
144.9 (C8), 141.2 (C3), 133.8 (C4), 133.1 (C5), 129.8 (C7), 127.9 (C6), 69.5 (C1), 32.7 
(C2), 21.7 (C9), 0.0 (CTMS). Data in agreement with literature values.
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(±)-(Z)-5-(Trimethylsilyl)pent-4-en-2-yl 4-methylbenzenesulfonate (255).
OS
O
O
TMS
5
1
10
 C15H24O3SSi
Mol. Wt.: 312.5
Following the general procedure A, (±)-(Z)-5-trimethylsilyl-4-penten-2-ol  253 (2.00 g, 
12.64 mmol) gave  after overnight stirring a  yellow oil  which was  purified by  flash 
column chromatography  (90% petroleum ether  10%  ethyl  acetate) to  give  the  title 
compound 255 (2.26 g, 7.23 mmol, 57%) as a colourless oil.
δH (300 MHz; CDCl3) 7.80 (2H, d, J 8.1, H-C7), 7.34 (2H, d, J 8.1, H-C8), 6.07 (1H, ddd, 
J 7.0, 7.0, 14.1, H-C4), 5.57 (1H, d, J 14.1, H-C5), 4.66-4.60 (1H, m, H-C2), 2.51-2.30 
(2H, m, H-C3), 2.45 (3H, s, H-C10), 1.28 (3H, d, J 6.4, H-C1), 0.07 (9H, s, H-CTMS); δ
C (75.5 MHz; CDCl3) 144.6 (C9), 141.3 (C4), 133.2 (C6), 132.2 (C5), 129.7 (C8), 127.8 
(C7), 79.5 (C2), 40.8 (C3), 21.6 (C10), 20.4 (C1), 0.0 (CTMS). Data in agreement with 
literature values.
(Z)-N-Benzyl-4-(trimethylsilyl)but-3-en-1-amine (256).
N
H
Ph
TMS
C14H23NSi
Mol. Wt.: 233.42
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Following  the  general  procedure  B,  (±)-(Z)-4-(trimethylsilyl)but-3-enyl(4-
methylbenzene)sulfonate 254 (2.50 g, 8.39 mmol), in the presence of benzylamine (4.50 
g, 41.95 mmol), was consumed based on analysis by TLC after 5 hours of stirring and 
heating. The excess of benzylamine was distilled (50 °C, 2 mmHg) and the work-up gave 
a yellow oil, which was purified by flash column chromatography (90% petroleum ether 
9% ethyl acetate 1% triethylamine) to give the title compound 256 (1.53 g, 6.56 mmol, 
78%) as a colourless oil.
δH (300 MHz; CDCl3) 7.39-7.23 (5H, m, ArH), 6.30 (1H, td, J 7.0, 14.1, H-C3), 5.60 (1H, 
td, J 1.2, 14.1, H-C4) 3.81 (2H, s, H-C5), 2.72 (2H, t, J 7.0, H-C1), 2.37 (2H, ddt, J 1.2, 
7.0, 7.0 H-C2), 1.34 (1H. bs, H-NH) 0.13 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 145.8 
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(C3), 140.5 (ArC), 131.1 (C4), 128.2 (ArC), 127.9 (ArC), 126.8 (ArC), 53.6 (C5), 48.7 
(C1), 33.6 (C2), 0.0 (CTMS). Data in agreement with literature values.
(Z)-N-Benzyl-5-(trimethylsilyl)pent-4-en-2-amine (257).
N
H
Ph
TMS
C15H25NSi
Mol. Wt.: 247.45
5
1
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Following  the  general  procedure  B,  (±)-(Z)-5-(trimethylsilyl)pent-4-en-2-yl(4-
methylbenzene)sulfonate 255 (2.26 g, 7.23 mmol), in the presence of benzylamine (3.88 
g, 36.15 mmol), was consumed based on analysis by TLC after 5 hours of stirring and 
heating. The excess of benzylamine was distilled (50 °C, 2 mmHg) and the work-up gave 
a yellow oil, which was purified by flash column chromatography (90% petroleum ether 
9% ethyl acetate 1% triethylamine) to give the title compound 257 (1.92 g, 7.74 mmol, 
100 %) as a colourless oil.
δH (300 MHz; CDCl3) 7.39-7.24 (5H, m, ArH), 6.29 (1H, ddd, J 7.1, 7.1, 14.2, H-C4), 
5.63 (1H, ddd, J 1.4, 1.4, 14.2, H-C5), 3.90 (1H, d, J 13.2, H-C6), 3.80 (1H, d, J 13.2, H-
C6), 2.80 (1H, ddq, J 6.4, 6.4, 6.4, H-C2), 2.45-2.33 (1H, m, H-C3), 2.31-2.19 (1H, m, H-
C3), 1.68 (1H, bs, H-NH), 1.15 (3H, d,  J 6.4, H-C1), 0.14 (9H, s, H-CTMS); δC (75.5 
MHz; CDCl3) 145.7 (C4), 140.7 (ArC), 131.3 (C5), 128.2 (ArC), 127.9 (ArC), 126.7 
(ArC), 52.3 (C2), 51.1 (C6), 40.3 (C3), 19.9 (C1), 0.0 (CTMS). Data in agreement with 
literature values.
 (±)-trans-Ethyl 1-benzyl-6-methyl-1,2,5,6-tetrahydropyridine-2-carboxylate (258).
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C16H21NO2
Mol. Wt.: 259.34
Following  the  general  procedure M,  (Z)-N-benzyl-5-(trimethylsilyl)pent-4-en-2-amine 
257 (604 mg, 2.44 mmol), in the presence of a pre-heated 42% solution of ethyl 2-
oxoacetate in toluene (558 mg, 2.44 mmol, 1.00 eq.), was consumed based on analysis by 
TLC after 48 hours of stirring at room temperature instead of reflux. The work-up gave a 
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yellow oil, which was purified by flash column chromatography (90% hexane 10% ethyl 
acetate) to give the title compound 258 (468 mg, 1.81 mmol, 74%) as a colourless oil.
νmax(neat)/cm-1 2964, 1737, 1453, 1273; δH (300 MHz; CDCl3) 7.48-7.42 (2H, m, ArH), 
7.35-7.23 (3H, m, ArH), 5.94-5.86 (1H, m, H-C4), 5.76-5.66 (1H, m, H-C3), 4.23-4.07 
(2H, m, H-C9), 3.88 (1H, d, J 13.6, H-C7), 3.83 (1H, m, H-C2), 3.80 (1H, d, J 13.6, H-
C7), 3.37-3.32 (1H, m, H-C6), 2.27-2.21 (1H, m, H-C5), 2.00-1.88 (1H, m, H-C5), 1.28 
(3H, t,  J 7.1, H-C10), 1.16 (3H, d,  J 6.6, H-C11);  δC (75.5 MHz; CDCl3) 172.8 (C9), 
139.6 (ArC), 128.8 (ArC), 128.4 (ArC), 127.0 (ArC), 126.4 (C4), 123.2 (C3), 60.7 (C9), 
57.1 (C2), 53.2 (C7), 51.0 (C6), 31.8 (C5), 15.6 (C11), 14.3 (C10); m/z (CI) 260 (MH+, 
100), 186 (44); HRMS (CI) Found [M]+ 259.1574, C16H21NO2 requires 259.1572.
 (±)-Ethyl 1-benzyl-6-methyl-1,4,5,6-tetrahydropyridine-2-carboxylate (259).
7
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6 N O
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 C16H21NO2
Mol. Wt.: 259.34
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A round-bottomed flask  was  charged  with  (±)-trans-ethyl  1-benzyl-6-methyl-1,2,5,6-
tetrahydropyridine-2-carboxylate 258 (69 mg, 0.27 mmol, 1.0 eq.) and methanol (3 mL). 
The resulting solution was stirred at room temperature and a 1.0 M aqueous solution of 
lithium  hydroxide  (0.72  mL)  added  dropwise.  The  mixture  was  stirred  at  room 
temperature overnight, water (5 mL) and dichloromethane (5 mL) added, the organic 
layer separated and the aqueous layer extracted with dichloromethane (2 x 5 mL). The 
combined organic layers were dried over magnesium sulfate, filtered and concentrated in 
vacuo. This gave the  title compound 259 (40 mg, 0.15 mmol, 58%) as a colourless oil 
which was used in the next step without any further purification.
δH (300 MHz; CDCl3) 7.52-7.26 (5H, m, Ar-H), 6.16-6.12 (1H, m, H-C3), 4.32-4.19 (3H, 
m, H-C9 and H-C7), 3.73 (1H, d, J 14.4, H-C7), 3.15-3.06 (1H, m, H-C6), 2.18-2.12 (2H, 
m, H-C4), 1.65-1.52 (1H, m, H-C5), 1.47-1.38 (1H, m, H-C5), 1.34 (3H, t, J 7.3, H-C10), 
0.91 (3H, d, J 6.3, H-C11); δC (75.5 MHz; CDCl3) 166.2 (C8), 139.7 (C2), 137.1 (ArC), 
128.3 (ArC), 128.1 (ArC), 126.8 (ArC), 117.1 (C3), 60.6 (C9), 56.7 (C7), 49.5 (C6), 22.3 
(C5), 19.4 (C4), 17.3 (C11), 14.2 (C10); m/z (CI) 260 (MH+, 100), 217 (18), 143 (10).
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(±)-trans-Ethyl  6-methylpiperidine-2-carboxylate  (262)  and  (±)-cis-Ethyl  6-
methylpiperidine-2-carboxylate (263).
26
10 N
H 7O
O
26
10 N
H 7O
O
8 8
 C9H17NO2
Mol. Wt.: 171.24
A solution of (±)-trans-ethyl 1-benzyl-6-methyl-1,2,5,6-tetrahydropyridine-2-carboxylate 
258 (125 mg, 0.48 mmol) in absolute ethanol (3 mL) was injected into a hydrogenation 
flask containing a prehydrogenated suspension of 20% palladium hydroxide (70 mg, 10% 
weight) in absolute ethanol (2 mL). The hydrogenation was complete in 5 hours. The 
mixture was filtered through celite, which was washed with diethyl ether (10 mL) and 
concentrated in vacuo to afford the  title compounds 262 and  263 (72 mg, 0.42 mmol, 
87%) as a colourless oil.
Data for 262: δH (300 MHz; CDCl3) 4.19 (2H, q, J 7.1, H-C8), 3.72 (1H, dd, J  4.8, 3.0, 
H-C2), 2.98-2.85 (1H, m, H-C6), 2.57 (1H, bs, H-NH), 2.13-2.03 (1H, m, H-C3), 1.81-
1.71 (1H, m, H-C3), 1.64-1.60 (1H, m, H-C4), 1.59-1.54 (1H, m, H-C5), 1.37-1.30 (1H, 
m, H-C4), 1.27 (3H, t,  J  7.1, H-C9), 1.22-1.17 (1H, m, H-C5), 1.07 (3H, d,  J  6.3, H-
C10); δC (75.5 MHz; CDCl3) 173.9 (C7), 60.8 (C2), 55.9 (C8), 47.8 (C6), 33.0 (C5), 26.1 
(C10), 22.5 (C3), 21.3 (C9), 14.3 (C4); m/z (CI) (mixture) 172 (MH+, 100), 170 (15). Data 
in agreement with literature values.
Data for 263: δH (300 MHz; CDCl3) 4.19 (2H, q, J  7.1, H-C8), 3.34 (1H, dd, J  11.3, 2.8, 
H-C2), 2.72-2.57 (1H, m, H-C6), 2.57 (1H, s, N-NH), 2.02-1.93 (1H, m, H-C3), 1.90-1.81 
(1H, m, H-C4), 1.71-1.64 (1H, m, H-C4), 1.44-1.37 (1H, m, H-C3), 1.36-1.32 (1H, m, H-
C5), 1.25 (3H, t, J  7.1, H-C9), 1.18-1.13 (1H, m, H-C5), 1.12 (3H, d, J  6.3, H-C10); δ
C (75.5 MHz; CDCl3) 173.2 (C7), 60.9 (C2), 59.3 (C8), 51.9 (C6), 33.6 (C5), 28.8 (C10), 
24.5 (C3), 22.7 (C9), 14.2 (C4). Data in agreement with literature values.
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(±)-trans-6-Methylpiperidine-2-carboxylic  acid  hydrochloride  (264)  and (±)-cis-6-
Methylpiperidine-2-carboxylic acid hydrochloride (265).
26
8 N
H 7O
OH
.HCl
C7H14ClNO2
Mol. Wt.: 179.64
26
8 N
H 7O
OH
.HCl
A round-bottomed flask fitted with a condenser was charged with a 2:1 mixture of (±)-
trans-ethyl 6-methylpiperidine-2-carboxylate 262 and (±)-cis-ethyl 6-methylpiperidine-2-
carboxylate 263 (40 mg, 0.23 mmol, 1.00 eq.). To this was added 10.15 M hydrochloric 
acid (3 mL) and the resulting mixture was heated to reflux temperature for 2 hours. The 
resulting solution was concentrated  in vacuo and then freeze dried to afford the  title 
compound 264 and 265 (34 mg, 0.19 mmol, 83%) as a pale yellow solid.
Data  for  265: M.p.  (mixture)  >250  °C  decomposes (Lit.:  >250  °C  decomposes); 
νmax(neat)/cm-1 (mixture) 3390, 2945, 1731; δH (300 MHz; D2O) 3.78 (1H, dd, J  12.0, 2.9, 
H-C2), 3.31-3.16 (1H, m, H-C6), 2.31-2.21 (1H, m, H-C3), 1.98-1.81 (2H, m, H-C5), 
1.66-1.53 (2H, m, H-C4), 1.45-1.34 (1H, m, H-C3), 1.32 (3H, d, J  6.4, H-C8); δC (75.5 
MHz; D2O) 173.1 (C7), 59.2 (C2), 53.8 (C6), 30.2 (C5), 26.4 (C3), 22.8 (C4), 19.2 (C8). 
Data in agreement with literature values.
Data for 264:  δH (300 MHz; D2O) 4.13 (1H, t,  J  5.2, H-C2), 3.66-3.54 (1H, m, H-C6), 
2.16-2.00 (1H, m, H-C3), 1.94-1.81 (2H, m, H-C5), 1.80-1.69 (1H, m, H-C3), 1.54-1.44 
(2H, m, H-C4), 1.31 (3H, d, J  6.7, H-C8); δC (75.5 MHz; D2O) 173.0 (C7), 55.3 (C2), 
50.6 (C6), 29.5 (C5), 25.5 (C3), 19.0 (C4), 17.7 (C8). Data in agreement with literature 
values.
(±)-Ethyl 1-benzyl-1,2,5,6-tetrahydropyridine-2-carboxylate (268).7
N
Ph
O
O
C15H19NO2
Mol. Wt.: 245.32
6
2
7
10
Following the general procedure M, (Z)-N-benzyl-4-(trimethylsilyl)but-3-en-1-amine 256 
(162 mg, 0.70 mmol), was consumed based on analysis by TLC after 15 hours of stirring 
at  reflux.  The  work  up  gave  a  yellow  oil,  which  was  purified  by  flash  column 
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chromatography (90% hexane 10% ethyl acetate) to give the title compound 268 (120 mg, 
0.49 mmol, 70%) as a colourless oil. 
δH (400 MHz; CDCl3) 7.38-7.27 (5H, m, ArH), 5.97-5.95 (1H, m, H-C4), 5.72-5.67 (1H, 
m, H-C5), 4.26-4.16 (2H, m, H-C9), 3.88 (1H, d, J 13.8, H-C7), 3.85 (1H, bs, H-C6), 3.64 
(1H, d, J 13.8, H-C7), 3.13 (1H, m, H-C2), 2.53 (1H, m, H-C2), 2.15 (2H, m, H-C3), 1.27 
(3H, t,  J 7.2, H-C10); δC (75.5 MHz; CDCl3) 172.3 (C8), 138.5 (ArC), 129.5 (ArCH), 
128.8 (ArCH), 128.7 (ArCH), 127.6 (C5), 123.9 (C4), 63.1 (C6), 61.1 (C9), 59.8 (C7), 
45.3 (C2), 25.6 (C3), 14.7 (C10). Data in agreement with literature values.
(2R*,3S*,4R*)-Ethyl 1-benzyl-3,4-dihydroxypiperidine-2-carboxylate (269).
7
9
10
2
4
6 N
OH
OH
O
Ph O
 C15H21NO4
Mol. Wt.: 279.33
Following  the  general  procedure  J,  ethyl  1-benzyl-1,2,5,6-tetrahydropyridine-2-
carboxylate 268 (36 mg, 0.15 mmol) afforded the title compound 269 (15 mg, 0.05 mmol, 
36%)  as  a  pale  yellow  oil  which  was  used  in  the  next  step  without  any  further 
purification.
νmax(neat)/cm-1 3413, 2958, 2850, 1732, 1657;  δH (300 MHz; CDCl3) 7.39-7.26 (5H, m, 
Ar-H), 4.29-4.26 (2H, q, J 7.1, H-C9), 4.11-4.08 (1H, m, H-C3), 3.93 (1H, d, J 14.5, H-
C7), 3.88-3.82 (1H, m, H-C4), 3.73 (1H, d,  J 14.5, H-C7), 3.55 (1H, d,  J 6.0, H-C2), 
2.95-2.85 (1H, m, H-C6), 2.64-2.57 (1H, m, H-C6), 1.89-1.75 (2H, m, H-C5), 1.25 (3H, t, 
J 7.1, H-C10); δC (75.5 MHz; CDCl3) 169.7 (C8), 129.2 (ArC), 128.5 (ArC), 128.5 (ArC), 
127.7 (ArC), 70.1 (C4), 67.0 (C3), 64.9 (C2), 60.1 (C9), 58.1 (C7), 44.9 (C6), 28.9 (C5), 
14.2 (C10).
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(2R*,3S*,4R*)-Ethyl 3,4-diacetoxy-1-benzylpiperidine-2-carboxylate (270).
7
9
10
13
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O
O
O
O
O
Ph O
C19H25NO6
Mol. Wt.: 363.4
Following the general procedure N, (2R,3S,4R)-ethyl 1-benzyl-3,4-dihydroxypiperidine-
2-carboxylate 269 and (2S,3R,4S)-ethyl 1-benzyl-3,4-dihydroxypiperidine-2-carboxylate 
269 (9 mg, 0.03 mmol) afforded a pale yellow oil, which was purified by preparatory 
TLC (90% hexane, 10% ethyl acetate) to give the title compound 270 (8 mg, 0.02 mmol, 
69 %) as a sticky pale yellow oil.
νmax(neat)/cm-1 2958, 2853, 1745, 1651; δH (300 MHz; CDCl3) 7.37-7.27 (5H, m, Ar-H), 
5.30 (1H, dd, J  7.1, 3.1, H-C3), 5.22 (1H, td, J  6.7, 3.1, H-C4), 4.25-4.16 (2H, m, H-C9), 
3.82 (2H, d, J  13.6, H-C7), 3.54 (2H, d, J  13.6, H-C7), 3.53 (1H, d, J  7.1, H-C2), 2.92-
2.80 (1H, m, H-C6), 2.53-2.42 (1H, m, H-C6), 2.06 (3H, s, H-C13), 2.06 (3H, s, H-C14), 
1.95-1.76 (2H, m, H-C5), 1.32-1.26 (3H, m, H-C10); δC (75.5 MHz; CDCl3) 170.4 (C8), 
170.1 (C11), 169.8 (C12), 128.7 (ArC), 128.3 (ArC), 128.3 (ArC), 127.3 (ArC), 70.4 
(C3), 67.7 (C4), 64.8 (C2), 61.1 (C9), 59.3 (C7), 45.3 (C6), 29.7 (C5), 21.1 (C13), 20.8 
(C14), 14.2 (C10); m/z (CI) 364 (MH+, 100), 304 (15), 290 (25); HRMS (FI) Found [M]+ 
363.1676, C19H25NO6 requires 363.1682.
General procedure P: Epoxidation of alkenes with  meta-chloroperbenzoic acid on 
53.48 mmol scale. A round-bottomed flask was charged with 77% meta-chloroperbenzoic 
acid in water (23.98 g, 106.95 mmol, 2.00 eq.), sodium hydrogen carbonate (18.02 g, 
213.90 mmol, 4.00 eq.) and dichloromethane (230 mL). The resulting suspension was 
stirred  and  cooled  to  0  °C  and  an  alkene  derivative  (53.48  mmol,  1.00  eq.)  in 
dichloromethane was added dropwise. The mixture was stirred vigorously until  NMR 
showed complete consumption of starting material and a saturated aqueous solution of 
sodium hydrogen carbonate (200 mL) was added. The organic layer was separated and the 
aqueous layer was extracted with dichloromethane (3 x 100 mL). The combined organic 
layers were washed with a saturated solution of sodium sulfite (2 x 100 mL), a saturated 
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aqueous solution of sodium hydrogen carbonate (100 mL), dried over magnesium sulfate, 
filtered, and concentrated in vacuo.  
 (±)-(2,3-cis)-2,3-Dipropyloxirane (298).
29
O
3 6
 C8H16O
Mol. Wt.: 128.21
Following  the  general  procedure  P,  (Z)-oct-4-ene  298 (6.00  g,  53.48  mmol),  was 
consumed based on analysis by NMR after 72 hours of stirring at 0  °C. The work-up 
afforded a pale yellow oil, which was purified by distillation under reduced pressure (28 
°C, 2mmHg) to give the title compound 298 (5.69 g, 44.41 mmol, 83%) as a colourless 
oil.
δH (300 MHz; CDCl3) 2.95-2.87 (2H, m, H-C2 and H-C3), 1.58-1.41 (8H, m, H-C4, H-
C5, H-C7 and H-C8), 1.02-0.93 (6H, m, H-C6 and H-C9); m/z (CI) 129 (MH+, 64), 111 
(100). Data in agreement with literature values.
 (±)-(2,3-trans)-2,3-Dipropyloxirane (301).
2
3
6
 C8H16O
Mol. Wt.: 128.21
O
9
Following  the  general  procedure  P,  (E)-oct-4-ene  299 (3.93  g,  35.00  mmol),  was 
consumed based on analysis by NMR after 92 hours of stirring at 0  °C. The work-up 
afforded a pale yellow oil, which was purified by distillation under reduced pressure (20 
°C, 1.5 mmHg) to give the title compound 301 (3.02 g, 23.53 mmol, 67%) as a colourless 
oil.
δH (300 MHz; CDCl3) 2.68-2.62 (2H, m, H-C2 and H-C3), 1.55-1.39 (8H, m, H-C4, H-
C5, H-C7 and H-C8), 0.98-0.90 (6H, m, H-C6 and H-C9); m/z (CI) 129 (MH+, 98), 111 
(100). Data in agreement with literature values.
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 (±)-(4,5-syn)-5-((Trimethylsilyl)ethynyl)octan-4-ol (302).
1
8
3
10
7 4
OH
 C13H26OSi
Mol. Wt.: 226.43
TMS
Following the general procedure G, (±)-(2,3-cis)-2,3-dipropyloxirane 300 (2.33 g, 18.18 
mmol) afforded a pale yellow oil, which was purified by flash column chromatography 
(97% hexane, 3% ethyl acetate) to give the  title compound 302 (822 mg, 3.63 mmol, 
20%) as a colourless oil.
δH (300 MHz; CDCl3) 3.50-3.39 (1H, m, H-4), 2.44 (1H, td, J  9.2, 4.7, H-C5), 1.73 (1H, 
d, J  7.7, H-OH), 1.66-1.25 (8H, m, H-C3 and H-C2, H-C8 and H-C9), 0.98-0.88 (6H, m, 
H-C1 and H-C10), 0.16 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 106.4 (C7), 88.6 (C6), 
72.6 (C4), 40.0 (C3), 37.7 (C5), 33.8 (C8), 20.7 (C9), 19.0 (C2), 14.1 (C1), 13.9 (C10), 
0.2 (CTMS). Data in agreement with literature values.
(±)-(4,5-anti)-5-((Trimethylsilyl)ethynyl)octan-4-ol (303).
1
8
3
10
7 4
OH
 C13H26OSi
Mol. Wt.: 226.43
TMS
Following  the  general  procedure G,  (±)-(2,3-trans)-2,3-dipropyloxirane  301  (1.37 g, 
10.67  mmol)  afforded  a  pale  yellow  oil,  which  was  purified  by  flash  column 
chromatography (95% hexane, 5% ethyl acetate) to give the title compound 303 (1.23 g, 
5.43 mmol, 51%) as a colourless oil.
δH (300 MHz; CDCl3)  3.57-3.49 (1H, m, H-C4), 2.49 (1H, td,  J  9.8, 5.1, H-C5), 1.90 
(1H, bs, H-OH), 1.61-1.44 (4H, m, H-C3 and H-C8), 1.44-1.24 (4H, m, H-C2 and H-C9), 
0.95-0.86 (6H, m, H-C1 and H-C10),  0.12 (9H, s,  H-CTMS);  δC (75.5 MHz; CDCl3) 
107.5 (C7), 87.7 (C6), 73.0 (C4), 40.0 (C3), 35.8 (C5), 32.1 (C8), 20.6 (C9), 19.0 (C2), 
14.0 (C1), 13.9 (C10), 0.1 (CTMS). Data in agreement with literature values.
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 (±)-(4,5-syn,Z)-5-(2-(Trimethylsilyl)vinyl)octan-4-ol  (304) and  (±)-(4,5-syn,E)-5-(2-
(Trimethylsilyl)vinyl)octan-4-ol (305).
1
8
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10
7
OH
TMS
 C13H28OSi
Mol. Wt.: 228.45
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Following  the  general  procedure H,  (±)-(4,5-syn)-5-((trimethylsilyl)ethynyl)octan-4-ol 
302 (812 mg, 3.57 mmol) afforded a yellow oil, which was purified by flash column 
chromatography (97% hexane, 3% ethyl acetate) to give the title compounds 304 and 305 
(227 mg, 0.99 mmol, 28%) as a colourless oil.
Data for  304:  νmax(neat)/cm-1 (mixture) 3435, 2958, 1672, 1608;  δH (300 MHz; CDCl3) 
6.07 (1H, dd, J  14.2, 10.6, H-C6), 5.71 (1H, d, J  14.2, H-C7), 3.50-3.33 (1H, m, H-C4), 
2.09-1.95 (1H, m, H-C5), 1.61-1.13 (8H, m, H-C3 and H-C2 and H-C8 and H-C9), 0.98-
0.84 (6H, m, H-C1 and H-C10), 0.06 (9H, s, H-CTMS);  δC (75.5 MHz; CDCl3)  146.9 
(C6), 134.4 (C7), 73.1 (C4), 53.1 (C5), 36.8 (C3), 32.8 (C8), 20.5 (C9), 18.9 (C2), 14.6 
(C1), 14.2 (C10), -1.1 (CTMS); m/z (CI) 229 (MH+, 4), 211 (70), 156 (50).
Data for 305: δH (300 MHz; CDCl3) 6.01-5.74 (2H, m, H-C6 and H-C7), 3.50-3.33 (1H, 
m, H-C4), 2.29-2.14 (1H, m, H-C5), 1.61-1.13 (8H, m, H-C3 and H-C2 and H-C8 and H-
C9), 0.98-0.84 (6H, m, H-C1 and H-C10), 0.13 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 
149.3 (C6), 132.9 (C7), 73.0 (C4), 49.4 (C5), 36.3 (C3), 33.3 (C8), 20.7 (C9), 18.8 (C2), 
14.5 (C1), 14.2 (C10), 0.5 (CTMS).
 (±)-(4,5-anti,Z)-5-(2-(Trimethylsilyl)vinyl)octan-4-ol (306).
1
8
3
10
7
OH
TMS
 C13H28OSi
Mol. Wt.: 228.45
Following the  general procedure H,  (±)-(4,5-anti)-5-((trimethylsilyl)ethynyl)octan-4-ol 
303 (1.23 g, 5.40 mmol) afforded after 48 hours at reflux temperature a pale yellow oil, 
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which was purified by flash column chromatography (94% hexane, 6% ethyl acetate) to 
give the title compound 306 (860 mg, 3.76 mmol, 70%) as a colourless oil.
νmax(neat)/cm-1 3352, 2957, 1608; δH (300 MHz; CDCl3) 6.08 (1H, dd, J  14.2, 10.6, H-
C6), 5.63 (1H, d,  J  14.2, H-C7), 3.52-3.43 (1H, m, H-C4), 2.35-2.24 (1H, m, H-C5), 
1.63-1.41 (2H, m, H-C3), 1.40-1.11 (6H, m, H-C2 and H-C8 and H-C9), 0.95-0.86 (6H, 
m, H-C1 and H-C10), 0.12 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 149.5 (C6), 131.7 
(C7), 74.6 (C4), 49.4 (C5), 36.3 (C3), 32.9 (C8), 20.6 (C9), 19.5 (C2), 14.6 (C1), 14.0 
(C10), 0.6 (CTMS); m/z (CI) 229 (MH+, 30), 211 (97), 137 (100).
 (±)-(4,5-anti)-5-((Z)-2-(Trimethylsilyl)vinyl)octan-4-yl  trifluoromethanesulfonate 
(308).
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 C14H27F3O3SSi
Mol. Wt.: 360.51
Following the general procedure K, (±)-(4,5-anti,Z)-5-(2-(trimethylsilyl)vinyl)octan-4-ol 
306 (100 mg, 0.44 mmol) afforded a pale pink oil, which was purified by flash column 
chromatography (90% dichloromethane, 10% methanol) to give the title compound 308 
(91 mg, 0.25 mmol, 58%) as a colourless oil.
νmax(neat)/cm-1 2959, 1605, 837; δH (300 MHz; CDCl3) 5.97 (1H, dd, J  14.0, 10.1, H-C6), 
5.34 (1H, d, J 14.0, H-C7), 5.22-5.11 (1H, m, H-C4), 2.79-2.66 (1H, m, H-C5), 1.95-1.84 
(2H, m, H-C3), 1.37-1.09 (6H, m, H-C2 and H-C8 and H-C9), 0.86 (3H, t, J  7.4, H-C1), 
0.81-0.75 (3H, m, H-C10), 0.01 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3)  152.1 (C6), 
131.7 (C7), 131.4 (C4), 127.3 (C5), 46.3 (C3), 37.8 (C8), 25.7 (C9), 20.3 (C2), 14.2 (C1), 
13.9 (C10), 0.4 (CTMS).
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 (±)-(4,5-anti)-5-((Z)-2-(Trimethylsilyl)vinyl)octan-4-yl  4-methylbenzenesulfonate 
(307).
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 C20H34O3SSi
Mol. Wt.: 382.63
Following the general procedure A,  (±)-(4,5-anti,Z)-5-(2-(trimethylsilyl)vinyl)octan-4-ol 
306 (482 mg, 2.11 mmol) was consumed based on analysis by TLC after 48 hours of 
stirring at 0 °C. The work-up afforded a yellow oil, which was purified by flash column 
chromatography (97% petroleum ether, 3% ethyl acetate) to give the title compound 307 
(246 mg, 0.64 mmol, 30%) as a colourless oil.
νmax(neat)/cm-1 2959, 2873, 1609; δH (300 MHz; CDCl3) 7.78 (2H, d, J  8.2, H-C12), 7.31 
(2H, d, J  8.2, H-C13), 5.84 (1H, dd, J  14.3, 10.4, H-C6), 5.43 (1H, d, J  14.3, H-C7), 
4.49 (1H, dd, J  11.9, 5.8, H-C4), 2.49-2.42 (1H, m, H-C5), 2.43 (3H, s, H-C15), 1.75-
1.51 (2H, m, H-C3), 1.49-1.01 (6H, m, H-C2 and H-C8 and H-C9), 0.82 (3H, t, J  7.3, H-
C1),  0.84-0.79 (6H, m,  H-C10 and H-C15), 0.07  (9H, s,  H-CTMS); δC (75.5 MHz; 
CDCl3) 147.3 (C6), 144.3 (C14), 134.6 (C11), 131.5 (C7), 129.5 (C13), 127.8 (C12), 87.0 
(C4), 46.1 (C5), 34.5 (C3), 32.1 (C8), 21.6 (C15), 20.2 (C9), 18.4 (C2), 14.3 (C1), 13.8 
(C10), 0.3 (CTMS).
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 (±)-(4,5-syn,Z)-N-Benzyl-5-(2-(trimethylsilyl)vinyl)octan-4-amine (309).
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 C20H35NSi
Mol. Wt.: 317.58
Following the general procedure B, (±)-(4,5-anti)-5-((Z)-2-(trimethylsilyl)vinyl)octan-4-
yl 4-methylbenzenesulfonate 307 (156 mg, 0.41 mmol), in the presence of benzylamine 
(214 mg, 2.00 mmol), was consumed based on analysis by TLC after 20 hours of stirring 
and heating. The excess of benzylamine was distilled (104 °C, 245 mmHg) and the work-
up gave a yellow oil, which was purified by flash column chromatography (94% hexane 
5% ethyl acetate 1% triethylamine) to give the title compound 309 (22 mg, 0.07 mmol, 
17%) as a colourless oil.
νmax(neat)/cm-1 3327, 2956, 1604;  δH (300 MHz; CDCl3)  7.38-7.19 (5H, m, Ar-H), 6.12 
(1H, dd, J  14.2, 10.4, H-C6), 5.58 (1H, d, J  14.2, H-C7), 3.81 (1H, d, J 13.0, H-C11), 
3.74 (1H, d, J 13.0, H-C11), 2.48 (1H, dd, J  9.9, 4.9, H-C4), 2.35 (1H, ddd, J  14.2, 9.6, 
4.9, H-C5), 1.58-1.25 (6H, m, H-C3 and H-C8 and H-C2), 1.23-1.06 (2H, m, H-C9), 
0.93-0.84 (6H, m, H-C1 and H-C10), 0.11 (9H, s,  H-CTMS);  δC (75.5 MHz; CDCl3) 
150.9 (C6), 141.3 (ArC), 130.8 (C7), 128.3 (ArC), 127.9 (ArC), 126.8 (ArC), 60.3 (C4), 
52.2 (C11), 46.0 (C5), 33.3 (C3), 33.0 (C8), 20.8 (C9), 19.1 (C2), 14.6 (C1), 14.4 (C10), 
0.5 (CTMS); m/z (CI) 318 (MH+, 20), 162 (100); HRMS (ES) Found [M+H]+ 318.2614, 
C20H36NSi requires 318.2612.
(E)-N-Butylidene(phenyl)methanamine  (314)  and  (±)-(4,5-anti)-N-Benzyl-5-
((trimethylsilyl)ethynyl)octan-4-amine (315).
1
4
5
N
C11H15N
Mol. Wt.: 161.24
7
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3
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4
HN PhTMS
 C20H33NSi
Mol. Wt.: 315.57
and
A round-bottomed flask was charged with magnesium sulfate (120.36 g, 277.20 mmol, 
4.00 eq.), benzylamine (7.42 g, 69.30 mmol, 1.00 eq.) and dichloromethane (200 mL). 
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The resulting suspension was stirred at room temperature and butyraldehyde 313 (6.21 
mL, 69.30 mmol, 1.00 eq.) added dropwise. The mixture was stirred overnight at room 
temperature,  filtered and concentrated in vacuo  to afford  a pale yellow oil.  This was 
purified by  distillation under reduced pressure (130 °C,  20 mmHg) to give the  title 
compound 314 (2.10 g, 13.02 mmol, 19%) as a colourless oil which was used in the next 
step immediately.
δH (300 MHz; CDCl3) 7.79 (1H, t, J 4.9, H-C1), 7.38-7.21 (5H, m, Ar-H), 4.57 (2H, s, H-
C5), 2.34-2.24 (2H, m, H-C2), 1.67-1.53 (2H, m, H-C3), 0.97 (3H, t, J 7.4, H-C4). Data 
in agreement with literature values.
A three-necked round-bottomed flask equipped with a dropping funnel and a thermometer 
was charged with  hex-1-ynyltrimethylsilane  311 (308 mg, 2.00 mmol, 1.00 eq.)  and 
tetrahydrofuran (10 mL). The resulting solution was stirred and cooled to –40 °C and a 
1.4 M solution of sec-butyllithium in cyclohexane (1.57 mL, 2.20 mmol, 1.10 eq.) was 
added dropwise. The mixture was slowly warmed to 0 °C for 1 hour, cooled to –20 °C 
and a 1.0 M solution of anhydrous zinc (II) bromide in tetrahydrofuran (2.20 mL, 2.20 
mmol, 1.10 eq.) added dropwise, which gave a colourless solution. This solution was then 
cooled to –70 °C and 314 (322 mg, 2.00 mmol, 1.00 eq.) in tetrahydrofuran (5 mL) added 
dropwise over 10 minutes. The mixture was then stirred at –70 °C for 1 hour, warmed 
slowly to  0  °C, and a  solution of  2  parts saturated aqueous  solution of  ammonium 
chloride to 1 part 30% aqueous solution of ammonia (10 mL) was added dropwise. Also 
to the mixture was added water (10 mL) and diethyl ether (10 mL) and the organic layer 
was separated. The aqueous layer was extracted with diethyl ether (2 x 10 mL) and the 
combined organic  layers were washed with  a  saturated aqueous solution  of  sodium 
chloride, dried over magnesium sulfate, filtered, and concentrated in vacuo. This afforded 
a yellow oil, which was purified by flash column chromatography (95% hexane, 5% ethyl 
acetate) to give the title compound  315 (410 mg, 1.30 mmol, 65%) as a pale yellow oil.
νmax(neat)/cm-1 3340, 2958, 2164, 1604; δH (300 MHz; CDCl3) 7.39-7.19 (5H, m, Ar-H), 
3.92-3.69 (2H, m, H-C11), 2.62-2.47 (2H, m, H-C4 and H-C5), 1.68-1.19 (8H, m, H-C3 
and H-C2 and H-C8 and H-C9), 1.02-0.84 (6H, m, H-C1 and H-C10), 0.14 (9H, s, H-
CTMS);  δC (75.5 MHz; CDCl3)  141.1 (ArC), 128.2 (ArC), 128.1 (ArC), 126.7 (ArC), 
108.9 (C7), 86.7 (C6), 59.1 (C4), 51.2 (C11), 36.7 (C5), 34.1 (C3), 33.0 (C8), 21.0 (C9), 
19.3 (C2), 14.3 (C1), 14.0 (C10), 0.2 (CTMS); m/z (CI) 316 (MH+, 65), 162 (100); HRMS 
(ES) Found [M+H]+ 316.2458, C20H34NSi requires 316.2455.
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 (±)-(4,5-syn,Z)-N-Benzyl-5-(2-(trimethylsilyl)vinyl)octan-4-amine (316) and (±)-(4,5-
syn,E)-N-Benzyl-5-(2-(trimethylsilyl)vinyl)octan-4-amine (317).
1
8
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HN Ph
 C20H35NSi
Mol. Wt.: 317.58
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Following  the  general  procedure  H,  (±)-(4,5-anti)-N-benzyl-5-
((trimethylsilyl)ethynyl)octan-4-amine 315 (1.23 g, 3.90 mmol) afforded a pale yellow 
oil,  which was purified by flash column chromatography (98% dichloromethane, 2% 
methanol) to give the title compound 316 (124 mg, 0.39 mmol, 10%) as a colourless oil.
Further elution (98% dichloromethane, 2% methanol) provided the other title compound 
317 (250 mg, 0.79 mmol, 20%) as a colourless oil.
Data for  317:  νmax(neat)/cm-1 3328, 3027, 2956, 1605;  δH (300 MHz; CDCl3)  7.39-7.19 
(5H, m, Ar-H), 5.86-5.60 (2H, m, H-C6 and H-C7), 3.80 (1H, d,  J  12.9, H-C11), 3.68 
(1H, d,  J  12.9, H-C11), 2.50-2.37 (1H, m, H-C4), 2.21-2.06 (1H, m, H-C5), 1.56-1.07 
(8H, m, H-C3 and H-C2 and H-C8 and H-C9), 0.93-0.82 (6H, m, H-C1 and H-C10), 0.04 
(9H, s, H-CTMS); δC (75.5 MHz; CDCl3)  148.9 (C6), 132.3 (ArC), 128.3 (C7), 128.3 
(ArC), 128.2 (ArC), 126.7 (ArC), 59.7 (C4), 51.8 (C11), 49.9 (C5), 33.4 (C3), 32.4 (C8), 
20.7 (C9), 18.8 (C2), 14.5 (C1), 14.2 (C10), -1.1 (CTMS); m/z (CI) 318 (MH+, 80), 162 
(100); HRMS (ES) Found [M+H]+ 318.2615, C20H36NSi requires 318.2612.
 (Z)-(1-Azidobut-3-enyl)trimethylsilane (361).
N3
1
4
TMS
C7H15N3Si
Mol. Wt.: 169.30
A round-bottomed flask  equipped with  a  reflux condenser  was  charged  with  (Z)-4-
(trimethylsilyl)but-3-enyl 4-methylbenzenesulfonate 254 (9.13 g, 30.59 mmol, 1.00 eq.) 
and  N,N-dimethylformamide (61 mL). Sodium azide (5.98 g, 91.78 mmol, 3.00 eq.) was 
added portionwise and the resulting solution was allowed to warm to 60 °C, stirred at this 
temperature for 4 hour and poured into a mixture of diethyl ether:water (200 mL, 3:7, 
v/v). The resulting biphasic solution was stirred for 30 minutes at room temperature, the 
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aqueous layer separated and the organic layer washed with water (3 x  30 mL).  The 
combined aqueous layers were extracted with diethyl ether (3 x 50 mL) and the combined 
organic layers washed with saturated aqueous solution of sodium chloride (50 mL), dried 
over magnesium sulfate, filtered and concentrated under reduced pressure. This afforded a 
pale yellow oil which was purified by flash column chromatography (95% hexane 5% 
diethyl ether) to afford the title compound 361 (4.26 g, 25.16 mmol, 82%) as a colourless 
oil.
δH (300 MHz; CDCl3) 6.25 (1H, td, J  13.7, 6.7, H-C3), 5.67 (1H, d, J  13.7, H-C4), 3.30 
(2H, t,  J  6.9, H-C1), 2.42 (2H, td,  J  6.9, 6.7, H-C2), 0.13 (9H, s, H-CTMS); δC (75.5 
MHz; CDCl3)  143.5  (C3),  133.1 (C4),  51.2 (C1),  33.0  (C2),  0.2  (CTMS). Data  in 
agreement with literature values.
 (Z)-4-(Trimethylsilyl)but-3-en-1-amine (322).
1
4
TMS
NH2
 C7H17NSi
Mol. Wt.: 143.3
A  round-bottomed  flask  connected  to  a  syringe  pump  was  charged  with  lithium 
aluminium hydride (1.00 g, 26.43 mmol, 1.05 eq.) and tetrahydrofuran (106 mL). The 
resulting suspension was allowed to cool to 0 °C and stirred before adding a solution of 
(Z)-(1-azidobut-3-enyl)trimethylsilane  361  (4.26  g,  25.17  mmol,  1.00  eq.)  in 
tetrahydrofuran (25 mL) dropwise over 2 hours. The reaction was then stirred for a further 
30 minutes at 0 °C, carefully quenched at 0 °C by addition of a saturated aqueous solution 
of  sodium chloride (100  mL),  and then diethyl  ether (100 mL) was added and the 
resulting  mixture allowed to  warm to  room temperature whilst  being  stirred for  30 
minutes. The mixture was filtered through a pad of celite, the organic layer separated and 
the aqueous layer extracted with diethyl ether (3 x 30 mL). The combined organic layers 
were dried over sodium sulfate, filtered and concentrated in vacuo. This afforded a pale 
yellow oil, which was purified by distillation under reduced pressure (110 °C, 90 mmHg) 
to give the title compound 322 (2.42 g, 16.86 mmol, 67%) as a colourless oil.
δH (300 MHz; CDCl3) 6.17 (1H, td, J 14.3, 7.4, H-C3), 5.52 (1H, td, J  14.3, 1.2, H-C4), 
2.67 (2H, t, J  6.9, H-C1), 2.18 (2H, dq, J  6.9, 1.2, H-C2), 1.17 (2H, bs, H-NH2), 0.03 
(9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 145.9 (C3), 131.5 (C4), 42.0 (C1), 37.6 (C2), 
0.2 (CTMS). Data in agreement with literature values.
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General Procedure Q: imine formation followed by imine-vinylsilane cyclisation and 
benzyloxyl carbonyl protection: A round-bottomed flask was charged with magnesium 
sulfate (2.0 g) and an aldehyde derivative (1.40 mmol, 1.00 eq.) in dichloromethane (5 
mL). To the resulting suspension was added a primary amine (200 mg, 1.40 mmol, 1.00 
eq.) in dichloromethane (1 mL) dropwise and the mixture was stirred vigorously at room 
temperature overnight. The mixture was filtered and concentrated in vacuo. This afforded 
an imine derivative, which was used in the next step without further purification. A round-
bottomed  flask  equipped  with  a  reflux  condenser  was  charged  with  scandium(III) 
trifluoromethanesulfonate (268 mg, 0.55 mmol, 2.00 eq.) and acetonitrile (1.5 mL). To the 
resulting suspension was added an imine derivative (0.28 mmol, 1.00 eq.) in acetonitrile 
(0.5 mL) and the mixture was heated to reflux temperature until NMR showed complete 
consumption of starting material. The solution was cooled to room temperature, water (5 
mL) and dichloromethane (5 mL) were added and the resulting biphasic solution was 
stirred for 30 minutes at  room temperature. The organic layer was separated and the 
aqueous layers were extracted with dichloromethane (3 x 5 mL). The combined organic 
layers  were dried over  magnesium sulfate,  filtered and  concentrated  in  vacuo.  This 
afforded a 2-substituted tetrahydropyridine derivative, which was used in the next step 
without further purification. A round-bottomed flask was charged with a 2-substituted 
tetrahydropyridine derivative (0.40 mmol, 1.00 eq.), water (1.0 mL) and tetrahydrofuran 
(1.0 mL). The resulting biphasic solution was stirred and cooled to 0  °C, then sodium 
hydrogen carbonate (155 mg, 1.19 mmol, 3.00 eq.) was added portionwise, followed by 
benzyloxycarbonyl chloride (78  µL, 0.55 mmol, 1.40 eq.) dropwise. The mixture was 
allowed to warm slowly to room temperature and stirred until GCMS showed complete 
consumption of starting material. The solution was then diluted with ethyl acetate (5 mL), 
the organic layer was separated and the aqueous layer extracted with ethyl acetate (3 x 5 
mL). The combined organic layers were washed with a saturated aqueous solution of 
sodium chloride (5 mL),  dried over magnesium sulfate, filtered, and concentrated  in 
vacuo. 
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(3Z)-N-Benzylidene-4-(trimethylsilyl)but-3-en-1-amine  (362)  and  (±)-2-Phenyl-
1,2,5,6-tetrahydropyridine (369).
1
4
TMS
N
Ph5
and 2
4
6
N
H
Ph
 C11H13N
  Mol. Wt.: 159.23
 C14H21NSi
Mol. Wt.: 231.41
Following the general procedure Q, (Z)-4-(trimethylsilyl)but-3-en-1-amine 322 (350 mg, 
2.44 mmol) in the presence of benzaldehyde (259 mg, 2.44 mmol), afforded the  title 
compound 362 (706 mg, 2.44 mmol, quantitative) as a yellow oil which was used in the 
next step without any further purification. The (3Z)-N-benzylidene-4-(trimethylsilyl)but-
3-en-1-amine 362 (45 mg, 0.20 mmol) after 240 hours at reflux was consumed based on 
analysis  by  NMR  to afford  a  yellow  oil,  which  was  purified  by  flash  column 
chromatography (95% dichloromethane, 5% methanol) to give the title compound 369 (16 
mg, 0.10 mmol, 50%) as a pale yellow oil.
δH (400 MHz; CDCl3) 7.38-7.24 (5H, m, Ar-H), 5.99-5.94 (1H, m, H-C4), 5.77-5.73 (1H, 
m, H-C3), 4.50-4.47 (1H, m, H-C2), 3.14-3.08 (1H, m, H-C6), 3.01-2.94 (1H, m, H-C6), 
2.30-2.21 (1H, m, H-C5), 2.13-2.07 (1H, m, H-C5); m/z (ES) 160 (MH+, 100). Data in 
agreement with literature values.
(3Z)-N-(Naphthalen-2-ylmethylene)-4-(trimethylsilyl)but-3-en-1-amine  (363)  and 
(±)-2-(Naphthalen-2-yl)-1,2,5,6-tetrahydropyridine (371a).  
2
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H
 C15H15N
Mol. Wt.: 209.29
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 C18H23NSi
Mol. Wt.: 281.47
Following the general procedure Q, (Z)-4-(trimethylsilyl)but-3-en-1-amine 322 (350 mg, 
2.44 mmol) in the presence of 2-naphthaldehyde (381 mg, 2.44 mmol), afforded the title 
compound 363 (706 mg, 2.44 mmol, quantitative) as a yellow oil which was used in the 
next  step  without  any  further purification.  The  (3Z)-N-(naphthalen-2-ylmethylene)-4-
(trimethylsilyl)but-3-en-1-amine 363 (40 mg, 0.14 mmol) after 120 hours at reflux was 
consumed based on analysis by NMR to afford a yellow oil, which was purified by flash 
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column chromatography (95% dichloromethane, 5% methanol) to give the title compound 
370 (14 mg, 0.07 mmol, 48%) as a pale yellow oil.
δH (400 MHz; CDCl3) 7.84-7.79 (4H, m, Ar-H), 7.56-7.43 (3H, m, Ar-H), 6.14-6.12 (1H, 
m, H-C4), 5.79 (1H, dd, J 10.4, 2.0, H-C3), 4.96 (1H, bs, H-C2), 3.01-2.90 (2H, m, H-
C6), 2.39-2.35 (1H, m, H-C5), 2.19-2.14 (1H, m, H-C5); m/z (ES) 210 (MH+, 95), 181 
(100).
 (±)-Benzyl 2-(naphthalen-2-yl)-1,2,5,6-tetrahydropyridine-1-carboxylate (372a).
2
4
6
N
OOPh
78
 C23H21NO2
Mol. Wt.: 343.42
Following the general procedure Q, 2-(naphthalen-2-yl)-1,2,5,6-tetrahydropyridine 371a 
(10 mg, 0.05 mmol) afforded a  yellow oil,  which was  purified by  preparative  high 
performance liquid chromatography to give the title compound 372a (7 mg, 0.22 mmol, 
43%) as a sticky colourless oil.
νmax(neat)/cm-1 3057, 2896, 1698, 1600; δH (300 MHz; CDCl3) 7.88-7.67 (4H, m, Ar-H), 
7.54-7.40 (3H, m, Ar-H), 7.39-7.28 (5H, m, Ar-H), 6.16-6.05 (1H, m, H-C4), 6.03-5.88 
(1H, m, H-C3), 5.93-5.65 (1H, m, H-C2), 5.23 (1H, d,  J  12.3, H-C8), 5.14 (1H, d,  J 
12.3, H-C8), 4.35-3.98 (1H, m, H-C6), 3.04 (1H, ddd, J  13.3, 12.2, 4.0, H-C6), 2.49-2.26 
(1H, m, H-C5), 2.18-2.03 (1H, m, H-C5); δC (75.5 MHz; CDCl3) 155.3 (C7), 138.1 (ArC), 
133.1 (ArC), 128.5 (ArC), 128.2 (ArC), 128.0 (ArC), 128.0 (ArC), 127.6 (ArC), 126.9 
(C4), 126.7 (C3), 126.1 (ArC), 125.9 (ArC), 67.2 (C8), 55.0 (C2), 37.2 (C6), 24.9 (C5); 
m/z (CI) 344 (MH+,  60), 252 (27), 126 (100); HRMS (ES) Found [M+H]+ 344.1649, 
C23H22NO2 requires 344.1645.
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 (3Z)-N-(4-Nitrobenzylidene)-4-(trimethylsilyl)but-3-en-1-amine (364) and  (±)-2-(4-
Nitrophenyl)-1,2,5,6-tetrahydropyridine  (371b)  and  (±)-Benzyl  2-(4-nitrophenyl)-
1,2,5,6-tetrahydropyridine-1-carboxylate (372b).
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Following the general procedure Q, (Z)-4-(trimethylsilyl)but-3-en-1-amine 322 (150 mg, 
1.05 mmol) in the presence of 4-nitrobenzaldehyde (158 mg, 1.05 mmol), afforded the 
title compound 364 (288 mg, 1.04 mmol, quantitative) as a yellow oil, which was used in 
the  next  step  without  any  further  purification.  The  (3Z)-N-(4-nitrobenzylidene)-4-
(trimethylsilyl)but-3-en-1-amine 364 (190 mg, 0.69 mmol) after 17 hours at reflux was 
consumed based on analysis by NMR to afford the title compound 371b (121 mg, 0.59 
mmol,  86%) as  a  yellow oil  which  was  used in  the  next  step  without  any  further 
purification.  Then  2-(4-nitrophenyl)-1,2,5,6-tetrahydropyridine 371b (121  mg,  0.59 
mmol) afforded a yellow oil, which was purified by flash column chromatography (90% 
hexane, 10% ethyl acetate) to give the title compound 372b (124 mg, 0.37 mmol, 62%) as 
a colourless oil.
νmax(neat)/cm-1 3034, 2930, 1694, 1346;  δH (300 MHz; CDCl3)  8.15 (2H, d,  J  6.7, H-
C11), 7.67-7.39 (2H, m, H-C10), 7.40-7.24 (5H, m, Ar-H), 6.15-6.06 (1H, m, H-C4), 
5.93-5.75 (1H, m, H-C3), 5.77-5.52 (1H, m, H-C2), 5.20 (1H, d, J  12.2, H-C8), 5.11 (1H, 
d, J  12.2, H-C8), 4.39-4.04 (1H, m, H-C6), 2.95 (1H, ddd, J  13.5, 11.6, 4.1, H-C6), 2.45-
2.28 (1H, m, H-C5), 2.18-2.05 (1H, m, H-C5); δC (75.5 MHz; CDCl3) 155.1 (C7), 148.0 
(C12),  147.2 (C9), 136.3 (ArC), 128.5 (C10), 128.1 (ArC), 128.0 (ArC), 127.5 (C4), 
126.9 (ArC), 125.6 (C3), 123.6 (C11), 67.4 (C8), 54.4 (C2), 37.4 (C6), 24.7 (C5); m/z 
(CI)  339  (MH+,  100),  247  (25),  216  (35);  HRMS (ES)  Found  [M+H]+ 339.1340, 
C19H19N2O4 requires 339.1339.
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(3Z)-N-(3-Phenylpropylidene)-4-(trimethylsilyl)but-3-en-1-amine  (365)  and  (±)-2-
Phenethyl-1,2,5,6-tetrahydropyridine  (371c)  and  (±)-Benzyl  2-phenethyl-1,2,5,6-
tetrahydropyridine-1-carboxylate (372c).
2
4
6
N
OOPh
78
9
10
Ph
 C21H23NO2
Mol. Wt.: 321.41
2
4
6
N
H
7
8
Ph
 C13H17N
Mol. Wt.: 187.28
1
4
TMS
N
5 6
7 and and
Ph
 C16H25NSi
Mol. Wt.: 259.46
Following the general procedure Q, (Z)-4-(trimethylsilyl)but-3-en-1-amine 322 (150 mg, 
1.05 mmol) in the presence of 3-phenylpropanal (141 mg, 1.05 mmol), afforded the title 
compound 365 (262 mg, 1.01 mmol, 96%) as a yellow solid which was used in the next 
step  without  any  further  purification.  The  (3Z)-N-(3-phenylpropylidene)-4-
(trimethylsilyl)but-3-en-1-amine 365 (142 mg, 0.55 mmol) after 17 hours at reflux was 
consumed based on analysis by NMR to afford the  title compound 371c (58 mg, 0.31 
mmol,  57%) as  a  yellow oil  which  was  used in  the  next  step  without  any  further 
purification.  Then  2-phenethyl-1,2,5,6-tetrahydropyridine 371c (58  mg,  0.31  mmol) 
afforded a yellow oil, which was purified by flash column chromatography (90% hexane, 
10% ethyl  acetate) to  give the  title  compound 372c (55 mg, 0.17 mmol, 55%) as a 
colourless oil.
νmax(neat)/cm-1 3030, 2925, 1698; δH (300 MHz; CDCl3) 7.41-7.08 (10H, m, Ar-H), 5.90-
5.77 (1H, m, H-C4), 5.77-5.64 (1H, m, H-C3), 5.19 (1H, d, J  12.3, H-C8), 5.15-5.08 (1H, 
m, H-C8), 4.64-4.39 (1H, m, H-C2), 4.33-4.07 (1H, m, H-C6), 3.07-2.88 (1H, m, H-C6), 
2.73-2.57 (2H, m, H-C10), 2.38-2.16 (1H, m, H-C5), 2.06-1.93 (1H, m, H-C5), 1.95-1.81 
(2H, m, H-C9); δC (75.5 MHz; CDCl3)  155.3 (C7), 143.2 (ArC),  141.6 (ArC),  136.7 
(ArC), 129.6 (C3), 128.4 (ArC), 128.3 (ArC), 128.2 (ArC), 128.1 (ArC), 127.9 (ArC), 
127.0 (ArC), 125.8 (C4), 67.0 (C8), 51.9 (C2), 37.0 (C9), 35.8 (C6), 32.4 (C10), 24.8 
(C5); m/z (CI) 322 (MH+, 100), 216 (20), 188 (30); HRMS (ES) Found [M+H]+ 322.1796, 
C21H24NO2 requires 322.1802.
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(3Z)-N-Octylidene-4-(trimethylsilyl)but-3-en-1-amine (366) and (±)-2-Heptyl-1,2,5,6-
tetrahydropyridine  (371d)  and  (±)-Benzyl  2-heptyl-1,2,5,6-tetrahydropyridine-1-
carboxylate (372d).
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Following the general procedure Q, (Z)-4-(trimethylsilyl)but-3-en-1-amine 322 (150 mg, 
1.05 mmol) in the presence of octanal (134 mg, 1.05 mmol), afforded the title compound 
366 (232 mg, 0.92 mmol, 87%) as a yellow oil which was used in the next step without 
any further purification. The  (3Z)-N-octylidene-4-(trimethylsilyl)but-3-en-1-amine 366 
(143 mg, 0.56 mmol) after 17 hours at reflux was consumed based on analysis by NMR to 
afford the title compound 371d (85 mg, 0.47 mmol, 83%) as a yellow oil which was used 
in the next step without any further purification. Then 2-heptyl-1,2,5,6-tetrahydropyridine 
371d (85 mg, 0.47 mmol)  afforded a yellow oil, which was purified by flash column 
chromatography (90% hexane, 10% ethyl acetate) to give the  title compound 372d (74 
mg, 0.23 mmol, 50%) as a colourless oil.
νmax(neat)/cm-1 2926, 1702, 1425; δH (300 MHz; CDCl3) 7.41-7.28 (5H, m, Ar-H), 5.85-
5.74 (1H, m, H-C4), 5.74-5.59 (1H, m, H-C3), 5.23-5.07 (2H, m, H-C8), 4.54-4.31 (1H, 
m, H-C2), 4.30-4.04 (1H, m, H-C6), 3.08-2.80 (1H, m, H-C6), 2.35-2.09 (1H, m, H-C5), 
2.04-1.83 (1H, m, H-C5), 1.66-1.45 (2H, m, H-C9), 1.43-1.11 (10H, m, H-C10 to H-C14), 
0.88 (3H, t, J  6.7, H-C15); δC (75.5 MHz; CDCl3) 155.0 (C7), 136.9 (ArC), 129.0 (C3), 
128.4 (ArC), 128.3 (ArC), 127.8 (ArC), 124.6 (C4), 66.9 (C8), 52.2 (C2), 36.9 (C6), 34.3 
(C9), 31.8 (C13), 29.4 (C11 and C12), 26.1 (C10), 24.8 (C5), 22.6 (C14), 14.1 (C15); m/z 
(CI)  316  (MH+,  100),  216  (34),  111  (35);  HRMS (ES)  Found  [M+H]+ 316.2268, 
C20H30NO2 requires 316.2271.
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 (3Z)-N-(Cyclohexylmethylene)-4-(trimethylsilyl)but-3-en-1-amine (367) and  (±)-2-
Cyclohexyl-1,2,5,6-tetrahydropyridine  (371e)  and  (±)-Benzyl  2-cyclohexyl-1,2,5,6-
tetrahydropyridine-1-carboxylate (372e).
2
4
6
N
OOPh
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9
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 C19H25NO2
Mol. Wt.: 299.41
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H
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 C11H19N
Mol. Wt.: 165.28
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4
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N
5 6
7
97
8
8
 C14H27NSi
Mol. Wt.: 237.46
and and
Following the general procedure Q, (Z)-4-(trimethylsilyl)but-3-en-1-amine 322 (200 mg, 
1.40 mmol) in the presence of cyclohexanecarbaldehyde (156 mg, 1.40 mmol), afforded 
the title compound 367 (332 mg, 1.40 mmol, quantitative) as a yellow oil which was used 
in the next step without any further purification. The  (3Z)-N-(cyclohexylmethylene)-4-
(trimethylsilyl)but-3-en-1-amine 367 (66 mg, 0.28 mmol) after 17 hours at reflux was 
consumed based on analysis by NMR to afford the  title compound 371e (40 mg, 0.24 
mmol,  88%) as  a  yellow oil  which  was  used in  the  next  step  without  any  further 
purification.  Then  2-cyclohexyl-1,2,5,6-tetrahydropyridine  371e (40  mg,  0.24  mmol) 
afforded a yellow oil, which was purified by flash column chromatography (90% hexane, 
10% ethyl acetate) to  give the  title  compound 372e (32 mg, 0.11 mmol, 44%) as a 
colourless oil.
νmax(neat)/cm-1 3034, 2927, 1697, 1651; δH (300 MHz; CDCl3) 7.40-7.27 (5H, m, Ar-H), 
5.84-5.78 (1H, m, H-C4), 5.82-5.71 (1H, m, H-C3), 5.17 (1H, d, J  12.5, H-C8), 5.11 (1H, 
d, J  12.5, H-C8), 4.32-4.19 (1H, m, H-C2), 4.20-4.06 (1H, m, H-C6), 3.06-2.84 (1H, m, 
H-C6), 2.38-2.06 (1H, m, H-C5), 2.05-1.83 (1H, m, H-C5), 1.84-1.45 (5H, m, H-C9 and 
H-C10), 1.38-0.94 (6H, m, H-C11 and H-C12); δC (75.5 MHz; CDCl3) 155.6 (C7), 136.9 
(ArC), 128.4 (ArC), 127.8 (ArC), 127.7 (ArC), 127.3 (C3), 125.4 (C4), 66.9 (C8), 56.9 
(C2), 42.6 (C9), 38.1 (C6), 29.9 (C10), 29.8 (C10), 26.3 (C11), 26.2 (C11 and C12), 24.9 
(C5); m/z (CI) 300 (MH+, 100), 216 (30), 166 (12); HRMS (ES) Found [M+H]+ 300.1957, 
C19H26NO2 requires 300.1958.
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Pyridine-2,6-dicarbonyl dichloride (374).
6
4
2
N
Cl Cl
OO
 C7H3Cl2NO2
Mol. Wt.: 204.01
A round-bottomed flask equipped with a reflux condenser was charged with pyridine-2,6-
dicarboxylic acid 373 (8.40 g, 50.26 mmol, 1.00 eq.) and redistilled thionyl chloride (54 
mL) added dropwise. The resulting solution was stirred and heated to reflux temperature 
overnight, cooled to room temperature and concentrated in vacuo. This afforded the title 
compound 374 (10.20 g, 50.02 mmol, quantitative) as a cream solid, which was used in 
the next step without further purification.
M.p. 63-65 °C (Lit.: 60 °C in benzene); δH (300 MHz; CDCl3) 8.37 (2H, d, J 7.9, H-C3 
and H-C5), 8.19-8.13 (1H, m, H-C4); m/z (CI) 204 (M+, 100), 168 (64), 142 (22). Data in 
agreement with literature values.
(S)-2-Amino-3-methylbutan-1-ol (376). 
NH2
HO
C5H13NO
Mol. Wt.: 103.16
1
3
A round-bottomed flask equipped with  a  reflux condenser was  charged with  lithium 
aluminium hydride (10.63 g, 280.00 mmol, 2.00 eq.) and tetrahydrofuran (425 mL). The 
resulting suspension was stirred and cooled to 0 °C before adding slowly (S)-2-amino-3-
methyl-butyric acid 375 (16.40 g, 140 mmol,1 eq.) portionwise. The reaction was then 
stirred for an additional 1 hour at 0 °C, slowly warmed to room temperature and heated at 
reflux temperature overnight. After cooling to room temperature and then to 0 °C, a 2.0 M 
solution of sodium hydroxide (100 mL) was added dropwise to the reaction mixture, the 
organic layer separated and the precipitate extracted with boiling tetrahydrofuran (100 
mL) for 1 hour. The combined organic layers were concentrated in vacuo, the solution 
diluted  with  dichloromethane (50  mL)  and  washed with  saturated  aqueous sodium 
chloride  (40  mL).  The  organic  layer  was  dried  over  sodium  sulfate,  filtered  and 
concentrated in vacuo to afford the title compound 376 (11.18 g, 108 mmol, 77%) as a 
colourless oil which was used in the next step without any further purification.
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[α] 26D = +26.0 (c 1.0, CDCl3), (Lit.: [α]
18
D = +22.9 (c 0.6, EtOH)); δH (300 MHz; CDCl3) 
3.62-3.57 (1H, m, H-C1), 3.30-3.24 (1H, m, H-C1), 2.56-2.50 (1H, m, H-C2), 2.36 (3H, 
bs, H-OH and H-NH2) 1.61-1.49 (1H, m, H-C3), 0.89-0.86 (6H, m, H-C4); δC (75.5 MHz; 
CDCl3) 64.9 (C1), 58.8 (C2), 31.6 (C3), 19.7 (C4), 18.8 (C4). Data in agreement with 
literature values.
N,N-bis((R)-1-hydroxy-2-methylpropyl)pyridine-2,6-dicarboxamide (377)  and  2,6-
bis[(4S)-4-isopropyl-2-oxazolin-2-yl]pyridine (349).
N
HN
OO
NHHO OH
NO
N N
O
C17H23N3O2
Mol. Wt.: 301.38
26
4
8 8
10 10
2
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6
8 8
9 9
 C15H23N3O4
Mol. Wt.: 309.36
A round-bottomed flask equipped with a reflux condenser was charged with  (S)-(+)-2-
amino-3-methylbutan-1-ol 376 (7.60 g,  73.90 mmol),  triethylamine (28  mL,  201.50 
mmol) and chloroform (133 mL) and the resulting solution was stirred at 0 °C. To this 
solution was added dropwise, a solution of pyridine-2,6-dicarbonyl chloride 374 (6.85 g, 
33.58 mmol) in  chloroform (66 mL) over 45 minutes.  The resulting suspension was 
stirred and warmed to room temperature for 18 hours, thionyl chloride (24.80 mL) was 
added and the mixture heated to reflux temperature for 2 hours. The reaction mixture was 
slowly  poured  onto  ice  water  (100  mL),  the  organic  layer  separated, washed with 
saturated aqueous sodium chloride (50  mL), a  1.0 M aqueous solution of potassium 
carbonate (50  mL), and the  aqueous layer  extracted with  chloroform (50  mL). The 
combined organic layers were dried over sodium sulphate, filtered, and concencentrated 
in vacuo to give a brown solid which was purified by flash column chromatography (60% 
chloroform 40% ether) to afford the dihydrochloride salt of the title compound 377 as a 
light brown solid. A round-bottomed flask was charged with the dihydrochloride salt 377 
(12.63 g) a solution of sodium hydroxide (9.25 g) in water (123 mL) and methanol (262 
mL). The resulting suspension was stirred at room temperature for 72 hours, diluted with 
chloroform (420 mL), the organic layer was separated and washed with saturated aqueous 
sodium chloride (100 mL). The organic layer was dried over sodium sulphate, filtered, 
and concentrated in vacuo to afford a brown solid which was purified by recrystallization 
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(hexane / ethyl acetate) to afford the title compound 349 (3.40 g, 11.00 mmol, 22%) as a 
white solid.
M.p. 148-150 °C (Lit.: 151-154 °C; [α] 21D = -114.0 (c 1.0, CH2Cl2), (Lit.: [α]
20
D = -110.0 
(c 0.7, CH2Cl2)); δH (300 MHz; CDCl3) 8.22 (2H, d, J 7.8, H-C3 and H-C5), 7.88 (1H, t, J 
7.8, H-C4), 4.55 (2H, dd, J 8.3, 9.5, H-C8), 4.24 (2H, t,  J 8.3, H-C8), 4.16 (2H, ddd, J 
6.6, 8.3, 9.5, H-C9), 1.94-1.83 (2H, m, H-C10), 1.06 (6H, d, J 6.6, H-C11), 0.95 (6H, m, 
H-C11). Data in agreement with literature values.
(S)-Valine methyl ester hydrochloride (378).
6
3
1
54
OClH3N
O
 C6H14ClNO2
Mol. Wt.: 167.63
A round-bottomed flask equipped with a reflux condenser was charged with methanol 
(208 mL). This was stirred and cooled to –10 °C and re-distilled thionyl chloride (18.25 
mL, 250.00 mmol, 2.00 eq.) was added dropwise over 15 minutes. The resulting solution 
was stirred for a further 10 minutes and (S)-2-amino-3-methylbutanoic acid 375 (14.64 g, 
125.00 mmol, 1.00 eq.) added portionwise. The mixture was slowly warmed to room 
temperature and then heated to reflux temperature for 20 hours. The mixture was cooled 
to room temperature and filtered to afford the title compound 378 (14.42 g, 86.02 mmol, 
69%) as a white solid which was used in the next step without further purification.
M.p. 165-168 °C (Lit.: 168-170 °C); [α] 25D  + 14.1 (c 1.0, H2O), (Lit.: [α]
25
D  + 24.2 (c 
1.0, MeOH)); δH (300 MHz; CDCl3) 8.84 (3H, s, H-NH2+), 4.04-3.90 (1H, m, H-C2), 3.81 
(3H, s, H-C6), 2.53-2.40 (1H, m, H-C3), 1.14 (3H, d, J  4.5, H-C5), 1.12 (3H, d, J  4.4, H-
C4); δC (75.5 MHz; CDCl3) 168.7 (C1), 58.6 (C2), 52.9 (C6), 29.8 (C3), 18.3 (C5), 18.3 
(C4). Data in agreement with literature values.
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(S)-2-Amino-3-methyl-1,1-diphenylbutan-1-ol (379).
3
1
54
OH
Ph Ph
H2N
 C17H21NO
Mol. Wt.: 255.35
A round-bottomed flask equipped with a reflux condenser and a dropping funnel was 
charged with magnesium (4.80 g, 198.00 mmol, 5.50 eq.). Then bromobenzene (10.00 g, 
63.83 mmol, 1.77 eq.) was added dropwise and the resulting suspension was stirred and 
heated to 45 °C for 15 minutes. To the mixture was added bromobenzene (18.2 g, 114.89 
mmol, 3.19 eq.) in tetrahydrofuran (150 mL) at a dropwise rate that allowed steady reflux 
over 1 hour. The mixture was heated to 65 °C for 1 hour, cooled to 0 °C and (S)-valine 
methyl ester hydrochloride  378 (6.00 g, 36.00 mmol, 1.00 eq.) added portionwise. The 
mixture was heated to 65 °C, stirred overnight, cooled to room temperature and diluted 
with diethyl ether (100 mL). To the mixture was added dropwise a saturated aqueous 
solution of ammonium chloride (100 mL), the organic layer was separated and washed 
with a saturated aqueous solution of sodium chloride (100 mL). The organic layer was 
dried over sodium carbonate, filtered and concentrated in vacuo. This afforded a yellow 
oil which was purified by flash column chromatography (67% hexane 33% ethyl acetate) 
to afford the title compound 379 (7.01 g, 27.45 mmol, 76%) as a white solid.
M.p. 91-92 °C (Lit.: 94-95 °C); [α] 25D  - 127.0 (c 0.9, CHCl3), (Lit.: [α]
25
D  - 113.1 (c 1.0, 
CHCl3));  δH (300 MHz; CDCl3)  7.62 (2H, d,  J  7.6, Ar-H), 7.49 (2H, d,  J  7.6, Ar-H), 
7.35-7.24 (4H, m, Ar-H), 7.23-7.12 (2H, m, Ar-H), 3.85 (1H, d, J  1.9, H-C2), 1.83-1.67 
(1H, m, H-C3), 0.93 (3H, d, J  7.0, H-C5), 0.89 (3H, d, J  6.8, H-C4); m/z (CI) 238 (M(-
OH)+, 100), 182 (50), 105 (60). Data in agreement with literature values.
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N,N-Bis((S)-1-hydroxy-3-methyl-1,1-diphenylbutan-2-yl)pyridine-2,6-dicarboxamide 
(380) and 2,6-Bis((S)-4-isopropyl-5,5-diphenyl-4,5-dihydrooxazol-2-yl)pyridine (348).
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Mol. Wt.: 605.77
12
 C41H43N3O4
Mol. Wt.: 641.8
and
A round-bottomed flask was charged with (S)-2-amino-3-methyl-1,1-diphenylbutan-1-ol 
379 (6.83 g, 26.75 mmol, 2.00 eq.) and dichloromethane (80 mL). The resulting solution 
was stirred and cooled to 0 °C, triethylamine (9.32 mL, 66.88 mmol, 5.00 eq.) was added 
dropwise followed by a solution of pyridine-2,6-dicarbonyl dichloride 374 (2.73 g, 13.37 
mmol,  1.00  eq.)  in  dichloromethane (13  mL) dropwise.  The  resulting  solution  was 
warmed to room temperature and stirred for 20 hours, diluted with dichloromethane (50 
mL) and washed with a saturated aqueous solution of sodium hydrogen carbonate (50 
mL), water (50 mL) and a saturated aqueous solution of sodium chloride (50 mL). The 
organic layer was dried over magnesium sulfate, filtered and concentrated in vacuo. This 
afforded a pale yellow oil which was purified by flash column chromatography (67% 
hexane 33% ethyl acetate) to afford the title compound 380 (3.23 g, 5.03 mmol, 38%) as a 
sticky pale yellow oil which was used immediately in the next step.
[α] 25D  - 46.2 (c 1.0, CHCl3), (Lit.: [α]
25
D  - 50.3 (c 1.0, CHCl3)); δH (300 MHz; CDCl3) 
8.28 (2H, d, J 10.2, H-NH), 8.20 (2H, d, J  7.7, H-C3 and H-C5), 8.00-7.93 (1H, m, H-
C4), 7.57-7.49 (8H, m, Ar-H), 7.38 (4H, t, J  7.6, Ar-H), 7.25-7.16 (6H, m, Ar-H), 7.13-
7.05 (2H, m, Ar-H), 5.09 (2H, dd, J  10.2, 1.7, H-C8), 1.98-1.86 (2H, m, H-C10), 1.13 
(3H, d, J  6.1, H-C11), 0.93 (3H, d, J  6.9, H-C11), 0.92 (6H, d, J  6.7, H-C12). Data in 
agreement with literature values.
A round-bottomed flask equipped with a reflux condenser was charged with N,N-bis((S)-
1-hydroxy-3-methyl-1,1-diphenylbutan-2-yl)pyridine-2,6-dicarboxamide  380 (3.23  g, 
5.03 mmol, 1.00 eq.) and dichloromethane (90 mL). The resulting solution was stirred at 
room temperature and powdered calcium hydride (636 mg, 15.10 mmol, 3.00 eq.) was 
added portionwise, followed by addition of methanesulfonic acid (1.96 mL, 30.21 mmol, 
6.00 eq.) dropwise. The resulting suspension was heated to reflux temperature for 6 hours, 
the mixture cooled to room temperature, diluted with dichloromethane (90 mL) and a 
saturated aqueous solution  of  sodium hydrogen carbonate (90  mL) was  added. The 
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organic layer was separated and washed with water (100 mL) and a saturated aqueous 
solution  of  sodium  chloride  (100  mL),  dried  over  magnesium  sulfate,  filtered  and 
concentrated  in  vacuo.  This  afforded a  pale yellow oil  which was purified by flash 
column chromatography (80% hexane 20% ethyl acetate) to afford the title compound 348 
(2.29 g, 3.77 mmol, 75%) as a pale yellow solid.
M.p. 87-88 °C (Lit.: 65-66 °C); [α] 25D  - 233.2 (c 2.7, CHCl3), (Lit.: [α]
25
D  - 386.2 (c 1.1, 
CHCl3)); δH (300 MHz; CDCl3) 8.23 (2H, d, J 7.8, H-C3 and H-C5), 7.99-7.89 (1H, m, H-
C4), 7.63 (4H, d, J 8.0, Ar-H), 7.41-7.34 (8H, m, Ar-H), 7.34-7.25 (8H, m, Ar-H), 4.90 
(2H, d, J  4.9, H-C8), 2.01-1.83 (2H, m, H-C10), 1.07 (6H, d, J  6.8, H-C12), 0.69 (6H, d, 
J  6.5, H-C11); δC (75.5 MHz; CDCl3) 160.5 (C7), 147.1 (C2 and C6), 145.2 (ArC), 140.5 
(C4), 128.3 (ArC), 127.8 (ArC), 127.7 (ArC), 127.3 (ArC), 127.0 (ArC), 126.3 (ArC), 
125.5 (C3 and C5), 93.5 (C9), 80.5 (C8), 30.3 (C10), 22.0 (C12), 17.3 (C11).  Data in 
agreement with literature values.
But-3-enoyl chloride (497) and methyl but-3-enoate (484).
14
O
Cl
 C4H5ClO
Mol. Wt.: 104.53
1
5
4 O
O
 C5H8O2
Mol. Wt.: 100.12
and
A round-bottomed flask equipped with a reflux condenser was charged with but-3-enoic 
acid  496 (25.00 g,  290.00 mmol, 1.00 eq.).  With stirring, redistilled thionyl chloride 
(42.50 mL, 600.00 mmol, 2.07 eq.) was added dropwise and the resulting solution was 
heated to 40 °C for 3 hours. The mixture was cooled to room temperature and the excess 
thionyl chloride was removed by distillation under reduced pressure to afford the  title 
compound 497 (30.31 g, 290.00 mmol, 100%) as a pale yellow oil which was used in the 
next step without further purification.
δH (300 MHz; CDCl3) 5.87 (1H, tdd, J 17.0, 10.3, 6.8, H-C3), 5.30 (1H, ddd, J  13.2, 2.5, 
1.3, H-C4), 5.24 (1H, ddd, J 13.2, 2.5, 1.3, H-C4), 3.60 (2H, td, J  6.8, 1.3, H-C2). Data in 
agreement with literature values.
A round-bottomed flask was charged with methanol (300 mL), cooled to 0  °C and 497 
(30.31 g, 290.00 mmol, 1.00 eq.)  added dropwise. The resulting solution was slowly 
warmed to room temperature and stirred for 1 hour, water (100 mL) and dichloromethane 
(100 mL) added and the organic layer separated. The aqueous layer was extracted with 
dichloromethane (2 x 100 mL) and the combined organic layers were washed with a 
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saturated aqueous solution of sodium chloride (200 mL), dried over magnesium sulfate, 
filtered,  and concentrated  in  vacuo to afford  a pale yellow oil.  This  was purified by 
distillation under reduced pressure (80 °C, 250 mmHg) to give the  title compound 484 
(12.49 g, 125.00 mmol, 43%) as a colourless oil.
δH (300 MHz; CDCl3) 5.89-5.68 (1H, m, H-C3), 5.09-4.99 (2H, m, H-C4), 3.60-3.54 (3H, 
m, H-C5), 2.98 (2H, d,  J  6.9, H-C2);  δC (75.5 MHz; CDCl3) 171.5 (C1), 130.0 (C3), 
118.1 (C4), 51.4 (C5), 38.5 (C2). Data in agreement with literature values.
(±)-Methyl 2-(oxiran-2-yl)acetate (485).
1
5
4 O
OO
 C5H8O3
Mol. Wt.: 116.12
Following the general procedure P, albeit without the use of sodium hydrogen carbonate, 
methyl but-3-enoate 484 (10.24 g, 102.27 mmol), was consumed based on analysis by 
NMR after 24 hours of stirring at 0 °C. The work up gave the title compound 485 (10.46 
g, 90.08 mmol, 88%) as a colourless oil which was used in the next step without any 
further purification.
δH (300 MHz; CDCl3) 3.73 (3H, s, H-C5), 3.34-3.25 (1H, m, H-C3), 2.87-2.83 (1H, m, H-
C4), 2.59-2.56 (2H, m, H-C2), 2.58-2.55 (1H, m, H-C4); m/z (CI) 117 (MH+, 100). Data 
in agreement with literature values.
(±)-Methyl 3-hydroxy-6-(trimethylsilyl)hex-5-ynoate (486).
1
3
O
6
7
OH
O
TMS
 C10H18O3Si
Mol. Wt.: 214.33
Following the general procedure G,  methyl 2-(oxiran-2-yl)acetate 485  (1.79 g,  15.40 
mmol) afforded a pale yellow oil, which was purified by flash column chromatography 
(80% hexane, 20% ethyl acetate) to give the  title compound 486 (1.70 g, 7.94 mmol, 
52%) as a colourless oil.
νmax(neat)/cm-1 3469, 2958, 2176, 1738; δH (300 MHz; CDCl3) 4.25-4.06 (1H, m, H-C3), 
3.73 (3H, s, H-C7), 2.97 (1H, d, J  4.5, H-OH), 2.70 (1H, dd, J  16.5, 3.6, H-C2), 2.54 
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(1H, dd, J  16.5, 8.5, H-C2), 2.53-2.46 (2H, m, H-C4), 0.15 (9H, s, H-CTMS); δC (75.5 
MHz; CDCl3)  172.8 (C1), 102.0 (C6), 87.9 (C5), 66.5 (C3), 51.9 (C7), 39.9 (C2), 27.8 
(C4), -0.0 (CTMS); m/z (CI) 215 (MH+, 65), 197 (100), 183 (55); HRMS (ES) Found 
[M+H]+ 215.1096, C10H19O3Si requires 215.1098.
(±)-(Z)-Methyl 3-hydroxy-6-(trimethylsilyl)hex-5-enoate (487).
1
3
O
6
7
OH
TMS
O
 C10H20O3Si
Mol. Wt.: 216.35
Following the general procedure L, (±)-methyl 3-hydroxy-6-(trimethylsilyl)hex-5-ynoate 
486  (765 mg, 3.57 mmol) afforded a yellow oil, which was purified by flash column 
chromatography (95% hexane, 5% ethyl acetate) to give the title compound 487 (315 mg, 
1.46 mmol, 41%) as pale yellow oil.
νmax(neat)/cm-1 3450, 2955, 1738, 1607; δH (300 MHz; CDCl3) 6.30 (1H, td, J  14.6, 7.3, 
H-C5), 5.72-5.65 (1H, m, H-C6), 4.09 (1H, ddt, J  10.1, 6.8, 3.5, H-C3), 3.71 (3H, s, H-
C7), 2.91 (1H, d, J  3.6, H-OH), 2.54 (1H, dd, J  16.4, 3.5, H-C2), 2.48-2.40 (1H, m, H-
C2), 2.44-2.26 (2H, m, H-C4), 0.12 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 173.2 (C1), 
143.1 (C5), 133.0 (C6), 67.7 (C3), 51.8 (C7), 40.4 (C2), 40.1 (C4), 0.2 (CTMS);  m/z (CI) 
217 (MH+, 15), 199 (26), 127 (100); HRMS (ES) Found [M+H]+ 217.1253, C10H21O3Si 
requires 217.1254.
(±)-(Z)-6-(Trimethylsilyl)hex-5-ene-1,3-diol (501).
1
3
OH
6 OH
TMS
 C9H20O2Si
Mol. Wt.: 188.34
A round-bottomed flask equipped with  a  dropping funnel was  charged with  lithium 
aluminium hydride (70 mg,  1.85  mmol, 2.35 eq.) and  tetrahydrofuran (13 mL). The 
resulting suspension was stirred and cooled to 0 °C and a solution of (±)-(Z)-methyl 3-
hydroxy-6-(trimethylsilyl)hex-5-enoate  487  (170  mg,  0.79  mmol,  1.00  eq.)  in 
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tetrahydrofuran (5 mL) was added dropwise over 30 minutes. The mixture was stirred for 
a further hour at 0 °C and then warmed to room temperature for 1 hour. Again the mixture 
was cooled to 0 °C and a saturated aqueous solution of sodium chloride (4 mL) was added 
dropwise followed by diethyl ether (10 mL). The organic layer was separated and the 
aqueous layer was extracted with diethyl ether (3 x 10 mL). The combined organic layers 
were then dried over sodium sulfate, filtered and concentrated in vacuo. This gave the 
title compound 501 (121 mg, 0.64 mmol, 81%) as a colourless oil which was used in the 
next step without any further purification.
νmax(neat)/cm-1 3350, 2954, 1606; δH (300 MHz; CDCl3) 6.20 (1H, td, J  14.4, 7.4, H-C5), 
5.60 (1H, td, J  14.4, 1.2, H-C6), 3.88-3.78 (1H, m, H-C3), 3.82-3.69 (2H, m, H-C1), 2.33 
(1H, bs, H-OH), 2.30-2.21 (2H, m, H-C4), 1.70-1.57 (2H, m, H-C2), 1.54 (1H, bs, H-
OH), 0.03 (9H, s, H-CTMS); δC (75.5 MHz; CDCl3) 143.6 (C5), 133.4 (C6), 71.6 (C3), 
61.9 (C1), 41.5 (C2), 37.8 (C4), 0.2 (CTMS); m/z (CI) 189 (MH+, 80), 147 (72), 103 
(100); HRMS (ES) Found [M+H]+ 189.1305, C9H21O2Si requires 189.1305.
(But-3-enyloxy)(tert-butyl)dimethylsilane (504).
65 7
5
14 O Si 7
7
 C10H22OSi
Mol. Wt.: 186.37
A round-bottomed flask was charged with tert-butylchlorodimethylsilane (5.00 g, 33.00 
mmol, 1.00 eq.) and dichloromethane (100 mL). The resulting solution was stirred at 
room temperature and imidazole (2.25 g, 33.00 mmol, 1.00 eq.) was added followed by 3-
buten-1-ol  503 (2.35 g, 32.50 mmol, 0.98 eq.) dropwise. The mixture was stirred for 2 
hours at  room temperature and diluted with diethyl ether (75 mL). The mixture was 
washed with water (3 x 50 mL) and a saturated aqueous solution of sodium chloride (1 x 
50 mL), dried over sodium sulfate, filtered and concentrated in vacuo. This gave the title 
compound 504 (5.47 g, 29.35 mmol, 90%) as a colourless oil which was used in the next 
step without any further purification.
δH (300 MHz; CDCl3) 5.81 (1H, tdd, J  17.1, 10.2, 6.9, H-C3), 5.12-4.98 (2H, m, H-C4), 
3.65 (2H, t, J  6.8, H-C1), 2.32-2.23 (2H, m, H-C2), 0.89 (9H, s, H-C7), 0.05 (6H, s, H-
C5);  m/z (CI) 187 (MH+,  44), 171 (57), 145(100). Data  in  agreement with literature 
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values.
tert-Butyldimethyl(2-(oxiran-2-yl)ethoxy)silane (505).
65 7
5
14 O
Si
7
7
O
 C10H22O2Si
Mol. Wt.: 202.37
Following the general procedure P, albeit without the use of sodium hydrogen carbonate, 
(but-3-enyloxy)(tert-butyl)dimethylsilane 504 (5.47 g, 29.33 mmol), was consumed based 
on analysis of NMR after 72 hours of stirring at room temperature instead of 0 °C. The 
work-up gave the title compound 505 (5.21 g, 25.74 mmol, 88%) as a colourless oil which 
was used in the next step without any further purification.
δH (300 MHz; CDCl3) 3.80-3.75 (2H, m, H-C1), 3.05 (1H, dddd, J 6.6, 5.1, 4.1, 2.8, H-
C3), 2.81-2.76 (1H, m, H-C4), 2.52 (1H, dd, J  5.1, 2.8, H-C4), 1.84-1.63 (2H, m, H-C2), 
0.90 (9H, s, H-C7), 0.06 (6H, s, H-C5); δC (75.5 MHz; CDCl3) 60.0 (C1), 50.1 (C3), 47.2 
(C4), 35.9 (C2), 25.9 (C7), 18.3 (C6), -5.4 (C5). Data in agreement with literature values.
 
(±)-1-(tert-Butyldimethylsilyloxy)-6-(trimethylsilyl)hex-5-yn-3-ol (506).
1
9
9
9
3
8
O Si
6 7
7
OH
TMS
 C15H32O2Si2
Mol. Wt.: 300.58
A three-necked round-bottomed flask equipped with a dropping funnel and a thermometer 
was  charged  with  trimethylsilylacetylene  (2.15  g,  22.00  mmol,  1.00  eq.)  and 
tetrahydrofuran (25 ml). The resulting solution was cooled to -78 °C and a 2.5 M solution 
of n-butyllithium in hexane (8.80 mL, 22.00 mmol, 1.47 eq.) was added dropwise. The 
solution was stirred at this temperature for 1 hour, and then tert-butyldimethyl(2-(oxiran-
2-yl)ethoxy)silane  505  (3.03 g, 15.00 mmol, 1.00 eq.) in tetrahydrofuran (25 mL) was 
added dropwise, followed by boron trifluoride etherate (2.74 mL, 22.00 mmol, 1.47 eq.) 
dropwise. The resulting solution was stirred at –78 °C for 1 hour and then slowly warmed 
to room temperature for 30 minutes. To the mixture was  added a  saturated aqueous 
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solution of sodium chloride (100 mL) dropwise followed by ethyl acetate (100 mL). The 
organic layer was separated and the aqueous layer was extracted with ethyl acetate ( 2 x 
50  mL). The  combined organic  layers were dried over sodium sulfate, filtered, and 
concentrated  in  vacuo.  This afforded a  pale yellow oil,  which was purified by flash 
column chromatography (90% hexane, 10% ethyl acetate) to give the title compound  506 
(4.15 g, 13.80 mmol, 92%) as a pale yellow oil.
νmax(neat)/cm-1 3430, 2956, 2176, 1642; δH (300 MHz; CDCl3) 4.03-3.90 (1H, m, H-C3), 
3.95-3.79 (2H, m, H-C1), 2.49 (1H, dd, J  16.8, 5.8, H-C4), 2.39 (1H, dd, J  16.8, 7.0, H-
C4), 1.91-1.79 (1H, m, H-C2), 1.79-1.65 (1H, m, H-C2), 0.90 (9H, s, H-C9), 0.15 (9H, s, 
H-CTMS), 0.08 (6H, s, H-C7); δC (75.5 MHz; CDCl3) 103.5 (C6), 86.8 (C5), 70.3 (C3), 
62.2 (C1), 37.2 (C2), 28.5 (C4), 25.8 (C9), 18.1 (C8), 0.1 (CTMS), -5.5 (C7), -5.5 (C7); 
m/z (CI) 301 (MH+,  57), 283 (100), 189 (70); HRMS (ES) Found [M+H]+ 301.2017, 
C15H33O2Si2 requires 254.1209.
(±)-(Z)-1-(tert-Butyldimethylsilyloxy)-6-(trimethylsilyl)hex-5-en-3-ol (502).
1
9
9
9
3
8
O Si
6
7
7
OH
TMS
 C15H34O2Si2
Mol. Wt.: 302.6
Following  the  general  procedure  L,  (±)-1-(tert-butyldimethylsilyloxy)-6-
(trimethylsilyl)hex-5-yn-3-ol  506 (1.34 g, 4.47 mmol) afforded a yellow oil, which was 
purified by flash column chromatography (90% hexane, 10% ethyl acetate) to give the 
title compound  502 (807 mg, 2.67 mmol, 60%) as a pale yellow oil.
νmax(neat)/cm-1 3367, 2972, 1615; δH (300 MHz; CDCl3) 6.34 (1H, td, J  14.3, 7.3, H-C5), 
5.63 (1H, td, J  14.3, 1.3, H-C6), 3.96-3.86 (2H, m, H-C1), 3.85-3.76 (1H, m, H-C3), 3.43 
(1H, bs, H-OH), 2.47-2.23 (2H, m, H-C4), 1.71-1.62 (2H, m, H-C2), 0.90 (9H, s, H-C9), 
0.12 (9H, s, H-CTMS), 0.08 (6H, s, H-C7);  δC (75.5 MHz; CDCl3)  144.5 (C5), 131.8 
(C6), 71.9 (C3), 62.8 (C1), 41.2 (C2), 37.8 (C4), 25.8 (C9), 18.1 (C8), 0.2 (CTMS), -5.5 
(C7), -5.6 (C7); m/z (CI) 303 (MH+, 25), 285 (37), 189 (100); HRMS (ES) Found [M+H]+ 
303.2165, C15H35O2Si2 requires 303.2170.
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(±)-(Z)-(3-Azido-1-(tert-butyldimethylsilyloxy)hex-3-enyl)trimethylsilane (508).
1
9
9
9
3
8
O Si
6
7
7
N3
TMS
 C15H33N3OSi2
Mol. Wt.: 327.61
A  round-bottomed  flask  was  charged  with  (±)-(Z)-1-(tert-butyldimethylsilyloxy)-6-
(trimethylsilyl)hex-5-en-3-ol 502 (678 mg, 2.24 mmol, 1.00 eq.) and tetrahydrofuran (27 
mL). The resulting solution was stirred at room temperature and triphenylphosphine (1.18 
g,  4.48  mmol,  2.00  eq.)  was  added  in  one  portion,  followed  by  diisopropyl 
azodicarboxylate (896 µL, 4.48 mmol, 2.00 eq.) dropwise and diphenylphosphoryl azide 
(964 µL, 4.48 mmol, 2.00 eq.) dropwise. After stirring at room temperature for 1 hour, the 
mixture was concentrated in vacuo and filtered through a pad of celite, washing with 1 
part diethyl ether to 1 part pentane (50 mL). The filtrate was concentrated in vacuo to 
afford a  pale yellow oil,  which was purified by flash column chromatography (95% 
hexane, 5% ethyl acetate) to give the title compound 508 (671 mg, 2.05 mmol, 91%) as a 
colourless oil.
νmax(neat)/cm-1 2955, 2100, 1607; δH (300 MHz; CDCl3) 6.22 (1H, td, J  14.3, 7.2, H-C5), 
5.62-5.55 (1H, m, H-C6), 3.66-3.58 (2H, m, H-C1), 3.56-3.45 (1H, m, H-C3), 2.33-2.26 
(2H, m, H-C4), 1.71-1.58 (1H, m, H-C2), 1.56-1.41 (1H, m, H-C2), 0.79 (9H, s, H-C9), 
0.04 (9H, s, H-CTMS), -0.03 (3H, s, H-C7), -0.04 (3H, s, H-C7); δC (75.5 MHz; CDCl3) 
143.3 (C5), 132.8 (C6), 59.5 (C3), 59.4 (C1), 38.4 (C4), 37.1 (C2), 25.9 (C9), 18.3 (C8), 
0.1 (CTMS), -5.4 (C7), -5.4 (C7);  m/z (CI) 300 (M(-N2)H+, 100), 285 (65), 286 (37); 
HRMS (EI) Found [M-N2]+ 299.2092, C15H33NOSi2 requires 299.2095.
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(±)-(Z)-1-(tert-Butyldimethylsilyloxy)-6-(trimethylsilyl)hex-5-en-3-amine (509).
1
9
9
9
3
8
O Si
6
7
7
NH2
TMS
 C15H35NOSi2
Mol. Wt.: 301.62
A round-bottomed flask equipped with a reflux condenser was charged with  (±)-(Z)-(4-
azido-6-(tert-butyldimethylsilyloxy)hex-1-enyl)trimethylsilane  508 (1.13 g, 3.45 mmol, 
1.00 eq.), water (2.8 mL) and tetrahydrofuran (26 mL). The resulting biphasic solution 
was stirred at room temperature and triphenylphosphine (994 mg, 3.45 mmol, 1.00 eq.) 
was added portionwise. The mixture was heated to 60  °C and after 20 hours, GCMS 
showed complete consumption of starting material. To the solution was added a saturated 
aqueous solution of sodium chloride (10 mL), the organic layer was separated and the 
aqueous layer extracted with diethyl ether (2 x 20 mL). The combined organic layers were 
dried over sodium sulfate, filtered, and concentrated in vacuo. This afforded a yellow oil, 
which was purified by short  flash column chromatography (50% pentane, 50% ethyl 
acetate) to give the title compound 509 (1.04 g, 3.45 mmol, quantitative) as a pale yellow 
oil.
νmax(neat)/cm-1 3380, 2955, 1605; δH (300 MHz; CDCl3) 6.19 (1H, td, J  14.5, 7.4, H-C5), 
5.54-5.46 (1H, m, H-C6), 3.68-3.54 (2H, m, H-C1), 2.93-2.81 (1H, m, H-C3), 2.27-2.09 
(1H, m, H-C4), 2.09-1.94 (1H, m, H-C4), 1.64-1.47 (1H, m, H-C2), 1.44-1.30 (1H, m, H-
C2), 0.77 (9H, s, H-C9), 0.00 (9H, s, H-CTMS), -0.07 (6H, s, H-C7); δC (75.5 MHz; 
CDCl3)  145.6 (C5), 131.7 (C6), 61.0 (C1), 49.3 (C3), 42.0 (C2), 40.1 (C4), 25.9 (C9), 
18.2 (C8), 0.3 (CTMS), -5.4 (C7); m/z (CI) 302 (MH+, 100), 286 (40), 188 (82); HRMS 
(ES) Found [M+H]+ 302.2328, C15H36NOSi2 requires 302.2330.
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(±)-(Z)-Benzyl-1-(tert-butyldimethylsilyloxy)-6-(trimethylsilyl)hex-5-en-3-
ylcarbamate (510).
1
9
9
9
3
8
O Si
10
11
6
7
7
NH
TMS OO Ph
 C23H41NO3Si2
Mol. Wt.: 435.75
 A round-bottomed  flask  was  charged  with  (±)-(Z)-1-(tert-butyldimethylsilyloxy)-6-
(trimethylsilyl)hex-5-en-3-amine 509 (1.46 g, 4.84 mmol, 1.00 eq.), water (4.7 mL) and 
tetrahydrofuran (4.7 mL). The resulting biphasic solution was stirred and cooled to 0 °C, 
then sodium hydrogen carbonate (1.22g, 14.53 mmol, 3.00 eq.) was added portionwise 
followed by benzyl chloroformate (968 µL, 6.78 mmol, 1.40 eq.) dropwise. The mixture 
was allowed to warm slowly to room temperature and stirred for 72 hours. The solution 
was then diluted with ethyl acetate (10 mL), the organic layer separated and the aqueous 
layer extracted with ethyl acetate (3 x 10 mL). The combined organic layers were washed 
with a saturated aqueous solution of sodium chloride (10 mL), dried over magnesium 
sulfate, filtered and concentrated in vacuo. This afforded a yellow oil, which was purified 
by  flash column chromatography  (90% hexane, 10% ethyl  acetate) to  give the  title 
compound  510 (1.35 g, 3.10 mmol, 64%) as a colourless oil.
νmax(neat)/cm-1 3332, 3034, 2954, 1712, 1607; δH (300 MHz; CDCl3) 7.42-7.27 (5H, m, 
Ar-H), 6.28 (1H, td, J  14.2, 7.2, H-C5), 5.61 (1H, d, J  14.2, H-C6), 5.33-5.15 (1H, m, H-
NH), 5.08 (2H, s, H-C11), 3.93-3.80 (1H, m, H-C3), 3.79-3.63 (2H, m, H-C1), 2.50-2.27 
(2H, m, H-C4), 1.90-1.72 (1H, m, H-C2), 1.71-1.59 (1H, m, H-C2), 0.88 (9H, s, H-C9), 
0.11 (9H, s, H-CTMS), 0.04 (3H, s, H-C7), 0.04 (3H, s, H-C7); δC (75.5 MHz; CDCl3) 
155.8 (C10), 144.0 (C5),  136.7 (ArC),  132.0 (C6), 128.4 (ArC), 127.9 (ArC),  127.9 
(ArC), 66.3 (C11), 60.4 (C1), 49.4 (C3), 38.3 (C2), 36.1 (C4), 25.9 (C9), 18.1 (C8), 0.2 
(CTMS), -5.5 (C7), -5.5 (C7); m/z (CI) 436 (MH+, 98), 328 (70), 224 (100);
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(±)-(Z)-tert-Butyl-1-(tert-butyldimethylsilyloxy)-6-(trimethylsilyl)hex-5-en-3-
ylcarbamate (511).
1
9
9
9
3
8
O Si
10
11
6
7
7
NH
TMS OO
12
12
12
 C20H43NO3Si2
Mol. Wt.: 401.73
A  round-bottomed  flask  was  charged  with  (±)-(Z)-1-(tert-butyldimethylsilyloxy)-6-
(trimethylsilyl)hex-5-en-3-amine 509 (300 mg, 1.00 mmol, 1.00 eq.) and dichloromethane 
(16 mL). The resulting solution was stirred and cooled to 0 °C, then triethylamine (142 µ
L,  1.00  mmol,  1.00  eq.)  added  dropwise,  followed  by  a  solution  of  di-tert-butyl 
dicarbonate (267 mg, 1.23 mmol, 1.23 eq.) in dichloromethane (2 mL) dropwise. The 
mixture was allowed to warm slowly to room temperature and after 1 hour, analysis by 
GCMS showed complete consumption of starting material. The solution was concentrated 
in vacuo to afford a pale yellow oil, which was purified by flash column chromatography 
(90% hexane, 10% ethyl acetate) to give the title compound  511 (290 mg, 0.72 mmol, 
72%) as a colourless oil.
νmax(neat)/cm-1 3422, 2263, 2955, 1716, 1606; δH (300 MHz; CDCl3) 6.24 (1H, td, J  14.4, 
7.3, H-C5), 5.59-5.51 (1H, m, H-C6), 4.98 (1H, d, J  6.9, H-NH), 3.78-3.68 (1H, m, H-
C3), 3.71-3.59 (2H, m, H-C1), 2.39-2.21 (2H, m, H-C4), 1.82-1.65 (1H, m, H-C2), 1.61-
1.46 (1H, m, H-C2), 1.38 (9H, s, H-C12), 0.85 (9H, s, H-C9), 0.07 (9H, s, H-CTMS), 
0.01 (6H, s, H-C7); δC (75.5 MHz; CDCl3)  155.5 (C10), 144.4 (C5), 132.2 (C6), 78.7 
(C11), 60.6 (C1), 48.9 (C3), 38.6 (C2), 36.3 (C4), 28.4 (C12), 25.9 (C9), 18.2 (C8), 0.2 
(CTMS),  -5.5  (C7); m/z (CI)  402  (MH+,  10),  346  (68),  302  (100);
HRMS (ES) Found [M+H]+ 402.2853, C20H44NO3Si2 requires 402.2854.
292
Experimental
(±)-2-(6-Phenethyl-3,6-dihydro-2H-pyran-2-yl)ethanol (515).
7
5
8 10
2
9O PhHO
 C15H20O2
Mol. Wt.: 232.32
Following  the  general  procedure  I,  (±)-(Z)-1-(tert-butyldimethylsilyloxy)-6-
(trimethylsilyl)hex-5-en-3-ol 502 (500  mg,  1.65  mmol)  in  the  presence  of  3-
phenylpropanal (203 mg, 1.65 mmol), was consumed based on analysis by TLC after 20 
hours of stirring at room temperature instead of reflux temperature. The work-up afforded 
the title compound 515 (303 mg, 1.30 mmol, 79%) as a colourless oil which was used in 
the next step without any further purification. 
νmax(neat)/cm-1 3401, 3027, 2928, 1603; δH (300 MHz; CDCl3) 7.29-7.08 (5H, m, Ar-H), 
5.82-5.72 (1H, m, H-C4), 5.57 (1H, tdd, J  10.2, 2.6, 1.3, H-C3), 4.20-4.07 (1H, m, H-
C2), 3.84-3.78 (2H, m, H-C8), 3.80-3.73 (1H, m, H-C6), 2.79-2.57 (2H, m, H-C10), 2.17-
1.99 (1H, m, H-C7), 1.97-1.80 (1H, m, H-C7), 1.83-1.69 (4H, m, H-C5 and H-C9); δ
C (75.5 MHz; CDCl3)  141.9 (ArC), 129.8 (C3), 128.4 (ArC), 128.3 (ArC), 125.8 (ArC), 
124.6 (C4), 74.8 (C6), 74.0 (C2), 61.8 (C8), 37.4 (C9), 37.1 (C5), 31.4 (C10), 31.1 (C7); 
m/z (CI) 233 (MH+, 75), 197 (50), 159 (100); HRMS (ES) Found [M+NH4]+ 250.1800, 
C15H24NO2 requires 250.1802.
(±)-(2,3-syn)-Ethyl 2,3-dihydroxyoctanoate (517).
10
9
81
O
OH
OH
O
 C10H20O4
Mol. Wt.: 204.26
Following the general procedure J,  (E)-ethyl  oct-2-enoate  516 (5.00 g,  29.37 mmol) 
afforded the  title compound 517 (5.99 g, 29.37 mmol, quantitative) as a colourless oil 
which was used in the next step without any further purification.
δH (300 MHz; CDCl3) 4.25 (2H, q, J  7.1, H-C9), 4.06 (1H, d, J  2.2, H-C2), 3.89-3.82 
(1H, m, H-C3), 2.85 (2H, bs, H-OH), 1.63-1.54 (2H, m, H-C4), 1.53-1.27 (6H, m, H-C5 
to H-C7), 1.29 (3H, t, J  7.1, H-C10), 0.90-0.84 (3H, m, H-C8); m/z (CI) 205 (MH+, 100), 
187 (76), 169 (40). Data in agreement with literature values.
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 (±)-(2,3-syn)-Ethyl 2,3-bis(tert-butyldiphenylsilyloxy)octanoate (518).
14
13
9
8
11
10
1
12
O
O
O Si
Si
Ph
Ph
Ph
Ph
10
10
12
12
O
 C42H56O4Si2
Mol. Wt.: 681.06
A round-bottomed flask was charged with (±)-(2,3-syn)-ethyl 2,3-dihydroxyoctanoate 517 
(2.00  g,  9.79  mmol,  1.00  eq.)  and  N,N-dimethylformamide  (20  mL).  The  resulting 
solution was stirred at room temperature and imidazole (3.33 g, 48.95 mmol, 5.00 eq.) 
was added followed by tert-butylchlorodiphenylsilane (6.36 mL, 24.47 mmol, 2.50 eq.). 
The resulting mixture was stirred for 20 hours at  room temperature until  analysis by 
GCMS showed complete consumption of starting material. To the mixture was added 
water (40 mL) followed by ethyl acetate (300 mL). The organic layer was separated and 
washed with water (100 mL) then a saturated aqueous solution of sodium chloride (100 
mL), dried over sodium sulfate, filtered and concentrated in vacuo. This afforded a pale 
yellow oil, which was purified by flash column chromatography (90% hexane, 10% ethyl 
acetate) to give the title compound 518 (5.38 g, 7.90 mmol, 81%) as a  sticky colourless 
oil.
νmax(neat)/cm-1 3071, 2955, 1747; δH (300 MHz; CDCl3) 7.73-7.66 (4H, m, Ar-H), 7.65-
7.56 (4H, m, Ar-H), 7.43-7.27 (12H, m, Ar-H), 4.31 (1H, d, J  3.0, H-C2), 3.97 (1H, dt, J 
6.4, 3.0, H-C3), 3.93-3.69 (2H, m, H-C13), 1.96-1.72 (1H, m, H-C4), 1.38-1.18 (3H, m, 
H-C4 and H-C5), 1.06 (9H, s, H-C10), 1.00 (9H, s, H-C12), 0.95 (3H, t, J  7.2, H-C14), 
0.94-0.83 (4H, m, H-C6 and H-C7), 0.70 (3H, t,  J  7.0, H-C8); δC (75.5 MHz; CDCl3) 
171.7 (C1), 136.0 (ArC), 136.0 (ArC), 135.9 (ArC), 135.7 (ArC), 134.3 (ArC), 133.7 
(ArC), 133.5 (ArC), 133.4 (ArC), 129.6 (ArC), 129.5 (ArC), 129.5 (ArC), 129.4 (ArC), 
127.5 (ArC), 127.4 (ArC), 127.3 (ArC), 127.3 (ArC), 75.5 (C2), 74.7 (C3), 60.4 (C13), 
32.6 (C4), 31.4 (C6), 26.9 (C10), 26.8 (C12), 25.3 (C5), 22.3 (C7), 19.6 (C9), 19.4 (C11), 
14.1 (C14), 13.9 (C8);  m/z (CI) 698 (MNH4+,  15), 623 (30), 603 (100); HRMS (ES) 
Found [M+NH4]+ 698.4055, C42H60NO4Si2 requires 698.4055.
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 (±)-(2,3-syn)-2,3-Bis(tert-butyldiphenylsilyloxy)octan-1-ol (519).
9
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11
10
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12
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O
O Si
Si
Ph
Ph
Ph
Ph
10
10
12
12
 C40H54O3Si2
Mol. Wt.: 639.03
A round-bottomed flask equipped with a dropping funnel and a thermometer was charged 
with  (±)-(2,3-syn)-ethyl  2,3-bis(tert-butyldiphenylsilyloxy)octanoate  518 (1.00 g,  1.47 
mmol, 1.00 eq.) and toluene (8 mL). The resulting solution was stirred and cooled to –78 
°C and a  1.0 M solution of diisopropylaluminium hydride in hexane (2.94 mL, 2.94 
mmol, 2.00 eq.) was added dropwise. After 2 hours of stirring at –78 °C, TLC showed full 
consumption of starting material. Water (10 mL) was added dropwise and the resulting 
suspension was warmed to room temperature for 30 minutes and then filtered through a 
pad of celite, washing with diethyl ether (50 mL). The filtrate was concentrated in vacuo 
to afford the  title compound 519 (824 mg, 1.29 mmol, 88%) as a sticky colourless oil 
which was used in the next step without any further purification.
νmax(neat)/cm-1 3584, 3071, 2930; δH (300 MHz; CDCl3) 7.59-7.44 (8H, m, Ar-H), 7.44-
7.22 (12H, m, Ar-H), 3.95-3.89 (1H, m, H-C2), 3.84-3.74 (1H, m, H-C3), 3.75-3.64 (2H, 
m, H-C1), 1.98 (1H, dd, J  6.6, 5.7, H-OH), 1.83-1.69 (1H, m, H-C4), 1.51-1.34 (1H, m, 
H-C4), 1.18-1.01 (6H, m, H-C5 to H-C7), 0.99 (9H, s, H-C10), 0.96 (9H, s, H-C11), 0.74 
(3H, t,  J  7.1, H-C8); δC (75.5 MHz; CDCl3)  135.9 (ArC), 135.8 (ArC), 135.6 (ArC), 
133.8 (ArC), 133.6 (ArC), 133.4 (ArC), 133.1 (ArC), 129.7 (ArC), 129.6 (ArC), 129.5 
(ArC), 127.7 (ArC), 127.6 (ArC), 127.5 (ArC), 127.4 (ArC), 75.4 (C3), 74.3 (C2), 63.5 
(C1), 31.7 (C4), 31.3 (C6), 26.9 (C10), 26.9 (C12), 25.8 (C5), 22.4 (C7), 19.3 (C9), 19.2 
(C11), 13.9 (C8); m/z (CI)  656 (MNH4+,  2),  503 (30), 187 (80); HRMS (ES) Found 
[M+NH4]+ 656.3939, C40H58NO3Si2 requires 656.3950.
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 (±)-(2,3-syn)-2,3-Bis(tert-butyldiphenylsilyloxy)octanal (520).
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A round-bottomed flask was charged with pyridium chlorochromate (532 mg, 2.47 mmol, 
2.04 eq.), 4Å molecular sieves (300 mg) and dichloromethane (10 mL). The resulting 
suspension  was  stirred  at  room  temperature  and  (±)-(2,3-syn)-2,3-bis(tert-
butyldiphenylsilyloxy)octan-1-ol  519 (774 mg, 1.21 mmol, 1.00 eq) in dichloromethane 
(2.50 mL) was added dropwise. After stirring for 4 hours at room temperature, analysis by 
NMR showed full consumption of starting material. The mixture was diluted with diethyl 
ether (100 mL), filtered twice through Florisil® (2 x 25 g) and concentrated in vacuo to 
afford the  title compound 520 (491 mg, 0.77 mmol, 64%) as a sticky pale yellow oil 
which was used in the next step without any further purification.
νmax(neat)/cm-1 3049, 2930, 1738; δH (300 MHz; CDCl3)  9.75 (1H, s, H-C1), 7.62-7.46 
(8H, m, Ar-H), 7.41-7.18 (12H, m, Ar-H), 4.08 (1H, d, J  3.8, H-C2), 3.89 (1H, dt, J  6.3, 
3.8, H-C3), 1.83-1.65 (1H, m, H-C4), 1.38-1.21 (1H, m, H-C4), 1.05 (9H, s, H-C10), 0.95 
(9H, s, H-C12), 1.00-0.82 (6H, m, H-C5 to H-C7), 0.69 (3H, t,  J  7.1, H-C8); δC (75.5 
MHz; CDCl3)  203.5 (C1), 135.9 (ArC), 135.8 (ArC), 135.7 (ArC), 133.7 (ArC), 133.2 
(ArC), 133.0 (ArC), 132.9 (ArC), 129.8 (ArC), 129.8 (ArC), 129.7 (ArC), 129.6 (ArC), 
127.6 (ArC), 127.6 (ArC), 127.6 (ArC), 127.4 (ArC), 79.6 (C2), 75.4 (C3), 32.8 (C4), 
31.4 (C6), 26.9 (C10), 26.9 (C12), 25.2 (C5), 22.3 (C7), 19.5 (C9), 19.3 (C11), 13.9 (C8); 
m/z (CI)  654  (MNH4+,  10),  381  (30),  339  (100);
HRMS (ES) Found [M+NH4]+ 654.3797, C40H56NO3Si2 requires 654.3793.
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 (±)-(2,3-syn)-Ethyl 2,3-bis(benzyloxy)octanoate (521).
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Mol. Wt.: 384.51
A round-bottomed flask equipped with  a  dropping  funnel was  charged with  a  60% 
suspension of  sodium hydride  in  mineral  oil  (783 mg,  19.58  mmol,  2.00  eq.)  and 
tetrahydrofuran (10 mL). The resulting suspension was cooled to 0 °C and (±)-(2,3-syn)-
ethyl 2,3-dihydroxyoctanoate 517 (2.00 g, 9.79 mmol, 1.00 eq.) in tetrahydrofuran (7 mL) 
added  dropwise.  The  resulting  mixture  was  stirred  for  1  hour  at  0  °C  and 
tetrabutylammonium bromide (634 mg, 1.97 mmol, 0.20 eq.) and 16-crown-6 (5 mg, 0.02 
mmol) were added portionwise, followed by benzyl bromide (2.38 mL, 19.58 mmol, 2.00 
eq) dropwise. The resulting mixture was warmed to room temperature for 1 hour and 1.0 
M hydrochloric acid (10 mL) added dropwise followed by water (20 mL). The organic 
layer was separated and the aqueous layer was extracted with diethyl ether (3 x 20 mL). 
The combined organic layers were washed with a saturated aqueous solution of sodium 
hydrogen carbonate (20 mL), a saturated aqueous solution of sodium chloride (20 mL), 
dried over magnesium sulfate, filtered and concentrated in vacuo. This afforded a yellow 
oil,  which  was  purified  by  flash  column chromatography (90% hexane, 10%  ethyl 
acetate) to give the title compound 521 (1.34 g, 3.48 mmol, 36%) as a pale yellow oil.
νmax(neat)/cm-1 3031, 2930, 1744; δH (300 MHz; CDCl3) 7.35-7.19 (10H, m, Ar-H), 4.78 
(1H, d, J 12.0, H-C11), 4.57-4.54 (2H, m, H-C12), 4.39 (1H, d, J 12.0, H-C11), 4.21-4.09 
(2H, m, H-C9), 3.96 (1H, d, J 4.3, H-C2), 3.70 (1H, dt, J 6.7, 4.3, H-C3), 1.60-1.51 (2H, 
m, H-C4), 1.29-1.06 (6H, m, H-C5 to H-C7), 1.22 (3H, t, J 7.1, H-C10), 0.85-0.78 (3H, 
m, H-C8); δC (75.5 MHz; CDCl3)  171.2 (C1), 138.4 (ArC), 137.3 (ArC), 128.3 (ArC), 
128.3 (ArC), 128.2 (ArC), 128.0 (ArC), 127.9 (ArC), 127.5 (ArC), 79.7 (C2), 79.6 (C3), 
72.7 (C11), 72.4 (C12), 60.9 (C9), 31.7 (C6), 30.1 (C4), 25.1 (C5), 22.5 (C7), 14.2 (C10), 
14.0 (C8);  m/z (CI) 385 (MH+, 6), 293 (40), 181 (100); HRMS (ES) Found [M+NH4]+ 
402.2642, C24H36NO4 requires 402.2639.
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 (±)-(2,3-syn)-2,3-Bis(benzyloxy)octan-1-ol  (522)  and  (±)-(2,3-syn)-2,3-
Bis(benzyloxy)octanal (523).
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Mol. Wt.: 342.47
and
A round-bottomed flask equipped with a dropping funnel and a thermometer was charged 
with  (±)-(2,3-syn)-ethyl 2,3-bis(benzyloxy)octanoate  521 (1.26 g, 3.29 mmol, 1.00 eq.) 
and toluene (18 mL). The resulting solution was stirred and cooled to –78 °C and a 1.0 M 
solution of diisopropylaluminium hydride in hexane (10.20 mL, 10.20 mmol, 3.10 eq.) 
was added dropwise. After 4 hours of stirring at –78 °C, TLC showed full consumption of 
starting material and water (20 mL) was added dropwise. The resulting suspension was 
warmed to room temperature for 30 minutes and then filtered through a pad of celite, 
washing with diethyl ether (70 mL). The filtrate was concentrated in vacuo to afford the 
title compound 522 (716 mg, 2.09 mmol, 64%) as a pale yellow oil which was used in the 
next step without any further purification.
A round-bottomed flask was charged with pyridium chlorochromate (850 mg, 3.95 mmol, 
2.04 eq.), 4Å molecular sieves (250 mg) and dichloromethane (16 mL). The resulting 
suspension  was  stirred  at  room  temperature  and  a  solution  of  (±)-(2,3-syn)-2,3-
bis(benzyloxy)octan-1-ol 522 (676 mg, 1.97 mmol, 1.00 eq) in dichloromethane (3.6 mL) 
was added dropwise. After stirring for 4 hours at room temperature, NMR showed full 
consumption of starting material. The mixture was diluted with diethyl ether (100 mL), 
filtered twice through Florisil® (2 x 25 g) and concentrated in vacuo to afford the title 
compound 523 (264 mg, 0.78 mmol, 39%) as a pale yellow oil which was used in the next 
step without any further purification.
νmax(neat)/cm-1 3064, 2929, 1732; δH (300 MHz; CDCl3) 9.76 (1H, d, J 1.5, H-C1), 7.41-
7.23 (10H, m, Ar-H), 4.80 (1H, d, J 12.0, H-C9), 4.57-4.50 (2H, m, H-C10), 4.53 (1H, d, 
J 12.0, H-C9), 3.84 (1H, dd, J 3.9, 1.5, H-C2), 3.77-3.68 (1H, m, H-C3), 1.81-1.51 (2H, 
m, H-C4), 1.34-1.05 (6H, m, H-C5 to H-C7), 0.85 (3H, t,  J 6.6, H-C8); δC (75.5 MHz; 
CDCl3)  203.9 (C1), 137.8 (ArC), 134.5 (ArC), 129.0 (ArC), 129.7 (ArC), 128.5 (ArC), 
128.3 (ArC), 128.2 (ArC), 128.0 (ArC), 83.7 (C2), 79.3 (C3), 73.1 (C9), 72.4 (C10), 31.7 
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(C6), 30.1 (C4), 25.2 (C5), 22.5 (C7), 14.0 (C8); m/z (CI) 358 (MNH4+, 25), 250 (100), 
144 (50).
(±)-(5Z)-N-(2,3-Bis(benzyloxy)octylidene)-1-(tert-butyldimethylsilyloxy)-6-
(trimethylsilyl)hex-5-en-3-amine  (526)  and  (±)-6-(2-(1,2-Bis(benzyloxy)heptyl)-
1,2,3,6-tetrahydropyridin-6-yl)ethanol (527). 
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Following  the  general  procedure  Q,  (±)-(Z)-1-(tert-butyldimethylsilyloxy)-6-
(trimethylsilyl)hex-5-en-3-amine 509 (233 mg, 0.78 mmol) in the presence of (±)-(2,3-
syn)-2,3-bis(benzyloxy)octanal  523 (264 mg, 0.78 mmol), afforded the  title compound 
526 (455 mg, 0.73 mmol, 94%) as a yellow oil which was used in the next step without 
any  further  purification.  Then  (±)-(5Z)-N-(2,3-bis(benzyloxy)octylidene)-1-(tert-
butyldimethylsilyloxy)-6-(trimethylsilyl)hex-5-en-3-amine 526 (455  mg,  0.73  mmol) 
after 17 hours at reflux was consumed, based on analysis by NMR, to afford a orange oil 
which  was  purified  by  flash  column  chromatography  (95%  dichloromethane, 5% 
methanol) to give the title compound 527 as a 1.24:1 mixture of two diastereomers 527a 
and 527b (176 mg, 0.40 mmol, 55%) as a pale yellow oil.
Data for 527a:  νmax(neat)/cm-1 (mixture) 3435, 3063, 2931, 1605; δH (300 MHz; CDCl3) 
7.34-7.19 (10H, m, Ar-H), 5.90-5.78 (1H, m, H-C4), 5.73-5.64 (1H, m, H-C3), 4.68 (1H, 
d, J 11.6, H-C16), 4.61-4.58 (2H, m, H-C17), 4.43 (1H, d, J 11.6, H-C16), 3.97-3.87 (1H, 
m, H-C2), 3.82-3.69 (1H, m, H-C9), 3.79-3.61 (2H, m, H-C8), 3.65-3.51 (1H, m, H-C6), 
3.55-3.43 (1H, m, H-C10), 2.30-2.09 (1H, m, H-C5), 2.05-1.89 (2H, m, H-C7), 2.01-1.86 
(1H, m, H-C5), 1.68-1.51 (2H, m, H-C11), 1.29-0.99 (6H, m, H-C12 to H-C14), 0.81 (3H, 
t,  J  6.5, H-C15); δC (75.5 MHz; CDCl3)  137.3 (ArC), 136.9 (ArC), 128.5 (ArC), 128.3 
(ArC), 128.1 (ArC), 128.0 (ArC), 127.4 (ArC), 126.9 (ArC), 125.8 (C4), 121.6 (C3), 79.0 
(C10), 76.8 (C9), 74.0 (C16), 71.6 (C17), 60.8 (C8), 54.1 (C2), 51.4 (C6), 31.6 (C12), 
31.7 (C14), 28.7 (C7), 27.8 (C5), 25.5 (C11), 22.4 (C13), 13.9 (C15); m/z (ES) (mixture) 
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438 (MH+,  100), 278 (5),  150 (8); HRMS (ES) Found [M+H]+ (mixture) 438.3001, 
C28H40NO3 requires 438.3003.
Data for 527b:  δH (300 MHz; CDCl3)  7.35-7.17 (10H, m, Ar-H), 5.90-5.79 (1H, m, H-
C4), 5.63-5.54 (1H, m, H-C3), 4.71 (1H, d,  J 11.4, H-C16), 4.61-4.57 (2H, m, H-C17), 
4.45-4.38 (1H, m, H-C2), 4.24 (1H, d,  J 11.4, H-C16), 3.80-3.71 (2H, m, H-C9), 3.74-
3.66 (2H, m, H-C8), 3.62-3.51 (1H, m, H-C6), 3.55-3.43 (1H, m, H-C10), 2.27-2.14 (1H, 
m, H-C5), 2.02-1.91 (2H, m, H-C7), 1.93-1.86 (1H, m, H-C5), 1.60-1.34 (2H, m, H-C11), 
1.27-0.98 (6H, m, H-C12 to H-C14), 0.80 (3H, t, J 6.6, H-C15); δC (75.5 MHz; CDCl3) 
136.8 (ArC), 136.6 (ArC), 128.7 (ArC), 128.5 (ArC), 128.4 (ArC), 128.2 (ArC), 127.6 
(ArC), 127.2 (ArC), 125.6 (C4), 120.0 (C3), 79.0 (C10), 75.7 (C9), 72.7 (C16), 71.8 
(C17), 60.5 (C8), 51.5 (C6), 50.5 (C2), 31.6 (C12), 31.7 (C14), 28.4 (C7), 27.3 (C5), 25.1 
(C11), 22.4 (C13), 13.9 (C15).
(±)-(5Z)-N-(2,3-Bis(tert-butyldiphenylsilyloxy)octylidene)-1-(tert-
butyldimethylsilyloxy)-6-(trimethylsilyl)hex-5-en-3-amine (528) and (±)-6-(2-(2,2,9,9-
Tetramethyl-6-pentyl-3,3,8,8-tetraphenyl-4,7-dioxa-3,8-disiladecan-5-yl)-1,2,3,6-
tetrahydropyridin-6-yl)ethanol (529).
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Following  the  general  procedure  Q,  (±)-(Z)-1-(tert-butyldimethylsilyloxy)-6-
(trimethylsilyl)hex-5-en-3-amine 509 (60 mg, 0.20 mmol) in the presence of (±)-(2,3-
syn)-2,3-bis(tert-butyldiphenylsilyloxy)octanal 520 (127 mg, 0.20 mmol), afforded the 
title compound 528 (150 mg, 0.16 mmol, 82%) as a yellow oil which was used in the next 
step  without  any  further  purification.  Then  (±)-(5Z)-N-(2,3-bis(tert-
butyldiphenylsilyloxy)octylidene)-1-(tert-butyldimethylsilyloxy)-6-(trimethylsilyl)hex-5-
en-3-amine 528 (150 mg, 0.16 mmol) after 17 hours at reflux was consumed based on 
analysis  by  NMR  to afford  a  yellow  oil,  which  was  purified  by  flash  column 
300
Experimental
chromatography (95% dichloromethane, 5% methanol) to give the title compound 529 as 
a 1.25:1 mixture of two diastereomers 529a and 529b (44 mg, 0.06 mmol, 38%) as an off-
white solid.
Data for  529a:  M.p. 50-52 °C (mixture);  νmax(neat)/cm-1 (mixture) 3411, 3048, 2931, 
1590; δH (300 MHz; CDCl3) 7.59-7.16 (20H, m, Ar-H), 5.83-5.74 (1H, m, H-C4), 5.36-
5.27 (1H, m, H-C3), 4.19-4.09 (1H, m, H-C2), 4.00-3.91 (1H, m, H-C9), 3.82-3.73 (1H, 
m, H-C10), 3.74-3.62 (2H, m, H-C8), 3.43-3.28 (1H, m, H-C6), 2.25-2.09 (2H, m, H-C5), 
1.72-1.49 (2H, m, H-C7), 1.48-1.28 (2H, m, H-C11), 1.16-1.00 (6H, m, H-C12 to H-C13), 
0.99 (9H, s, H-C18), 0.96 (9H, s, H-C19), 0.77 (3H, t,  J  5.7, H-C15); δC (75.5 MHz; 
CDCl3) 136.2 (ArC), 136.0 (ArC), 135.9 (ArC), 135.8 (ArC), 133.4 (ArC), 133.0 (ArC), 
132.5 (ArC), 132.2 (ArC), 130.1 (ArC), 129.8 (ArC), 129.8 (ArC), 129.7 (ArC), 127.8 
(ArC), 127.8 (ArC), 127.7 (ArC), 127.5 (ArC), 125.3 (C4), 124.1 (C3), 75.3 (C9), 74.6 
(C10), 60.8 (C8), 53.1 (C2), 50.6 (C6), 34.6 (C11), 32.4 (C12), 32.1 (C14), 28.7 (C5), 
27.5 (C16), 27.3 (C17), 26.7 (C7), 22.8 (C13), 19.7 (C18), 19.6 (C19), 14.3 (C15); m/z 
(ES) (mixture) 734 (MH+, 100), 104 (5), 60 (40); HRMS (ES) Found [M+H]+ (mixture) 
734.4429, C46H64NO3Si2 requires 734.4419.
Data for 529b:  δH (300 MHz; CDCl3)  7.59-7.15 (20H, m, Ar-H), 5.84-5.72 (1H, m, H-
C4), 5.36-5.26 (1H, m, H-C3), 4.09-4.00 (1H, m, H-C2), 3.92-3.85 (1H, m, H-C9), 3.81-
3.71 (1H, m, H-C10), 3.71-3.62 (2H, m, H-C8), 3.06-2.88 (1H, m, H-C6), 2.10-1.91 (2H, 
m, H-C5), 1.67-1.49 (2H, m, H-C7), 1.45-1.26 (2H, m, H-C11), 1.15-1.02 (6H, m, H-C12 
to H-C14), 0.96 (9H, s, H-C18), 0.92 (9H, s, H-C19), 0.73 (3H, t, J 5.7, H-C15); δC (75.5 
MHz; CDCl3) 136.1 (ArC), 135.9 (ArC), 135.8 (ArC), 135.8 (ArC), 133.0 (ArC), 133.0 
(ArC), 132.8 (ArC), 132.1 (ArC), 130.1 (ArC), 130.0 (ArC), 129.8 (ArC), 129.6 (ArC), 
127.8 (ArC), 127.7 (ArC), 127.6 (ArC), 127.5 (ArC), 125.3 (C4), 124.1 (C3), 77.2 (C9), 
75.4 (C10), 61.1 (C7), 52.2 (C2), 50.6 (C6), 32.4 (C12), 32.1 (C14), 31.7 (C11), 28.7 
(C5), 27.6 (C16), 27.4 (C17), 26.3 (C7), 22.8 (C13), 19.9 (C18), 19.8 (C19), 14.3 (C15);
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